<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000448.pub3" GROUP_ID="DEPRESSN" ID="260099092010333975" MERGED_FROM="" MODIFIED="2009-07-28 10:41:56 +0100" MODIFIED_BY="[Empty name]" REVIEW_NO="4" REVMAN_SUB_VERSION="5.0.20" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2009-07-28 10:32:33 +0100" MODIFIED_BY="Jane Dennis">
<TITLE MODIFIED="2008-08-13 12:20:54 +0100" MODIFIED_BY="[Empty name]">St John's wort for major depression</TITLE>
<CONTACT>
<PERSON ID="5894" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Klaus</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Linde</LAST_NAME>
<SUFFIX/>
<POSITION>Wissenschaftlicher Leiter / Scientific Coordinator</POSITION>
<EMAIL_1>Klaus.Linde@lrz.tu-muenchen.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institut für Allgemeinmedizin / Institute of General Practice</DEPARTMENT>
<ORGANISATION>Technische Universität München / Klinikum rechts der Isar</ORGANISATION>
<ADDRESS_1>Wolfgangstr. 8</ADDRESS_1>
<ADDRESS_2/>
<CITY>München</CITY>
<ZIP>81667</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1>+49 89 6146589 16</PHONE_1>
<PHONE_2/>
<FAX_1>+49 89 6146589 15</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2009-07-28 10:32:33 +0100" MODIFIED_BY="Jane Dennis">
<PERSON ID="5894" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Klaus</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Linde</LAST_NAME>
<SUFFIX/>
<POSITION>Wissenschaftlicher Leiter / Scientific Coordinator</POSITION>
<EMAIL_1>Klaus.Linde@lrz.tu-muenchen.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institut für Allgemeinmedizin / Institute of General Practice</DEPARTMENT>
<ORGANISATION>Technische Universität München / Klinikum rechts der Isar</ORGANISATION>
<ADDRESS_1>Wolfgangstr. 8</ADDRESS_1>
<ADDRESS_2/>
<CITY>München</CITY>
<ZIP>81667</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1>+49 89 6146589 16</PHONE_1>
<PHONE_2/>
<FAX_1>+49 89 6146589 15</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="E1682DE482E26AA201DAB7D8016E5C44" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Michael</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Berner</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>michael.berner@uniklinik-freiburg.de</EMAIL_1>
<EMAIL_2>berner@nz.ukl.uni-freiburg.de</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Psychiatry and Psychotherapy</DEPARTMENT>
<ORGANISATION>University Medical Center Freiburg</ORGANISATION>
<ADDRESS_1>Hauptstrasse 5</ADDRESS_1>
<ADDRESS_2/>
<CITY>Freiburg im Breisgau</CITY>
<ZIP>D-79104</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1>+49 761 2706974</PHONE_1>
<PHONE_2/>
<FAX_1>+49 761 2706619</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="C55EFE5082E26AA20130726F0964539D" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Levente</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Kriston</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>levente.kriston@uniklinik-freiburg.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Psychiatry and Psychotherapy</DEPARTMENT>
<ORGANISATION>University Medical Center Freiburg</ORGANISATION>
<ADDRESS_1>Hauptstrasse 5</ADDRESS_1>
<ADDRESS_2/>
<CITY>Freiburg im Breisgau</CITY>
<ZIP>D-79104</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1>+ 49 761 2706597</PHONE_1>
<PHONE_2/>
<FAX_1>+ 49 761 2706989</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2009-02-08 14:45:31 +0000" MODIFIED_BY="Rachel Churchill" NOTES="&lt;p&gt;Minor update: 08/07/04&lt;/p&gt;" NOTES_MODIFIED="2009-02-08 14:45:31 +0000" NOTES_MODIFIED_BY="Rachel Churchill">
<UP_TO_DATE>
<DATE DAY="8" MONTH="8" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="8" MONTH="7" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="15" MONTH="7" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="1998"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2009-02-08 14:53:02 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;This updated version differs considerably from the last version: To sharpen the focus of the review inclusion was limited to trials in patients with major depression which resulted in the exclusion of 15 of 37 studies included in the previous version. Furthermore, one trial which compared a hypericum extract with a clearly underdosed standard antidepressant was excluded. Seven new, partly large trials have been included. The review now covers 28 trials with 17 comparison of a hypericum extract with a placebo and 17 with a standard antidepressant (six three-armed trials). Compared to the previous version our conclusions are now slightly more favorable as modest effects over placebo have been also shown in several large trials, and as side effects appear to be less frequent compared to both older antidepressants and selective serotonine reuptake inhibitors.&lt;/p&gt;" NOTES_MODIFIED="2009-02-08 14:53:02 +0000" NOTES_MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-08 14:53:02 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="2" YEAR="2009"/>
<DESCRIPTION>
<P>Contact details updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-02-08 14:49:20 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2009-02-08 14:49:20 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>1) The title of the review has been changed from 'St. John's wort for depression' to 'St. John's wort for major depression'. This reflects that inclusion has been now limited to trials in patients suffering from major depression only.</P>
<P>2) The modification of selection criteria resulted in the exclusion of 16 of 37 studies included in the previous version. Eight new trials have been included. The review now covers 29 trials with 18 comparisons of a hypericum extract with a placebo and 17 with a standard antidepressant (six three-armed trials).</P>
<P>3) Compared to the previous version our conclusions are now slightly more favourable, as modest effects over placebo have also been shown in several large trials, and as side effects appear to be less frequent compared to both older antidepressants and selective serotonin reuptake inhibitors.</P>
<P>4) The list of authors has been amended.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-08 14:49:17 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="12" MONTH="12" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Centre for Complementary Medicine Research, Department of Internal Medicine II, Technische Universität München</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Department of Psychiatry and Psychotherapy, University of Freiburg</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-08-13 13:19:13 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-08-06 14:13:55 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-08-06 14:13:55 +0100" MODIFIED_BY="[Empty name]">St. John's wort for treating depression.</TITLE>
<SUMMARY_BODY MODIFIED="2008-08-06 10:32:31 +0100" MODIFIED_BY="[Empty name]">
<P>Depression is characterised by depressed mood and/or loss of interest or pleasure in nearly all activities and a variety of other symptoms for periods longer than two weeks. Extracts of St. John's wort (botanical name <I>Hypericum perforatum L.</I>) are prescribed widely for the treatment of depression.</P>
<P>We have reviewed 29 studies in 5489 patients with depression that compared treatment with extracts of St. John's wort for 4 to 12 weeks with placebo treatment or standard antidepressants. The studies came from a variety of countries, tested several different St. John's wort extracts, and mostly included patients suffering from mild to moderately severe symptoms. Overall, the St. John's wort extracts tested in the trials were superior to placebo, similarly effective as standard antidepressants, and had fewer side effects than standard antidepressants. However, findings were more favourable to St. John's wort extracts in studies form German-speaking countries where these products have a long tradition and are often prescribed by physicians, while in studies from other countries St. John's wort extracts seemed less effective. This differences could be due to the inclusion of patients with slightly different types of depression, but it cannot be ruled out that some smaller studies from German-speaking countries were flawed and reported overoptimistic results.</P>
<P>Patients suffering from depressive symptoms who wish to use a St. John's wort product should consult a health professional. Using a St. John's wort extract might be justified, but important issues should be taken into account: St. John's wort products available on the market vary to a great extent. The results of this review apply only to the preparations tested in the studies included, and possibly to extracts with similar characteristics. Side effects of St. John's wort extracts are usually minor and uncommon. However, the effects of other drugs might be significantly compromised.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-08-06 10:31:36 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>In some countries extracts of the plant <I>Hypericum perforatum</I> L. (popularly called St. John's wort) are widely used for treating patients with depressive symptoms.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-08-06 10:28:06 +0100" MODIFIED_BY="[Empty name]">
<P>To investigate whether extracts of hypericum are more effective than placebo and as effective as standard antidepressants in the treatment of major depression; and whether they have fewer adverse effects than standard antidepressant drugs.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-08-06 10:28:33 +0100" MODIFIED_BY="[Empty name]">
<P>Trials were searched in computerised databases, by checking bibliographies of relevant articles, and by contacting manufacturers and researchers.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-08-05 22:35:21 +0100" MODIFIED_BY="[Empty name]">
<P>Trials were included if they: (1) were randomised and double-blind; (2) included patients with major depression; (3) compared extracts of St. John's wort with placebo or standard antidepressants; (4) included clinical outcomes assessing depressive symptoms.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-08-06 10:29:17 +0100" MODIFIED_BY="[Empty name]">
<P>At least two independent reviewers extracted information from study reports. The main outcome measure for assessing effectiveness was the responder rate ratio (the relative risk of having a response to treatment). The main outcome measure for adverse effects was the number of patients dropping out due to adverse effects.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-08-06 10:30:46 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 29 trials (5489 patients) including 18 comparisons with placebo and 17 comparisons with synthetic standard antidepressants met the inclusion criteria. Results of placebo-controlled trials showed marked heterogeneity. In nine larger trials the combined response rate ratio (RR) for hypericum extracts compared with placebo was 1.28 (95% confidence interval (CI), 1.10 to 1.49) and from nine smaller trials was 1.87 (95% CI, 1.22 to 2.87). Results of trials comparing hypericum extracts and standard antidepressants were statistically homogeneous. Compared with tri- or tetracyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs), respectively, RRs were 1.02 (95% CI, 0.90 to 1.15; 5 trials) and 1.00 (95% CI, 0.90 to 1.11; 12 trials). Both in placebo-controlled trials and in comparisons with standard antidepressants, trials from German-speaking countries reported findings more favourable to hypericum. Patients given hypericum extracts dropped out of trials due to adverse effects less frequently than those given older antidepressants (odds ratio (OR) 0.24; 95% CI, 0.13 to 0.46) or SSRIs (OR 0.53, 95% CI, 0.34-0.83).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-08-06 10:31:36 +0100" MODIFIED_BY="[Empty name]">
<P>The available evidence suggests that the hypericum extracts tested in the included trials a) are superior to placebo in patients with major depression; b) are similarly effective as standard antidepressants; c) and have fewer side effects than standard antidepressants. The association of country of origin and precision with effects sizes complicates the interpretation.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-08-13 13:19:13 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2008-08-11 11:06:44 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2008-08-11 11:06:44 +0100" MODIFIED_BY="[Empty name]">
<P>Depressive disorders are characterised by depressed mood and/or loss of interest or pleasure in nearly all activities in the presence of other symptoms such as loss of appetite, fatigue and lack of energy, sleep disturbance, restlessness or irritability, feelings of worthlessness or inappropriate guilt, difficulty in thinking, concentrating or making decisions and thoughts of death or suicide or attempts at suicide (<LINK REF="REF-Candy-2008" TYPE="REFERENCE">Candy 2008</LINK>). Depressive disorders are the largest source of non-fatal disease burden in the world, accounting for 12% of years lived with disability (<LINK REF="REF-Ustun-2004" TYPE="REFERENCE">Ustun 2004</LINK>). There are two major classification systems to diagnose depressive disorders, the Diagnostic and Statistical Manual of Mental Disorders (DSM; current version <LINK REF="REF-DSM_x002d_IV_x002d_TR" TYPE="REFERENCE">DSM-IV-TR</LINK>) and the International Statistical Classification of Diseases and Related Health Problems (ICD; current version <LINK REF="REF-ICD_x002d_10" TYPE="REFERENCE">ICD-10</LINK>). DSM-IV defined depressive diagnoses include recurrent or persistent major depression and minor depression. ICD-10 diagnoses include recurrent or persistent depression with mild, moderate or severe episodes. According to the DSM-IV diagnostic classification, either depressed mood or a loss of interest or pleasure in daily activities consistently for at least a two week period has to be present to diagnose a major depressive disorder. The ICD-10 system uses the term depressive episode instead of major depressive disorder, but lists similar criteria.</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-08-05 22:39:59 +0100" MODIFIED_BY="[Empty name]">
<P>Major depressive episodes are most commonly treated with antidepressant medication. Current first line dugs are selective serotonin reuptake inhibitors (SSRI) or tricyclic and related antidepressants (http://guidance.nice.org.uk/CG23). However, the size of effects over placebo in clinical trials has been modest (<LINK REF="REF-Turner-2008" TYPE="REFERENCE">Turner 2008</LINK>; <LINK REF="REF-Kirsch-2008" TYPE="REFERENCE">Kirsch 2008</LINK>), and although SSRIs are better tolerated than older antidepressants, side effects still occur in a relevant proportion of patients.</P>
<P>Extracts of the plant <I>Hypericum perforatum</I> L. (St. John's wort), a member of the Hypericaceae family, have been used in folk medicine for a long time for a range of indications including depressive disorders. Extracts of St. John's wort are licensed and widely used in Germany for the treatment of depressive, anxiety and sleep disorders. In recent years, hypericum extracts have also become increasingly popular in other countries.</P>
</INTERVENTION>
<THEORY MODIFIED="2008-08-06 10:44:02 +0100" MODIFIED_BY="[Empty name]">
<P>The exact mechanism of action of the antidepressant effects of hypericum extracts is still unclear. Hypericum extracts contain at least seven constituents or groups of components that may contribute to its pharmacological effects (<LINK REF="REF-Nahrstedt-1997" TYPE="REFERENCE">Nahrstedt 1997</LINK>). These include naphthodianthrons (e.g., hypericins), flavonoids (e.g., quercetin), biflavonoids (e.g., biapigenin), xanthons, and phloroglucinol derivatives (e.g., hyperforin). Hypericum extracts have been shown to be active in a number of standard animal models that are used to indicate antidepressant effects (<LINK REF="REF-Wheatley-1998" TYPE="REFERENCE">Wheatley 1998</LINK>; <LINK REF="REF-Caccia-2005" TYPE="REFERENCE">Caccia 2005</LINK>; <LINK REF="REF-Wurglics-2006" TYPE="REFERENCE">Wurglics 2006</LINK>). While some isolated substances, as for example hyperforin, have been shown to have antidepressant activity, the total extract seems to be more effective (<LINK REF="REF-Reichling-2003" TYPE="REFERENCE">Reichling 2003</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2008-08-06 10:46:30 +0100" MODIFIED_BY="[Empty name]">
<P>Hypericum extracts have been tested in a number of clinical trials since the 1980s. The first two versions of this review and other systematic reviews published between 1995 and 2000 concluded that hypericum extracts are more effective than placebo and are comparable to older antidepressants in the treatment of mild to moderate depressive disorders (<LINK REF="REF-Ernst-1995" TYPE="REFERENCE">Ernst 1995</LINK>; <LINK REF="REF-Linde-1996" TYPE="REFERENCE">Linde 1996</LINK>; <LINK REF="REF-Linde-1998" TYPE="REFERENCE">Linde 1998</LINK>; <LINK REF="REF-Kim-1999" TYPE="REFERENCE">Kim 1999</LINK>; <LINK REF="REF-Gaster-2000" TYPE="REFERENCE">Gaster 2000</LINK>; <LINK REF="REF-Williams-2000" TYPE="REFERENCE">Williams 2000</LINK>). Several trials included in these reviews were criticised because they included patients with few and/or mild symptoms who did not meet criteria for major depression, were conducted by primary care physicians who were not experienced in depression research, and/or used low doses of comparator drugs (<LINK REF="STD-Shelton-2001" TYPE="STUDY">Shelton 2001</LINK>). In the 2005 update of our review (<LINK REF="REF-Linde-2005a" TYPE="REFERENCE">Linde 2005a</LINK>; <LINK REF="REF-Linde-2005b" TYPE="REFERENCE">Linde 2005b</LINK>) several new well-designed placebo-controlled trials were included, some of which had negative findings (<LINK REF="STD-Shelton-2001" TYPE="STUDY">Shelton 2001</LINK>; <LINK REF="STD-HDTSG-2002" TYPE="STUDY">HDTSG 2002</LINK>) and which had spurred renewed debate about the efficacy of hypericum extracts. We systematically investigated possible reasons for the contradictory findings. We found that larger, more precise studies yielded less positive results, suggesting that small studies with a higher risk of bias might overestimate the effects of hypericum extracts over placebo. The analyses also showed that effects over placebo were less pronounced in studies restricted to patients with major depression. Finally, we had the impression that studies originating from German-speaking countries (Germany, Austria, and Switzerland) had more positive results than studies originating from other countries independently from precision and formal diagnosis, although multiple regression analyses did not identify this as an independent predictor.</P>
<P>Since we completed the search for our 2005 update, again, several new well-designed trials restricted to patients with major depression have been published. To sharpen the focus of this review, to reduce clinical heterogeneity, and to reflect the fact that almost all new high-quality trials of hypericum extracts are restricted to patients with major depression, we decided to limit the review now to this group of patients.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-08-06 10:48:33 +0100" MODIFIED_BY="[Empty name]">
<P>This updated review aimed to investigate whether extracts of hypericum:</P>
<UL>
<LI>are more effective than placebo and</LI>
<LI>as effective as standard antidepressant drugs, and</LI>
<LI>whether they have less adverse effects compared to standard antidepressant drugs</LI>
</UL>
<P>in the treatment of major depression in adults.</P>
<P>In addition, we investigated possible reasons for varying results across studies, with a focus on precision of the studies, baseline severity of depression, and country of origin.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-08-13 13:19:13 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-08-11 13:49:56 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2008-08-05 22:35:38 +0100" MODIFIED_BY="[Empty name]">
<P>To be included trials had to be double-blind and randomised.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-08-06 10:49:22 +0100" MODIFIED_BY="[Empty name]">
<P>Patients had to suffer from major depression (meeting DSM-IV or ICD-10 criteria). Trials in children (&lt; 16 years) were not eligible. In previous versions of this review (<LINK REF="REF-Linde-1998" TYPE="REFERENCE">Linde 1998</LINK>; <LINK REF="REF-Linde-2005a" TYPE="REFERENCE">Linde 2005a</LINK>) trials not restricted to patients with major depression had been included.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-08-06 11:26:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Experimental intervention</B>
<BR/>Preparations of hypericum (St. John's wort). Trials investigating combinations of hypericum with other herbs were excluded.</P>
<P>
<B>Control intervention</B>
<BR/>Placebo or synthetic antidepressants (tricyclic and related antidepressants, selective serotonine reuptake inhibitors, serotonine-noradrenaline reuptake inhibitors). Trials using clearly inadequate synthetic antidepressants (e.g., benzodiatepines) or a dosage clearly below the lower thresholds recommended in current guidelines (<LINK REF="REF-H_x00e4_rter-2003" TYPE="REFERENCE">Härter 2003</LINK>, <LINK REF="REF-ICSI-2007" TYPE="REFERENCE">ICSI 2007</LINK>) were excluded.</P>
<P>Experimental and control treatments had to be given for at least four weeks.</P>
<P>
<B>Main comparisons</B>
<BR/>The following comparisons were performed:<BR/>1. hypericum extracts vs. placebo<BR/>2. hypericum extracts vs. standard antidepressants</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-08-11 13:49:56 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
<BR/>To be included, trials had to measure clinical outcomes such as depression scales or symptoms. Trials that measured physiological parameters only were excluded. The primary outcomes of interest were</P>
<P>1. Effectiveness: treatment response<BR/>
</P>
<P>2. Safety: the proportion of patients who dropped out due to adverse effects</P>
<P>
<B>Secondary outcomes</B>
<BR/>1. Effectiveness: remission, depression scales such as the Hamilton Depression Scale (HAMD), the Clinical Global Impression Index (CGI), the Montgomery-Asberg Depression Rating Scale (MADRS), patient-rated depression scales</P>
<P>2. Safety: total proportion of drop-outs, proportion of patients reporting adverse effects<BR/>
</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-08-06 17:28:43 +0100" MODIFIED_BY="[Empty name]">
<P>For the first version of the review we searched for published and unpublished eligible trials in the following ways:</P>
<P>
<B>1. Electronic searches</B>
<BR/>a) Clinical Trials Register of the Cochrane Collaboration Depression, Anxiety &amp; Neurosis Group (CCDANTR)<BR/>b) database of the Cochrane Field for Complementary Medicine<BR/>c) full text searches in Medline SilverPlatter CD-ROM from 1983 onwards and Embase 1989 onwards using the terms 'St. John's wort', 'Johanniskraut' (German for St John's wort), 'hyperic*')<BR/>d) full text searches in Psychlit and Psychindex 1987 - 1997 CD-ROM<BR/>e) searches in the private database Phytodok, Munich.</P>
<P>
<B>2. Searching other resources</B>
<BR/>a) Checking bibliographies of obtained articles<BR/>b) Contacting pharmaceutical companies and authors.<BR/>There were no language restrictions.</P>
<P>For the updated version of the review, we searched for published and unpublished eligible trials in the following ways:</P>
<P>
<B>1. Electronic searches</B>
<BR/>For the update, regular electronic searches were performed in CCDANTR (last search July 2007) and PubMed (screening all hits for text word "hypericum", last search July 8, 2008).</P>
<P>
<B>2. Searching other resources</B>
<BR/>We screened bibliographies of published articles, and repeatedly contacted experts, researchers, and manufacturers inquiring for new trials. One reviewer (KL) initially screened reference lists to identify controlled studies on hypericum preparations in humans. All possibly relevant studies or publications were then checked formally for eligibility.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-08-13 13:19:13 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2008-08-06 17:29:18 +0100" MODIFIED_BY="[Empty name]">
<P>Two reviewers independently decided on eligibility for the revised inclusion criteria. Disagreements were resolved through discussion. Due to reading errors, disagreements occurred for two trials in which not all patients had major depression and which were excluded after discussion (<LINK REF="STD-Vorbach-1994" TYPE="STUDY">Vorbach 1994</LINK>, <LINK REF="STD-Winkel-2000" TYPE="STUDY">Winkel 2000</LINK>). In two trials both reviewers had problems with assessing eligibility: For one small, older trial (<LINK REF="STD-Lehrl-1993" TYPE="STUDY">Lehrl 1993</LINK>) the publication did not state that inclusion was limited to patients with major depression, but we had a statement of the sponsor obtained for our 1998 update that all patients met the criteria. As this information could not be verified for this update, we decided to exclude the trial. A Chinese trial (<LINK REF="STD-Gu-2001" TYPE="STUDY">Gu 2001</LINK>) referred to a Chinese classification. As this classification is not completely comparable to ICD-10 and DSM-IV, we decided to also exclude this trial.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-08-11 13:14:10 +0100" MODIFIED_BY="[Empty name]">
<P>Primary study characteristics and results were extracted by at least two independent reviewers using a pretested form. In particular, we extracted diagnoses and main inclusion criteria, age, gender, duration of episodes, baseline depression scores, country of origin, number and type of study centers, numbers of patients who were randomised and analysed and who completed protocols, the number and reasons for drop-outs and withdrawals, numbers of patients reporting adverse effects, and the number and type of adverse effects that were reported.</P>
<P>We assessed numbers of patients who were classified as responders based on score improvements on the Hamilton Rating Scale for Depression (HAMD), the Clinical Global Impression Index (CGI; subscale global improvement rating as at least "much improved"), or any other clinical response measurement. Missing or additional information was sought from authors/sponsors.</P>
<P>Most trials measured clinical outcomes with the Hamilton Depression Scale (HAMD) and the Clinical Global Impression Index (CGI). The HAMD is an observer-rated scale that focuses mainly on somatic symptoms of depression (<LINK REF="REF-Hamilton-1960" TYPE="REFERENCE">Hamilton 1960</LINK>). The original version includes 21 items, but a version with 17 items is more commonly used in clinical trials. Most studies using the HAMD report the number of 'treatment responders' (patients achieving a score less than 10 and/or less than 50% of the baseline score). When available, we extracted means and standard deviations before, during and after treatment as well as the number of 'responders'. The CGI (<LINK REF="REF-CGI-1970" TYPE="REFERENCE">CGI 1970</LINK>) is an observer rated instrument with three items (severity of illness, global improvement, and an efficacy index). We extracted the number of patients rated as 'much improved' or 'very much improved' for global improvement. As recently the Montgomery-Asberg Depression Rating Scale (MADRS (<LINK REF="REF-Montgomery-1979" TYPE="REFERENCE">Montgomery 1979</LINK>)) and the remission criterion for the HAMD (usually a score of less than 8 at the end of treatment) have been gaining importance as outcome criteria, we also checked all trials for the reporting of these measures. As the DS (Depression Scale von Zerssen (<LINK REF="REF-von-Zerssen-1996" TYPE="REFERENCE">von Zerssen 1996</LINK>)) was the most often used patient-rated instrument in the included trials, we extracted post-treatment data for this scale, if available. For additional post-hoc analyses, one reviewer (KL) also extracted data for other self-rating instruments.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-08-06 17:30:46 +0100" MODIFIED_BY="[Empty name]">
<P>The main part of the update process of this review was completed before the new risk of bias tool of the Cochrane Collaboration (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>) was available. The methodological quality of each trial was assessed by at least two independent reviewers using scales developed by A. Jadad et al. (<LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>) and by one of the reviewers (KL). The results of the quality scoring are displayed in the table of included studies.</P>
<P>The Jadad scale has three items adding up to a maximum score of five points. 0, 1 or 2 points can be given for randomisation (explicit statement that allocation was randomised and description of an adequate generation of the random sequence), 0, 1 or 2 points for double-blinding (explicit statement that patients and evaluators were blinded and that treatments were indistinguishable), 0 or 1 point for description of drop-outs and withdrawals (numbers and reasons for all compared groups separately). The display in the table of included studies is as follows (examples): 2-2-1 (full score in every item), 1-0-0 (only statement on randomisation).<BR/>The second quality scale, the "Internal Validity Scale" (IV), which has been used in other reviews on complementary medicine (<LINK REF="REF-Linde-1996b" TYPE="REFERENCE">Linde 1996b</LINK>, <LINK REF="REF-Linde-1997" TYPE="REFERENCE">Linde 1997</LINK>) has six items with possible scores of 0, 0.5 or 1 point for each. Items 1 through 6 refer to statement of random allocation, adequacy of randomization concealment, baseline comparability, blinding of patients, blinding of evaluators, and likelihood of selection bias after allocation, respectively. Results are displayed by item in the table of included studies (e.g., 1-1-1-0.5-1-1 represents a full score, with the exception of blinding of patients which was stated but treatment and placebo might have been distinguishable).</P>
<P>The assessments in the Jadad and IV scores are solely based on the information provided in the publication (as additional information could not be gathered for all studies). In the table 'Characteristics of included studies', however, additional information provided from authors or sponsors was included. This table also contains information on allocation concealment and attrition.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2008-08-13 13:19:13 +0100" MODIFIED_BY="[Empty name]">
<P>Our primary outcome measure, to assess the effectiveness of St John's wort versus placebo and versus other antidepressants, was the proportion of responders (according to the Hamilton Depression Scale (first preference) or other responder measures (second preference)) at the end of treatment, or in case of treatment phases longer than 6 weeks, at the time point defined for primary outcome measurement by the study investigators.</P>
<P>Secondary outcome measures were: proportion of responders according to HAMD, proportion of responders according to CGI, mean HAMD after treatment (or, if this was not available, difference after treatment - baseline), at 2, 4, 6 to 8 weeks, and mean DS score after treatment (or, if this was not available, difference after treatment - baseline).</P>
<P>The main outcome measure for the safety analysis was the proportion of patients who dropped out due to adverse effects. Secondary measures were the total proportion of drop-outs and the proportion of patients reporting adverse effects.</P>
<P>
<B>Dichotomous outcomes</B>
<BR/>We used responder rate ratios (= relative risks = proportion of responders in the treatment group/proportion of responders in the control group) and their 95% confidence intervals for the analysis of treatment response. Responder rate ratios greater than 1 indicate better response in the hypericum group.</P>
<P>Due to highly variable frequency of side or adverse effects reported, odds ratios instead of rate ratios were calculated in the safety analyses. Odds ratios less than 1 indicate that fewer events occurred in the hypericum group.</P>
<P>
<B>Continuous outcomes</B>
<BR/>For HAMD and DS scores we calculated mean differences (also termed weighted mean differences). Negative mean differences indicate better response in the hypericum group.</P>
<P>
<B>Unit of analysis issues</B>
<BR/>Two trials with more than one hypericum group were included in the analyses as follows: <LINK REF="STD-Laakmann-1998" TYPE="STUDY">Laakmann 1998</LINK> included an extract available on the market and an additional experimental extract with low hyperforin content which was never on the market and only used for control reasons. We did not include the data from the group receiving the experimental low-hyperforin extract in the analyses. <LINK REF="STD-Kasper-2006" TYPE="STUDY">Kasper 2006</LINK> et al tested two dosages (600 and 1200 mg) of an available product. We pooled the data from these two groups to prevent that the control group of this trial would have been included in the analyses twice.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2008-08-06 11:50:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Dichtomous outcomes</B>
<BR/>Responder proportions were calculated according to the intention to treat principle, counting drop-outs as non-responders. For the comparison hypericum extracts vs. standard antidepressants responder proportions were also calculated on a per protocol basis (as this is considered more appropriate to assess the equivalence of two treatments). </P>
<P>
<B>Continuous outcomes</B>
<BR/>If means and standard deviations from intent to treat analysis with missing values replaced were available, we preferably used these data. In other cases we used analysis based on available data.</P>
<P>
<B>Obtaining missing data</B>
<BR/>If the number of patients responding to treatment and means and/or standard deviations of HAMD scores after completion were not reported, we always tried to contact first or corresponding authors and/or sponsors to obtain these data. In general, we also tried to obtain other missing details on methods and secondary outcomes from authors or sponsors, but the extent to which we were doing this depended on the cooperation of authors/sponsors and the amount of missing information in the publications. We did not impute or recalculate missing standard deviations as these were unavailable only for a few secondary outcomes in a minority of trials.</P>
<P>We tried to contact authors and/or sponsors of 27 of the 29 included trials; for two trials (<LINK REF="STD-Kalb-2001" TYPE="STUDY">Kalb 2001</LINK>; <LINK REF="STD-Laakmann-1998" TYPE="STUDY">Laakmann 1998</LINK>) this was considered unnecessary. We did not receive responses for five trials (<LINK REF="STD-Behnke-2002" TYPE="STUDY">Behnke 2002</LINK>; <LINK REF="STD-Brenner-2000" TYPE="STUDY">Brenner 2000</LINK>; <LINK REF="STD-Fava-2005" TYPE="STUDY">Fava 2005</LINK>; <LINK REF="STD-Harrer-1999" TYPE="STUDY">Harrer 1999</LINK>; <LINK REF="STD-Moreno-2005" TYPE="STUDY">Moreno 2005</LINK>). Very limited additional information was available or needed for three studies (<LINK REF="STD-Bjerkenstedt-2005" TYPE="STUDY">Bjerkenstedt 2005</LINK>; <LINK REF="STD-Volz-2000" TYPE="STUDY">Volz 2000</LINK>; <LINK REF="STD-Woelk-2000" TYPE="STUDY">Woelk 2000</LINK>). We obtained relevant additional information to a variable extent from authors, sponsors, or both for the remaining 19 trials.</P>
</MISSING_DATA>
<DATA_SYNTHESIS MODIFIED="2008-08-11 13:32:21 +0100" MODIFIED_BY="[Empty name]">
<P>The following comparisons were performed:<BR/>1. hypericum extracts vs. placebo: a) for dichotomous outcomes (response rate ratios); b) for continuous outcomes; c) for drop-outs and adverse effects<BR/>2. hypericum extracts vs. standard antidepressants: a) for dichotomous outcomes; b) for continuous outcomes; c) for drop-outs and adverse effects</P>
<P>All main analyses were performed using RevMan 5. </P>
<P>Due to the clinical diversity of the studied populations, the hypericum extracts and the comparison drugs used, we considered that the included studies did not estimate a common underlying effect, but rather that each individual study estimated its single and unique underlying effect. Thus, the application of random effects model in all analyses seemed to be appropriate.</P>
<P>The primary analysis for the comparison of response rate ratios (= relative risks) under treatment with hypericum extracts or placebo was a random-effects intention to treat meta-analysis stratified by study precision (above or below median of variance of treatment effect).</P>
<P>
<B>Assessment of heterogeneity</B>
<BR/>Heterogeneity of trials' results was tested with the Chi-squared test, and the I-squared statistic was calculated to give an estimate of the degree of heterogeneity. I-squared values over 50% indicate considerable heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>).<BR/>
</P>
<P>
<B>Investigation of heterogeneity and subgroup analyses</B>
<BR/>Predefined subgroup analyses were performed (a) including only trials with response operationalised with the HAMD score; (b) including only trials with response operationalized with the CGI; (c) for the type of extract investigated; and (d) comparing trials originating from German-speaking countries and from other countries. Weighted mean differences for HAMD scores were calculated after therapy, at 2 to 3, 4, 6 to 8 weeks, and for differences compared to baseline values. For DS scores we calculated after therapy values, for MADRS score after therapy values and differences compared to baseline. As only relatively few studies used the DS, we performed an additional post-hoc random effects analysis calculating standardised mean differences for any available patient-rating scale (preferably end of treatment values, but if these were not available also differences from baseline) to investigate whether findings from physician-rated instruments could be broadly reproduced.</P>
<P>The primary analysis for the comparison of responder rate ratios under treatment with hypericum extracts or standard antidepressants was a random effects intent to treat meta-analysis stratified for type of synthetic antidepressant (selective serotonine inhibitors or older antidepressants). Predefined subgroup analyses were performed (a) using per protocol data; (b) stratified for country (German-speaking Europe versus other countries); (c) including only trials with response operationalised with the HAMD score; and (d) including only trials with response operationalised with the CGI.</P>
<P>Additional meta-regression analyses were performed to investigate the influence of country of origin (German-speaking versus not German speaking), precision and HAMD baseline values on study findings (responder ratio and mean difference of HAMD scores after treatment) both in placebo and standard antidepressants comparisons. According to current recommendations of experts (<LINK REF="REF-Thompson-1999" TYPE="REFERENCE">Thompson 1999</LINK>, <LINK REF="REF-Lipsey-2000" TYPE="REFERENCE">Lipsey 2000</LINK>), random effects meta-regression analyses were carried out using the restricted information maximum likelihood (REML) method. A main advantage of this approach is that it accounts for residual between-trial heterogeneity. Both univariable and multiple regression models were fitted. We calculated the proportion of explained heterogeneity variance by dividing the heterogeneity explained by the independent variable(s) through the total heterogeneity variance present in random-effects meta-analysis. When referring to a whole model, this coefficient was termed R<SUP>2</SUP>. When referring to the contribution of single covariates the coefficient was termed &#946;<SUP>2</SUP>. In univariable meta-regression analyses these coefficients are mathematically equal. In multiple meta-regression analyses, sum of &#946;<SUP>2 </SUP>values for all covariates may be slightly different from R<SUP>2</SUP>. For all meta-regression analyses the Statistical Package for the Social Sciences (SPSS; Chicago, Illinois) v13.0 software using additional macros by Wilson (<LINK REF="REF-Wilson-2002" TYPE="REFERENCE">Wilson 2002</LINK>; <LINK REF="REF-Lipsey-2000" TYPE="REFERENCE">Lipsey 2000</LINK>) was used.</P>
<P>
<B>Assessment of reporting biases</B>
<BR/>Visual analysis of funnel plots was performed to identify possible publication bias (<LINK REF="REF-Sterne-2001" TYPE="REFERENCE">Sterne 2001</LINK>). Furthermore, the asymmetry coefficient was calculated for formal examination of publication bias (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>).</P>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-08-11 14:05:26 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2008-08-06 17:36:45 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2008-08-06 14:07:11 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 79 possibly relevant studies were identified and checked formally for eligibility. </P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-08-06 17:35:16 +0100" MODIFIED_BY="[Empty name]">
<P>Twenty nine trials including a total of 5489 (range 30 to 388) patients met inclusion criteria (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).<BR/>Eighteen trials had a placebo-control group (<LINK REF="STD-Bjerkenstedt-2005" TYPE="STUDY">Bjerkenstedt 2005</LINK>; <LINK REF="STD-Bracher-2001" TYPE="STUDY">Bracher 2001</LINK>; <LINK REF="STD-Fava-2005" TYPE="STUDY">Fava 2005</LINK>; <LINK REF="STD-Gastpar-2006" TYPE="STUDY">Gastpar 2006</LINK>; <LINK REF="STD-HDTSG-2002" TYPE="STUDY">HDTSG 2002</LINK>; <LINK REF="STD-H_x00e4_nsgen-1996" TYPE="STUDY">Hänsgen 1996</LINK>; <LINK REF="STD-Kalb-2001" TYPE="STUDY">Kalb 2001</LINK>; <LINK REF="STD-Kasper-2006" TYPE="STUDY">Kasper 2006</LINK>; <LINK REF="STD-Laakmann-1998" TYPE="STUDY">Laakmann 1998</LINK>; <LINK REF="STD-Lecrubier-2002" TYPE="STUDY">Lecrubier 2002</LINK>; <LINK REF="STD-Montgomery-2000" TYPE="STUDY">Montgomery 2000</LINK>; <LINK REF="STD-Moreno-2005" TYPE="STUDY">Moreno 2005</LINK>; <LINK REF="STD-Philipp-1999" TYPE="STUDY">Philipp 1999</LINK>; <LINK REF="STD-Schrader-1998" TYPE="STUDY">Schrader 1998</LINK>; <LINK REF="STD-Shelton-2001" TYPE="STUDY">Shelton 2001</LINK>; <LINK REF="STD-Uebelhack-2004" TYPE="STUDY">Uebelhack 2004</LINK>; <LINK REF="STD-Volz-2000" TYPE="STUDY">Volz 2000</LINK>; <LINK REF="STD-Witte-1995" TYPE="STUDY">Witte 1995</LINK>), and 17 trials compared hypericum with standard antidepressants (<LINK REF="STD-Behnke-2002" TYPE="STUDY">Behnke 2002</LINK>; <LINK REF="STD-Bjerkenstedt-2005" TYPE="STUDY">Bjerkenstedt 2005</LINK>; <LINK REF="STD-Brenner-2000" TYPE="STUDY">Brenner 2000</LINK>; <LINK REF="STD-Fava-2005" TYPE="STUDY">Fava 2005</LINK>; <LINK REF="STD-Gastpar-2005" TYPE="STUDY">Gastpar 2005</LINK>; <LINK REF="STD-Gastpar-2006" TYPE="STUDY">Gastpar 2006</LINK>; <LINK REF="STD-Harrer-1993" TYPE="STUDY">Harrer 1993</LINK>; <LINK REF="STD-Harrer-1999" TYPE="STUDY">Harrer 1999</LINK>; <LINK REF="STD-HDTSG-2002" TYPE="STUDY">HDTSG 2002</LINK>; <LINK REF="STD-Moreno-2005" TYPE="STUDY">Moreno 2005</LINK>; <LINK REF="STD-Philipp-1999" TYPE="STUDY">Philipp 1999</LINK>; <LINK REF="STD-Schrader-2000" TYPE="STUDY">Schrader 2000</LINK>; <LINK REF="STD-Szegedi-2005" TYPE="STUDY">Szegedi 2005</LINK>; <LINK REF="STD-van-Gurp-2002" TYPE="STUDY">van Gurp 2002</LINK>; <LINK REF="STD-Vorbach-1997" TYPE="STUDY">Vorbach 1997</LINK>; <LINK REF="STD-Wheatley-1997" TYPE="STUDY">Wheatley 1997</LINK>; <LINK REF="STD-Woelk-2000" TYPE="STUDY">Woelk 2000</LINK>). Six trials had both a placebo and a standard antidepressant control group (<LINK REF="STD-Bjerkenstedt-2005" TYPE="STUDY">Bjerkenstedt 2005</LINK>; <LINK REF="STD-Fava-2005" TYPE="STUDY">Fava 2005</LINK>; <LINK REF="STD-Gastpar-2006" TYPE="STUDY">Gastpar 2006</LINK>; <LINK REF="STD-HDTSG-2002" TYPE="STUDY">HDTSG 2002</LINK>; <LINK REF="STD-Moreno-2005" TYPE="STUDY">Moreno 2005</LINK>; <LINK REF="STD-Philipp-1999" TYPE="STUDY">Philipp 1999</LINK>). Eight trials are newly included since the last update (<LINK REF="STD-Bracher-2001" TYPE="STUDY">Bracher 2001</LINK>; <LINK REF="STD-Fava-2005" TYPE="STUDY">Fava 2005</LINK>; <LINK REF="STD-Gastpar-2005" TYPE="STUDY">Gastpar 2005</LINK>; <LINK REF="STD-Gastpar-2006" TYPE="STUDY">Gastpar 2006</LINK>; <LINK REF="STD-Kasper-2006" TYPE="STUDY">Kasper 2006</LINK>; <LINK REF="STD-Moreno-2005" TYPE="STUDY">Moreno 2005</LINK>; <LINK REF="STD-Szegedi-2005" TYPE="STUDY">Szegedi 2005</LINK>; <LINK REF="STD-Uebelhack-2004" TYPE="STUDY">Uebelhack 2004</LINK>) and one trial which had been included based on an abstract reference only is now included fully (<LINK REF="STD-Bjerkenstedt-2005" TYPE="STUDY">Bjerkenstedt 2005</LINK>). These eight new trials included a total of 1947 (range 72 to 388) patients. Details on patients, methods, interventions, outcomes, and results of all included studies are described in the table of included studies.</P>
<P>
<B>Types of participants</B>
<BR/>The severity of depression was described as mild to moderate in 19 trials, and as moderate to severe in 9 trials (one trial did not classify severity). Eighteen trials were from German-speaking countries, four from the US, two from the UK, and one each from Brazil, Canada, Denmark, France and Sweden. Patients were recruited in private practices in all trials from German-language countries, in the trials from Sweden (<LINK REF="STD-Bjerkenstedt-2005" TYPE="STUDY">Bjerkenstedt 2005</LINK>) and Canada (<LINK REF="STD-van-Gurp-2002" TYPE="STUDY">van Gurp 2002</LINK>), and in one of the trials from the UK (<LINK REF="STD-Wheatley-1997" TYPE="STUDY">Wheatley 1997</LINK>). The second trial from the UK (<LINK REF="STD-Montgomery-2000" TYPE="STUDY">Montgomery 2000</LINK>) and the trial from France (<LINK REF="STD-Lecrubier-2002" TYPE="STUDY">Lecrubier 2002</LINK>) were performed both in private practices and psychiatric outpatient departments. Three trials from the US (<LINK REF="STD-Shelton-2001" TYPE="STUDY">Shelton 2001</LINK>; <LINK REF="STD-HDTSG-2002" TYPE="STUDY">HDTSG 2002</LINK>; <LINK REF="STD-Fava-2005" TYPE="STUDY">Fava 2005</LINK>) and the Brazilian trial (<LINK REF="STD-Moreno-2005" TYPE="STUDY">Moreno 2005</LINK>) were performed in academic and/or community psychiatry research clinics. Two trials from the US and Denmark (<LINK REF="STD-Brenner-2000" TYPE="STUDY">Brenner 2000</LINK>; <LINK REF="STD-Behnke-2002" TYPE="STUDY">Behnke 2002</LINK>) did not report on the setting.</P>
<P>
<B>Types of intervention</B>
<BR/>A variety of hypericum preparations were studied in the trials. The range of daily extract doses varied between 240 and 1800 mg, but in most trials 500 to 1200 mg were used. The standard antidepressants used as active comparators were fluoxetine (6 trials, dosage 20 to 40 mg), sertraline (4 trials, 50 to 100 mg), imipramine (in 3 trials, dosage 100 to 150 mg), citalopram (1 trial, 20 mg), paroxetine (1 trial, 20 to 40 mg), maprotiline (1 trial, 75 mg), and amitriptyline (1 trial, 75 mg). The comparator dosage of maprotiline and amitriptyline were slightly below of those recommended in current guidelines (<LINK REF="REF-H_x00e4_rter-2003" TYPE="REFERENCE">Härter 2003</LINK>, <LINK REF="REF-ICSI-2007" TYPE="REFERENCE">ICSI 2007</LINK>) and in most other studies at the minimum of recommended dosages. The treatment periods lasted 4 (1 trial), 6 (19), 7 (1), 8 (5) or 12 weeks (4 trials). Four trials included some long-term follow-up or continuation treatment after the main trial phase (<LINK REF="STD-Brenner-2000" TYPE="STUDY">Brenner 2000</LINK>; <LINK REF="STD-Gastpar-2005" TYPE="STUDY">Gastpar 2005</LINK>; <LINK REF="STD-Shelton-2001" TYPE="STUDY">Shelton 2001</LINK>; <LINK REF="STD-Szegedi-2005" TYPE="STUDY">Szegedi 2005</LINK>).</P>
<P>
<B>Types of outcome</B>
<BR/>The most frequently used instrument used for outcome measurement was the Hamilton Rating Scale for Depression (used in all trials). A variety of other ratings scales and instruments were used in addition.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2008-08-06 17:36:45 +0100" MODIFIED_BY="[Empty name]">
<P>Fifty trials (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>) did not meet inclusion criteria: eight trials were not limited to patients with depression (<LINK REF="STD-Albertini-1986" TYPE="STUDY">Albertini 1986</LINK>; <LINK REF="STD-Bendre-1980" TYPE="STUDY">Bendre 1980</LINK>; <LINK REF="STD-Dittmer-1992" TYPE="STUDY">Dittmer 1992</LINK>; <LINK REF="STD-Hottenrott-1997" TYPE="STUDY">Hottenrott 1997</LINK>; <LINK REF="STD-Maisenbacher-1995" TYPE="STUDY">Maisenbacher 1995</LINK>; <LINK REF="STD-Panijel-1985" TYPE="STUDY">Panijel 1985</LINK>; <LINK REF="STD-Sindrup-2000" TYPE="STUDY">Sindrup 2000</LINK>; <LINK REF="STD-Volz-2002" TYPE="STUDY">Volz 2002</LINK>), four trials were on prevention or treatment of depressive symptoms in patients suffering primarily from other diseases (<LINK REF="STD-H_x00e4_ring-1996" TYPE="STUDY">Häring 1996</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Mo-2004" TYPE="STUDY">Mo 2004</LINK>; <LINK REF="STD-Werth-1989" TYPE="STUDY">Werth 1989</LINK>), two measured physiological parameters only (as EEG) in depressed patients (<LINK REF="STD-Czekalla-1997" TYPE="STUDY">Czekalla 1997</LINK>; <LINK REF="STD-Kugler-1990b" TYPE="STUDY">Kugler 1990b</LINK>), five did not include a placebo or standard drug comparison group (<LINK REF="STD-Bernhadt-1993" TYPE="STUDY">Bernhadt 1993</LINK>; <LINK REF="STD-Lenoir-1999" TYPE="STUDY">Lenoir 1999</LINK>; <LINK REF="STD-Martinez-1993" TYPE="STUDY">Martinez 1993</LINK>; <LINK REF="STD-Spielberger-1985" TYPE="STUDY">Spielberger 1985</LINK>; <LINK REF="STD-Zeller-2000" TYPE="STUDY">Zeller 2000</LINK>), eight involved healthy volunteers (<LINK REF="STD-Brockm_x00f6_ller-1997" TYPE="STUDY">Brockmöller 1997</LINK>; <LINK REF="STD-Herberg-1992" TYPE="STUDY">Herberg 1992</LINK>; <LINK REF="STD-Johnson-1992" TYPE="STUDY">Johnson 1992</LINK>; <LINK REF="STD-Johnson-1993" TYPE="STUDY">Johnson 1993</LINK>; <LINK REF="STD-Schmidt-1993b" TYPE="STUDY">Schmidt 1993b</LINK>; <LINK REF="STD-Schulz-1993" TYPE="STUDY">Schulz 1993</LINK>; <LINK REF="STD-Staffeldt-1993" TYPE="STUDY">Staffeldt 1993</LINK>; <LINK REF="STD-Wienert-1991" TYPE="STUDY">Wienert 1991</LINK>), three tested combinations of hypericum and other herbal extracts (<LINK REF="STD-Ditzler-1992" TYPE="STUDY">Ditzler 1992</LINK>; <LINK REF="STD-Kniebel-1988" TYPE="STUDY">Kniebel 1988</LINK>; <LINK REF="STD-Steger-1985" TYPE="STUDY">Steger 1985</LINK>), and two compared hypericum extract with medications which are no longer considered adequate for depression (diazepam or bromazepam) (<LINK REF="STD-Kugler-1990a" TYPE="STUDY">Kugler 1990a</LINK>; <LINK REF="STD-Warnecke-1986" TYPE="STUDY">Warnecke 1986</LINK>); one of these trials also was not explicitly randomized. Due to the new exclusion criterion, we excluded 17 trials not restricted to patients with major depression. Fifteen had been included in the previous version of the review (<LINK REF="STD-Halama-1991" TYPE="STUDY">Halama 1991</LINK>; <LINK REF="STD-Harrer-1991" TYPE="STUDY">Harrer 1991</LINK>; <LINK REF="STD-Hoffmann-1979" TYPE="STUDY">Hoffmann 1979</LINK>; <LINK REF="STD-H_x00fc_bner-1993" TYPE="STUDY">Hübner 1993</LINK>; <LINK REF="STD-K_x00f6_nig-1993" TYPE="STUDY">König 1993</LINK>; <LINK REF="STD-Lehrl-1993" TYPE="STUDY">Lehrl 1993</LINK>; <LINK REF="STD-Osterheider-1992" TYPE="STUDY">Osterheider 1992</LINK>; <LINK REF="STD-Quandt-1993" TYPE="STUDY">Quandt 1993</LINK>; <LINK REF="STD-Reh-1992" TYPE="STUDY">Reh 1992</LINK>; <LINK REF="STD-Schlich-1987" TYPE="STUDY">Schlich 1987</LINK>; <LINK REF="STD-Schmidt-1989" TYPE="STUDY">Schmidt 1989</LINK>; <LINK REF="STD-Schmidt-1993" TYPE="STUDY">Schmidt 1993</LINK>; <LINK REF="STD-Sommer-1994" TYPE="STUDY">Sommer 1994</LINK>; <LINK REF="STD-Vorbach-1994" TYPE="STUDY">Vorbach 1994</LINK>; <LINK REF="STD-Winkel-2000" TYPE="STUDY">Winkel 2000</LINK>) while two were not (<LINK REF="STD-Agrawal-1994" TYPE="STUDY">Agrawal 1994</LINK>, for which it had not been possible to obtain a full copy and <LINK REF="STD-Gu-2001" TYPE="STUDY">Gu 2001</LINK>, which was newly identified in the update searches). Finally, we excluded one previously included trial as the standard antidepressant treatment was far below recommended dosages (30 mg Amitriptyline daily; <LINK REF="STD-Bergmann-1993" TYPE="STUDY">Bergmann 1993</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-08-11 13:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>The majority of the trials were of high quality. The median quality scores were 5 (out of 5, range 2 to 5) for the Jadad scale and 4.5 (out of 6; range 2 to 6) for the IV scale (see quality rating of the single trials in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
<P>
<B>Sequence generation/allocation concealment</B>
<BR/>The information on how the random sequence was generated was reported or provided on request for 18 trials (in all cases a computer program). Twenty two trials reported an adequate method of allocation concealment (most often consecutively numbered medication).</P>
<P>
<B>Blinding</B>
<BR/>All trials were described as double-blind, but only one trial reported that blinding was tested (<LINK REF="STD-HDTSG-2002" TYPE="STUDY">HDTSG 2002</LINK>). In this three-armed trial (hypericum vs. sertraline vs. placebo) about a third (as expected by chance alone) of guesses made by physicians were correct for hypericum and placebo patients, but in 66% of sertraline patients (p = 0.001).</P>
<P>
<B>Incomplete outcome data</B>
<BR/>In some trials attrition rates were high (for example, <LINK REF="STD-Fava-2005" TYPE="STUDY">Fava 2005</LINK>; see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). All placebo-controlled trials included an intent to treat analysis.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-08-11 14:05:26 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1: Hypericum extracts versus placebo</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Effectiveness</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">a) Responder analyses</HEADING>
<P>Sixteen of the 18 placebo-controlled trials reported the number of patients classified as responders based on score reduction on the HAMD scale, one trial reported response according to the MADRS scale (<LINK REF="STD-Bracher-2001" TYPE="STUDY">Bracher 2001</LINK>), and one trial only reported the proportion of patients rated at least as "improved" for the CGI (<LINK REF="STD-Volz-2002" TYPE="STUDY">Volz 2002</LINK>). Patients receiving hypericum extracts were significantly more likely to be responders (RR = 1.48; 95%CI 1.23 to 1.77; see comparison 1.1 and <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>) but study results were highly heterogeneous (I² = 75%). Effects in favour of hypericum extracts were less pronounced in more precise trials (RR = 1.28; 95%CI 1.10 to 1.49) compared to less precise trials (RR = 1.87; 95%CI 1.22 to 2.87) but heterogeneity was still strong in both subgroups (I² = 61% and 79%, respectively).</P>
<P>Findings were similar if response rates were based only on the trials reporting response according to the HAMD scale, or on the CGI (see comparisons 1.2 and 1.3). If trials investigating defined extracts were analysed separately (subgroups of trials testing the same extracts; see comparison 1.4), heterogeneity was strong in 3 of 4 subgroups.</P>
<P>Trials from German-speaking countries reported more positive findings than trials from other countries (RR = 1.78; 95%CI 1.42 to 2.25 vs.1.07; 95% CI 0.88 to 1.31, respectively; see comparison 1.5 and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). Six trials reported remission rates. These were significantly higher in patients receiving hypericum extracts than in those receiving placebo (RR = 2.77; 95%CI 1.80 to 4.26; I² = 29%; see comparison 1.6).</P>
<P>There was significant funnel plot asymmetry for the main responder analysis (coefficient = 2.19, p = 0.03; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
<P>In univariable meta-regression analyses, country of origin (studies from German-speaking countries showing larger effect sizes; p = 0.002), precision (more precise studies showing smaller effects; p = 0.032) and baseline values (higher values associated with smaller effect sizes; p = 0.048) were significantly associated with effects sizes. In multiple analyses the association remained significant for country of origin (p = 0.035) and precision (p = 0.017) but became non-significant for HAMD baseline values. Altogether over half of the variance (R² = 0.51) could be explained by these three variables. Findings of meta-regression analyses are summarised in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">b) Analyses of depression scales</HEADING>
<P>Analyses based on mean HAMD values yielded similar findings. At the completion of treatment HAMD values were 3.04 (95%CI 1.78 to 4.29) score points lower in hypericum groups compared to placebo groups, but there was strong heterogeneity (I² = 86%; see comparison 2.1). Effects over placebo were significant after 2 (comparison 2.2), 4 (comparison 2.3), 6 to 8 weeks of treatment (comparison 2.4), and for changes from baseline to end of treatment (comparison 2.5). Significant effects over placebo were also reported for the MADRS (comparisons 2.6, and 2.7). Studies from German-language countries reported much larger effects over placebo (weighted mean difference = 4.29, 95%CI 2.97 to 5.61 score points; comparison 2.8) than studies from other countries (MD = 0.77 score points, 95%CI 0.20 to 1.74 score points).</P>
<P>There was no significant funnel plot asymmetry (coefficient in the analysis of HAMD values at completion of treatment = -2.12, p = 0.35).</P>
<P>In multiple meta-regression analysis, country of origin was significantly associated with effects size (larger effects in trials from German-speaking countries; p &lt; 0.001) but not precision and HAMD baseline values (R² = 0.63; see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>).</P>
<P>The four trials reporting results for the patient-rated von Zerssen Depression Scale (D-S) showed a significant effect of hypericum extracts over placebo (comparison 2.9). Post-hoc analyses using available data from 12 placebo-controlled trials for a variety of self-rating instruments also confirmed analyses based on physician-rated outcomes. The pooled standardised mean difference (SMD) was -0.47 (95% CI -0.64 to -0.30; I² = 74%; see comparison 2.10). Trials from German-speaking countries again reported more favourable findings than trials from other countries (SMDs of -0.57 and -0.17 respectively; see comparison 2.11).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Safety</HEADING>
<P>
<I>Primary outcome</I>
<BR/>The number of patients dropping out for adverse effects was similar among patients receiving hypericum extracts and placebo (OR = 0.92, 95%CI 0.45 to 1.88, I<SUP>2</SUP>=0%; see comparison 3.1).</P>
<P>
<I>Secondary outcomes</I>
<BR/>The total number of patients dropping out and the number of patients dropping out for any reason were similar among patients receiving hypericum extracts and placebo (comparisons 3.2 and 3.3).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2: Hypericum extracts versus standard antidepressants</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Effectiveness</HEADING>
<P>
<I>a) Responder analyses</I>
<BR/>All 17 trials comparing hypericum extracts to standard antidepressant treatment reported the number of responders according to the HAMD score. Based on an intention to treat approach the pooled responder rate ratio was 1.01 for all 17 trials (95%CI 0.93 to 1.09; I² = 17%; see comparison 4.1 and <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). For the five trials comparing hypericum extracts with older antidepressants, the pooled estimate was 1.02 (95%CI 0.90 to 1.15; I² = 0%), and 1.00 for the 12 trials with selective serotonine reuptake inhibitors (95%CI 0.90 to 1.12; I² = 29%).</P>
<P>If analyses were based on per protocol data, the pooled responder rate ratio was 0.96 (95%CI 0.88 to 1.05; I² = 43%; see comparison 4.2). Analysis based on the CGI also found no relevant differences (RR = 1.01; 95%CI 0.94 to 1.09; I² = 24%; see comparison 4.3). In trials originating from German-speaking countries findings were slightly more favourable to hypericum than in trials from other countries (RR 1.04 and 0.90, respectively; see comparison 4.4 and <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). In the four trials reporting remission rates the response rate ratio was 1.24 (95%CI 1.02 to 1.50; I² = 0%; see comparison 4.5).</P>
<P>The asymmetry coefficient for the main responder analysis was -1.07 (p = 0.09; see funnel plot in <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). In univariable meta-regression analysis, there was a significant association between country of origin and response (trials from German-speaking countries favouring hypericum; p = 0.037). In the multivariable meta-regression analysis, none of the three tested predictors proved significant (R² = 0.24).</P>
<P>
<I>b) Analyses of depression scales</I>
<BR/>Analyses based on HAMD scores confirmed the findings of the responder analysis (see comparisons 5.1 to 5.5, and 5.8). Analyses of MADRS- and D-S-values are difficult to interpret, as only few trials reported these outcomes (see comparisons 5.6, 5.7, 5.9). There was no funnel plot asymmetry (0.30, p = 0.73). In the multivariable meta-regression analysis, trials with higher HAMD baseline values showed less favourable results (p = 0.010), while country of origin and precision had no significant influence (R² = 0.44).</P>
<P>Again, post-hoc analyses using available data for a variety of self-rating instruments from 10 trials comparing hypericum extracts and standard antidepressants confirmed analyses based on physician-rated outcomes. The pooled SMD was 0.01 (95%CI -0.13 to 0.15; I² = 43%; see comparison 5.10). The pooled SMDs in trials from German-speaking countries was -0.02 compared to 0.10 in trials from other countries (comparison 5.11).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Safety</HEADING>
<P>
<I>Primary outcome</I>
<BR/>Patients allocated to hypericum extracts were less likely to drop out from studies due to adverse effects than patients allocated to older standard antidepressants (OR = 0.24; 95%CI 0.13 to 0.46; I² = 0%) or to SSRIs (OR = 0.53; 95%CI 0.34 to 0.83; I² = 0%; see comparison 6.1 and <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>).</P>
<P>
<I>Secondary outcomes</I>
<BR/>Attrition for any reason was significantly lower for hypericum extracts compared to older antidepressants (OR = 0.67; 95%CI 0.47 to 0.95; I² = 0%), but not compared to SSRIs (OR = 0.83; 95% 0.63 to 1.08; I² = 0%; see comparison 6.2).</P>
<P>The number of patients reporting side effects was significantly higher in patients receiving older standard antidepressants (OR = 0.39; 95% 0.30 to 0.50; I² =0%); compared to SSRIs, the difference just missed significance (OR = 0.70; 95%CI 0.49 to 1.00; I² =57%; see comparison 6.3).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-08-06 18:32:15 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2008-08-06 18:31:38 +0100" MODIFIED_BY="[Empty name]">
<P>Overall, the findings from newer trials seem to corrobate the evidence in favour of hypericum extracts. The available data suggest that the hypericum extracts tested in the included trials a) are superior to placebo in patients with major depression; b) are similarly effective as standard antidepressants; c) and have less side effects than standard antidepressants. There are two issues which complicate the interpretation of our findings: 1) While the influence of precision on study results in placebo-controlled trials is less pronounced in this updated version of our review compared to the previous version (<LINK REF="REF-Linde-2005a" TYPE="REFERENCE">Linde 2005a</LINK>), results from more precise trials still show smaller effects over placebo than less precise trials. 2) Results from German-language countries are considerably more favourable for hypericum than trials from other countries.</P>
<SUBSECTION>
<HEADING LEVEL="3">Interpretation of the findings and limitations</HEADING>
<P>For this update we excluded for the first time from our review all trials which were not restricted to patients with major depression. This does not mean that we believe that major depression is necessarily the only or best indication for hypericum extracts. Some authors argue that patients with signs of atypical depression might be particularly suited for treatment with hypericum extracts (<LINK REF="REF-Murck-2002" TYPE="REFERENCE">Murck 2002</LINK>, <LINK REF="REF-Murck-2005" TYPE="REFERENCE">Murck 2005</LINK>), the National Institutes of Health are currently funding a trial in patients with minor depression (www.clinicaltrials.gov, identifier NCT00048815), and the findings from older trials (some of which, however, seem methodologically questionable) not restricted to patients with major discussion were very positive (<LINK REF="REF-Linde-1998" TYPE="REFERENCE">Linde 1998</LINK>). As pointed out in the introduction, we now focus on major depression to make our review better comparable to overviews on standard antidepressants, to have a more comparable set of studies for analysis, and also because almost all new trials of hypericum extracts are on this indication.</P>
<P>In spite of the tightened inclusion criteria, the findings of the placebo-controlled trials are still quite heterogeneous. In the trials a variety of hypericum extracts has been tested and daily doses cover a wide range. Differences in the interventions might contribute to some extent to the observed heterogeneity, but they do not seem to be a major factor. In three of four subgroup analyses of single extracts there was strong heterogeneity; for one extract the 95% confidence intervals of the two available trials (<LINK REF="STD-Gastpar-2006" TYPE="STUDY">Gastpar 2006</LINK>; <LINK REF="STD-Uebelhack-2004" TYPE="STUDY">Uebelhack 2004</LINK>) did not even overlap, indicating that the results are hardly compatible. However, some of the factors leading to considerable heterogeneity between study findings could be identified. Considering country of origin, precision, and baseline depression severity of included patients explained 50 to 60 percent of the variance between trial results in comparisons with placebo and 20 to 40 percent in comparison with standard antidepressants. Nevertheless, it has to be stated that meta-regression analyses are (even if a priori defined) entirely of observative nature. Findings on the association of baseline depression severity and effect size estimates may be biased through structural dependence and regression to the mean, and thus should be interpreted with caution (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). Furthermore, inferences drawn from a meta-regression analysis on aggregate data may differentiate from inferences drawn from a meta-regression analysis on individual data (<LINK REF="REF-Deeks-2006" TYPE="REFERENCE">Deeks 2006</LINK>; e.g. 'ecological bias').</P>
<P>The finding that more precise placebo-controlled trials yielded less positive results than less precise trials could indicate publication bias (trials with positive results are more likely to be published than trials with negative results) or bias within studies (smaller trials with less rigorous methods yielding overoptimistic results). We cannot rule out, but doubt, that selective publication of overoptimistic results in small trials strongly influences our findings. There is some evidence that "negative" trials without demonstrable differences between extracts and placebo were published less often as full articles than trials with "positive" findings. Our extensive searches identified three "negative" trials that were only published as abstracts or theses. Two that were conducted in the early 1990s (these were included in earlier versions of this review <LINK REF="REF-Linde-1996" TYPE="REFERENCE">Linde 1996</LINK>; <LINK REF="REF-Linde-1998" TYPE="REFERENCE">Linde 1998</LINK>; <LINK REF="REF-Linde-2005a" TYPE="REFERENCE">Linde 2005a</LINK>) involved patients without documented major depression (<LINK REF="STD-K_x00f6_nig-1993" TYPE="STUDY">König 1993</LINK>; <LINK REF="STD-Osterheider-1992" TYPE="STUDY">Osterheider 1992</LINK>), and one that was conducted in the late 1990s involved patients with major depression (<LINK REF="STD-Montgomery-2000" TYPE="STUDY">Montgomery 2000</LINK>). One positive trial included in our last update, but now excluded, was published as an abstract and as a chapter in a not widely available book (<LINK REF="STD-Winkel-2000" TYPE="STUDY">Winkel 2000</LINK>). One comparably large, positive trial (<LINK REF="STD-Bracher-2001" TYPE="STUDY">Bracher 2001</LINK>) has been published only in a short report as a supplement to a German medical newspaper. This trial is an example that sponsors or manufacturers of herbal medicines sometimes have very limited interest in a major publication if their trial includes a new aspect (in that case a once daily dosage), as there is no patent protection for herbal extracts and results can be exploited by competitors, too. We suspect that there are few additional relevant unpublished trials. Few manufacturers of hypericum extracts sponsor research trials, and the five manufacturers whose products were tested in most of the trials told us they had (with the exception of one smaller negative trial) no other unpublished trials that possibly met our inclusion criteria. Through personal communication we were informed that there are at least one or two unpublished negative trials on tea preparations of Hypericum. However, tea preparations are phytochemically very different from alcoholic extracts and have to be evaluated separately.</P>
<P>We found that the quality of the majority of trials was adequate, and we detected no systematic differences in design aspects known to be potential sources of bias. All trials were double-blind. Though adequacy of blinding was not formally assessed in most trials, achieving similarity between hypericum and placebo preparations is not particularly difficult. All trials were randomised, and most concealed allocation assignments by using consecutively numbered identical medication containers. Reported drop-out rates were low in the majority of trials. Investigators involved in older trials may have had less training and/or experience with diagnostic standards and rating scales for depressive symptoms (<LINK REF="STD-Shelton-2001" TYPE="STUDY">Shelton 2001</LINK>), but this issue, if true, is likely to affect generalisation of findings rather than internal validity. Finally, though we found no systematic differences in major factors generally related to trial quality, our subjective judgement was that larger trials tended to be of better quality than smaller trials. The dosages of standard antidepressants were (with two exceptions) within the range recommended in current guidelines (e.g., <LINK REF="REF-H_x00e4_rter-2003" TYPE="REFERENCE">Härter 2003</LINK>), but at the lower limit.</P>
<P>Our finding that studies from German-speaking countries yielded more favourable results than trials performed elsewhere is difficult to interpret. As our analyses are partly data-driven, they must be considered cautiously. However, the consistency and extent of the observed association suggest that there are important differences in trials performed in different countries. One possibility is that studies performed in German-speaking countries with a long history of hypericum prescription by physicians enrolled slightly different patients in spite of similar inclusion criteria. With one exception (the extremely positive trial by <LINK REF="STD-Uebelhack-2004" TYPE="STUDY">Uebelhack 2004</LINK> performed in a research clinic of a contract research organisation), all German studies recruited patients in private practices, while a number of trials from other countries were performed in academic research settings or hospital outpatient units. Depression with atypical or reversed vegetative features might be present more often in primary care outpatient populations (<LINK REF="REF-Murck-2005" TYPE="REFERENCE">Murck 2005</LINK>).The trend that trials with higher HAMD baseline values reported slightly less favourable results also suggests that effectiveness of hypericum extracts might differ between subgroups of depressive patients. While we did not systematically investigate this issue, it seems to us that the trials from countries other than Germany might be more often investigator-initiated. A closer link of trial planning, performance and analysis with manufacturer interests might influence study findings. This could result possibly in true bias, but also in conditions making a true positive outcome more likely. For example, for at least three trials (<LINK REF="STD-Kasper-2006" TYPE="STUDY">Kasper 2006</LINK>; <LINK REF="STD-Schrader-1998" TYPE="STUDY">Schrader 1998</LINK>; <LINK REF="STD-Uebelhack-2004" TYPE="STUDY">Uebelhack 2004</LINK>) with large effects performed in German-speaking countries authors or sponsors reported in the publication or in personal communications that contact times and interaction with patients were limited to minimise placebo response rates. Increasing placebo group response rates due to the intensive care and monitoring in antidepressant trials are considered by some researchers as a potential reason for the problem to show specific effects (<LINK REF="REF-Posternak-2007" TYPE="REFERENCE">Posternak 2007</LINK>). One could also speculate whether unblinding might lead German physicians (who often use hypericum extracts in their usual practice) to give more positive ratings and (the possibly more sceptic) colleagues from elsewhere to more negative ratings. However, as hypericum extracts have no characteristic side effects such a problem seems only relevant in comparisons with standard antidepressants.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<POTENTIAL_BIASES MODIFIED="2008-08-06 18:32:15 +0100" MODIFIED_BY="[Empty name]">
<P>The work for the first version of this review started in 1993 and three previous versions are available (<LINK REF="REF-Linde-1996" TYPE="REFERENCE">Linde 1996</LINK>; <LINK REF="REF-Linde-1998" TYPE="REFERENCE">Linde 1998</LINK>; <LINK REF="REF-Linde-2005a" TYPE="REFERENCE">Linde 2005a</LINK>). During that period a large number of new trials became available, diagnostic classifications used for including patients into studies have changed and the quality of trials has improved. In parallel the methods of our review were adapted. The changes over time make it difficult to report our searches and their results in a consistent and transparent manner. The way how we approached authors/sponsors for obtaining missing information and the contents of inquiries were not fully systematic and have changed over time. This could imply that additional data necessary for some secondary analyses were obtained for a selected subset of studies. However, data for the main analysis were available for all or almost all trials, therefore, major biases seem highly unlikely. A potential source of bias in the responder analyses could be slightly variable responder definitions in the primary studies. Response according to the HAMD was either defined as at least 50% reduction, a HAMD score &lt; 10 (or 11) after treatment, at least one or the combination of both. Whether these definitions were truly made a priori in each study could not be assessed. Decisions on the inclusion of subgroup analyses (for example, regarding precision or country effects) for updates were driven by findings in previous versions of the review. Therefore, these analyses must be interpreted with caution. Publication and small study bias have been discussed in the previous section.</P>
</POTENTIAL_BIASES>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-08-06 18:35:01 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2008-08-06 18:34:40 +0100" MODIFIED_BY="[Empty name]">
<P>In older systematic reviews and meta-analyses of hypericum extracts (<LINK REF="REF-Ernst-1995" TYPE="REFERENCE">Ernst 1995</LINK>; <LINK REF="REF-Linde-1996" TYPE="REFERENCE">Linde 1996</LINK>; <LINK REF="REF-Linde-1998" TYPE="REFERENCE">Linde 1998</LINK>; <LINK REF="REF-Kim-1999" TYPE="REFERENCE">Kim 1999</LINK>; <LINK REF="REF-Gaster-2000" TYPE="REFERENCE">Gaster 2000</LINK>; <LINK REF="REF-Williams-2000" TYPE="REFERENCE">Williams 2000</LINK>) the findings of the included studies were mostly positive, but reviewers drew cautious conclusions due to methodological limitations. The quality of trials on average clearly improved over recent years. However, study findings became more often contradictory, and in the last version of our review larger trials restricted to patients with major depression showed only minimal effects over placebo (<LINK REF="REF-Linde-2005a" TYPE="REFERENCE">Linde 2005a</LINK>). With the addition of several new, partly large trials, the cumulative evidence now suggests that hypericum extract have a modest effect over placebo in a similar range as standard antidepressants (<LINK REF="REF-Kirsch-2008" TYPE="REFERENCE">Kirsch 2008</LINK>; <LINK REF="REF-Turner-2008" TYPE="REFERENCE">Turner 2008</LINK>). The direct comparisons with older antidepressants and selective serotonine reuptake inhibitors seem to confirm this impression. The available clinical trials now also show that hypericum extracts have fewer side effects than both older antidepressants and selective serotonine reuptake inhibitors. This would imply that an attempt of treating mild to moderate major depression with one of the hypericum preparations positively tested in clinical trials is clearly justified. However, the differences in the findings from different countries make clear-cut recommendations difficult. The evidence for severe major depression is still insufficient to draw conclusions.</P>
<P>Many patients buy St John's wort products from health food stores and might not disclose this to their physicians (<LINK REF="REF-Smith-2004" TYPE="REFERENCE">Smith 2004</LINK>). Such uncontrolled use is problematic as serious interactions can occur with a number of frequently used drugs (<LINK REF="REF-Ernst-1999" TYPE="REFERENCE">Ernst 1999</LINK>; <LINK REF="REF-Hammerness-2003" TYPE="REFERENCE">Hammerness 2003</LINK>; <LINK REF="REF-Kn_x00fc_ppel-2004" TYPE="REFERENCE">Knüppel 2004</LINK>; <LINK REF="REF-Whitten-2006" TYPE="REFERENCE">Whitten 2006</LINK>). Therefore, physicians should regularly ask their patients about hypericum intake. However, it must be kept in mind that drug interactions are not a problem unique to hypericum extracts, but also common for standard antidepressants (<LINK REF="REF-Nieuwstraten-2006" TYPE="REFERENCE">Nieuwstraten 2006</LINK>).</P>
<P>It has to be emphasised that the quality of hypericum preparations can differ considerably. The composition of a product depends on the raw plant material used, the extraction process, and the solvents. In consequence, the amounts of bioactive constituents in different products can vary enormously. A recent study has shown that a number of products available on the German market contain only minor amounts of bioactive constitutents (<LINK REF="REF-Wurglics-2003" TYPE="REFERENCE">Wurglics 2003</LINK>). The hypericum extracts tested in clinical trials have to be considered high quality products. Results obtained with these extracts cannot be extrapolated directly to other products. In our meta-analysis, the type of extract did not contribute to the explanation of heterogeneity. This does not mean, however, that all products tested in the available trials are equally effective. Standardisation of a product on a defined component (for example, hyperforin or hypericin) does not resolve the problem, as currently the exact mechanism for the antidepressant effects of hypericum extracts is still unclear, and available research indicates that several components are relevant. The findings of this review most likely apply to products (using ethanol 50 to 60% or methanol 80% for extraction from dried plant material) with daily extract dosages of 500 to 1200 mg with a ratio of raw material to extract of 3-7:1.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-08-06 18:35:01 +0100" MODIFIED_BY="[Empty name]">
<P>There is a clear need to investigate the reasons for the differences in findings from trials originating from German-speaking countries and those from other countries. Mulitnational trials would seem desirable, but it is unlikely that there will be funding for such studies in the near future. Individual patient data meta-analysis of existing trials could be a possible tool to investigate predictors of treatment response in a more accurate manner. The authors will try to obtain such data from researchers and/or sponsors.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>The authors would like to thank <BR/>- the researchers and sponsors who provided additional information on trials<BR/>- Eva Israel and Karsten Schmidt who helped with assessing eligibility and doing extractions<BR/>- Cindy Mulrow and Matthias Egger who were involved in previous versions of the review</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>Michael Berner has received a grant for research on hypericum in the past and has received fees for speaking on conferences from a manufacturer (Schwabe). Klaus Linde once received reimbursement for travel expenses for speaking on a meeting organised by a manufacturer (Schwabe). Levente Kriston once received reimbursement for travel expenses (Schwabe).</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-07-10 08:56:56 +0100" MODIFIED_BY="[Empty name]">
<P>Study concept and design: Linde, Berner, Kriston<BR/>Acquisition of data: Linde, Berner, Kriston<BR/>Analysis and interpretation of data: Linde, Berner, Kriston<BR/>Drafting and revision of the manuscript: Linde, Berner, Kriston<BR/>Statistical expertise: Kriston<BR/>Study coordination: Linde</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-07-28 10:41:56 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2009-07-28 10:41:56 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2009-07-28 10:38:00 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Behnke-2002" MODIFIED="2009-07-28 10:37:05 +0100" MODIFIED_BY="[Empty name]" NAME="Behnke 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-07-28 10:37:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Behnke K, Jensen GS, Graubaum HJ, Gruenwald J</AU>
<TI>Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression</TI>
<SO>Advances in Therapy</SO>
<YR>2002</YR>
<VL>19</VL>
<PG>43-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bjerkenstedt-2005" MODIFIED="2008-07-10 08:59:09 +0100" MODIFIED_BY="[Empty name]" NAME="Bjerkenstedt 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-10 08:59:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bjerkenstedt L, Edman GV, Alken RG, Mannel M</AU>
<TI>Hypericum extract LI 160 and fluoxetine in mild to moderate depression. A randomized, placebo-controlled multi-center study in outpatients</TI>
<SO>European Archives of Psychiatry and Clinical Neuroscience</SO>
<YR>2005</YR>
<VL>255</VL>
<PG>40-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bracher-2001" MODIFIED="2008-07-02 14:36:27 +0100" MODIFIED_BY="[Empty name]" NAME="Bracher 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-07-02 14:36:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bracher A</AU>
<TI>Trial on HYP611 confirms effectiveness</TI>
<TO>HYP611-Studie bestätigt Wirksamkeit</TO>
<SO>Ärztliche Praxis</SO>
<YR>2001</YR>
<VL>51 (suppl.)</VL>
<PG>3-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brenner-2000" MODIFIED="2008-07-10 09:00:06 +0100" MODIFIED_BY="[Empty name]" NAME="Brenner 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-10 08:59:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brenner R, Azbel V, Madhusoodanan S, Pawlowska M</AU>
<TI>Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study</TI>
<SO>Clinical Therapeutics</SO>
<YR>2000</YR>
<VL>22</VL>
<PG>411-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:00:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brenner R, Madhusoodanan S, Pawlowska M</AU>
<TI>Efficacy of continuation treatment with hypericum perforatum in depression</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2002</YR>
<VL>63</VL>
<PG>455</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fava-2005" MODIFIED="2008-07-10 09:20:00 +0100" MODIFIED_BY="[Empty name]" NAME="Fava 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-10 09:20:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF</AU>
<TI>A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder</TI>
<SO>Journal of Clinical Psychopharmacology</SO>
<YR>2005</YR>
<VL>25</VL>
<PG>441-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Gastpar-2005" NAME="Gastpar 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gastpar M, Singer A, Zeller K</AU>
<TI>Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline</TI>
<SO>Pharmacopsychiatry</SO>
<YR>2005</YR>
<VL>38</VL>
<PG>78-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Gastpar-2006" NAME="Gastpar 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gastpar M, Singer A, Zeller K</AU>
<TI>Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study</TI>
<SO>Pharmacopsychiatry</SO>
<YR>2006</YR>
<VL>39</VL>
<PG>66-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Harrer-1993" MODIFIED="2008-07-10 09:21:14 +0100" MODIFIED_BY="[Empty name]" NAME="Harrer 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-10 09:21:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harrer G, Hübner WD, Podzuweit H</AU>
<TI>Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multi-center double-blind study</TI>
<SO>Journal of Geriatric Psychiatry and Neurology</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>suppl 1</NO>
<PG>S24-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harrer G, Hübner WD, Podzuweit H</AU>
<TI>Wirksamkeit und Verträglichkeit des Hypericum-Präparates LI 160 im Vergleich mit Maprotilin</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>297-301</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harrer-1999" MODIFIED="2008-07-10 09:21:33 +0100" MODIFIED_BY="[Empty name]" NAME="Harrer 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-07-10 09:21:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harrer G, Schmidt U, Kuhn U, Biller A</AU>
<TI>Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine</TI>
<SO>Arzneimittel-Forschung/Drug Research</SO>
<YR>1999</YR>
<VL>49</VL>
<PG>289-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-HDTSG-2002" MODIFIED="2009-07-28 10:38:00 +0100" MODIFIED_BY="[Empty name]" NAME="HDTSG 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-07-28 10:38:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hypericum Depression Trial Study Group</AU>
<TO>Effect of Hypericum perforatum (St John's wort) in major depressive disorder. A randomized controlled trial</TO>
<SO>JAMA</SO>
<YR>2002</YR>
<VL>287</VL>
<PG>1807-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:22:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vitiello B, Shader RI, Parker CB, Ritz L, Harlan W, Greenblatt DJ, Gadde KM, Krishnan KRR, Davidson JRT</AU>
<TI>Hyperforim plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial</TI>
<SO>Journal of Clin Psychopharmacology</SO>
<YR>2005</YR>
<VL>25</VL>
<PG>243-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-H_x00e4_nsgen-1996" MODIFIED="2008-07-10 09:22:56 +0100" MODIFIED_BY="[Empty name]" NAME="Hänsgen 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-07-10 09:22:31 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;H&amp;#228;ngsen KD, Vesper J. Antidepressive Wirksamkeit eines hochdosierten Hypericum-Extraktes. Muench med Wschr 1996; 138:(3)29-33.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:22:31 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hängsen KD, Vesper J</AU>
<TI>Antidepressive Wirksamkeit eines hochdosierten Hypericum-Extraktes</TI>
<SO>Muenchener medizinische Wochenschrift</SO>
<YR>1996</YR>
<VL>138</VL>
<NO>3</NO>
<PG>29-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:22:37 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;H&amp;#228;nsgen KD, Vesper J, Ploch M. Multizentrische Doppelblindstudie zur antidepressiven Wirksamkeit des Hypericumextraktes LI 160. Nervenheilkunde 1993;12:285-289&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:22:37 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hänsgen KD, Vesper J, Ploch M</AU>
<TI>Multizentrische Doppelblindstudie zur antidepressiven Wirksamkeit des Hypericumextraktes LI 160</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>285-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:22:56 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Vesper J, Ploch M. Multi-center double-blind study examinng the antidepressant effectiveness of the hypericum extract LI 160. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S15-18&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:22:56 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesper J, Ploch M</AU>
<TI>Multi-center double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160</TI>
<SO>Journal of Geriatric Psychiatry and Neurology</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>suppl 1</NO>
<PG>S15-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kalb-2001" NAME="Kalb 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kalb R, Trautmann-Sponsel RD, Kieser M</AU>
<TI>Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly depressed patients</TI>
<SO>Pharmacopsychiatry</SO>
<YR>2001</YR>
<VL>34</VL>
<PG>96-103</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Kasper-2006" MODIFIED="2008-07-08 13:20:53 +0100" MODIFIED_BY="[Empty name]" NAME="Kasper 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M</AU>
<TI>Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placeb-controlled, multi-center trial [ISRCTN77277298]</TI>
<SO>BMC Medicine</SO>
<YR>2006</YR>
<VL>4</VL>
<PG>14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laakmann-1998" MODIFIED="2008-07-10 09:24:02 +0100" MODIFIED_BY="[Empty name]" NAME="Laakmann 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-07-10 09:23:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laakmann G, Dienel A, Kieser M</AU>
<TI>Clinical significance of hyperforin for the efficacy of hypericum extracts on depressive disorders of different severities</TI>
<SO>Phytomedicine</SO>
<YR>1998</YR>
<VL>5</VL>
<PG>435-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:24:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laakmann G, Schüle C, Baghai T, Kieser M</AU>
<TI>St John's wort in mild and moderate depression: the relevance of hyperforin for the clinical efficacy</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1998</YR>
<VL>31 (suppl)</VL>
<PG>54-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lecrubier-2002" MODIFIED="2008-07-10 09:24:31 +0100" MODIFIED_BY="[Empty name]" NAME="Lecrubier 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-07-10 09:24:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lecrubier Y, Bech P</AU>
<TI>The Ham D6 is more homogeneous and as sensitive as the Ham D17</TI>
<SO>European Psychiatry</SO>
<YR>2007</YR>
<VL>22</VL>
<PG>252-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:24:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lecrubier Y, Clerc G, Didi R, Kieser M</AU>
<TI>Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2002</YR>
<VL>159</VL>
<PG>1361-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Montgomery-2000" NAME="Montgomery 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;In addition copy of poster presented at the Phytomedicine Congress 2000, Munich&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Montgomery SA, Hübner WD, Grigoleit HG</AU>
<TI>Efficacy and tolerability of St. John's wort extract compared with placebo in patients with a mild to moderate depressive disorder</TI>
<SO>Phytomedicine</SO>
<YR>2000</YR>
<VL>7 (suppl II)</VL>
<PG>107</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moreno-2005" MODIFIED="2008-07-10 09:25:16 +0100" MODIFIED_BY="[Empty name]" NAME="Moreno 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-10 09:25:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moreno RA, Teng CT, de Almeida KM, Tavares H jr</AU>
<TI>Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression: a randomized double-blind trial in a Brazilian sample</TI>
<SO>Revista Brasileira de Psiquiatria</SO>
<YR>2005</YR>
<VL>28</VL>
<PG>29-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Philipp-1999" MODIFIED="2008-07-10 09:25:31 +0100" MODIFIED_BY="[Empty name]" NAME="Philipp 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-07-10 09:25:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Philipp M, Kohnen R, Hiller KO</AU>
<TI>Hypericum extract versus imipramine or placebo in patients with moderate depression: randomized multicentre study of treatment for 8 weeks</TI>
<SO>BMJ</SO>
<YR>1999</YR>
<VL>319</VL>
<PG>1534-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Schrader-1998" MODIFIED="2008-07-10 09:26:23 +0100" MODIFIED_BY="[Empty name]" NAME="Schrader 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-07-10 09:26:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schrader E, Meier B, Brattström A</AU>
<TI>Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, mulitcentre study</TI>
<SO>Human Psychopharmacology</SO>
<YR>1998</YR>
<VL>13</VL>
<PG>163-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Schrader-2000" MODIFIED="2008-07-10 09:26:41 +0100" MODIFIED_BY="[Empty name]" NAME="Schrader 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-10 09:26:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schrader E</AU>
<TI>Equivalence of St John's wort (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression</TI>
<SO>International Clinical Psychopharmacology</SO>
<YR>2001</YR>
<VL>15</VL>
<PG>61-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Shelton-2001" MODIFIED="2008-07-10 09:27:15 +0100" MODIFIED_BY="[Empty name]" NAME="Shelton 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-07-10 09:27:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gelenberg AJ, Shelton RC, Crits-Christoph P, Keller MB, Dunner DL, Hirschfeld RMA, Thase MAE, Russel JM, Lydiard RB, Gallop RJ, Todd L, Hellersteim DJ, Goodnick PJ, Keitner GI, Stahl SM, Halbreich U, Hopkins KS</AU>
<TI>The effectiveness of St. John's wort in major depressive disorder: a naturalistic phase 2 follow-up in which non-responders were provided alternate medication</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2004</YR>
<VL>65</VL>
<PG>1114-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:27:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, et al</AU>
<TI>Effectiveness of St. John's wort in major depression. A randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2001</YR>
<VL>285</VL>
<PG>1978-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Szegedi-2005" MODIFIED="2008-07-10 09:27:32 +0100" MODIFIED_BY="[Empty name]" NAME="Szegedi 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-10 09:27:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anghelescu IG, Kohnen R, Szegedi A, Klement S, Kieser M</AU>
<TI>Comparison of hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study</TI>
<SO>Pharmacopsychiatry</SO>
<YR>2006</YR>
<VL>39</VL>
<PG>213-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:27:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Szegedi A, Kohnen R, Dienel A, Kieser M</AU>
<TI>Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine</TI>
<SO>BMJ</SO>
<YR>2005</YR>
<VL>330</VL>
<PG>503-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Uebelhack-2004" MODIFIED="2008-07-10 09:28:04 +0100" MODIFIED_BY="[Empty name]" NAME="Uebelhack 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-07-10 09:28:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uebelhack R, Gruenwald J, Graubaum HJ, Busch R</AU>
<TI>Efficacy and tolerability of hypericum extract STW 3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial</TI>
<SO>Advances in Therapy</SO>
<YR>2004</YR>
<VL>21</VL>
<PG>265-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-van-Gurp-2002" MODIFIED="2008-07-10 09:27:53 +0100" MODIFIED_BY="[Empty name]" NAME="van Gurp 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-07-10 09:27:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Gurp G, Meterissian GB, Haiek LN, McCusker J, Bellavance F</AU>
<TI>St John's wort or sertraline? Randomized controlled trial in primary care</TI>
<SO>Canadian Family Physician</SO>
<YR>2002</YR>
<VL>48</VL>
<PG>905-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Volz-2000" MODIFIED="2008-07-10 09:28:10 +0100" MODIFIED_BY="[Empty name]" NAME="Volz 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-10 09:28:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Volz HP, Eberhardt R, Grilll G</AU>
<TI>Efficacy and tolerance of the St John's wort extract D-0496 in mild to moderate depression - a placebo-controlled, double-blind 6-week trial</TI>
<TO>Wirksamkeit und Verträglichkeit des Johanniskrautextraktes D-0496 bei leichten bis mittelschweren depressiven Episoden. Plazebokontrollierte Doppelblindstudie über 6 Wochen</TO>
<SO>Nervenheilkunde</SO>
<YR>2000</YR>
<VL>19</VL>
<PG>401-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Vorbach-1997" MODIFIED="2008-07-10 09:28:14 +0100" MODIFIED_BY="[Empty name]" NAME="Vorbach 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-07-10 09:28:14 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Vorbach EU, Arnoldt KH, H&amp;#252;bner WD. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry 1997; 30 (supp.2):81-85.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:28:14 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vorbach EU, Arnoldt KH, Hübner WD</AU>
<TI>Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1997</YR>
<VL>30</VL>
<NO>suppl.2</NO>
<PG>81-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Wheatley-1997" NAME="Wheatley 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Wheatley D. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial. Pharmacopsychiatry 1997; 30 (suppl.2):77-80.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wheatley D</AU>
<TI>LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1997</YR>
<VL>30</VL>
<NO>suppl.2</NO>
<PG>77-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Witte-1995" MODIFIED="2008-07-10 09:28:30 +0100" MODIFIED_BY="[Empty name]" NAME="Witte 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-07-10 09:28:30 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Witte B, Harrer G, Kaptan T, Podzuweit H, Schmidt U. Behandlung depressiver Verstimmungen mit einem hochkonzentrierten Hypericumpr&amp;#228;parat - eine multizentrische plazebokontrollierte Doppelblindstudie. Fortschr Med 1995; 113:(28)404-408.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:28:30 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Witte B, Harrer G, Kaptan T, Podzuweit H, Schmidt U</AU>
<TI>Behandlung depressiver Verstimmungen mit einem hochkonzentrierten Hypericumpräparat - eine multizentrische plazebokontrollierte Doppelblindstudie</TI>
<SO>Fortschritte der Medizin</SO>
<YR>1995</YR>
<VL>113</VL>
<PG>404-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Woelk-2000" MODIFIED="2008-07-10 09:28:54 +0100" MODIFIED_BY="[Empty name]" NAME="Woelk 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-10 09:28:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Woelk H for the Remotiv/Imipramine Study Group</AU>
<TI>Comparison of St John's wort and imipramine for treating depression: randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>321</VL>
<PG>536-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2009-07-28 10:41:56 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Agrawal-1994" MODIFIED="2008-07-10 09:29:19 +0100" MODIFIED_BY="[Empty name]" NAME="Agrawal 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-07-10 09:29:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agrawal A, Dixit SP, Dubey GP, Gupta BS</AU>
<TI>Clinical evaluation of anti-depressant properties of basant (hypericum perforatum)</TI>
<SO>Pharmacopsychoecologia</SO>
<YR>1994</YR>
<VL>7</VL>
<PG>253-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Albertini-1986" MODIFIED="2008-07-10 09:29:39 +0100" MODIFIED_BY="[Empty name]" NAME="Albertini 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-07-10 09:29:39 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Albertini H. Evaluation d'un traitement homeopathique de la nevralgie dentaire. In: Boiron J, Belon P, Hariveau E, eds. Recherche en homeopathie. Lyon: Fondation francaise pour la recheche en homeopathie, 1986;75-77.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:29:39 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Albertini H</AU>
<TI>Evaluation d'un traitement homeopathique de la nevralgie dentaire</TI>
<SO>Recherche en homeopathie</SO>
<YR>1986</YR>
<PG>75-7</PG>
<ED>Boiron J, Belon P, Hariveau E</ED>
<PB>Fondation francaise pour la recheche en homeopathie</PB>
<CY>Lyon</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bendre-1980" MODIFIED="2008-07-10 09:29:34 +0100" MODIFIED_BY="[Empty name]" NAME="Bendre 1980" YEAR="1980">
<REFERENCE MODIFIED="2008-07-10 09:29:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bendre VV, Dharmadhikari SD</AU>
<TI>Arnica montana and hypericum in dental practice</TI>
<SO>Hahnemann Gleanings</SO>
<YR>1980</YR>
<VL>47</VL>
<PG>70-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bergmann-1993" MODIFIED="2008-07-10 09:29:31 +0100" MODIFIED_BY="[Empty name]" NAME="Bergmann 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-10 09:29:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bergmann R, Nübner J, Demling J</AU>
<TI>Behandlung leichter bis mittelschwerer Depressionen</TI>
<SO>Therapiewoche Neurol Psychiatr</SO>
<YR>1993</YR>
<VL>7</VL>
<PG>235-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bernhadt-1993" NAME="Bernhadt 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Bernhardt M, Liske E, Ebeling L. Hypericum perforatum in der Therapie leichter bis mittelschwerer Depressionen: Vergleich der antidepressiven Wirksamkeit von zwei unterschiedlichen Dosierungsschemata. 5. Phytotherapie-Kongre&amp;#223;; Bonn 1993.&lt;/p&gt;" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Bernhardt M, Liske E, Ebeling L</AU>
<TI>Hypericum perforatum in der Therapie leichter bis mittelschwerer Depressionen: Vergleich der antidepressiven Wirksamkeit von zwei unterschiedlichen Dosierungsschemata</TI>
<SO>Bonn, 5. Phytotherapie-Kongreß</SO>
<YR>1993</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brockm_x00f6_ller-1997" NAME="Brockmöller 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Brockm&amp;#246;ller J, Reum T, Bauer S, Kerb R, H&amp;#252;bner WD, Roots I. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 1997; 30 (suppl.2):94-101.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brockmöller J, Reum T, Bauer S, Kerb R, Hübner WD, Roots I</AU>
<TI>Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1997</YR>
<VL>30</VL>
<NO>suppl.2</NO>
<PG>94-101</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Czekalla-1997" MODIFIED="2008-07-10 09:29:52 +0100" MODIFIED_BY="[Empty name]" NAME="Czekalla 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-07-10 09:29:52 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Czekalla J, Gastpar M, H&amp;#252;bner WD, J&amp;#228;ger D. The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine. Pharmacopschychiatry 1997; 30 (supp.2):86-88.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:29:52 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Czekalla J, Gastpar M, Hübner WD, Jäger D</AU>
<TI>The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine</TI>
<SO>Pharmacopschychiatry</SO>
<YR>1997</YR>
<VL>30</VL>
<NO>supp.2</NO>
<PG>86-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dittmer-1992" MODIFIED="2008-07-10 09:29:58 +0100" MODIFIED_BY="[Empty name]" NAME="Dittmer 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-07-10 09:29:58 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Dittmer TLJ. Die Behandlung von psychovegetativen St&amp;#246;rungen mit Johanniskraut-&amp;#214;l (Jukunda-Rot-&amp;#214;l-Kapseln). Naturheilpraxis mit Naturmedizin 1992;45,2:118-122.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:29:58 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dittmer TLJ</AU>
<TI>Die Behandlung von psychovegetativen Störungen mit Johanniskraut-Öl (Jukunda-Rot-Öl-Kapseln)</TI>
<SO>Naturheilpraxis mit Naturmedizin</SO>
<YR>1992</YR>
<VL>45</VL>
<PG>118-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ditzler-1992" MODIFIED="2008-07-10 09:30:15 +0100" MODIFIED_BY="[Empty name]" NAME="Ditzler 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-07-10 09:30:09 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Ditzler K, Gessner B, Schatton WFH, Willems M. Clinical trial on Neuropas versus placebo in patients with mild to moderate depressive symptoms: a placebo-controlled, randomised double-blind study. Complementary Therapies in Medicine 1994;2:5-13.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:30:09 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ditzler K, Gessner B, Schatton WFH, Willems M</AU>
<TI>Clinical trial on Neuropas versus placebo in patients with mild to moderate depressive symptoms: a placebo-controlled, randomised double-blind study</TI>
<SO>Complementary Therapies in Medicine</SO>
<YR>1994</YR>
<VL>2</VL>
<PG>5-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:30:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ditzler K, Schatton W</AU>
<TI>Johanniskraut bei leichten bis mittelschweren Depressionen - Ergebnisse einer plazebo-kontrollierten Doppelblindstudie</TI>
<SO>Heilkunst</SO>
<YR>1992</YR>
<VL>104</VL>
<PG>263-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gu-2001" MODIFIED="2008-07-10 09:30:31 +0100" MODIFIED_BY="[Empty name]" NAME="Gu 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-07-10 09:30:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gu N, Li H, Shu L. Zhang H, Weng Z, Ma C, Wang M</AU>
<TI>Multicenter study of St John's wort extract in treatment of mild to moderate depression</TI>
<SO>Chinese Journal of Clinical Pharmacy</SO>
<YR>2001</YR>
<VL>10</VL>
<PG>271-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Halama-1991" MODIFIED="2008-07-10 09:30:41 +0100" MODIFIED_BY="[Empty name]" NAME="Halama 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-07-10 09:30:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Halama P</AU>
<TI>Wirksamkeit des Hypericum-Extraktes LI 160 bei 50 Patienten einer psychiatrischen Fachpraxis</TI>
<SO>Nervenheilkunde</SO>
<YR>1991</YR>
<VL>10</VL>
<PG>305-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:30:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Halama P</AU>
<TI>Wirksamkeit des Johanniskrautextraktes LI 160 bei depressiver Verstimmung</TI>
<SO>Nervenheilkunde</SO>
<YR>1991</YR>
<VL>10</VL>
<PG>250-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Harrer-1991" MODIFIED="2008-07-10 09:30:55 +0100" MODIFIED_BY="[Empty name]" NAME="Harrer 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-07-10 09:30:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harrer G, Schmidt U, Kuhn U</AU>
<TI>"Alternative" Depressionsbehandlung mit einem Hypericum-Extrakt</TI>
<SO>Therapiewoche Neurologie</SO>
<YR>1991</YR>
<VL>5</VL>
<PG>710-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herberg-1992" MODIFIED="2008-07-10 09:31:02 +0100" MODIFIED_BY="[Empty name]" NAME="Herberg 1992" YEAR="1994">
<REFERENCE MODIFIED="2008-07-10 09:31:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herberg KW</AU>
<TI>Psychotrope Phytopharmaka im Test - Alternative zu synthetischen Psychopharmaka</TI>
<SO>Therapiewoche</SO>
<YR>1992</YR>
<VL>44</VL>
<PG>704-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hoffmann-1979" MODIFIED="2008-07-10 09:31:15 +0100" MODIFIED_BY="[Empty name]" NAME="Hoffmann 1979" YEAR="1979">
<REFERENCE MODIFIED="2008-07-10 09:31:15 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Hoffmann J, K&amp;#252;hl ED. Therapie von depressiven Zust&amp;#228;nden mit Hypericin. Z Allgemeinmed 1979;55,12:776-782.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:31:15 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hoffmann J, Kühl ED</AU>
<TI>Therapie von depressiven Zuständen mit Hypericin</TI>
<SO>Zeitschrift für Allgemeinmedizin</SO>
<YR>1979</YR>
<VL>55</VL>
<PG>776-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hottenrott-1997" MODIFIED="2008-07-10 09:31:31 +0100" MODIFIED_BY="[Empty name]" NAME="Hottenrott 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-07-10 09:31:31 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Hottenrott K, Sommer HM, Lehrl S, Hauer H. Der Einfluss von Vitamin E und Johanniskraut-Trockenextrakt auf die Ausdauerleistungsf&amp;#228;higkeit von Wettkampfsportlern. Eine placebo-kontrollierte Doppelblindstudie mit Langstreckenl&amp;#228;ufern und Triathleten. Deutsche Zeitschrift f&amp;#252;r Sportmedizin 1997; 48:22-27.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:31:31 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hottenrott K, Sommer HM, Lehrl S, Hauer H</AU>
<TI>Der Einfluss von Vitamin E und Johanniskraut-Trockenextrakt auf die Ausdauerleistungsfähigkeit von Wettkampfsportlern. Eine placebo-kontrollierte Doppelblindstudie mit Langstreckenläufern und Triathleten</TI>
<SO>Deutsche Zeitschrift für Sportmedizin</SO>
<YR>1997</YR>
<VL>48</VL>
<PG>22-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-H_x00e4_ring-1996" NAME="Häring 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;H&amp;#228;ring B, Hauns B, Hermann C, H&amp;#252;bner WD, Maier-Lenz H, Marschner N. A double-blind, placebo-controlled pilot study of LI 160 in combination with chemotherapy in pationts with solid tumors. In: Abstracts of the 2nd International Congress  on Phytomedicine. M&amp;#252;nchen: 1996:SL-88.&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Häring B, Hauns B, Hermann C, Hübner WD, Maier-Lenz H, Marschner N</AU>
<TI>A double-blind, placebo-controlled pilot study of LI 160 in combination with chemotherapy in patients with solid tumors</TI>
<SO>Abstracts of the 2nd International Congress on Phytomedicine</SO>
<YR>1996</YR>
<PG>SL-88</PG>
<CY>Munich</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-H_x00fc_bner-1993" MODIFIED="2008-07-10 09:32:15 +0100" MODIFIED_BY="[Empty name]" NAME="Hübner 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hübner WD, Lande S, Podzuweit H</AU>
<TI>Behandlung larvierter Depressionen mit Johanniskraut</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>278-280</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:32:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hübner WD, Lande S, Podzuweit H</AU>
<TI>Hypericum treatment of mild depression with somatic symptoms</TI>
<SO>Journal of Geriatric Psychiatry and Neurology</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>suppl 1</NO>
<PG>S12-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-1992" MODIFIED="2008-07-10 09:33:59 +0100" MODIFIED_BY="[Empty name]" NAME="Johnson 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-07-10 09:33:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Johnson D, Siebenhüner G, Hofer E, Sauerwein-Giese E, Frauendorf A</AU>
<TI>Einfluß von Johanniskraut auf die ZNS-Aktivität</TI>
<SO>Neurologie und Psychiatrie</SO>
<YR>1992</YR>
<VL>6</VL>
<PG>436-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:33:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson D</AU>
<TI>Neurophysiologische Wirkungen von Hypericum im Doppelblindversuch mit Probanden</TI>
<SO>Nervenheilkunde</SO>
<YR>1991</YR>
<VL>10</VL>
<PG>316-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-1993" MODIFIED="2008-07-10 09:34:47 +0100" MODIFIED_BY="[Empty name]" NAME="Johnson 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-10 09:34:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson D, Ksciuk H, Woelk H, Sauerwein-Giese E, Frauendorf A</AU>
<TI>Effetcs of hypericum extract LI 160 compared with maprotiline on resting EEG and evoked potentials in 24 volunteers</TI>
<SO>Journal of Geriatric Psychiatry and Neurology</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>suppl 1</NO>
<PG>S44-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:34:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson D, Ksciuk H, Woelk H, Sauerwein-Giese E, Frauendorf A</AU>
<TI>Wirkungen mit Johanniskraut-Extrakt LI 160 im Vergleich mit Maprotilin auf Ruhe-EEG und evozierte Potentiale bei 24 Probanden</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>328-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Kniebel-1988" MODIFIED="2008-07-10 09:35:12 +0100" MODIFIED_BY="[Empty name]" NAME="Kniebel 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-07-10 09:35:01 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Hiller KO, Rahlfs V. Therapeutische &amp;#196;quivalenz eines hochdosierten Phytopharmakons mit Amitriptylin bei &amp;#228;ngstlich-depressiven Verstimmungen - Reanalyse einer randomisierten Studie unter besonderer Beachtung biometrischer und klinischer Aspekte. Forschende Komplement&amp;#228;rmedizin 1995;2:123-132.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:35:01 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hiller KO, Rahlfs V</AU>
<TI>Therapeutische Äquivalenz eines hochdosierten Phytopharmakons mit Amitriptylin bei ängstlich-depressiven Verstimmungen - Reanalyse einer randomisierten Studie unter besonderer Beachtung biometrischer und klinischer Aspekte</TI>
<SO>Forschende Komplementärmedizin</SO>
<YR>1995</YR>
<VL>2</VL>
<PG>123-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:35:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kniebel R, Burchard JM</AU>
<TI>Zur Therapie depressiver Verstimmungen in der Praxis</TI>
<SO>Zeitschrift für Allgemeinmedizin</SO>
<YR>1988</YR>
<VL>64</VL>
<PG>689-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kugler-1990a" MODIFIED="2008-07-10 09:35:37 +0100" MODIFIED_BY="[Empty name]" NAME="Kugler 1990a" YEAR="1990">
<REFERENCE MODIFIED="2008-07-10 09:35:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kugler J, Weidenhammer W, Schmidt A, Groll S</AU>
<TO>Therapie depressiver Zustände. Hypericum-Extrakt Steigerwald als Alternative zur Benzodiazepin-Behandlung</TO>
<SO>Zeitschrift für Allgemeinmedizin</SO>
<YR>1990</YR>
<VL>66 (suppl 1)</VL>
<PG>21-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kugler-1990b" MODIFIED="2008-07-10 09:35:47 +0100" MODIFIED_BY="[Empty name]" NAME="Kugler 1990b" YEAR="1990">
<REFERENCE MODIFIED="2008-07-10 09:35:47 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Kugler J, Schmidt A, Groll S, Weidenhammer W. Zur Pharmakodynamik eines Hypericum-Extraktes. Untersuchungen bei Patienten mit depressiven Zust&amp;#228;nden im Vergleich zu Bromazepam und Placebo. Zeitschrift fuer Allgemeinmedizin 1990;66:13-20.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:35:47 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kugler J, Schmidt A, Groll S, Weidenhammer W</AU>
<TI>Zur Pharmakodynamik eines Hypericum-Extraktes. Untersuchungen bei Patienten mit depressiven Zuständen im Vergleich zu Bromazepam und Placebo</TI>
<SO>Zeitschrift für Allgemeinmedizin</SO>
<YR>1990</YR>
<VL>66</VL>
<NO>suppl.</NO>
<PG>13-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-K_x00f6_nig-1993" NAME="König 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;K&amp;#246;nig CD. Hypericum perforatum L. (gemeines Johanniskraut) als Therapeutikum bei depressiven Verstimmungszust&amp;#228;nden - eine Alternative zu synthetischen Arzneimitteln. Thesis, University of Basel, 1993&lt;/p&gt;" PRIMARY="NO" TYPE="BOOK">
<AU>König CD</AU>
<SO>Hypericum perforatum L. (gemeines Johanniskraut) als Therapeutikum bei depressiven Verstimmungszuständen - eine Alternative zu synthetischen Arzneimitteln</SO>
<YR>1993</YR>
<PB>Thesis</PB>
<CY>University of Basel</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lehrl-1993" MODIFIED="2008-07-10 09:36:07 +0100" MODIFIED_BY="[Empty name]" NAME="Lehrl 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-10 09:36:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lehrl S, Woelk H</AU>
<TI>Ergebnisse von Messungen der kognitiven Leistungsfähigkeit bei Patienten unter der Therapie mit Johanniskraut</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>281-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:36:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lehrl S, Woelk H</AU>
<TI>Psychometrische Messung der Leistungkapazität unter antidepressiver Therapie mit Johanniskraut</TI>
<SO>Nervenheilkunde</SO>
<YR>1991</YR>
<VL>10</VL>
<PG>313-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lenoir-1999" MODIFIED="2009-07-28 10:41:56 +0100" MODIFIED_BY="[Empty name]" NAME="Lenoir 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-07-28 10:41:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lenoir S, Degenring FH, Saller R</AU>
<TI>A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoot tips of hypericum perforatum L</TI>
<SO>Phytomedicine</SO>
<YR>1999</YR>
<VL>6</VL>
<PG>141-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2005" MODIFIED="2008-07-10 09:36:24 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-10 09:36:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li YM, Li GY, Wang XL, &amp; Yu LF</AU>
<TI>Rehabilitation effect of Saint John's Wort extract on depression and myocardial function after coronary artery bypass grafting: A randomized grouping, placebo-control and blind evaluation</TI>
<SO>Chinese Journal of Clinical Rehabilitation</SO>
<YR>2005</YR>
<VL>9</VL>
<NO>28</NO>
<PG>38-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maisenbacher-1995" NAME="Maisenbacher 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maisenbacher J, Schmidt U, Schenk N</AU>
<TI>Therapie mit Hypericum bei Angstzuständen</TI>
<SO>Therapiewoche Neurologie Psychiatrie</SO>
<YR>1995</YR>
<VL>9</VL>
<PG>65-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martinez-1993" MODIFIED="2008-07-10 09:36:43 +0100" MODIFIED_BY="[Empty name]" NAME="Martinez 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Kasper S. Treatment of seasonal affective disorder (SAD) with hypericum extract. Pharmacopsychiatry 1997; 30 (suppl.2):89-93.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kasper S</AU>
<TI>Treatment of seasonal affective disorder (SAD) with hypericum extract</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1997</YR>
<VL>30</VL>
<NO>suppl.2</NO>
<PG>89-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:36:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez B, Kasper S, Ruhrmann B, Möller HJ</AU>
<TI>Hypericum in der Behandlung von saisonal abhängigen Depressionen</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>302-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:36:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez B, Kasper S, Ruhrmann B, Möller HJ</AU>
<TI>Hypericum in the treatment of seasonal affective disorders</TI>
<SO>Journal of Geriatric Psychiatry and Neurology</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>suppl 1</NO>
<PG>S29-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mo-2004" MODIFIED="2008-07-10 09:36:48 +0100" MODIFIED_BY="[Empty name]" NAME="Mo 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-07-10 09:36:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mo WY, Yu HY, Yang Y</AU>
<TI>Comparison of Saint John' Wort extract with fluoxetine in the treatment of post-stroke depression</TI>
<SO>Chinese Journal of New Drugs</SO>
<YR>2004</YR>
<VL>13</VL>
<PG>942-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Osterheider-1992" MODIFIED="2008-07-10 09:37:42 +0100" MODIFIED_BY="[Empty name]" NAME="Osterheider 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-07-10 09:37:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Osterheider M, Schmidtke A, Beckmann H</AU>
<TI>Behandlung depressiver Syndrome mit Hypericum (Johanniskraut - eine placebokontrollierte Doppelblindstudie</TI>
<SO>Fortschritte Neurologie Psychiatrie</SO>
<YR>1992</YR>
<VL>60</VL>
<NO>suppl.2</NO>
<PG>210-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Panijel-1985" MODIFIED="2008-07-10 09:37:48 +0100" MODIFIED_BY="[Empty name]" NAME="Panijel 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-07-10 09:37:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Panijel J</AU>
<TI>Die Behandlung mittelschwerer Angstzustände</TI>
<SO>Therapiewoche</SO>
<YR>1985</YR>
<VL>41</VL>
<PG>4659-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Quandt-1993" NAME="Quandt 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Quandt J, Schmidt U, Schenk N. Ambulante Behandlung leichter und mittelschwerer depressiver Verstimmungen. Der Allgemeinarzt 1993;2:97-102.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quandt J, Schmidt U, Schenk N</AU>
<TI>Ambulante Behandlung leichter und mittelschwerer depressiver Verstimmungen</TI>
<SO>Der Allgemeinarzt</SO>
<YR>1993</YR>
<VL>15</VL>
<NO>2</NO>
<PG>97-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Reh-1992" MODIFIED="2008-07-10 09:38:00 +0100" MODIFIED_BY="[Empty name]" NAME="Reh 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-07-10 09:38:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reh C, Laux P, Schenk N</AU>
<TI>Hypericum-Extrakt bei Depressionen - eine wirksame Alternative</TI>
<SO>Therapiewoche</SO>
<YR>1992</YR>
<VL>42</VL>
<PG>1576-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Schlich-1987" MODIFIED="2008-07-10 09:38:21 +0100" MODIFIED_BY="[Empty name]" NAME="Schlich 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-07-10 09:38:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schlich D, Braukmann F, Schenk N</AU>
<TI>Behandlung depressiver Zustände mit Hypericinium</TI>
<SO>Psycho</SO>
<YR>1987</YR>
<VL>13</VL>
<PG>440-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Schmidt-1989" MODIFIED="2008-07-10 09:38:12 +0100" MODIFIED_BY="[Empty name]" NAME="Schmidt 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-07-10 09:38:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt U, Schenk N, Schwarz I, Vorberg G</AU>
<TI>Zur Therapie depressiver Verstimmungen</TI>
<SO>Psycho</SO>
<YR>1989</YR>
<VL>15</VL>
<PG>665-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Schmidt-1993" MODIFIED="2008-07-10 09:38:46 +0100" MODIFIED_BY="[Empty name]" NAME="Schmidt 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-10 09:38:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt U, Sommer H</AU>
<TI>Johanniskraut-Extrakt zur ambulanten Therapie der Depression</TI>
<SO>Fortschritte der Medizin</SO>
<YR>1993</YR>
<VL>111</VL>
<PG>339-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:38:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt U</AU>
<TI>Konstantes Reaktionsvermögen unter antidepressiver Theerapie mit dem Hypericum-Präparat LI 160</TI>
<SO>Nervenheilkunde</SO>
<YR>1991</YR>
<VL>10</VL>
<PG>311-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmidt-1993b" MODIFIED="2008-07-10 09:38:52 +0100" MODIFIED_BY="[Empty name]" NAME="Schmidt 1993b" YEAR="1993">
<REFERENCE MODIFIED="2008-07-10 09:38:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt U, Harrer G, Kuhn U, Berger-Deinert W, Luther D</AU>
<TI>Wechselwirkungen von Hypericin-Extrakt mit Alkohol</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>314-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schulz-1993" MODIFIED="2008-07-10 09:39:03 +0100" MODIFIED_BY="[Empty name]" NAME="Schulz 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-10 09:38:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schulz H, Jobert M</AU>
<TI>Der Einfluß von Johanniskraut auf das Schlaf-EEG bei älteren Probandinnen</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>323-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:39:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schulz H, Jobert M</AU>
<TI>Effetcs of hypericum extract on the sleep EEG in older volunteers</TI>
<SO>Journal of Geriatric Psychiatry and Neurology</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>suppl 1</NO>
<PG>S39-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sindrup-2000" NAME="Sindrup 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sindrup SS, Madsen C, Bach FW, Gram LF, Jensen TS</AU>
<TO>St. John's wort has no effect on pain in polyneuropathy</TO>
<SO>Pain</SO>
<YR>2000</YR>
<VL>91</VL>
<PG>361-365</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Sommer-1994" MODIFIED="2008-07-10 09:40:04 +0100" MODIFIED_BY="[Empty name]" NAME="Sommer 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-07-10 09:39:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harrer G, Sommer H</AU>
<TI>Therapie leichter/mittelschwerer Depressionen mit Hypericum</TI>
<SO>Münchener medizinische Wochenschrift</SO>
<YR>1993</YR>
<VL>135</VL>
<PG>305-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:39:50 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Harrer G, Sommer H. Treatment of mild/moderate depressions with Hypericum. Phytomedicine 1994;1:3-8.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:39:50 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harrer G, Sommer H</AU>
<TI>Treatment of mild/moderate depressions with Hypericum</TI>
<SO>Phytomedicine</SO>
<YR>1994</YR>
<VL>1</VL>
<PG>3-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:39:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sommer H, Harrer G</AU>
<TI>Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients</TI>
<SO>Journal of Geriatric Psychiatry and Neurology</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>suppl 1</NO>
<PG>S9-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:40:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sommer H, Harrer G</AU>
<TI>Placebo-kontrollierte Studie zur Wirksamkeit eine Hypericumpräparates bei 105 Patienten mit Depressionen</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>274-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:40:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sommer H</AU>
<TI>Besserung psychovegetativer Beschwerden durch Hypericum im Rahmen einer multizentrischen Dopppelblindstudie</TI>
<SO>Nervenheilkunde</SO>
<YR>1991</YR>
<VL>10</VL>
<PG>308-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spielberger-1985" MODIFIED="2008-07-10 09:40:13 +0100" MODIFIED_BY="[Empty name]" NAME="Spielberger 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-07-10 09:40:13 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Spielberger E. Johanniskraut-Pr&amp;#228;parat lindert selbst mittelschwere Depressionen. &amp;#196;rztliche Praxis 1985;37,60:2546-2547.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:40:13 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spielberger E</AU>
<TI>Johanniskraut-Präparat lindert selbst mittelschwere Depressionen</TI>
<SO>Ärztliche Praxis</SO>
<YR>1985</YR>
<VL>37</VL>
<PG>2546-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Staffeldt-1993" MODIFIED="2008-07-10 09:40:24 +0100" MODIFIED_BY="[Empty name]" NAME="Staffeldt 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-10 09:40:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Staffeldt B, Kerb R, Brockmöller J, Ploch M, Roots I</AU>
<TI>Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers</TI>
<SO>Journal of Geriatric Psychiatry and Neurology</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>suppl 1</NO>
<PG>S47-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:40:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Staffeldt B, Kerb R, Brockmöller J, Ploch M, Roots I</AU>
<TI>Pharmakokinetik von Hypericin und Pseudohypericin nach oraler Einnahme des Johanniskraut-Extrakts LI 160 bei gesunden Probanden</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>331-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Steger-1985" MODIFIED="2008-07-10 09:40:45 +0100" MODIFIED_BY="[Empty name]" NAME="Steger 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-07-10 09:40:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steger W</AU>
<TI>Depressive Verstimmungen</TI>
<SO>Zeitschrift für Allgemeinmedizin</SO>
<YR>1985</YR>
<VL>61</VL>
<PG>914-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Volz-2002" MODIFIED="2008-07-10 09:41:18 +0100" MODIFIED_BY="[Empty name]" NAME="Volz 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-07-10 09:41:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Volz HP, Murck H, Kasper S, Möller HJ</AU>
<TI>St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial</TI>
<SO>Psychopharmacology</SO>
<YR>2002</YR>
<VL>164</VL>
<PG>294-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Vorbach-1994" MODIFIED="2008-07-10 09:41:30 +0100" MODIFIED_BY="[Empty name]" NAME="Vorbach 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-07-10 09:41:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vorbach EU, Hübner WD, Arnoldt KH</AU>
<TI>Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study in 135 outpatients</TI>
<SO>Journal of Geriatric Psychiatry and Neurology</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>suppl 1</NO>
<PG>S19-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-07-10 09:41:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vorbach EU, Hübner WD, Arnoldt KH</AU>
<TI>Wirksamkeit und Verträglichkeit des Hypericum-Extraktes LI 160 im Vergleich mit Imipramin</TI>
<SO>Nervenheilkunde</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>290-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warnecke-1986" MODIFIED="2008-07-10 09:41:41 +0100" MODIFIED_BY="[Empty name]" NAME="Warnecke 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-07-10 09:41:41 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Warnecke G. Beeinflussung klimakterischer Depressionen. Zeitschrift fuer Allgemeinmedizin 1986;62:1111-1113&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:41:41 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warnecke G</AU>
<TI>Beeinflussung klimakterischer Depressionen</TI>
<SO>Zeitschrift für Allgemeinmedizin</SO>
<YR>1986</YR>
<VL>62</VL>
<PG>1111-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Werth-1989" MODIFIED="2008-07-10 09:41:47 +0100" MODIFIED_BY="[Empty name]" NAME="Werth 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-07-10 09:41:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Werth W</AU>
<TI>Psychotonin M versus Imipramin in der Chirurgie</TI>
<SO>Der Kassenarzt</SO>
<YR>1989</YR>
<VL>15</VL>
<PG>64-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wienert-1991" NAME="Wienert 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Wienert V, Classen R, Hiller KO. Zur Frage der Photosensibilisierung von Hypericin in einer Baldrian-Johanniskraut-Kombination - klinisch-experimentelle, plazebokontrollierte Vergleichsstudie. Poster presented at the 3rd Phytotherapie-Kongre&amp;#223;, L&amp;#252;beck 1991.&lt;/p&gt;" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Wienert V, Classen R, Hiller KO</AU>
<TI>Zur Frage der Photosensibilisierung von Hypericin in einer Baldrian-Johanniskraut-Kombination - klinisch-experimentelle, plazebokontrollierte Vergleichsstudie</TI>
<SO>Lübeck-Travemünde, 3rd Phytotherapy Congress</SO>
<YR>1991</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Winkel-2000" MODIFIED="2008-07-10 09:41:56 +0100" MODIFIED_BY="[Empty name]" NAME="Winkel 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-10 09:41:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Winkel R, Koritsch HD, Piayda H, Trenckmann U</AU>
<TI>St. John's wort extract LI 160 in depressive, alcohol addicted patients</TI>
<SO>Phytomedicine</SO>
<YR>2000</YR>
<VL>7 (suppl II)</VL>
<PG>19</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="BOOK_SECTION">
<AU>Winkel R, Koritsch HD, Piayda H, Trenckmann</AU>
<TO>Phytopharmakotherapie der komorbiden depressiven Störungen bei Alkoholabhängigkeit - Wirksamkeit des Johanniskrautextraktes LI 160 bei komorbid-depressiv Alkoholerkrankten</TO>
<SO>Phytopharmaka und seelische Störungen</SO>
<YR>2000</YR>
<PG>43-51</PG>
<ED>Trenckmann U</ED>
<PB>LinguaMed</PB>
<CY>Neu-Isenburg</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeller-2000" MODIFIED="2008-07-10 09:42:10 +0100" MODIFIED_BY="[Empty name]" NAME="Zeller 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-10 09:42:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Zeller K</AU>
<TO>Once daily administration of hypericum extract (STW 3): a convenient treatment</TO>
<SO>Herbal medicinal products for the treatment of pain</SO>
<YR>2000</YR>
<PG>164-8</PG>
<ED>Chrubasik S, Roufogalis BD</ED>
<PB>Southern Cross University Press</PB>
<CY>Lismore</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-07-28 10:40:58 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2009-07-28 10:38:38 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Caccia-2005" MODIFIED="2008-07-10 09:43:32 +0100" MODIFIED_BY="[Empty name]" NAME="Caccia 2005" TYPE="JOURNAL_ARTICLE">
<AU>Caccia S</AU>
<TI>Anti-depressant-like components of hypericum perforatum extracts: an overview of their pharmacokinetics and metabolism</TI>
<SO>Current Drug Metabolism</SO>
<YR>2005</YR>
<VL>6</VL>
<PG>531-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Candy-2008" MODIFIED="2008-07-04 10:46:46 +0100" MODIFIED_BY="[Empty name]" NAME="Candy 2008" TYPE="COCHRANE_REVIEW">
<AU>M Candy B; Jones L; Williams R; Tookman A; King</AU>
<TI>Psychostimulants for depression</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-07-04 10:46:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-07-04 10:46:46 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006722.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-CGI-1970" MODIFIED="2008-08-11 13:03:46 +0100" MODIFIED_BY="[Empty name]" NAME="CGI 1970" TYPE="BOOK_SECTION">
<AU>National Institutes of Mental Health</AU>
<TI>CGI - Clinical Global Impressions</TI>
<SO>ECDEU Assessment Manual for Psychopharmacology</SO>
<YR>1970</YR>
<PG>217-222</PG>
<ED>Guy W</ED>
<PB>US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration</PB>
<CY>Rockville, MD</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2006" NAME="Deeks 2006" TYPE="BOOK_SECTION">
<AU>Deeks JJ, Higgins JPT, Altman DG on behalf of the Cochrane Statistical Methods Group</AU>
<TI>Analysing and presenting results</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. In: The Cochrane Library, Issue 4, 2006</SO>
<YR>2006</YR>
<ED>Higgins JPT, Green S</ED>
<PB>John Wiley &amp; Sons, Ltd</PB>
<CY>Chichester</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DSM_x002d_IV_x002d_TR" MODIFIED="2008-08-11 11:02:08 +0100" MODIFIED_BY="[Empty name]" NAME="DSM-IV-TR" TYPE="OTHER">
<AU>American Psychiatric Association</AU>
<TI>DSM-IV-TR<SUP>®</SUP>
</TI>
<SO>http://www.dsmivtr.org/index.cfm</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2008-07-10 09:43:28 +0100" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder CE</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ernst-1995" MODIFIED="2008-07-10 09:43:14 +0100" MODIFIED_BY="[Empty name]" NAME="Ernst 1995" NOTES="&lt;p&gt;Ernst E. St. John&amp;#8217;s wort, an anti-depressant? A systematic, criteria-based review. Phytomedicine 1995;2:67-71.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:43:14 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Ernst E</AU>
<TI>St. John&#8217;s wort, an anti-depressant? A systematic, criteria-based review</TI>
<SO>Phytomedicine</SO>
<YR>1995</YR>
<VL>2</VL>
<PG>67-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ernst-1999" MODIFIED="2008-07-10 09:43:21 +0100" MODIFIED_BY="[Empty name]" NAME="Ernst 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ernst E</AU>
<TI>Second thoughts about safety of St John's wort</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<PG>2014-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gaster-2000" MODIFIED="2008-07-10 09:43:43 +0100" MODIFIED_BY="[Empty name]" NAME="Gaster 2000" TYPE="JOURNAL_ARTICLE">
<AU>Gaster B</AU>
<TI>St John's wort for depression. A systematic review</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2000</YR>
<VL>160</VL>
<PG>152-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamilton-1960" MODIFIED="2008-08-11 12:25:18 +0100" MODIFIED_BY="[Empty name]" NAME="Hamilton 1960" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton M</AU>
<TI>A rating scale for depression</TI>
<SO>Journal of Neurology, Neurosurgery and Psychiatry</SO>
<YR>1960</YR>
<VL>23</VL>
<PG>56-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hammerness-2003" MODIFIED="2008-07-10 09:43:48 +0100" MODIFIED_BY="[Empty name]" NAME="Hammerness 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hammerness P, Basch E, Ulbricht C</AU>
<TI>St. John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist</TI>
<SO>Psychosomatics</SO>
<YR>2003</YR>
<VL>44</VL>
<PG>271-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2008-07-10 09:43:52 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2008-07-08 12:45:12 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="BOOK_SECTION">
<AU>Higgins JPT, Altman DG on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group</AU>
<TI>Chapter 8:  Assessing risk of bias in included studies</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]</SO>
<YR>2008</YR>
<ED>Higgins JPT, Green S</ED>
<PB>The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-H_x00e4_rter-2003" MODIFIED="2008-07-10 09:45:26 +0100" MODIFIED_BY="[Empty name]" NAME="Härter 2003" TYPE="JOURNAL_ARTICLE">
<AU>Härter M, Bermejo I, Schneider F, Katz S, Gaebel W, Hegerl U, Niebling W, Berger M</AU>
<TI>Clinical practice guideline for the diagnosis and treatment of depressive disorders in primary care</TI>
<TO>Versorgungsleitlinien zur Diagnostik und Therapie depressiver Störungen in der hausärztlichen Praxis</TO>
<SO>Zeitschrift für ärztliche Fortbildung und Qualitätssicherung</SO>
<YR>2003</YR>
<VL>7 (suppl. IV)</VL>
<PG>16-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ICD_x002d_10" MODIFIED="2008-08-11 11:05:44 +0100" MODIFIED_BY="[Empty name]" NAME="ICD-10" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Version for 2007</TI>
<SO>http://www.who.int/classifications/apps/icd/icd10online/</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ICSI-2007" NAME="ICSI 2007" TYPE="OTHER">
<AU>Institute for Clinical Systems Improvement (ICSI)</AU>
<TI>Health care guideline: major depression in adults in primary care</TI>
<SO>www.icsi.org</SO>
<YR>2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" MODIFIED="2008-07-10 09:45:40 +0100" MODIFIED_BY="[Empty name]" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moore RA, Carrol D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ</AU>
<TI>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Khan-2000" MODIFIED="2008-07-10 09:45:51 +0100" MODIFIED_BY="[Empty name]" NAME="Khan 2000" TYPE="JOURNAL_ARTICLE">
<AU>Khan A, Warner HA, Brown WA</AU>
<TI>Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2000</YR>
<VL>57</VL>
<PG>311-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kim-1999" MODIFIED="2008-07-10 09:46:08 +0100" MODIFIED_BY="[Empty name]" NAME="Kim 1999" TYPE="JOURNAL_ARTICLE">
<AU>Kim HL, Streltzer J, Goebert D</AU>
<TI>St John's wort for depression: a meta-analysis of well-defined clinical trials</TI>
<SO>Journal of Nerval and Mental Diseases</SO>
<YR>1999</YR>
<VL>187</VL>
<PG>532-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kirsch-2002" NAME="Kirsch 2002" TYPE="JOURNAL_ARTICLE">
<AU>Kirsch I, Moore TJ, Scoboria A, Nicholls SS</AU>
<TI>The emporor's new drugs: an analysis of antidepressant medication submitted to the U.S. Food and Drug Administration</TI>
<SO>Prevention &amp; Treatment</SO>
<YR>2002</YR>
<VL>5</VL>
<PG>article 23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kirsch-2008" MODIFIED="2008-07-10 09:46:17 +0100" MODIFIED_BY="[Empty name]" NAME="Kirsch 2008" TYPE="JOURNAL_ARTICLE">
<AU>Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT</AU>
<TI>Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration</TI>
<SO>PLoS Medicine</SO>
<YR>2008</YR>
<VL>5</VL>
<PG>260-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kn_x00fc_ppel-2004" MODIFIED="2008-07-10 09:47:41 +0100" MODIFIED_BY="[Empty name]" NAME="Knüppel 2004" TYPE="JOURNAL_ARTICLE">
<AU>Knüppel L, Linde K</AU>
<TI>Adverse effects of St. John's wort - a systematic review</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2004</YR>
<VL>65</VL>
<PG>1470-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Linde-1996" MODIFIED="2008-07-10 09:47:50 +0100" MODIFIED_BY="[Empty name]" NAME="Linde 1996" TYPE="JOURNAL_ARTICLE">
<AU>Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D</AU>
<TI>St John's wort for depression - an overview and meta-analysis of randomized clinical trials</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>313</VL>
<PG>253-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Linde-1996b" MODIFIED="2008-07-10 09:48:00 +0100" MODIFIED_BY="[Empty name]" NAME="Linde 1996b" NOTES="&lt;p&gt;Linde K, Worku F, Melchart D, et al. Randomized clinical trials of acupuncture for asthma - a systematic review. Forsch Komplement&amp;#228;rmed 1996;3:148-155.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:48:00 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Linde K, Worku F, Melchart D, Wiesner-Zechmeister M, Pothmann R, Weinschütz T, Melchart D</AU>
<TI>Randomized clinical trials of acupuncture for asthma - a systematic review</TI>
<SO>Forschende Komplementärmedizin</SO>
<YR>1996</YR>
<VL>3</VL>
<PG>148-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Linde-1997" MODIFIED="2008-07-10 09:48:05 +0100" MODIFIED_BY="[Empty name]" NAME="Linde 1997" NOTES="&lt;p&gt;Linde K, Clausisus N, Ramirez G, et al. Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997;350:834-843.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:48:05 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Linde K, Clausisus N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB</AU>
<TI>Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo-controlled trials</TI>
<SO>Lancet</SO>
<YR>1997</YR>
<VL>350</VL>
<PG>834-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lipsey-2000" NAME="Lipsey 2000" TYPE="BOOK">
<AU>Lipsey M, Wilson DB</AU>
<SO>Practical meta-analysis. Applied social research methods series, Vol. 49</SO>
<YR>2000</YR>
<PB>Sage Publications</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Montgomery-1979" MODIFIED="2008-08-11 13:06:35 +0100" MODIFIED_BY="[Empty name]" NAME="Montgomery 1979" TYPE="JOURNAL_ARTICLE">
<AU>Montgomery SA, Asberg M</AU>
<TI>A new depression scale designed to be sensitive to change</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1979</YR>
<VL>134</VL>
<PG>382-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murck-2002" MODIFIED="2008-07-10 09:48:22 +0100" MODIFIED_BY="[Empty name]" NAME="Murck 2002" TYPE="JOURNAL_ARTICLE">
<AU>Murck H</AU>
<TI>Atypical depression and related disorders - neurobiological basis for their treatment with St. John's wort</TI>
<TO>Die atypische Depression und verwandte Erkrankungen - neurobiologische Grundlagen für ihre Behandlung mit Johanniskraut-Extrakt</TO>
<SO>Wiener medizinische Wochenschrift</SO>
<YR>2002</YR>
<VL>152</VL>
<PG>398-403</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murck-2005" MODIFIED="2008-07-10 09:48:46 +0100" MODIFIED_BY="[Empty name]" NAME="Murck 2005" TYPE="JOURNAL_ARTICLE">
<AU>Murck H, Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Mannel M, Rosenbaum JF</AU>
<TI>Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo</TI>
<SO>International Journal of Neuropsychopharmacology</SO>
<YR>2005</YR>
<VL>8</VL>
<PG>215-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nahrstedt-1997" MODIFIED="2008-07-10 09:48:53 +0100" MODIFIED_BY="[Empty name]" NAME="Nahrstedt 1997" NOTES="&lt;p&gt;Nahrstedt A, Butterweck V. Biologically active and other chemical constitutents of the herb hypericum perforatum L. Pharmacopsychiatry 1997;30 (suppl 2):129-134.&lt;/p&gt;" NOTES_MODIFIED="2008-07-10 09:48:53 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Nahrstedt A, Butterweck V</AU>
<TI>Biologically active and other chemical constitutents of the herb hypericum perforatum L</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1997</YR>
<VL>30</VL>
<NO>suppl 2</NO>
<PG>129-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nieuwstraten-2006" MODIFIED="2008-07-10 09:49:03 +0100" MODIFIED_BY="[Empty name]" NAME="Nieuwstraten 2006" TYPE="JOURNAL_ARTICLE">
<AU>Nieuwstraten C, Labiris NR, Holbrock A</AU>
<TI>Systematic overview of drug interactions with antidepressant medications</TI>
<SO>Canadian Journal of Psychiatry</SO>
<YR>2006</YR>
<VL>51</VL>
<PG>300-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Posternak-2007" MODIFIED="2008-07-10 09:49:19 +0100" MODIFIED_BY="[Empty name]" NAME="Posternak 2007" TYPE="JOURNAL_ARTICLE">
<AU>Posternak MA, Zimmerman M</AU>
<TI>Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant effiacy trials</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2007</YR>
<VL>190</VL>
<PG>287-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reichling-2003" MODIFIED="2008-07-10 09:49:36 +0100" MODIFIED_BY="[Empty name]" NAME="Reichling 2003" TYPE="JOURNAL_ARTICLE">
<AU>Reichling J, Hostanska K, Saller R</AU>
<TI>St. John's wort (Hypericum perforatum L.) - multicompound preparations versus single substances</TI>
<TO>Johanniskraut (Hypericum perforatum L.) - Vielstoffgemische kontra phytogene Einzelstoffe</TO>
<SO>Forschende Komplementärmedizin und Klassische Naturheilkunde</SO>
<YR>2003</YR>
<VL>10 (suppl 1)</VL>
<PG>28-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-2004" MODIFIED="2008-07-10 09:49:54 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 2004" TYPE="JOURNAL_ARTICLE">
<AU>Smith L, Ernst E, Ewings P, Myers P, Smith C</AU>
<TI>Co-ingestion of herbal medicines and warfarin</TI>
<SO>British Journal of General Practice</SO>
<YR>2004</YR>
<VL>54</VL>
<PG>439-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sterne-2001" MODIFIED="2008-07-10 09:50:12 +0100" MODIFIED_BY="[Empty name]" NAME="Sterne 2001" TYPE="JOURNAL_ARTICLE">
<AU>Sterne JA, Egger M, Davey Smith G</AU>
<TI>Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>323</VL>
<PG>101-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thompson-1999" MODIFIED="2008-07-10 09:50:26 +0100" MODIFIED_BY="[Empty name]" NAME="Thompson 1999" TYPE="JOURNAL_ARTICLE">
<AU>Thompson SD, Sharp SJ</AU>
<TI>Explaining heterogeneity in meta-analyses: a comparison of methods</TI>
<SO>Statitics in Medicine</SO>
<YR>1999</YR>
<VL>18</VL>
<PG>2693-708</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Turner-2008" MODIFIED="2008-07-10 09:50:46 +0100" MODIFIED_BY="[Empty name]" NAME="Turner 2008" TYPE="JOURNAL_ARTICLE">
<AU>Turner EH, Matthews MM, Linardatos E, Tell RA, Rosenthal R</AU>
<TI>Selective publication of antidepressant trials and its influence on apparent efficacy</TI>
<SO>New England Journal of Medicine</SO>
<YR>2008</YR>
<VL>358</VL>
<PG>252-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ustun-2004" MODIFIED="2008-07-10 09:50:57 +0100" MODIFIED_BY="[Empty name]" NAME="Ustun 2004" TYPE="JOURNAL_ARTICLE">
<AU>Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murrary CJ.</AU>
<TI>Global burden of depressive disorders in the year 2000</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2004</YR>
<VL>184</VL>
<PG>386-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Volz-1997" MODIFIED="2009-07-28 10:38:38 +0100" MODIFIED_BY="[Empty name]" NAME="Volz 1997" TYPE="JOURNAL_ARTICLE">
<AU>Volz HP</AU>
<TI>Controlled clinical trials of hypericum extract in depressed patients - an overview</TI>
<SO>Pharmacopsychiatry</SO>
<YR>1997</YR>
<VL>30</VL>
<NO>suppl 2</NO>
<PG>72-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-von-Zerssen-1996" MODIFIED="2008-08-11 13:12:26 +0100" MODIFIED_BY="[Empty name]" NAME="von Zerssen 1996" TYPE="BOOK_SECTION">
<AU>von Zerssen D</AU>
<TI>D-S</TI>
<SO>Rating scales for psychiatry</SO>
<YR>1990</YR>
<PG>section 2.8</PG>
<ED>AMDP and CIPS</ED>
<PB>Beltz Test</PB>
<CY>Weinheim</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wheatley-1998" NAME="Wheatley 1998" TYPE="JOURNAL_ARTICLE">
<AU>Wheatley D</AU>
<TI>Hypericum extract - potential in the treatment of depression</TI>
<SO>CNS Drugs</SO>
<YR>1998</YR>
<VL>9</VL>
<PG>431-440</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Whitten-2006" MODIFIED="2008-07-10 09:51:18 +0100" MODIFIED_BY="[Empty name]" NAME="Whitten 2006" TYPE="JOURNAL_ARTICLE">
<AU>Whitten DL, Myers SP, Hawrelak JA, Wohlmuth H</AU>
<TI>The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>2006</YR>
<VL>62</VL>
<PG>512-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williams-2000" MODIFIED="2008-07-10 09:51:30 +0100" MODIFIED_BY="[Empty name]" NAME="Williams 2000" TYPE="JOURNAL_ARTICLE">
<AU>Williams JW jr, Mulrow CD, Chiquette E, Hitchcock NP, Aguilar C, Cornell J</AU>
<TI>A systmatic review of newer pharmacotherapies for depression in adults: evidence report summary</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2000</YR>
<VL>132</VL>
<PG>743-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wilson-2002" MODIFIED="2008-07-08 15:17:58 +0100" MODIFIED_BY="[Empty name]" NAME="Wilson 2002" TYPE="OTHER">
<AU>Wilson DB</AU>
<TI>SPSS, Stata, and SAS macros for performing meta-analytic analyses</TI>
<SO>http://mason.gmu.edu/~dwilsonb/ma.html. last uptated: 15-1-2002. accessed: 10-11-2003</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wurglics-2003" MODIFIED="2008-07-10 09:51:38 +0100" MODIFIED_BY="[Empty name]" NAME="Wurglics 2003" TYPE="JOURNAL_ARTICLE">
<AU>Wurglics M, Schulte-Löbbert S, Dingermann T, Schubert-Zsilavecs M</AU>
<TI>Rational and traditional hypericum preparations</TI>
<TO>Rationale und traditionelle Johanniskraut-Präparate</TO>
<SO>Deutsche Apotheker Zeitung</SO>
<YR>2003</YR>
<VL>143</VL>
<PG>1454-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wurglics-2006" MODIFIED="2008-07-10 09:52:32 +0100" MODIFIED_BY="[Empty name]" NAME="Wurglics 2006" TYPE="JOURNAL_ARTICLE">
<AU>Wurglics M, Schubert-Zsilavecz M</AU>
<TI>Hypericum perforatum: a "modern" herbal antidepresant: pharmacokinetics of active ingredients</TI>
<SO>Clinical Pharmacokinetics</SO>
<YR>2006</YR>
<VL>45</VL>
<PG>449-68</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2009-07-28 10:40:58 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Linde-1998" MODIFIED="2009-07-28 10:40:58 +0100" MODIFIED_BY="[Empty name]" NAME="Linde 1998" TYPE="COCHRANE_REVIEW">
<AU>Linde K, Mulrow CD</AU>
<TI>St John's wort for depression</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>4</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Linde-2005a" NAME="Linde 2005a" TYPE="COCHRANE_REVIEW">
<AU>Linde K, Mulrow CD, Berner M, Egger M</AU>
<TI>St John's wort for depression</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>2</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Linde-2005b" MODIFIED="2008-07-10 09:53:10 +0100" MODIFIED_BY="[Empty name]" NAME="Linde 2005b" TYPE="JOURNAL_ARTICLE">
<AU>Linde K, Berner M, Egger M, Culrow C</AU>
<TI>St John's wort for depression - meta-analysis of randomised controlled trials</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2005</YR>
<VL>186</VL>
<PG>99-107</PG>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-07-15 07:55:52 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-07-15 07:55:52 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-07-08 13:00:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Behnke-2002">
<CHAR_METHODS>
<P>Concealment: unclear<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: 6 of 35 in hypericum group, 3 of 35 in fluoxetine group<BR/>Jadad score: 1-1-1<BR/>IV score: 1-0-1-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 70/61<BR/>Demographics: 47 female, mean age 51 (treatment group) and 48 (control group)<BR/>Diagnosis: mild to modedrate depression (ICD 10 F32.0 and 32.1)<BR/>Setting: multicenter trial from Denmark<BR/>Baseline: HAMD score treatment group 20.0 +/- 3.2, control group 20.7 +/- 2.9</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract (Calmigen) 2x1 coated tablet daily (300 mg extract) for 6 weeks<BR/>Control: Fluoxetine 2x20 mg for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: von Zerssen Depression Scale, Clinical Global Impression Index (CGI), global assessment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-07-08 13:00:23 +0100" MODIFIED_BY="[Empty name]">
<P>Contract research organization which performed the study contacted for additional information but no answer was received</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-07-08 13:18:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bjerkenstedt-2005">
<CHAR_METHODS>
<P>Concealment: consecutively numbered pharmacy<BR/>Blinding: double-blind (double-dummy)<BR/>Drop-outs/withdrawals: ITT analysis on 163 of 174 patients randomized<BR/>Jadad score: 1-2-0<BR/>IV score: 1-1-1-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 177 /163<BR/>Demographics: 129 female, mean age 50 years<BR/>Diagnosis: mild to moderate major depression (DSM-IV 296.31 or 32)<BR/>Setting: 15 practices (psychiatry, neurology, GP) in Sweden<BR/>Baseline: HAMD score hypericum group 24.9, fluoxetine group 23.8, placebo group 25.2</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract LI 160 (Jarsin 300) 3x1 coated table (900 mg) for 6 weeks Control 1: Fluoxetine 1x1 capsule (20 mg) for 6 weeks<BR/>Control 2: Placebo for 4 weeks, then randomized to hypericum or fluoxetine</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD), Montgomery Asberg Depression Rating Scale (MADRS), Clinical Global Impression Index (CGI)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-07-08 13:18:03 +0100" MODIFIED_BY="[Empty name]">
<P>Due to the request of the ethical review board patients allocated to placebo had to be re-randomized to hypericum or fluoxetine after 4 weeks. Prioir to publication of the main reference authors provided some additional information; after publication of the full report no further unpublished information was considered necessary</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-07-08 13:13:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bracher-2001">
<CHAR_METHODS MODIFIED="2008-07-08 13:08:05 +0100" MODIFIED_BY="[Empty name]">
<P>Concealment: consecutively numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: ITT analysis on 207 of 218 patients randomized<BR/>Jadad score: not performed (see notes)<BR/>IV score: not performed (see notes)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-08 13:10:47 +0100" MODIFIED_BY="[Empty name]">
<P>Number of patients included/analyzed: 218/207<BR/>Demographics: 167 female, mean age 44 years<BR/>Diagnosis: mild to moderate major depression (DSM-IV 296.31 or 32)<BR/>Setting: 17 practices (GP, various other) in Germany<BR/>Baseline: HAMD score hypericum group 19.7, placebo group 19.7</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-08 13:12:29 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: Hypericum extract HYP611 (Felis 650) 1x1 coated table (650 mg) for 6 weeks<BR/>Control: Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-08 13:13:31 +0100" MODIFIED_BY="[Empty name]">
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD), Montgomery Asberg Depression Rating Scale (MADRS), Clinical Global Impression Index (CGI)<BR/>Patient-rated: von Zerssen Paranoid Depression Scale (PDS)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-07-08 13:07:32 +0100" MODIFIED_BY="[Empty name]">
<P>This trial was identified during the revision process. It is only published as a short report in a sponsored supplement to a nonscientific journal. The sponsor (Hexal AG, Holzkirchen, Germany) allowed a reviewer (KL) to extract detailed information from the full unpublished study report</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Brenner-2000">
<CHAR_METHODS>
<P>Concealment: unclear<BR/>Blinding: double-blind (double-dummy)<BR/>Drop-outs/withdrawals: 7 of 15 hypericum patients, 3 of 15 sertraline patients<BR/>Jadad score: 1-2-0<BR/>IV score: 1-0-1-1-1-0</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 30/28<BR/>Demographics: 19 female, mean age 45 years<BR/>Diagnosis: mild to moderate depressive disorder<BR/>Setting: community hospital in USA<BR/>Baseline: HAMD score hypericum group 21.3 +/- 3.2, sertraline group 21.7 +/- 2.7</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract LI 160 3x1 tablet (900 mg extract) for 7 weeks<BR/>Control: Sertraline 3x1 capsule (75 mg) for 7 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 7 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: von Zerssen Depression Scale (D-S)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Small study. High drop-out rate with more losses in the hypericum group. In spite of intention to treat analysis bias cannot be ruled out</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fava-2005">
<CHAR_METHODS>
<P>Concealment: unclear<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: 18/45 in the hypericum group, 23 of 47 in the fluoxetine group and 22 of 43 in the placebo group<BR/>Jadad score: 1-1-0<BR/>IV score: 1-0-1-0.5-0.5-0</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 135/135<BR/>Demographics: 57% female, mean age 37 years<BR/>Diagnosis: mild to moderate major depression<BR/>Setting: 2 psychiatric outpatient departments in the US<BR/>Baseline: HAMD score (17 items) 19.6 +/- 3.5 in the hypericum group, 19.9 +/- 2.9 in the fluoxetine and 19.6 +/- 3.1 in the placebo group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract LI 160 3x1 tablets (900 mg) for 12 weeks (+ 1 capsule placebo)<BR/>Control 1: Fluoxetine 1x20 mg (capsule) for 12 weeks (+ 3x1 placebo tablets)<BR/>Control 2: Placebo (1x1 capsule, 3x1 tablets)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 12 weeks (+ 1 week placebo run-in)<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: Beck Depression Inventory (BDI)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>High drop-out rate (intent to treat analysis); recruitment stopped before planned sample size was reached due to decision of the sponsor (lichtwer Pharma, Berlin). Only remission rates reported (and use instead of responder data for analyses)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gastpar-2005">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind (double-dummy technique)<BR/>Drop-out/withdrawals17 of 123 (hypericum), 19 of 118 (sertaline)<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 241/118 (in per protocol analysis)<BR/>Demographics: 74% female, mean age 19 years<BR/>Diagnosis: moderate depression (F32.1 or F33.1)<BR/>Setting: 18 primary care physicians in Germany<BR/>Baseline: HAMD values 22.0 +/- 1.1 vs. 22.1 +/- 1.1</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Interventions: Hypericum extract STW3 1x1 tablet (612 mg extract) + 1 capsule placebo daily for 12 weeks<BR/>Control: 1x1 tablet sertraline (50 mg) + 1 tablet placebo daily for 12 weeks<BR/>After the 12 week-treatment phase there was an optional continuation phase</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 12 weeks for the main comparison + 12 weeks continuation phase<BR/>Physician-rated: Hamitlon Depression Scale (HAMD, 17 items; response = HAMD score &lt; 10 or at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: Adjective Mood Scale (BfS)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information provided by first author and sponsor.<BR/>The number of adverse effects in the hypericum group is much higher than in the sertraline group (189 vs. 112). For the number of patients reporting adverse effects the difference is less pronounced (74 vs. 60; 1 patient in the hypericum gorup had reported 26 adverse effects). In the hypericum group there was a higher number of infections (48 vs. 26; not observed in any other trial before). The number of adverse effects which were possibly causally related with the treatment was higher in the sertraline group (12 vs. 16). Also the intensity of side effects was more pronounced in the sertraline group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gastpar-2006">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind (double-dummy technique)<BR/>Drop-outs/withdrawals: 6 of 131 (hypericum), 6 of 127 (citalopram), 8 of 130 (placebo)<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-0.5-0.5-1</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 388/388<BR/>Demographics: 67% female, mean age 50 years<BR/>Diagnosis: moderate depression (ICD-10 F32.1 or F33.1)<BR/>Setting: 21 general practitioners and internists in Germany<BR/>Baseline: HAMD score hypericum group 21.9 +/- 1.2, citalopram group 21.8 +/-1.2, placebo group 22.0 +/- 1.2</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract STW3-VI 1x1 tablet (900 mg extract) for 6 weeks<BR/>Control 1: Placebo for 6 weeks<BR/>Control 2: Citalopram 1x1 tablet 20 mg for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamitlon Depression Scale (HAMD, 17 items; response = HAMD score &lt; 10 or at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: Adjective Mood Scale (BfS)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information provided by first author and sponsor</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-07-15 07:54:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Harrer-1993">
<CHAR_METHODS>
<P>Concealment: consecutively numbered pharmacy<BR/>Blinding: Double-blind<BR/>Drop-outs/withdrawals: 7 of 51 in hypericum group, 9 of 51 in maprotiline group<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 102 /86<BR/>Demographics: 73 female, mean age 44 years in the Hypericum group and 48 years in the maprotiline group<BR/>Diagnosis: single, moderately severe depressive episode (ICD 10 F32.1) (according to information from the sponsor patients met DSM-III-R criteria for major depression); Setting: 6 practices in Germany (neurology/psychiatry)<BR/>Baseline: HAMD scores 20.5 +/- 3.7 in hypericum group and 21.5 +/- 3.9 in maprotiline group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-15 07:54:38 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: Hypericum extract LI 160 (Jarsin 300) 3x1 coated tablet (900 mg extract) daily for 4 weeks<BR/>Control: Maprotiline 3x1 coated tablet (75 mg) daily for 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period 4 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction or score &lt; 10), Clinical Global Impression Index (CGI), global assessment<BR/>Patient rated: Depression Scale von Zerssen D-S, global assessment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information provided from sponsor (Lichtwer, Berlin, Germany)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Harrer-1999">
<CHAR_METHODS>
<P>Concealment: unclear<BR/>Blinding: double-blinding<BR/>Drop-outs/withsdrawals: 8 of 77 hypericum patients and 16 of 84 fluoxetine patients<BR/>Jadad score: 1-1-1<BR/>IV score: 1-0-1-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 161/149<BR/>Demographics: 129 female, mean age 69 years<BR/>Diagnosis: mild to moderate depression (ICD 10 F32.0 or F32.1)<BR/>Setting: 17 practices in Germany<BR/>Baseline: HAMD score hypericum group 16.6, fluoxetine group 17.2</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract LoHyp-57 2x2 coated tablets (800 mg) for 6 weeks<BR/>Control: Fluoxetine 2x2 coated tablets (20 mg) for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physcian-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction or score &lt; 11), Clinical Global Impression Index (CGI)<BR/>Patient-rated: Self-Rating Scale for Depression (SDS), Fragebogen Alltagsleben (German quality of life questionnaire)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Reporting of results partly insufficient</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-HDTSG-2002">
<CHAR_METHODS>
<P>Concealment: central telephone randomization<BR/>Blinding: double-blind (double-dummy)<BR/>Drop-outs/withdrawals: 31 of 113 in hypericum group, 32 of 116 in placebo group, and 32 of 111 in sertraline group<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 340/340<BR/>Demographics: 66% female, mean age 43 years<BR/>Diagnosis: major depression (DSM-IV)<BR/>Setting: 12 academic and community psychiatric research clinics in the US<BR/>Baseline: HAMD scores 23.1 +/- 2.7 (hypericum), 22.7 +/- 2.7 (placebo), 22.5 +/- 2.5 (sertraline)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum LI 160 extract 900 to 1500 mg for 8 weeks<BR/>Control 1: Placebo for 8 weeks<BR/>Control 2: Sertraline 50 to 100 mg for 8 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 1 weeks run-in, 8 weeks treatment, 18 weeks follow-up for responders<BR/>Physician-rated: Hamilton Depression Scale (HAMD, response = at least 50% reduction or score &lt; 10), Clinical Global Impression Index (CGI), Global Assessment of Functioning (GAF)<BR/>Patient-rated: Beck Depression Inventory (BDI), Sheehan Disability Scale (SDS)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Trial funded by public institution (NIH). Large proportion of patients with chronic depression. Some unblinding detected (sole trial which reported a check of blinding). Authors provided additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-H_x00e4_nsgen-1996">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: 3 of 54 in hypericum group, 4 of 54 in placebo group<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-1-1-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 108/101<BR/>Demographics: 66 female, mean age 52 years<BR/>Diagnosis: major depression (DSM-III-R, HAMD score &gt; 15)<BR/>Setting: 17 practices in Germany (neurologists/psychiatrist, general practitioners)<BR/>Baseline: HAMD score 21.8 +/- 2.8 (hypericum), 20.4 +/- 3.4 (placebo)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract LI160 (Jarsin 300) 3x1 coated tablet daily (900 mg extract) for 4 weeks<BR/>Control: Placebo<BR/>For further 2 weeks both groups received Hypericum</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 4 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 21 items; response = at least 50% reduction or score &lt; 10), Clinical Global Impression Index (CGI) after 2 and 4 weeks<BR/>Patient-rated: Depression Scale von Zerssen (D-S), complaints check list (BEB) after 2 and 4 weeks</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information provided by author and sponsor (Lichtwer, Berlin, Germany). This trial was first published in 1993 (in German, 1994 in English) with 72 patients and re-published with 108 patients in 1996 (without refering to the earlier publications)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kalb-2001">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: none<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-1-1-1</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 72/72<BR/>Demographics: 48 female, mean age 48 years<BR/>Diagnosis: mild to moderate depression (DSM-IV 296.21/31/22/32)<BR/>Setting: 11 practices (psychiatry, internal medicine, GP) in Germany<BR/>Baseline: HAMD score 19.7 +/- 3.4 hpyericum group, 20.1 +/- 2.6 placebo group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract WS 5572 (Neuroplant) 3x1 coated tablet (900 mg) for 6 weeks <BR/>Control: Placebo for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 3-7 days run-in, 6 weeks treatment<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: von Zerssen Depression Scale (D-S), Patient's Global Assessment Scale (GPA)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Trial with adaptive design stopped early due to significant superiority at preplanned interim analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kasper-2006">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind <BR/>Drop-out/withdrawals: 12 of 123 (hypericum 600 mg), 19 of 127 (hypericum 1200 mg), 8 of 82 (placebo)<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-0.5-1-1-1</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patientns included/analyzed: 332/324<BR/>Demographics: 63% female, mean age 46 years<BR/>Diagnosis: mild or moderate, single or recurrent, major depressive episode (DSM IV 296.21/22, 296.31/32)<BR/>Setting: 11 psychiatric and 5 GP practices in Germany<BR/>Baseline: HAMD score hypericum 600 mg group 22.8 +/- 3.3, hypericum 1200 mg group 22.6 +/-3.8, placebo group 23.6 +/- 4.2</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment 1: 1 tablet hypericum extract (600 mg) daily + 1 placebo tablet for 6 weeks<BR/>Treatment 2: 2x1 tablet hypericum extract (total daily extract dosage 1200 mg) daily for 6 weeks<BR/>Control: 2x1 tablet placebo daily for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton depression Scale (HAMD, 17 items; response = atleast 50% score reduction), Clinical Global Impression Index (CGI), Montgomery-Asberg Depression Scale (MADRS)<BR/>Patient-rated: Beck Depression Inventory (BDI), qualtiy of life (SF-36)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Randomization in 3:3:2 ratio<BR/>Additional information provided by sponsor</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Laakmann-1998">
<CHAR_METHODS>
<P>Concealment: unclear<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: 3 in group hypericum 1, 1 in group hypericum 2, 4 in placebo group<BR/>Jadad score: 2-2-1<BR/>IV score: 1-0-1-1-1-1</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 147/147<BR/>Demographics: 117 female, mean age 49 years<BR/>Diagnosis: mild to moderate depression (DSM-IV)<BR/>Setting: 11 practices in Germany<BR/>Baseline: HAMD score 20.9 +/- 3.1 (hypericum 1), 20.3 +/- 2.7 (hypericum 2), 21.2 +/- 3.3 (placebo)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment 1: Hypericum extract WS 5572 (5% hyperforin) 3x1 coated tablet (900 mg) for 6 weeks<BR/>Treatment 2: Hypericum extract WS 5573 (0.5% hyperforin) 3x1 coated tablet (900 mg) for 6 weeks<BR/>Control: Placebo for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: von Zerssen Depression Scale (D-S), global assessment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Includes a group receiving a second hypericum extract with very low hyperforin content (not included in meta-analysis as this tests an extract which was not marketed)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lecrubier-2002">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: 18 of 186 (hypericum), 25 of 189 placebo)<BR/>Jadad score: 1-2-0<BR/>IV score: 1-0-1-1-1-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 375/375<BR/>Demographics: 297 female, mean age 41 years<BR/>Diagnosis: mild to moderate depression (DSM-IV 296.21/22/31/32)<BR/>Setting: 26 psychiatric centers and practices in France<BR/>Baseline: HAMD score hypericum group 21.9 +/- 1.7, placebo group 21.9 +/- 1.7</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract WS 5570 3x1 tablet (900 mg) for 6 weeks<BR/>Control: placebo for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 3-7 days run-in, 6 weeks treatment<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction), Montgomery-Asberg Depression Rating Scale (MADRS), Clinical Global Impression Index (CGI)<BR/>Patient-rated: Symptom Check List (SCL-58)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Trial with preplanned interim analysis with 169 patients (no significant difference)<BR/>Additional information provided by sponsor (Schwabe, Karlsruhe)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Montgomery-2000">
<CHAR_METHODS>
<P>Concealment: unclear<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: unclear<BR/>Jadad score: 1-2-0<BR/>IV score: 1-0-0-1-1-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 247/?<BR/>Demographics: 183 female, mean age 43 years<BR/>Diagnosis: mild to moderate depression (DSM-IV 296.2x/3x)<BR/>Setting: 18 GPs and psychiatric outpatient clinics in the UK<BR/>Baseline: HAMD about 22 in both groups (data extrapolated from figure in poster)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract LI 160 3x1 coated tablet (900 mg) for 12 weeks<BR/>Control: Placebo for 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 3 to 7 days run-in, 12 weeks treatment<BR/>Physician-rated: Hamilton depression Scale (HAMD, 17 items; response = at least 50% reduction or score &lt; 10), Montgomery-Asberg Depression Rating Scale (MADRS), Clinical Global Impression Index (CGI)<BR/>Patient-rated: None mentioned</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Available as congress abstract and poster handout only. Additional information from sponsor (Lichtwer, Berlin)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Moreno-2005">
<CHAR_METHODS>
<P>Concealment: unclear<BR/>Blinding: double-blind (double-dummy technique)<BR/>Drop-outs/withdrawals: 19 of 72 (no details for single groups reported)<BR/>Jadad score: 1-1-0<BR/>IV score: 1-0-0-0.5-0.5-0</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 72/66<BR/>Demographics: 83% female, mean age 40 years<BR/>Diagnosis: mild to moderate major depression (DSM-IV criteria)<BR/>Setting: Institute of Psychiatry, University Sao Paulo, Brasil<BR/>Baseline: extrapolated from figure HAMD score hypericum group 15, placebo 17, fluoxetine, 15</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract Iperisan 3x1 (900 mg) daily for 8 weeks<BR/>Control 1: Placebo<BR/>Control 2: Fluoxetine 20 mg/day for 8 weeks (1 capsule fluoxetine and 2 capsules placebo per day)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 1-week prerandomzationw ash-out, 8 weeks post randomization<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 21 items, response = at least 50% redution, remission &lt; 8 on the 17 item scale), Montgomery-Asberg Depression rating Scale (MADRS), Clinical Global Impression Index (CGI)<BR/>Patient-rated: none</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Publication misses important details. Authors inquired for additional information but no response received</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Philipp-1999">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: Double-blind<BR/>Drop-outs/withdrawals: 13 of 106 (hypericum), 11 of 110 (imipramine), 9 of 47 (placebo)<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 263/251<BR/>Demographics: 197 female, mean age 47 years<BR/>Diagnosis: moderate depression (ICD-10 F32.1/F32.2)<BR/>Setting: 18 GPs in Germany<BR/>Baseline: HAMD score 22.7 +/- 4.2 (hypericum), 22.2 +/- 4.2 (imipramine), 22.7 +/- 4.0 (placebo)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract STEI 300 3x1 capsule (1050 mg) for 8 weeks<BR/>Control 1: Imipramine 100 mg for 8 weeks<BR/>Control 2: Placebo for 8 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 1 week screening, 8 weeks treatment<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction), Hamilton Anxiety Scale (HAMA), Clinical Global Impression Scale (CGI)<BR/>Patient-rated: Zung Depression Scale, Quality of life (SF-36)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information from sponsor (Steiner, Berlin). Primary outcome comparison with placebo after 6 weeks, with imipramine after 8 weeks</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-07-15 07:55:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schrader-1998">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: 1 of 81 (hypericum), 2 of 81 (placebo)<BR/>Jadad score: 2-2-1<BR/>IV score: 1-0-0-1-1-1</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 162/159<BR/>Demographics: 108 female, mean age 47 (hypericum) vs. 39 (placebo)<BR/>Diagnosis: mild to moderate depression (F32.0/32.1)<BR/>Setting: 16 private practices in Germany<BR/>Baseline: HAMD values 20.1 +/- 2.8 (hypericum) vs. 18.7 +/- 3.5</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 2x1 coated tablet (500 mg extract) Hypericum extract ZE117 daily for 6 weeks<BR/>Control: Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-15 07:55:52 +0100" MODIFIED_BY="[Empty name]">
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 21 items; response = at least 50% reduction or score &lt; 10), Clinical Global Impression Index (CGI)<BR/>Patient-rated: visual analogue scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information provided by author and sponsor (Zeller AG, Romanshorn, Switzerland). Baseline HAMD score lower in placebo group. Low response rate in placebo group.<BR/>In meta-analyses HAMD values were calculated for the 17-item version (data provided by author)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Schrader-2000">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind (double-dummy)<BR/>Drop-outs/withdrawals: 1 of 126 (hypericum), 1 of 113 (fluoxetine)<BR/>Jadad score: 1-2-1<BR/>IV score: 1-0-1-0.5-0.5-1</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 230/228<BR/>Demographics: 157 female, mean age 46 years<BR/>Diagnosis: mild to moderate depression (ICD-10 F32.0/32.1)<BR/>Setting: 7 practices (internal medicine) in Germany<BR/>Baseline: HAMD values 19.6 +/- 3.1 (hypericum), 19.5 +/- 2.4 (fluoxetine)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract Ze 117 2x1 coated tablet (500 mg) for 6 weeks<BR/>Control: Fluoxetine 1x1 capsule (20 mg) for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 21 items; response = at least 50% reduction or score &lt; 10), Clinical Global Impression (CGI)<BR/>Physician-rated: visual analogue scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information (particulary responder rates and 17-item HAMD scores) provided by author and sponsor (Zeller AG, Romanshorn, Switzerland)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Shelton-2001">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals:15 of 98 (hypericum), 13 of 102 (placebo)<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-1-1-1</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 200/195<BR/>Demographics: 64% female, mean age 42 years<BR/>Diagnosis: major depression (DSM-IV)<BR/>Setting: 11 academic medical centers in the USA<BR/>Baseline: mean HAMD values above 22 in both groups</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: Hypericum extract LI 160 3x1 to 4x1 tablet (900 to 1200 mg) for 8 weeks<BR/>Control: placebo for 8 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 1 week run-in, 8 weeks treatment<BR/>Phsician-rated: Hamilton Depression Scale (HAMD, 17 items, at least 50% reduction), Clinical Global Impression Index (CGI), Hamilton Anxiety Scale (HAMA)<BR/>Patient-rated: Beck Depression Inventory (BDI)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Average duration of current depressive episode more than 2 years. Additional information provided from authors</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Szegedi-2005">
<CHAR_METHODS>
<P>Allocation concealment: numbered pharmacy<BR/>Blinding: double-blind (double dummy technique)<BR/>Drop-out/wothdrawals: 17 of 125 in hypericum group, 29 of 126 in the paroxetine group<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 251/244<BR/>Demographics: 69% female, mean age 47 years<BR/>Diagnosis: moderate or severe unupolar major depression (DSM IV 296.22/23, 296.32/33)<BR/>Setting: 21 Psychiatric primary care centers in Germany<BR/>Baseline: HAMD score 25.5.+/- 2.7 (hypericum), 25.5 +/- 2.9 (paroxetine)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 3x1 tablet (900 mg daily) hypericum extract WS 5570 daily for 6 weeks (in patients whose depression score was not improved by at least 20% 3x 600 mg were used after 2 weeks) <BR/>Control: 1x1 tablet (20 mg) paroxetine daily for 6 weeks (in patients whose depression score was not improved by at least 20% 40 mg were used after 2 weeks) packed in capsules<BR/>For each drug an indentically matched placebo was available</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks (+ 16 weeks continuation phase)<BR/>Physician-reated: Hamilton Depression Scale (HAMD, 17 items, at least 50% reduction), Clinical Global Impression (CGI), Montgomery-Asberg Depression Rating Scale (MADRS)<BR/>Patient-rated: Beck Depression Inventory (BDI)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information provided by sponsor</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Uebelhack-2004">
<CHAR_METHODS>
<P>Concelment: consecutively numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-out/withdrawals: none<BR/>Jadad score: 2-2-1<BR/>IV score: 1-0-1-1-1-1</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 140/140<BR/>Demographics: 67% female, mean age 45 years<BR/>Diagnosis: moderate depressive disorder (ICD-10 F32.1 or F33.1)<BR/>Setting: clinical trial center in Germany<BR/>Baseline: 22-.8 +/- 1.1 in hypericum group, 22.8 +/- 1.2 in placebo group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 1x1 tablet (900 mg) STW3-VI daily for 6 weeks<BR/>Control: Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamitlon Depression Scale (HAMD, 17 items; response = HAMD score &lt; 10 or at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: Adjective Mood Scale (BfS)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Trial performed in a single clinical trial unit with short recruitment period and low placebo response. Additional information from sponsor</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-van-Gurp-2002">
<CHAR_METHODS>
<P>Concealment: independent pharmacist<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: 16 of 45 (hypericum), 17 of 45 (sertraline)<BR/>Jadad score: 2-2-1<BR/>IV score: 1-1-1-0.5-0.5-0</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 90/87<BR/>Demographics: 61% female, mean age 40 years)<BR/>Diagnosis: major depression (DSM IV)<BR/>Setting: 12 community based offices for family medicine in Canada<BR/>Baseline: mean HAMD values 18.8 +/- 3.6 (hypericum group), 19.7 +/- 3.5 (sertraline group)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 3x1 to 3x2 (in case of insufficient response at 4 weeks) capsules (900-1800 mg) Hypericum extract daily for 12 weeks<BR/>Control: 3x1 to 3x2 (in case of insufficient response at 4 weeks) capsules Sertraline (50 to 100 mg) daily for 12 weeks<BR/>In 9 patients of each group the dosage was doubled during the trial</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction or score &lt; 10)<BR/>Patient-rated: Beck Depression Inventory (BDI)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information provided from author. High drop-out rate</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Volz-2000">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals:2/71 (hypericum), 5/71 (placebo)<BR/>Jadad score: 1-2-0<BR/>IV score: 1-1-1-1-1-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 142/140<BR/>Demographics: 81% female, mean age 47 years<BR/>Diagnosis: mild or moderate episode of a major depression (DSM-IV)<BR/>Setting: 17 practices for psychiatry, neurology, internal medicine and GP in Germany<BR/>Baseline: HAMD 21.0 +/- 2.0 (hypericum group), 20.7 +/- 1.9 (placebo group)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 2x1 capsule (500 mg) Hypericum extract D-0496 daily for 6 weeks<BR/>Control: Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 1 week placebo run in, 6 weeks treatment<BR/>Phyiscian-rated: Hamilton Depression Scale (HAMD, 21 items; response = at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: von Zerssen Depression Scale (D-S)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Manufacturer/sponsor no longer existing. Author could provide only minimal additional information</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Vorbach-1997">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: 9 of 107 in hypericum group, 14 of 102 in imipraimine group<BR/>Jadad score: 2-2-1, IV score: 1-1-0.5-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 209/209 (186 per protocol) <BR/>Demographics: 154 female, mean age 49 years<BR/>Diagnosis: severe episode of a major depression<BR/>Setting: 20 psychiatric practices<BR/>Baseline: HAMD score 25.3 +/- 4.7 (hypericum group), 26.1 +/- 4.8 (imipramine group)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 3x2 coated tablets (1800 mg extract) Hypericum extract LI 160 daily for 6 weeks<BR/>Control: 3x2 coated tablets imipramine (150 mg) daily for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: Depression-Scale (D-S von Zerssen)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information provided from sponsor</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wheatley-1997">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blinding: double-blind<BR/>Drop-outs/withdrawals: 20 of 87 in hypericum group, 24 of 78 amitriptyline group<BR/>Jadad score: 2-2-0<BR/>IV score: 1-1-0.5-0.5-0.5-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 165/156<BR/>Demographics: 126 female, mean age 40 years<BR/>Diagnosis: major depression (DSM-IV)<BR/>Setting: 18 general practices and one hospital outpatient clinic in the UK<BR/>Baseline: HAMD score 20.6 +/- 2.1 (hypericum group), 20.8 +/- 2.3 (amitriptyline group)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 3x1 coated tablet (900 mg extract) Hypericum extract LI 160 daily for 6 weeks<BR/>Control: 3x1 coated tablet amitriptyline (75 mg) daily for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; response = at least 50% reduction or score &lt; 10), Montgomery-Asberg Reating Scale for Depression (MADRS), Clinical Global Impression Index (CGI)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Some additional information provided from sponsor. HAMD mean values extrapolated from figure</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Witte-1995">
<CHAR_METHODS>
<P>Concealment: numbered pharmacy<BR/>Blidning: double-blind<BR/>Drop-outs/withdrawals: 1 of 48 in hypericum group, 1 of 49 in placebo group<BR/>Jadad score: 1-2-1<BR/>IV score: 1-0-0.5-1-1-0.5</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Number of patients included/analyzed: 97/95<BR/>Demographics: 64 female, mean age 43 years<BR/>Diagnosis: depression (ICD-10 F32.1)<BR/>Setting: 5 general practitioners in Germany<BR/>Baseline: HAMD score 24.6 +/5.4 (hypericum group), 22.7 +/- 4.4 (placebo group)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 2x1 capsules (200 to 240 mg) Hypericum extract (Psychotonin forte) daily for 6 weeks<BR/>Control: placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 21 items; response = at least 50% reduction or score &lt; 10), Clinical Global Impression Index (CGI)<BR/>Patient-rated: Depression Scale (D-S von Zerssen), State Trait Anxiety Inventory (STAI)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information provided by author</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Woelk-2000">
<CHAR_METHODS>
<P>Concealment: unclear<BR/>Blinding: Double-blind (double dummy)<BR/>Drop-outs/withdrawals: 15/157 (hypericum), 32 of 167 (imipramine)<BR/>Jadad score: 2-2-0<BR/>IV score: 1-0-1-0.5-0.5-0</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients included/analyzed: 324/324<BR/>Demographics: 71% female, mean age 46 years<BR/>Diagnosis: mild to moderate depression (ICD10 F32.0 or 1, F33.0 or 1)<BR/>Setting: 40 practices for psychiatry, internal medicine, GP in Germany<BR/>Baseline: HAMD 22.4 +/-3.4 (hypericum), 22.1 +/- 2.9 (imipramine)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 2x1 coated tablet (500 mg extract) Hypericum extract ZE 117 daily for 6 weeks<BR/>Control: Imipramine 150 mg daily for 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Observation period: 6 weeks<BR/>Physician-rated: Hamilton Depression Scale (HAMD, 17 items; at least 50% reduction), Clinical Global Impression Index (CGI)<BR/>Patient-rated: global assessment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Some additional information by manufacturer of the extract</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-07-08 15:30:41 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Agrawal-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (Study in patients with fatigue and minor depression)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Albertini-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not depression (RCT of hypericum in homeopathic preparation for dental neuralgia)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bendre-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not depression (CCT of homeopathic preparations of hypericum and arnica in dental practice)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bergmann-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inadequate dosage of amitriptyline (30 mg daily) - RCT included in previous versions of this review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bernhadt-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing two doses of hypericum for depression</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brockm_x00f6_ller-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT on pharmacokinetics and photosensitivity in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Czekalla-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Report of results on ECG analyses undertaken in the Vorbach 1997 study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dittmer-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only a minority of patients suffered from depression (RCT of Hypericum for "psychovegetative complaints")</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ditzler-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Placebo-controlled randomized controlled trial in depressed patients using a fixed combination of several herbs including hypericum</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gu-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing 900 mg of a hypericum extract with fluoxetine in patients with depression according to the Chinese classification CCMD-2. As it is not clear whether all included patients meet criteria for major depression the study was excluded. Response rates were similar in both groups</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Halama-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Harrer-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Herberg-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing hypericum and a combination of Hypericum and Valerian on concentration, reaction etc. in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hoffmann-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hottenrott-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not depression (RCT of a combination of hypericum and vitamine E to enhance performance of athlets)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-H_x00e4_ring-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Placebo-controlled RCT of hypericum to prevent reactive depression in 28 patients with solid tumors undergoing chemotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-H_x00fc_bner-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Johnson-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT on neurophysiological effects of hypericum in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Johnson-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing neurophysiological effects of hypericum and maprotiline in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kniebel-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing a combination of hypericum and valerian vs. amitriptyline in depressive patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kugler-1990a">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing hypericum and bromazepam in depressed patients (included in earlier versions of this review; inclusion has now been limited to commonly recommended standard antidepressants)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kugler-1990b">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT on pharmacodynamics in depressed patients (reason for exclusion: no symptomatic outcomes related to depressive symptoms)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-K_x00f6_nig-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lehrl-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Diagnosis not decscribed as major depression in publication. An information collected from the sponsor for a previous version of the review that patients met criteria for major depression could not be verified (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lenoir-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing three dosages of a hypericum extract in depressive patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Li-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled RCT in depressive patients undergoing coronary artery bypass grafting)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Maisenbacher-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not all patients suffered from depression (RCT of hypericum for anxiety)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Martinez-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing light therapy and a combination of light therapy and hypericum in patients with seasonal affective disorder</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mo-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (RCT comparing an hypericum extract and fluoxetine in post-stroke depression)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Osterheider-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Panijel-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not depression (RCT of a combination of hypericum and valerian for anxiety)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Quandt-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Reh-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schlich-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schmidt-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schmidt-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schmidt-1993b">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT investigating possible interactions of hypericum and alcohol in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schulz-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT investigating the effects of hypericum on the sleep-EEG in elderly volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sindrup-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT in patients with polyneuropathy (depression not mentioned)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sommer-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Spielberger-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing two hypericum preparations for depression</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Staffeldt-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT on pharmacokinetics in healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Steger-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT of a comination of of hypericum and valerian vs. desipramine for depression</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Volz-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT hypreicum vs. placebo in patients with somatoform disorders</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vorbach-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not all patients met criteria for major depression (comparison with maprotiline; included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Warnecke-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Open controlled trial of hypericum vs. diazepam in women with climacteric depression; method of allocation unclear (included in earlier version of this review; now inclusion limited to explicitely randomized, double-blind trials)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Werth-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT of hypericum vs. amitriptyline for about two weeks in patients undergoing amputation to prevent reactive depression (included in earlier version of this review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wienert-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT on photosensitivtity after application of a combination of hypericum and valerian</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Winkel-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not major depression (placebo-controlled trial included in previous versions of the review)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-07-08 15:30:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zeller-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-07-08 15:30:41 +0100" MODIFIED_BY="[Empty name]">
<P>(Nonrandomized?) comparison of different administration schedules of a hypericum extract in patients with mild to moderate depression (not restricted to major depression)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-07-08 13:03:49 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-07-08 13:03:49 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Behnke-2002">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Bjerkenstedt-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-08 13:03:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bracher-2001">
<DESCRIPTION>
<P>A - adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Brenner-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fava-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Gastpar-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Gastpar-2006">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-HDTSG-2002">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Harrer-1993">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Harrer-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-H_x00e4_nsgen-1996">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Kalb-2001">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Kasper-2006">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Laakmann-1998">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Lecrubier-2002">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Montgomery-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Moreno-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Philipp-1999">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Schrader-1998">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Schrader-2000">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Shelton-2001">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Szegedi-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Uebelhack-2004">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Volz-2000">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Vorbach-1997">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Wheatley-1997">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Witte-1995">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Woelk-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-van-Gurp-2002">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-08-13 22:15:43 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2008-07-15 08:10:27 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Hypericum mono-preparations vs. placebo A. Dichotomous measures</NAME>
<DICH_OUTCOME CHI2="68.87364107281029" CI_END="1.7682677157065556" CI_START="1.2308808054687699" CI_STUDY="95" CI_TOTAL="95" DF="17.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4753056599204475" ESTIMABLE="YES" EVENTS_1="877" EVENTS_2="518" I2="75.31711735404214" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.24754801783326827" LOG_CI_START="0.0902159992891483" LOG_EFFECT_SIZE="0.16888200856120827" METHOD="MH" MODIFIED="2008-07-15 08:10:27 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="3.3677110988783454E-8" P_Q="0.0" P_Z="2.5798758292203778E-5" Q="0.0" RANDOM="YES" SCALE="14.842480658576743" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10364724786296471" TOTALS="YES" TOTAL_1="1635" TOTAL_2="1429" WEIGHT="100.0" Z="4.20769602372999">
<NAME>Responder - grouped by precision - primary analysis</NAME>
<GROUP_LABEL_1>Hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours hypericum</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="38.33088590092679" CI_END="2.86749312420911" CI_START="1.221058369080463" DF="8.0" EFFECT_SIZE="1.8711965363361" ESTIMABLE="YES" EVENTS_1="237" EVENTS_2="119" I2="79.1291022579612" ID="CMP-001.01.01" LOG_CI_END="0.4575023852056951" LOG_CI_START="0.08673642460309168" LOG_EFFECT_SIZE="0.27211940490439335" MODIFIED="2008-07-09 12:08:54 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="6.539199482680225E-6" P_Z="0.004014934478632884" STUDIES="9" TAU2="0.3240068919927502" TOTAL_1="506" TOTAL_2="514" WEIGHT="38.75148974184442" Z="2.876985968400349">
<NAME>Less precise trials</NAME>
<DICH_DATA CI_END="1.699313661642309" CI_START="0.6699942608763411" EFFECT_SIZE="1.0670194003527338" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.23027354893831486" LOG_CI_START="-0.17392891741919023" LOG_EFFECT_SIZE="0.02817231575956235" ORDER="1" O_E="0.0" SE="0.23743052957287605" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" VAR="0.056373256373256374" WEIGHT="5.337449742297699"/>
<DICH_DATA CI_END="3.603733805291571" CI_START="0.9040074379302385" EFFECT_SIZE="1.8049382716049382" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="9" LOG_CI_END="0.5567527037380443" LOG_CI_START="-0.04382799625166046" LOG_EFFECT_SIZE="0.2564623537431919" ORDER="2" O_E="0.0" SE="0.35278407609636414" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" VAR="0.12445660434716523" WEIGHT="3.7443532444650045"/>
<DICH_DATA CI_END="5.174392173823469" CI_START="1.7704672394565684" EFFECT_SIZE="3.0267295597484276" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="12" LOG_CI_END="0.7138593413640908" LOG_CI_START="0.24808789502812034" LOG_EFFECT_SIZE="0.4809736181961056" ORDER="3" O_E="0.0" SE="0.2735964531835927" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="53" TOTAL_2="55" VAR="0.07485501919464183" WEIGHT="4.784821017552281"/>
<DICH_DATA CI_END="2.292464409861165" CI_START="0.9177051997676703" EFFECT_SIZE="1.4504504504504505" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="15" LOG_CI_END="0.3603026020428717" LOG_CI_START="-0.037296807552487106" LOG_EFFECT_SIZE="0.1615028972451923" ORDER="4" O_E="0.0" SE="0.23355186134513312" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" VAR="0.054546471937776286" WEIGHT="5.399085375663347"/>
<DICH_DATA CI_END="2.4565995947101875" CI_START="0.915900175529191" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="16" LOG_CI_END="0.3903343758619522" LOG_CI_START="-0.03815185775058964" LOG_EFFECT_SIZE="0.17609125905568124" ORDER="5" O_E="0.0" SE="0.25169493466507115" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" VAR="0.06335034013605442" WEIGHT="5.114453503981043"/>
<DICH_DATA CI_END="1.2655803297048804" CI_START="0.1765759700391964" EFFECT_SIZE="0.4727272727272727" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.10228971617966408" LOG_CI_START="-0.7530683992265159" LOG_EFFECT_SIZE="-0.3253893415234259" ORDER="6" O_E="0.0" SE="0.5024415910805479" STUDY_ID="STD-Moreno-2005" TOTAL_1="20" TOTAL_2="26" VAR="0.25244755244755246" WEIGHT="2.3985225236459047"/>
<DICH_DATA CI_END="6.455377648631762" CI_START="2.1242962862957433" EFFECT_SIZE="3.703125" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="12" LOG_CI_END="0.8099216541809597" LOG_CI_START="0.32721508987147363" LOG_EFFECT_SIZE="0.5685683720262167" ORDER="7" O_E="0.0" SE="0.28354422531142176" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" VAR="0.0803973277074543" WEIGHT="4.640731173145444"/>
<DICH_DATA CI_END="2.4018143007688595" CI_START="0.844594521101798" EFFECT_SIZE="1.4242749731471536" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="19" LOG_CI_END="0.38053942635206495" LOG_CI_START="-0.07335174017724158" LOG_EFFECT_SIZE="0.1535938430874117" ORDER="8" O_E="0.0" SE="0.2666179180168249" STUDY_ID="STD-Shelton-2001" TOTAL_1="98" TOTAL_2="102" VAR="0.07108511420762637" WEIGHT="4.888055017266423"/>
<DICH_DATA CI_END="27.08635707720228" CI_START="3.8787977172621613" EFFECT_SIZE="10.25" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="4" LOG_CI_END="1.4327505994349778" LOG_CI_START="0.5886971313485683" LOG_EFFECT_SIZE="1.0107238653917732" ORDER="9" O_E="0.0" SE="0.49580118528600803" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" VAR="0.24581881533101047" WEIGHT="2.4440181438272797"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="20.330643537815398" CI_END="1.4854667794299126" CI_START="1.0978567050381516" DF="8.0" EFFECT_SIZE="1.2770394136081151" ESTIMABLE="YES" EVENTS_1="640" EVENTS_2="399" I2="60.6505323595889" ID="CMP-001.01.02" LOG_CI_END="0.17186294380605788" LOG_CI_START="0.04054565862737968" LOG_EFFECT_SIZE="0.10620430121671878" MODIFIED="2008-07-09 12:09:09 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.009154953224271178" P_Z="0.0015228952154832073" STUDIES="9" TAU2="0.03202430927129974" TOTAL_1="1129" TOTAL_2="915" WEIGHT="61.248510258155584" Z="3.1702849340021295">
<NAME>More precise trials</NAME>
<DICH_DATA CI_END="1.7357489195898135" CI_START="1.0242136738289869" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="48" LOG_CI_END="0.2394869036037583" LOG_CI_START="0.010390569612841566" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="966" O_E="0.0" SE="0.1345723206314074" STUDY_ID="STD-Bracher-2001" TOTAL_1="109" TOTAL_2="109" VAR="0.01810970948012232" WEIGHT="7.01480570585611"/>
<DICH_DATA CI_END="1.8018454004437559" CI_START="1.0592608790078595" EFFECT_SIZE="1.3815297111210896" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="51" LOG_CI_END="0.25571752548072324" LOG_CI_START="0.02500293306369959" LOG_EFFECT_SIZE="0.1403602292722114" ORDER="10" O_E="0.0" SE="0.13552289364141099" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" VAR="0.01836645470094119" WEIGHT="7.000044922418626"/>
<DICH_DATA CI_END="1.1286623687301924" CI_START="0.6299914502232515" EFFECT_SIZE="0.843236409608091" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="56" LOG_CI_END="0.05256404526679658" LOG_CI_START="-0.2006653444290518" LOG_EFFECT_SIZE="-0.0740506495811276" ORDER="11" O_E="0.0" SE="0.14874819701303663" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" VAR="0.022126026114629157" WEIGHT="6.79080198906265"/>
<DICH_DATA CI_END="2.8344665422908304" CI_START="1.4659991154556462" EFFECT_SIZE="2.0384615384615383" ESTIMABLE="YES" EVENTS_1="159" EVENTS_2="26" LOG_CI_END="0.4524713349963389" LOG_CI_START="0.16613370826360316" LOG_EFFECT_SIZE="0.30930252162997107" ORDER="12" O_E="0.0" SE="0.16819613933692074" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" VAR="0.02828994128784485" WEIGHT="6.473545515068488"/>
<DICH_DATA CI_END="1.5433769450913795" CI_START="1.003917185691926" EFFECT_SIZE="1.2447580645161291" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="80" LOG_CI_END="0.18847200848722867" LOG_CI_START="0.0016978888245296054" LOG_EFFECT_SIZE="0.09508494865587915" ORDER="13" O_E="0.0" SE="0.10971204243667267" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" VAR="0.012036732255626265" WEIGHT="7.383056826212256"/>
<DICH_DATA CI_END="1.2792720846470618" CI_START="0.7396834333830369" EFFECT_SIZE="0.9727570959920125" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="57" LOG_CI_END="0.10696292312905956" LOG_CI_START="-0.13095410803988033" LOG_EFFECT_SIZE="-0.011995592455410417" ORDER="14" O_E="0.0" SE="0.13975364181693342" STUDY_ID="STD-Montgomery-2000" TOTAL_1="123" TOTAL_2="124" VAR="0.01953108040109572" WEIGHT="6.933860940757434"/>
<DICH_DATA CI_END="1.8926131184482329" CI_START="0.9634437928594055" EFFECT_SIZE="1.3503430531732419" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="22" LOG_CI_END="0.2770618460319398" LOG_CI_START="-0.016173616932804932" LOG_EFFECT_SIZE="0.13044411454956742" ORDER="15" O_E="0.0" SE="0.17224796248444282" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="47" VAR="0.029669360580042024" WEIGHT="6.40656411135074"/>
<DICH_DATA CI_END="1.8162867759762953" CI_START="1.0077978055011227" EFFECT_SIZE="1.3529411764705883" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="34" LOG_CI_END="0.25918442094234767" LOG_CI_START="0.0033734083362903034" LOG_EFFECT_SIZE="0.13127891463931898" ORDER="16" O_E="0.0" SE="0.1502646550897329" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" VAR="0.022579466569236394" WEIGHT="6.766407593986145"/>
<DICH_DATA CI_END="1.9291208032245668" CI_START="0.9991439837373781" EFFECT_SIZE="1.3883333333333334" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="25" LOG_CI_END="0.2853594243940738" LOG_CI_START="-3.719223477858606E-4" LOG_EFFECT_SIZE="0.14249375102314396" ORDER="17" O_E="0.0" SE="0.16784000746914576" STUDY_ID="STD-Witte-1995" TOTAL_1="48" TOTAL_2="49" VAR="0.028170268107242904" WEIGHT="6.47942265344314"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="69.13288889812418" CI_END="1.8721630899075854" CI_START="1.2191666261252485" CI_STUDY="95" CI_TOTAL="95" DF="15.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.510787462841432" ESTIMABLE="YES" EVENTS_1="767" EVENTS_2="436" I2="78.30265704344521" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.2723436787833687" LOG_CI_START="0.0860630656359243" LOG_EFFECT_SIZE="0.17920337220964647" METHOD="MH" MODIFIED="2008-07-09 12:44:37 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="6.372075311844583E-9" P_Q="0.0" P_Z="1.6259425786870153E-4" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.1346234542069003" TOTALS="YES" TOTAL_1="1456" TOTAL_2="1250" WEIGHT="100.0" Z="3.7710006372056193">
<NAME>Responder - according to HAMD</NAME>
<GROUP_LABEL_1>Hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours hypericum</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="37.14356174570964" CI_END="3.184999569406222" CI_START="1.187083720215105" DF="7.0" EFFECT_SIZE="1.9444436576394404" ESTIMABLE="YES" EVENTS_1="214" EVENTS_2="104" I2="81.15420366005004" ID="CMP-001.02.01" LOG_CI_END="0.503109377957236" LOG_CI_START="0.07448134906855841" LOG_EFFECT_SIZE="0.2887953635128972" MODIFIED="2008-07-09 12:15:13 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="4.4058980509520396E-6" P_Z="0.008263303578062828" STUDIES="8" TAU2="0.39594267778352427" TOTAL_1="469" TOTAL_2="479" WEIGHT="40.2831648976896" Z="2.641117580924411">
<NAME>Less precise trials</NAME>
<DICH_DATA CI_END="1.699313661642309" CI_START="0.6699942608763411" EFFECT_SIZE="1.0670194003527338" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.23027354893831486" LOG_CI_START="-0.17392891741919023" LOG_EFFECT_SIZE="0.02817231575956235" ORDER="2569" O_E="0.0" SE="0.23743052957287605" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" VAR="0.056373256373256374" WEIGHT="6.268803168389647"/>
<DICH_DATA CI_END="3.603733805291571" CI_START="0.9040074379302385" EFFECT_SIZE="1.8049382716049382" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="9" LOG_CI_END="0.5567527037380443" LOG_CI_START="-0.04382799625166046" LOG_EFFECT_SIZE="0.2564623537431919" ORDER="2570" O_E="0.0" SE="0.35278407609636414" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" VAR="0.12445660434716523" WEIGHT="4.621431657531553"/>
<DICH_DATA CI_END="5.174392173823469" CI_START="1.7704672394565684" EFFECT_SIZE="3.0267295597484276" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="12" LOG_CI_END="0.7138593413640908" LOG_CI_START="0.24808789502812034" LOG_EFFECT_SIZE="0.4809736181961056" ORDER="2571" O_E="0.0" SE="0.2735964531835927" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="53" TOTAL_2="55" VAR="0.07485501919464183" WEIGHT="5.715722312630107"/>
<DICH_DATA CI_END="2.4565995947101875" CI_START="0.915900175529191" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="16" LOG_CI_END="0.3903343758619522" LOG_CI_START="-0.03815185775058964" LOG_EFFECT_SIZE="0.17609125905568124" ORDER="2573" O_E="0.0" SE="0.25169493466507115" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" VAR="0.06335034013605442" WEIGHT="6.047875116050659"/>
<DICH_DATA CI_END="1.2655803297048804" CI_START="0.1765759700391964" EFFECT_SIZE="0.4727272727272727" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.10228971617966408" LOG_CI_START="-0.7530683992265159" LOG_EFFECT_SIZE="-0.3253893415234259" ORDER="2574" O_E="0.0" SE="0.5024415910805479" STUDY_ID="STD-Moreno-2005" TOTAL_1="20" TOTAL_2="26" VAR="0.25244755244755246" WEIGHT="3.0932846011526838"/>
<DICH_DATA CI_END="6.455377648631762" CI_START="2.1242962862957433" EFFECT_SIZE="3.703125" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="12" LOG_CI_END="0.8099216541809597" LOG_CI_START="0.32721508987147363" LOG_EFFECT_SIZE="0.5685683720262167" ORDER="2575" O_E="0.0" SE="0.28354422531142176" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" VAR="0.0803973277074543" WEIGHT="5.568395639607497"/>
<DICH_DATA CI_END="2.4018143007688595" CI_START="0.844594521101798" EFFECT_SIZE="1.4242749731471536" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="19" LOG_CI_END="0.38053942635206495" LOG_CI_START="-0.07335174017724158" LOG_EFFECT_SIZE="0.1535938430874117" ORDER="2576" O_E="0.0" SE="0.2666179180168249" STUDY_ID="STD-Shelton-2001" TOTAL_1="98" TOTAL_2="102" VAR="0.07108511420762637" WEIGHT="5.820471133823392"/>
<DICH_DATA CI_END="27.08635707720228" CI_START="3.8787977172621613" EFFECT_SIZE="10.25" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="4" LOG_CI_END="1.4327505994349778" LOG_CI_START="0.5886971313485683" LOG_EFFECT_SIZE="1.0107238653917732" ORDER="2577" O_E="0.0" SE="0.49580118528600803" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" VAR="0.24581881533101047" WEIGHT="3.147181268504063"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="20.318902911688603" CI_END="1.5299358460698413" CI_START="1.0643621216432129" DF="7.0" EFFECT_SIZE="1.2760900293869943" ESTIMABLE="YES" EVENTS_1="553" EVENTS_2="332" I2="65.54932109069138" ID="CMP-001.02.02" LOG_CI_END="0.18467322017576449" LOG_CI_START="0.027089410548602238" LOG_EFFECT_SIZE="0.10588131536218333" MODIFIED="2008-07-09 12:15:13 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.00492052611803262" P_Z="0.008443064449523799" STUDIES="8" TAU2="0.04367958165307293" TOTAL_1="987" TOTAL_2="771" WEIGHT="59.7168351023104" Z="2.633818350204889">
<NAME>More precise trials</NAME>
<DICH_DATA CI_END="1.8018454004437559" CI_START="1.0592608790078595" EFFECT_SIZE="1.3815297111210896" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="51" LOG_CI_END="0.25571752548072324" LOG_CI_START="0.02500293306369959" LOG_EFFECT_SIZE="0.1403602292722114" ORDER="767" O_E="0.0" SE="0.13552289364141099" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" VAR="0.01836645470094119" WEIGHT="7.826142214112515"/>
<DICH_DATA CI_END="1.1286623687301924" CI_START="0.6299914502232515" EFFECT_SIZE="0.843236409608091" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="56" LOG_CI_END="0.05256404526679658" LOG_CI_START="-0.2006653444290518" LOG_EFFECT_SIZE="-0.0740506495811276" ORDER="769" O_E="0.0" SE="0.14874819701303663" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" VAR="0.022126026114629157" WEIGHT="7.63843543200848"/>
<DICH_DATA CI_END="2.292464409861165" CI_START="0.9177051997676703" EFFECT_SIZE="1.4504504504504505" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="15" LOG_CI_END="0.3603026020428717" LOG_CI_START="-0.037296807552487106" LOG_EFFECT_SIZE="0.1615028972451923" ORDER="773" O_E="0.0" SE="0.23355186134513312" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" VAR="0.054546471937776286" WEIGHT="6.329340021633139"/>
<DICH_DATA CI_END="2.8344665422908304" CI_START="1.4659991154556462" EFFECT_SIZE="2.0384615384615383" ESTIMABLE="YES" EVENTS_1="159" EVENTS_2="26" LOG_CI_END="0.4524713349963389" LOG_CI_START="0.16613370826360316" LOG_EFFECT_SIZE="0.30930252162997107" ORDER="771" O_E="0.0" SE="0.16819613933692074" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" VAR="0.02828994128784485" WEIGHT="7.34943115512872"/>
<DICH_DATA CI_END="1.5433769450913795" CI_START="1.003917185691926" EFFECT_SIZE="1.2447580645161291" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="80" LOG_CI_END="0.18847200848722867" LOG_CI_START="0.0016978888245296054" LOG_EFFECT_SIZE="0.09508494865587915" ORDER="766" O_E="0.0" SE="0.10971204243667267" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" VAR="0.012036732255626265" WEIGHT="8.163911510795852"/>
<DICH_DATA CI_END="1.2792720846470618" CI_START="0.7396834333830369" EFFECT_SIZE="0.9727570959920125" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="57" LOG_CI_END="0.10696292312905956" LOG_CI_START="-0.13095410803988033" LOG_EFFECT_SIZE="-0.011995592455410417" ORDER="768" O_E="0.0" SE="0.13975364181693342" STUDY_ID="STD-Montgomery-2000" TOTAL_1="123" TOTAL_2="124" VAR="0.01953108040109572" WEIGHT="7.767016309196405"/>
<DICH_DATA CI_END="1.8926131184482329" CI_START="0.9634437928594055" EFFECT_SIZE="1.3503430531732419" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="22" LOG_CI_END="0.2770618460319398" LOG_CI_START="-0.016173616932804932" LOG_EFFECT_SIZE="0.13044411454956742" ORDER="772" O_E="0.0" SE="0.17224796248444282" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="47" VAR="0.029669360580042024" WEIGHT="7.287724578762574"/>
<DICH_DATA CI_END="1.9291208032245668" CI_START="0.9991439837373781" EFFECT_SIZE="1.3883333333333334" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="25" LOG_CI_END="0.2853594243940738" LOG_CI_START="-3.719223477858606E-4" LOG_EFFECT_SIZE="0.14249375102314396" ORDER="770" O_E="0.0" SE="0.16784000746914576" STUDY_ID="STD-Witte-1995" TOTAL_1="48" TOTAL_2="49" VAR="0.028170268107242904" WEIGHT="7.354833880672718"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="47.30910577963351" CI_END="1.7429600459005847" CI_START="1.2381079455558943" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4690039760381794" ESTIMABLE="YES" EVENTS_1="776" EVENTS_2="453" I2="74.63490420661051" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.24128743183530396" LOG_CI_START="0.09275851069021149" LOG_EFFECT_SIZE="0.16702297126275772" METHOD="MH" MODIFIED="2008-07-11 09:01:45 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="4.120735692003663E-6" P_Q="0.0" P_Z="1.0432133560351675E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.06906080610503867" TOTALS="YES" TOTAL_1="1258" TOTAL_2="1048" WEIGHT="99.99999999999999" Z="4.408017048021085">
<NAME>Responder - according to CGI (Clinical Global Impression Index at least "much improved")</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hypericum</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="21.899694935890803" CI_END="2.33399713668598" CI_START="1.300255510573955" DF="6.0" EFFECT_SIZE="1.742065624091061" ESTIMABLE="YES" EVENTS_1="286" EVENTS_2="137" I2="72.60235808049195" ID="CMP-001.03.01" LOG_CI_END="0.36810031892347234" LOG_CI_START="0.11402870302121274" LOG_EFFECT_SIZE="0.24106451097234255" MODIFIED="2008-07-11 09:01:45 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0012626055672575465" P_Z="1.9981626170793114E-4" STUDIES="7" TAU2="0.11142085287604514" TOTAL_1="462" TOTAL_2="407" WEIGHT="47.117639716323175" Z="3.719248667574991">
<NAME>Less precise trials</NAME>
<DICH_DATA CI_END="1.7841632191867585" CI_START="0.7508236311093428" EFFECT_SIZE="1.1574074074074074" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="22" LOG_CI_END="0.2514345820746806" LOG_CI_START="-0.12446206703246719" LOG_EFFECT_SIZE="0.06348625752110672" ORDER="18" O_E="0.0" SE="0.220803552403961" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" VAR="0.04875420875420875" WEIGHT="6.460953489758609"/>
<DICH_DATA CI_END="2.7011611291484248" CI_START="1.2435566421191397" EFFECT_SIZE="1.8327702702702702" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="16" LOG_CI_END="0.43155049141175705" LOG_CI_START="0.09466557151149996" LOG_EFFECT_SIZE="0.2631080314616285" ORDER="19" O_E="0.0" SE="0.19788786955665938" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" VAR="0.039159608917673436" WEIGHT="7.033768362846005"/>
<DICH_DATA CI_END="2.2033507118953004" CI_START="1.1118999207957245" EFFECT_SIZE="1.565217391304348" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="23" LOG_CI_END="0.34308363020491933" LOG_CI_START="0.04606569929446943" LOG_EFFECT_SIZE="0.1945746647496944" ORDER="20" O_E="0.0" SE="0.17446980287926836" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" VAR="0.030439712116730754" WEIGHT="7.650184592046443"/>
<DICH_DATA CI_END="1.9601452988573387" CI_START="1.0382536999687457" EFFECT_SIZE="1.4265791632485645" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="23" LOG_CI_END="0.2922882653121523" LOG_CI_START="0.0163034874565089" LOG_EFFECT_SIZE="0.15429587638433057" ORDER="21" O_E="0.0" SE="0.16211482465908827" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="47" VAR="0.02628121637424694" WEIGHT="7.983859704320807"/>
<DICH_DATA CI_END="2.060127224096872" CI_START="0.8216260057430882" EFFECT_SIZE="1.3010204081632653" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="24" LOG_CI_END="0.313894041251252" LOG_CI_START="-0.08532582309629382" LOG_EFFECT_SIZE="0.11428410907747909" MODIFIED="2008-07-11 09:01:45 +0100" MODIFIED_BY="[Empty name]" ORDER="22" O_E="0.0" SE="0.23450372448794815" STUDY_ID="STD-Shelton-2001" TOTAL_1="98" TOTAL_2="102" VAR="0.05499199679871949" WEIGHT="6.136075232345729"/>
<DICH_DATA CI_END="8.17811659489705" CI_START="2.8565392581572984" EFFECT_SIZE="4.833333333333333" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="12" LOG_CI_END="0.9126532979717342" LOG_CI_START="0.4558401970588907" LOG_EFFECT_SIZE="0.6842467475153124" ORDER="23" O_E="0.0" SE="0.26833427673752297" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" VAR="0.07200328407224957" WEIGHT="5.396109884834263"/>
<DICH_DATA CI_END="2.9631536439703963" CI_START="1.2461135781863406" EFFECT_SIZE="1.9215686274509804" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="17" LOG_CI_END="0.47175417088556926" LOG_CI_START="0.0955576283035477" LOG_EFFECT_SIZE="0.2836558995945585" ORDER="24" O_E="0.0" SE="0.22097971131559851" STUDY_ID="STD-Witte-1995" TOTAL_1="48" TOTAL_2="49" VAR="0.04883203281312526" WEIGHT="6.4566884501713195"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.33949474167494" CI_END="1.4968733170020403" CI_START="1.0642789840721014" DF="5.0" EFFECT_SIZE="1.2621770133794896" ESTIMABLE="YES" EVENTS_1="490" EVENTS_2="316" I2="65.13126794162086" ID="CMP-001.03.02" LOG_CI_END="0.17518504679928332" LOG_CI_START="0.02705548638140096" LOG_EFFECT_SIZE="0.10112026659034216" MODIFIED="2008-07-09 12:10:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.013590832131493591" P_Z="0.007452246832441075" STUDIES="6" TAU2="0.028676901219067383" TOTAL_1="796" TOTAL_2="641" WEIGHT="52.88236028367681" Z="2.6759288296684045">
<NAME>More precise trials</NAME>
<DICH_DATA CI_END="1.476191710340438" CI_START="0.9836557217633024" EFFECT_SIZE="1.2050163576881134" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="70" LOG_CI_END="0.16914276218648822" LOG_CI_START="-0.007156877484271345" LOG_EFFECT_SIZE="0.08099294235110842" ORDER="25" O_E="0.0" SE="0.10355928103989517" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" VAR="0.010724524689499991" WEIGHT="9.540567467985245"/>
<DICH_DATA CI_END="1.1730981427912355" CI_START="0.6559867708544208" EFFECT_SIZE="0.8772325020112631" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="55" LOG_CI_END="0.06933434723034784" LOG_CI_START="-0.183104918860403" LOG_EFFECT_SIZE="-0.0568852858150276" ORDER="26" O_E="0.0" SE="0.1482840744962274" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" VAR="0.02198816674920272" WEIGHT="8.360306629921059"/>
<DICH_DATA CI_END="1.5628244173689398" CI_START="0.9830947151161958" EFFECT_SIZE="1.2395178197064989" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="36" LOG_CI_END="0.19391018796722878" LOG_CI_START="-0.00740463855572073" LOG_EFFECT_SIZE="0.09325277470575404" ORDER="27" O_E="0.0" SE="0.11825332562404359" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="53" TOTAL_2="55" VAR="0.013983849021146084" WEIGHT="9.166120688251306"/>
<DICH_DATA CI_END="2.865806602610375" CI_START="1.4521566096642133" EFFECT_SIZE="2.04" ESTIMABLE="YES" EVENTS_1="153" EVENTS_2="25" LOG_CI_END="0.45724687892485594" LOG_CI_START="0.16201345592694155" LOG_EFFECT_SIZE="0.3096301674258988" ORDER="28" O_E="0.0" SE="0.17342157409798833" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" VAR="0.03007504236262406" WEIGHT="7.678325683056144"/>
<DICH_DATA CI_END="1.468960518558004" CI_START="1.0262687597771647" EFFECT_SIZE="1.2278225806451613" ESTIMABLE="YES" EVENTS_1="116" EVENTS_2="96" LOG_CI_END="0.16701012335811236" LOG_CI_START="0.011261108927243382" LOG_EFFECT_SIZE="0.08913561614267788" ORDER="29" O_E="0.0" SE="0.09148774204674791" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" VAR="0.008370006944812285" WEIGHT="9.830677238410868"/>
<DICH_DATA CI_END="1.8162867759762953" CI_START="1.0077978055011227" EFFECT_SIZE="1.3529411764705883" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="34" LOG_CI_END="0.25918442094234767" LOG_CI_START="0.0033734083362903034" LOG_EFFECT_SIZE="0.13127891463931898" ORDER="30" O_E="0.0" SE="0.1502646550897329" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" VAR="0.022579466569236394" WEIGHT="8.306362576052194"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="68.8736410728103" CI_END="1.7682677157065556" CI_START="1.2308808054687699" CI_STUDY="95" CI_TOTAL="95" DF="17.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4753056599204475" ESTIMABLE="YES" EVENTS_1="877" EVENTS_2="518" I2="75.31711735404213" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.24754801783326827" LOG_CI_START="0.0902159992891483" LOG_EFFECT_SIZE="0.16888200856120827" METHOD="MH" MODIFIED="2008-07-09 12:44:53 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="3.367711221002878E-8" P_Q="0.0" P_Z="2.5798758292203683E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10364724786296474" TOTALS="SUB" TOTAL_1="1635" TOTAL_2="1429" WEIGHT="500.0" Z="4.207696023729991">
<NAME>Responder - grouped by extract</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours hypericum</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="20.942576846829212" CI_END="1.8599341725065182" CI_START="0.9156910980757855" DF="5.0" EFFECT_SIZE="1.3050383767426808" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="174" I2="76.12519205936675" ID="CMP-001.04.01" LOG_CI_END="0.26949757377540096" LOG_CI_START="-0.03825100780224944" LOG_EFFECT_SIZE="0.11562328298657577" NO="1" P_CHI2="8.305496355983655E-4" P_Z="0.14082002149254974" STUDIES="6" TAU2="0.14062700891812743" TOTAL_1="486" TOTAL_2="495" WEIGHT="99.99999999999997" Z="1.4727442074061465">
<NAME>extract LI 160</NAME>
<DICH_DATA CI_END="1.699313661642309" CI_START="0.6699942608763411" EFFECT_SIZE="1.0670194003527338" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.23027354893831486" LOG_CI_START="-0.17392891741919023" LOG_EFFECT_SIZE="0.02817231575956235" ORDER="31" O_E="0.0" SE="0.23743052957287605" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" VAR="0.056373256373256374" WEIGHT="16.433367862822067"/>
<DICH_DATA CI_END="3.603733805291571" CI_START="0.9040074379302385" EFFECT_SIZE="1.8049382716049382" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="9" LOG_CI_END="0.5567527037380443" LOG_CI_START="-0.04382799625166046" LOG_EFFECT_SIZE="0.2564623537431919" ORDER="32" O_E="0.0" SE="0.35278407609636414" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" VAR="0.12445660434716523" WEIGHT="11.528414738413243"/>
<DICH_DATA CI_END="1.1286623687301924" CI_START="0.6299914502232515" EFFECT_SIZE="0.843236409608091" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="56" LOG_CI_END="0.05256404526679658" LOG_CI_START="-0.2006653444290518" LOG_EFFECT_SIZE="-0.0740506495811276" ORDER="33" O_E="0.0" SE="0.14874819701303663" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" VAR="0.022126026114629157" WEIGHT="20.908065191787617"/>
<DICH_DATA CI_END="5.174392173823469" CI_START="1.7704672394565684" EFFECT_SIZE="3.0267295597484276" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="12" LOG_CI_END="0.7138593413640908" LOG_CI_START="0.24808789502812034" LOG_EFFECT_SIZE="0.4809736181961056" ORDER="34" O_E="0.0" SE="0.2735964531835927" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="53" TOTAL_2="55" VAR="0.07485501919464183" WEIGHT="14.73189027262855"/>
<DICH_DATA CI_END="1.2792720846470618" CI_START="0.7396834333830369" EFFECT_SIZE="0.9727570959920125" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="57" LOG_CI_END="0.10696292312905956" LOG_CI_START="-0.13095410803988033" LOG_EFFECT_SIZE="-0.011995592455410417" ORDER="35" O_E="0.0" SE="0.13975364181693342" STUDY_ID="STD-Montgomery-2000" TOTAL_1="123" TOTAL_2="124" VAR="0.01953108040109572" WEIGHT="21.34852655307025"/>
<DICH_DATA CI_END="2.4018143007688595" CI_START="0.844594521101798" EFFECT_SIZE="1.4242749731471536" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="19" LOG_CI_END="0.38053942635206495" LOG_CI_START="-0.07335174017724158" LOG_EFFECT_SIZE="0.1535938430874117" ORDER="36" O_E="0.0" SE="0.2666179180168249" STUDY_ID="STD-Shelton-2001" TOTAL_1="98" TOTAL_2="102" VAR="0.07108511420762637" WEIGHT="15.049735381278259"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.257097093208064" CI_END="2.5623556744483262" CI_START="0.9592894124350566" DF="1.0" EFFECT_SIZE="1.5678139779295144" ESTIMABLE="YES" EVENTS_1="257" EVENTS_2="106" I2="84.01814795098069" ID="CMP-001.04.02" LOG_CI_END="0.40863941296883055" LOG_CI_START="-0.018050348760930306" LOG_EFFECT_SIZE="0.1952945321039501" NO="2" P_CHI2="0.012369765454601667" P_Z="0.07279107671246436" STUDIES="2" TAU2="0.10600061913206628" TOTAL_1="429" TOTAL_2="270" WEIGHT="99.99999999999999" Z="1.7941384285839361">
<NAME>extract WS 5570</NAME>
<DICH_DATA CI_END="2.8344665422908304" CI_START="1.4659991154556462" EFFECT_SIZE="2.0384615384615383" ESTIMABLE="YES" EVENTS_1="159" EVENTS_2="26" LOG_CI_END="0.4524713349963389" LOG_CI_START="0.16613370826360316" LOG_EFFECT_SIZE="0.30930252162997107" ORDER="37" O_E="0.0" SE="0.16819613933692074" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" VAR="0.02828994128784485" WEIGHT="46.71813014206877"/>
<DICH_DATA CI_END="1.5433769450913795" CI_START="1.003917185691926" EFFECT_SIZE="1.2447580645161291" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="80" LOG_CI_END="0.18847200848722867" LOG_CI_START="0.0016978888245296054" LOG_EFFECT_SIZE="0.09508494865587915" ORDER="38" O_E="0.0" SE="0.10971204243667267" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" VAR="0.012036732255626265" WEIGHT="53.28186985793121"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.009670086229137755" CI_END="2.0605307805162014" CI_START="1.0532359474143913" DF="1.0" EFFECT_SIZE="1.47316838439925" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="31" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="0.31397910646482485" LOG_CI_START="0.022525673352077984" LOG_EFFECT_SIZE="0.1682523899084514" NO="3" P_CHI2="0.9216650197905892" P_Z="0.023640315335281683" STUDIES="2" TAU2="0.0" TOTAL_1="86" TOTAL_2="84" WEIGHT="100.0" Z="2.2629249620524208">
<NAME>extract WS 5572</NAME>
<DICH_DATA CI_END="2.292464409861165" CI_START="0.9177051997676703" EFFECT_SIZE="1.4504504504504505" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="15" LOG_CI_END="0.3603026020428717" LOG_CI_START="-0.037296807552487106" LOG_EFFECT_SIZE="0.1615028972451923" ORDER="39" O_E="0.0" SE="0.23355186134513312" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" VAR="0.054546471937776286" WEIGHT="51.353644452836846"/>
<DICH_DATA CI_END="2.4565995947101875" CI_START="0.915900175529191" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="16" LOG_CI_END="0.3903343758619522" LOG_CI_START="-0.03815185775058964" LOG_EFFECT_SIZE="0.17609125905568124" ORDER="40" O_E="0.0" SE="0.25169493466507115" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" VAR="0.06335034013605442" WEIGHT="48.64635554716315"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="18.64869708425964" CI_END="31.558434938174205" CI_START="0.40905942359094627" DF="1.0" EFFECT_SIZE="3.59294798254051" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="55" I2="94.63769508678412" ID="CMP-001.04.04" LOG_CI_END="1.4991154573203846" LOG_CI_START="-0.38821359795096877" LOG_EFFECT_SIZE="0.5554509296847079" NO="4" P_CHI2="1.5715659371973167E-5" P_Z="0.2486414349274707" STUDIES="2" TAU2="2.331262902458625" TOTAL_1="201" TOTAL_2="200" WEIGHT="100.0" Z="1.1536555475799566">
<NAME>extract STW3-VI</NAME>
<DICH_DATA CI_END="1.8018454004437559" CI_START="1.0592608790078595" EFFECT_SIZE="1.3815297111210896" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="51" LOG_CI_END="0.25571752548072324" LOG_CI_START="0.02500293306369959" LOG_EFFECT_SIZE="0.1403602292722114" ORDER="41" O_E="0.0" SE="0.13552289364141099" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" VAR="0.01836645470094119" WEIGHT="74.12111580912179"/>
<DICH_DATA CI_END="27.08635707720228" CI_START="3.8787977172621613" EFFECT_SIZE="10.25" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="4" LOG_CI_END="1.4327505994349778" LOG_CI_START="0.5886971313485683" LOG_EFFECT_SIZE="1.0107238653917732" ORDER="42" O_E="0.0" SE="0.49580118528600803" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" VAR="0.24581881533101047" WEIGHT="25.87888419087821"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="16.98305977758105" CI_END="1.9294291122263125" CI_START="1.0844456420801383" DF="5.0" EFFECT_SIZE="1.4464995653149622" ESTIMABLE="YES" EVENTS_1="260" EVENTS_2="152" I2="70.55889771641513" ID="CMP-001.04.05" LOG_CI_END="0.2854288270978864" LOG_CI_START="0.035207787852015865" LOG_EFFECT_SIZE="0.16031830747495113" MODIFIED="2008-07-02 14:58:11 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.004532051795243075" P_Z="0.01202110134634493" STUDIES="6" TAU2="0.08311378639305837" TOTAL_1="433" TOTAL_2="380" WEIGHT="100.00000000000001" Z="2.5115242879681903">
<NAME>other extracts</NAME>
<DICH_DATA CI_END="1.7357489195898135" CI_START="1.0242136738289869" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="48" LOG_CI_END="0.2394869036037583" LOG_CI_START="0.010390569612841566" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="967" O_E="0.0" SE="0.1345723206314074" STUDY_ID="STD-Bracher-2001" TOTAL_1="109" TOTAL_2="109" VAR="0.01810970948012232" WEIGHT="20.811461672908514"/>
<DICH_DATA CI_END="1.2655803297048804" CI_START="0.1765759700391964" EFFECT_SIZE="0.4727272727272727" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.10228971617966408" LOG_CI_START="-0.7530683992265159" LOG_EFFECT_SIZE="-0.3253893415234259" ORDER="43" O_E="0.0" SE="0.5024415910805479" STUDY_ID="STD-Moreno-2005" TOTAL_1="20" TOTAL_2="26" VAR="0.25244755244755246" WEIGHT="7.115914775913603"/>
<DICH_DATA CI_END="1.8926131184482329" CI_START="0.9634437928594055" EFFECT_SIZE="1.3503430531732419" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="22" LOG_CI_END="0.2770618460319398" LOG_CI_START="-0.016173616932804932" LOG_EFFECT_SIZE="0.13044411454956742" ORDER="44" O_E="0.0" SE="0.17224796248444282" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="47" VAR="0.029669360580042024" WEIGHT="19.00693605057377"/>
<DICH_DATA CI_END="6.455377648631762" CI_START="2.1242962862957433" EFFECT_SIZE="3.703125" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="12" LOG_CI_END="0.8099216541809597" LOG_CI_START="0.32721508987147363" LOG_EFFECT_SIZE="0.5685683720262167" ORDER="45" O_E="0.0" SE="0.28354422531142176" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" VAR="0.0803973277074543" WEIGHT="13.768078973814026"/>
<DICH_DATA CI_END="1.8162867759762953" CI_START="1.0077978055011227" EFFECT_SIZE="1.3529411764705883" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="34" LOG_CI_END="0.25918442094234767" LOG_CI_START="0.0033734083362903034" LOG_EFFECT_SIZE="0.13127891463931898" ORDER="46" O_E="0.0" SE="0.1502646550897329" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" VAR="0.022579466569236394" WEIGHT="20.074516417177623"/>
<DICH_DATA CI_END="1.9291208032245668" CI_START="0.9991439837373781" EFFECT_SIZE="1.3883333333333334" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="25" LOG_CI_END="0.2853594243940738" LOG_CI_START="-3.719223477858606E-4" LOG_EFFECT_SIZE="0.14249375102314396" ORDER="47" O_E="0.0" SE="0.16784000746914576" STUDY_ID="STD-Witte-1995" TOTAL_1="48" TOTAL_2="49" VAR="0.028170268107242904" WEIGHT="19.223092109612463"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="68.87364107281029" CI_END="1.7682677157065558" CI_START="1.2308808054687699" CI_STUDY="95" CI_TOTAL="95" DF="17.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4753056599204477" ESTIMABLE="YES" EVENTS_1="877" EVENTS_2="518" I2="75.31711735404214" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.2475480178332683" LOG_CI_START="0.0902159992891483" LOG_EFFECT_SIZE="0.16888200856120833" METHOD="MH" MODIFIED="2008-07-15 08:09:16 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="3.3677110988783454E-8" P_Q="0.0" P_Z="2.5798758292203537E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.10364724786296468" TOTALS="YES" TOTAL_1="1635" TOTAL_2="1429" WEIGHT="100.0" Z="4.207696023729992">
<NAME>Responder among studies from German-speaking countries and other studies</NAME>
<GROUP_LABEL_1>Hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hypericum</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="40.01520541474619" CI_END="2.2475572296762194" CI_START="1.4164621679340195" DF="10.0" EFFECT_SIZE="1.7842588898763982" ESTIMABLE="YES" EVENTS_1="609" EVENTS_2="265" I2="75.00949977301666" ID="CMP-001.05.01" LOG_CI_END="0.3517107590108923" LOG_CI_START="0.15120497950812634" LOG_EFFECT_SIZE="0.25145786925950936" MODIFIED="2008-07-15 08:09:16 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.6840624484038003E-5" P_Z="8.83071835202044E-7" STUDIES="11" TAU2="0.10585300673124963" TOTAL_1="996" TOTAL_2="774" WEIGHT="62.52389971629263" Z="4.916051483403958">
<NAME>Studies from German-speaking countries</NAME>
<DICH_DATA CI_END="1.7357489195898135" CI_START="1.0242136738289869" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="48" LOG_CI_END="0.2394869036037583" LOG_CI_START="0.010390569612841566" LOG_EFFECT_SIZE="0.12493873660829992" ORDER="968" O_E="0.0" SE="0.1345723206314074" STUDY_ID="STD-Bracher-2001" TOTAL_1="109" TOTAL_2="109" VAR="0.01810970948012232" WEIGHT="7.01480570585611"/>
<DICH_DATA CI_END="1.8018454004437559" CI_START="1.0592608790078595" EFFECT_SIZE="1.3815297111210896" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="51" LOG_CI_END="0.25571752548072324" LOG_CI_START="0.02500293306369959" LOG_EFFECT_SIZE="0.1403602292722114" ORDER="48" O_E="0.0" SE="0.13552289364141099" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" VAR="0.01836645470094119" WEIGHT="7.000044922418626"/>
<DICH_DATA CI_END="5.174392173823469" CI_START="1.7704672394565684" EFFECT_SIZE="3.0267295597484276" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="12" LOG_CI_END="0.7138593413640908" LOG_CI_START="0.24808789502812034" LOG_EFFECT_SIZE="0.4809736181961056" MODIFIED="2008-07-15 08:08:48 +0100" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.2735964531835927" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="53" TOTAL_2="55" VAR="0.07485501919464183" WEIGHT="4.7848210175522805"/>
<DICH_DATA CI_END="2.292464409861165" CI_START="0.9177051997676703" EFFECT_SIZE="1.4504504504504505" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="15" LOG_CI_END="0.3603026020428717" LOG_CI_START="-0.037296807552487106" LOG_EFFECT_SIZE="0.1615028972451923" ORDER="50" O_E="0.0" SE="0.23355186134513312" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" VAR="0.054546471937776286" WEIGHT="5.399085375663346"/>
<DICH_DATA CI_END="2.8344665422908304" CI_START="1.4659991154556462" EFFECT_SIZE="2.0384615384615383" ESTIMABLE="YES" EVENTS_1="159" EVENTS_2="26" LOG_CI_END="0.4524713349963389" LOG_CI_START="0.16613370826360316" LOG_EFFECT_SIZE="0.30930252162997107" ORDER="51" O_E="0.0" SE="0.16819613933692074" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" VAR="0.02828994128784485" WEIGHT="6.473545515068487"/>
<DICH_DATA CI_END="2.4565995947101875" CI_START="0.915900175529191" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="16" LOG_CI_END="0.3903343758619522" LOG_CI_START="-0.03815185775058964" LOG_EFFECT_SIZE="0.17609125905568124" ORDER="52" O_E="0.0" SE="0.25169493466507115" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" VAR="0.06335034013605442" WEIGHT="5.114453503981043"/>
<DICH_DATA CI_END="1.8926131184482329" CI_START="0.9634437928594055" EFFECT_SIZE="1.3503430531732419" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="22" LOG_CI_END="0.2770618460319398" LOG_CI_START="-0.016173616932804932" LOG_EFFECT_SIZE="0.13044411454956742" ORDER="53" O_E="0.0" SE="0.17224796248444282" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="47" VAR="0.029669360580042024" WEIGHT="6.40656411135074"/>
<DICH_DATA CI_END="6.455377648631762" CI_START="2.1242962862957433" EFFECT_SIZE="3.703125" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="12" LOG_CI_END="0.8099216541809597" LOG_CI_START="0.32721508987147363" LOG_EFFECT_SIZE="0.5685683720262167" MODIFIED="2008-07-15 08:08:56 +0100" MODIFIED_BY="[Empty name]" ORDER="54" O_E="0.0" SE="0.28354422531142176" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" VAR="0.0803973277074543" WEIGHT="4.6407311731454435"/>
<DICH_DATA CI_END="27.08635707720228" CI_START="3.8787977172621613" EFFECT_SIZE="10.25" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="4" LOG_CI_END="1.4327505994349778" LOG_CI_START="0.5886971313485683" LOG_EFFECT_SIZE="1.0107238653917732" MODIFIED="2008-07-15 08:09:16 +0100" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="0.49580118528600803" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" VAR="0.24581881533101047" WEIGHT="2.444018143827279"/>
<DICH_DATA CI_END="1.8162867759762953" CI_START="1.0077978055011227" EFFECT_SIZE="1.3529411764705883" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="34" LOG_CI_END="0.25918442094234767" LOG_CI_START="0.0033734083362903034" LOG_EFFECT_SIZE="0.13127891463931898" ORDER="56" O_E="0.0" SE="0.1502646550897329" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" VAR="0.022579466569236394" WEIGHT="6.766407593986145"/>
<DICH_DATA CI_END="1.9291208032245668" CI_START="0.9991439837373781" EFFECT_SIZE="1.3883333333333334" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="25" LOG_CI_END="0.2853594243940738" LOG_CI_START="-3.719223477858606E-4" LOG_EFFECT_SIZE="0.14249375102314396" ORDER="57" O_E="0.0" SE="0.16784000746914576" STUDY_ID="STD-Witte-1995" TOTAL_1="48" TOTAL_2="49" VAR="0.028170268107242904" WEIGHT="6.47942265344314"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.909308336354094" CI_END="1.3120899839979447" CI_START="0.8797688359764482" DF="6.0" EFFECT_SIZE="1.0744002410266988" ESTIMABLE="YES" EVENTS_1="268" EVENTS_2="253" I2="45.00109617393756" ID="CMP-001.05.02" LOG_CI_END="0.11796362026348715" LOG_CI_START="-0.055631426086336234" LOG_EFFECT_SIZE="0.03116609708857551" NO="2" P_CHI2="0.09122021625920473" P_Z="0.4815836670878595" STUDIES="7" TAU2="0.029080021686221147" TOTAL_1="639" TOTAL_2="655" WEIGHT="37.47610028370737" Z="0.7037577294595275">
<NAME>Studies from other countries</NAME>
<DICH_DATA CI_END="1.699313661642309" CI_START="0.6699942608763411" EFFECT_SIZE="1.0670194003527338" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.23027354893831486" LOG_CI_START="-0.17392891741919023" LOG_EFFECT_SIZE="0.02817231575956235" ORDER="58" O_E="0.0" SE="0.23743052957287605" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" VAR="0.056373256373256374" WEIGHT="5.337449742297698"/>
<DICH_DATA CI_END="3.603733805291571" CI_START="0.9040074379302385" EFFECT_SIZE="1.8049382716049382" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="9" LOG_CI_END="0.5567527037380443" LOG_CI_START="-0.04382799625166046" LOG_EFFECT_SIZE="0.2564623537431919" ORDER="59" O_E="0.0" SE="0.35278407609636414" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" VAR="0.12445660434716523" WEIGHT="3.7443532444650045"/>
<DICH_DATA CI_END="1.1286623687301924" CI_START="0.6299914502232515" EFFECT_SIZE="0.843236409608091" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="56" LOG_CI_END="0.05256404526679658" LOG_CI_START="-0.2006653444290518" LOG_EFFECT_SIZE="-0.0740506495811276" ORDER="60" O_E="0.0" SE="0.14874819701303663" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" VAR="0.022126026114629157" WEIGHT="6.79080198906265"/>
<DICH_DATA CI_END="1.5433769450913795" CI_START="1.003917185691926" EFFECT_SIZE="1.2447580645161291" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="80" LOG_CI_END="0.18847200848722867" LOG_CI_START="0.0016978888245296054" LOG_EFFECT_SIZE="0.09508494865587915" ORDER="61" O_E="0.0" SE="0.10971204243667267" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" VAR="0.012036732255626265" WEIGHT="7.383056826212256"/>
<DICH_DATA CI_END="1.2792720846470618" CI_START="0.7396834333830369" EFFECT_SIZE="0.9727570959920125" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="57" LOG_CI_END="0.10696292312905956" LOG_CI_START="-0.13095410803988033" LOG_EFFECT_SIZE="-0.011995592455410417" ORDER="62" O_E="0.0" SE="0.13975364181693342" STUDY_ID="STD-Montgomery-2000" TOTAL_1="123" TOTAL_2="124" VAR="0.01953108040109572" WEIGHT="6.933860940757434"/>
<DICH_DATA CI_END="1.2655803297048804" CI_START="0.1765759700391964" EFFECT_SIZE="0.4727272727272727" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.10228971617966408" LOG_CI_START="-0.7530683992265159" LOG_EFFECT_SIZE="-0.3253893415234259" ORDER="63" O_E="0.0" SE="0.5024415910805479" STUDY_ID="STD-Moreno-2005" TOTAL_1="20" TOTAL_2="26" VAR="0.25244755244755246" WEIGHT="2.398522523645904"/>
<DICH_DATA CI_END="2.4018143007688595" CI_START="0.844594521101798" EFFECT_SIZE="1.4242749731471536" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="19" LOG_CI_END="0.38053942635206495" LOG_CI_START="-0.07335174017724158" LOG_EFFECT_SIZE="0.1535938430874117" ORDER="64" O_E="0.0" SE="0.2666179180168249" STUDY_ID="STD-Shelton-2001" TOTAL_1="98" TOTAL_2="102" VAR="0.07108511420762637" WEIGHT="4.8880550172664226"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.999291109851002" CI_END="4.257825394940289" CI_START="1.8021009857058865" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.7700237076937535" ESTIMABLE="YES" EVENTS_1="193" EVENTS_2="61" I2="28.564194265861328" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.6291878479034443" LOG_CI_START="0.2557791242157166" LOG_EFFECT_SIZE="0.4424834860595804" METHOD="MH" MODIFIED="2008-07-09 12:45:12 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.2206931165160414" P_Q="0.0" P_Z="3.3998880439039E-6" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="WEIGHT" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.07973474522138202" TOTALS="YES" TOTAL_1="696" TOTAL_2="540" WEIGHT="100.0" Z="4.6450532160344995">
<NAME>Remission (HAMD score &lt; 8 or &lt; 7)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="135.22866986170112" CI_START="2.2004394504827887" EFFECT_SIZE="17.25" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="1" LOG_CI_END="2.1310687762413676" LOG_CI_START="0.34250942257721817" LOG_EFFECT_SIZE="1.236789099409293" ORDER="70" O_E="0.0" SE="1.0506086178539098" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" VAR="1.1037784679089027" WEIGHT="4.065097934047669"/>
<DICH_DATA CI_END="13.337655263349717" CI_START="1.225349203003189" EFFECT_SIZE="4.0426829268292686" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="4" LOG_CI_END="1.1250794880744042" LOG_CI_START="0.08825987263974641" LOG_EFFECT_SIZE="0.6066696803570752" ORDER="65" O_E="0.0" SE="0.6090329744461878" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" VAR="0.3709211639627708" WEIGHT="10.675766187830162"/>
<DICH_DATA CI_END="9.352040674162426" CI_START="1.1178784191270368" EFFECT_SIZE="3.2333333333333334" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="5" LOG_CI_END="0.9709063870038568" LOG_CI_START="0.048394572089307815" LOG_EFFECT_SIZE="0.5096504795465824" ORDER="69" O_E="0.0" SE="0.5418880065879377" STUDY_ID="STD-Shelton-2001" TOTAL_1="98" TOTAL_2="102" VAR="0.2936426116838488" WEIGHT="12.885347835474589"/>
<DICH_DATA CI_END="5.932200692215194" CI_START="0.8868266999325712" EFFECT_SIZE="2.2936507936507935" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="9" LOG_CI_END="0.7732158352166372" LOG_CI_START="-0.052161239938667295" LOG_EFFECT_SIZE="0.36052729763898494" ORDER="66" O_E="0.0" SE="0.4848305796286409" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" VAR="0.23506069094304388" WEIGHT="15.283249262549909"/>
<DICH_DATA CI_END="6.469787357239252" CI_START="1.7068063662240527" EFFECT_SIZE="3.323051948051948" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="12" LOG_CI_END="0.810890006929099" LOG_CI_START="0.23218425406706142" LOG_EFFECT_SIZE="0.5215371304980803" ORDER="67" O_E="0.0" SE="0.33993462387083784" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" VAR="0.115555548506208" WEIGHT="24.635618216259264"/>
<DICH_DATA CI_END="2.90866668414969" CI_START="1.0425991695484653" EFFECT_SIZE="1.7414285714285713" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="30" LOG_CI_END="0.4636939565415379" LOG_CI_START="0.018117374666712302" LOG_EFFECT_SIZE="0.24090566560412507" ORDER="68" O_E="0.0" SE="0.26173388983292495" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" VAR="0.0685046290870737" WEIGHT="32.45492056383841"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-07-15 08:05:02 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Hypericum mono-preparations vs. placebo. B. Continuous measures</NAME>
<CONT_OUTCOME CHI2="111.95210698416625" CI_END="-1.7805624530317348" CI_START="-4.292655986797184" CI_STUDY="95" CI_TOTAL="95" DF="16.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0366092199144594" ESTIMABLE="YES" I2="85.70817429790497" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2008-07-02 16:16:10 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.1102230246251565E-15" P_Q="1.0" P_Z="2.1541845713942097E-6" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="5.8014800476010455" TOTALS="YES" TOTAL_1="1543" TOTAL_2="1328" UNITS="" WEIGHT="99.99999999999997" Z="4.738394192857555">
<NAME>Mean HAMD (Hamilton Rating Scale for Depression) scores after therapy</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.355667178982588" CI_START="-3.355667178982588" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="15.5" ORDER="2440" SD_1="8.4" SD_2="6.7" SE="1.4569998232149806" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" WEIGHT="5.1826629447117485"/>
<CONT_DATA CI_END="-0.8652303446045599" CI_START="-3.97476965539544" EFFECT_SIZE="-2.42" ESTIMABLE="YES" MEAN_1="11.03" MEAN_2="13.45" MODIFIED="2008-07-02 16:12:35 +0100" MODIFIED_BY="[Empty name]" ORDER="2456" SD_1="4.96" SD_2="6.36" SE="0.7932644006008603" STUDY_ID="STD-Bracher-2001" TOTAL_1="104" TOTAL_2="103" WEIGHT="6.386367640150341"/>
<CONT_DATA CI_END="0.3162004723091001" CI_START="-5.116200472309101" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="10.2" MEAN_2="12.6" ORDER="2441" SD_1="6.6" SD_2="6.4" SE="1.3858420326772038" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" WEIGHT="5.318430555713241"/>
<CONT_DATA CI_END="-1.0850770628653548" CI_START="-4.314922937134644" EFFECT_SIZE="-2.6999999999999993" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="13.0" ORDER="2442" SD_1="6.4" SD_2="6.9" SE="0.8239554144223825" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" WEIGHT="6.337453597379716"/>
<CONT_DATA CI_END="3.1212531809402897" CI_START="-1.321253180940289" EFFECT_SIZE="0.9000000000000004" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="12.0" ORDER="2443" SD_1="7.1" SD_2="7.5" SE="1.1333132641524288" STUDY_ID="STD-HDTSG-2002" TOTAL_1="82" TOTAL_2="84" WEIGHT="5.795910970747503"/>
<CONT_DATA CI_END="-3.658521244262742" CI_START="-7.341478755737258" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="14.4" ORDER="2444" SD_1="4.3" SD_2="5.1" SE="0.9395472418180169" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="51" TOTAL_2="50" WEIGHT="6.14418258768581"/>
<CONT_DATA CI_END="-2.8552302443876463" CI_START="-8.144769755612353" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="14.4" ORDER="2445" SD_1="4.3" SD_2="6.8" SE="1.349397119780751" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" WEIGHT="5.387985286997192"/>
<CONT_DATA CI_END="-3.9529302131607182" CI_START="-8.247069786839285" EFFECT_SIZE="-6.100000000000001" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="17.6" ORDER="2446" SD_1="7.7" SD_2="8.8" SE="1.0954638982017504" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" WEIGHT="5.865742982774013"/>
<CONT_DATA CI_END="-0.2816155486588978" CI_START="-4.918384451341105" EFFECT_SIZE="-2.6000000000000014" ESTIMABLE="YES" MEAN_1="10.7" MEAN_2="13.3" ORDER="2447" SD_1="5.0" SD_2="6.6" SE="1.1828709453991115" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" WEIGHT="5.703519208468602"/>
<CONT_DATA CI_END="-0.2926014620574182" CI_START="-3.1073985379425837" EFFECT_SIZE="-1.700000000000001" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="13.8" ORDER="2448" SD_1="6.7" SD_2="7.2" SE="0.7180736733143889" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" WEIGHT="6.501252128842926"/>
<CONT_DATA CI_END="2.0961060020353752" CI_START="-1.496106002035374" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="12.4" MEAN_2="12.1" ORDER="2449" SD_1="7.3" SD_2="7.1" SE="0.916397452301588" STUDY_ID="STD-Montgomery-2000" TOTAL_1="123" TOTAL_2="124" WEIGHT="6.18393151597796"/>
<CONT_DATA CI_END="-0.4140823462280827" CI_START="-4.985917653771919" EFFECT_SIZE="-2.700000000000001" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="11.9" ORDER="2450" SD_1="6.2" SD_2="6.7" SE="1.1663059483760645" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="46" WEIGHT="5.734509870792015"/>
<CONT_DATA CI_END="-4.998220608178304" CI_START="-8.281779391821694" EFFECT_SIZE="-6.639999999999999" ESTIMABLE="YES" MEAN_1="9.47" MEAN_2="16.11" ORDER="2451" SD_1="4.82" SD_2="5.7" SE="0.8376579390090028" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" WEIGHT="6.3152654252370795"/>
<CONT_DATA CI_END="0.8897479980670155" CI_START="-3.1097479980670144" EFFECT_SIZE="-1.1099999999999994" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="16.11" ORDER="2452" SD_1="6.88" SD_2="6.2" SE="1.0202983390719278" STUDY_ID="STD-Shelton-2001" TOTAL_1="79" TOTAL_2="87" WEIGHT="6.00207400515899"/>
<CONT_DATA CI_END="-6.038061737609322" CI_START="-8.761938262390675" EFFECT_SIZE="-7.399999999999999" ESTIMABLE="YES" MEAN_1="11.8" MEAN_2="19.2" ORDER="2453" SD_1="4.4" SD_2="3.8" SE="0.6948792289723034" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" WEIGHT="6.5351559921395435"/>
<CONT_DATA CI_END="-0.4730684371461349" CI_START="-4.1269315628538665" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="14.3" ORDER="2454" SD_1="5.1" SD_2="5.9" SE="0.9321250682484314" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" WEIGHT="6.156978676519823"/>
<CONT_DATA CI_END="1.1301631078187944" CI_START="-6.130163107818794" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="7.9" MEAN_2="10.4" ORDER="2455" SD_1="7.5" SD_2="8.1" SE="1.852158068440572" STUDY_ID="STD-Witte-1995" TOTAL_1="39" TOTAL_2="33" WEIGHT="4.4485766107034825"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="42.885784988197926" CI_END="-0.366358390400062" CI_START="-2.067774687551587" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.2170665389758246" ESTIMABLE="YES" I2="72.01870036119806" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2008-07-02 16:16:19 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.360768141029812E-5" P_Q="1.0" P_Z="0.005046905289440221" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="1.6118984520867534" TOTALS="YES" TOTAL_1="1255" TOTAL_2="1044" UNITS="" WEIGHT="100.00000000000001" Z="2.804024608410096">
<NAME>Mean HAMD (Hamilton Rating Scale for Depression) scores after 2 to 3 weeks of treatment</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.9770429943130767" CI_START="-4.1770429943130765" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.9" ORDER="2470" SD_1="5.9" SD_2="6.0" SE="1.314842014771936" STUDY_ID="STD-Fava-2005" TOTAL_1="42" TOTAL_2="40" WEIGHT="5.639316759297021"/>
<CONT_DATA CI_END="-0.3674204563187373" CI_START="-3.232579543681264" EFFECT_SIZE="-1.8000000000000007" ESTIMABLE="YES" MEAN_1="13.5" MEAN_2="15.3" ORDER="2471" SD_1="5.7" SD_2="6.1" SE="0.7309213613011606" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" WEIGHT="8.778211615014344"/>
<CONT_DATA CI_END="2.445980867786355" CI_START="-0.6459808677863506" EFFECT_SIZE="0.9000000000000021" ESTIMABLE="YES" MEAN_1="18.6" MEAN_2="17.7" ORDER="2472" SD_1="5.7" SD_2="5.7" SE="0.7887802428926514" STUDY_ID="STD-HDTSG-2002" TOTAL_1="102" TOTAL_2="107" WEIGHT="8.43272033037807"/>
<CONT_DATA CI_END="-2.2139350225411816" CI_START="-5.586064977458819" EFFECT_SIZE="-3.9000000000000004" ESTIMABLE="YES" MEAN_1="13.4" MEAN_2="17.3" ORDER="2473" SD_1="3.9" SD_2="4.7" SE="0.8602530407488527" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="51" TOTAL_2="50" WEIGHT="8.010136555416315"/>
<CONT_DATA CI_END="0.31264810351398875" CI_START="-4.712648103513991" EFFECT_SIZE="-2.200000000000001" ESTIMABLE="YES" MEAN_1="13.9" MEAN_2="16.1" ORDER="2474" SD_1="4.9" SD_2="5.9" SE="1.2819868749290484" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" WEIGHT="5.787115345127583"/>
<CONT_DATA CI_END="0.7296685876527347" CI_START="-2.7296685876527347" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="18.1" MEAN_2="19.1" ORDER="2475" SD_1="6.5" SD_2="7.0" SE="0.8825001894402855" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" WEIGHT="7.880232060903945"/>
<CONT_DATA CI_END="1.2864783742926043" CI_START="-2.8864783742926057" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="15.7" MEAN_2="16.5" ORDER="2476" SD_1="4.8" SD_2="5.7" SE="1.0645493441463618" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" WEIGHT="6.862727376482217"/>
<CONT_DATA CI_END="0.36593165146670836" CI_START="-1.7659316514667105" EFFECT_SIZE="-0.7000000000000011" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="16.1" ORDER="2477" SD_1="4.8" SD_2="5.7" SE="0.5438526727402352" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" WEIGHT="9.875538840322484"/>
<CONT_DATA CI_END="1.5731713468458315" CI_START="-1.173171346845833" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="17.4" MEAN_2="17.2" ORDER="2478" SD_1="5.7" SD_2="5.0" SE="0.700610499824095" STUDY_ID="STD-Montgomery-2000" TOTAL_1="115" TOTAL_2="120" WEIGHT="8.959352704172089"/>
<CONT_DATA CI_END="1.270906561136739" CI_START="-3.070906561136736" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="16.5" MEAN_2="17.4" ORDER="2479" SD_1="5.8" SD_2="6.4" SE="1.1076257412179873" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="46" WEIGHT="6.636520207722253"/>
<CONT_DATA CI_END="0.7846023342353212" CI_START="-2.1646023342353238" EFFECT_SIZE="-0.6900000000000013" ESTIMABLE="YES" MEAN_1="17.45" MEAN_2="18.14" ORDER="2480" SD_1="5.34" SD_2="4.84" SE="0.7523619545393678" STUDY_ID="STD-Shelton-2001" TOTAL_1="90" TOTAL_2="94" WEIGHT="8.65003179545627"/>
<CONT_DATA CI_END="-2.253738999986595" CI_START="-3.9462610000134077" EFFECT_SIZE="-3.1000000000000014" ESTIMABLE="YES" MEAN_1="16.9" MEAN_2="20.0" ORDER="2481" SD_1="2.7" SD_2="2.4" SE="0.4317737502773547" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" WEIGHT="10.476020340039428"/>
<CONT_DATA CI_END="4.041817809149306" CI_START="-2.8418178091493105" EFFECT_SIZE="0.5999999999999979" ESTIMABLE="YES" MEAN_1="19.4" MEAN_2="18.8" ORDER="2482" SD_1="8.0" SD_2="6.9" SE="1.7560617625109072" STUDY_ID="STD-Witte-1995" TOTAL_1="39" TOTAL_2="33" WEIGHT="4.012076069667982"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="32.576390655604506" CI_END="-0.5165236613138287" CI_START="-2.7750857010862706" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.6458046812000495" ESTIMABLE="YES" I2="69.30292215083202" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2008-07-15 07:59:38 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="3.208102068466001E-4" P_Q="1.0" P_Z="0.004284276322273803" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="2.382862297537356" TOTALS="YES" TOTAL_1="839" TOTAL_2="795" UNITS="" WEIGHT="100.00000000000001" Z="2.8564350626069372">
<NAME>Mean HAMD (Hamilton Rating Scale for Depression) score after 4 weeks of treatment</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.355667178982588" CI_START="-3.355667178982588" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="15.5" ORDER="2494" SD_1="8.4" SD_2="6.7" SE="1.4569998232149806" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" WEIGHT="7.367914278799441"/>
<CONT_DATA CI_END="1.0007331811854083" CI_START="-5.800733181185409" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="13.9" ORDER="2495" SD_1="6.9" SD_2="7.6" SE="1.7350998324509828" STUDY_ID="STD-Fava-2005" TOTAL_1="35" TOTAL_2="35" WEIGHT="6.155205105974754"/>
<CONT_DATA CI_END="2.9067723941308863" CI_START="-0.9067723941308901" EFFECT_SIZE="0.9999999999999982" ESTIMABLE="YES" MEAN_1="16.9" MEAN_2="15.9" ORDER="2496" SD_1="7.1" SD_2="6.5" SE="0.9728609347780192" STUDY_ID="STD-HDTSG-2002" TOTAL_1="97" TOTAL_2="99" WEIGHT="9.971310619016064"/>
<CONT_DATA CI_END="-3.658521244262742" CI_START="-7.341478755737258" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="14.4" ORDER="2497" SD_1="4.3" SD_2="5.1" SE="0.9395472418180169" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="51" TOTAL_2="50" WEIGHT="10.16584265107909"/>
<CONT_DATA CI_END="-1.0662733889483742" CI_START="-5.933726611051625" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="11.1" MEAN_2="14.6" ORDER="2498" SD_1="4.5" SD_2="5.9" SE="1.2417200674341726" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" WEIGHT="8.458590056668541"/>
<CONT_DATA CI_END="0.3789930056531623" CI_START="-4.1789930056531635" EFFECT_SIZE="-1.9000000000000004" ESTIMABLE="YES" MEAN_1="13.2" MEAN_2="15.1" ORDER="2499" SD_1="5.5" SD_2="6.0" SE="1.1627728997214075" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" WEIGHT="8.88850120005846"/>
<CONT_DATA CI_END="0.565313251250245" CI_START="-1.9653132512502436" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="13.5" MEAN_2="14.2" ORDER="2500" SD_1="6.1" SD_2="6.4" SE="0.6455798480129603" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" WEIGHT="11.857861202602953"/>
<CONT_DATA CI_END="1.1487418507646092" CI_START="-1.94874185076461" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="13.1" MEAN_2="13.5" ORDER="2501" SD_1="5.7" SD_2="6.1" SE="0.7901889335624979" STUDY_ID="STD-Montgomery-2000" TOTAL_1="108" TOTAL_2="115" WEIGHT="11.039179002003568"/>
<CONT_DATA CI_END="0.43006449680400616" CI_START="-4.230064496804003" EFFECT_SIZE="-1.8999999999999986" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="14.2" ORDER="2502" SD_1="5.9" SD_2="7.0" SE="1.1888302617717754" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="46" WEIGHT="8.745026192321934"/>
<CONT_DATA CI_END="0.8739657355067629" CI_START="-2.533965735506767" EFFECT_SIZE="-0.8300000000000018" ESTIMABLE="YES" MEAN_1="16.04" MEAN_2="16.87" ORDER="2503" SD_1="6.02" SD_2="5.33" SE="0.869386248394067" STUDY_ID="STD-Shelton-2001" TOTAL_1="83" TOTAL_2="89" WEIGHT="10.576909668389318"/>
<CONT_DATA CI_END="0.8101949566830697" CI_START="-5.410194956683071" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="14.3" ORDER="2504" SD_1="6.6" SD_2="6.8" SE="1.5868633205588936" STUDY_ID="STD-Witte-1995" TOTAL_1="39" TOTAL_2="33" WEIGHT="6.773660023085889"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="101.63767738697364" CI_END="-1.6316590154128299" CI_START="-4.312352517128637" CI_STUDY="95" CI_TOTAL="95" DF="14.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.9720057662707338" ESTIMABLE="YES" I2="86.22558055247895" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2008-07-02 16:20:31 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.5543122344752192E-15" P_Q="1.0" P_Z="1.3870041717095128E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="5.861439073463618" TOTALS="YES" TOTAL_1="1397" TOTAL_2="1181" UNITS="" WEIGHT="99.99999999999999" Z="4.345908444965926">
<NAME>Mean HAMD (Hamilton Rating Scale for Depression) scores after 6 to 8 weeks of treatment</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.8652303446045599" CI_START="-3.97476965539544" EFFECT_SIZE="-2.42" ESTIMABLE="YES" MEAN_1="11.03" MEAN_2="13.45" ORDER="2521" SD_1="4.96" SD_2="6.36" SE="0.7932644006008603" STUDY_ID="STD-Bracher-2001" TOTAL_1="104" TOTAL_2="103" WEIGHT="7.2052011984567965"/>
<CONT_DATA CI_END="1.785989327650885" CI_START="-3.985989327650884" EFFECT_SIZE="-1.0999999999999996" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="11.4" ORDER="2522" SD_1="5.9" SD_2="5.5" SE="1.4724705915084155" STUDY_ID="STD-Fava-2005" TOTAL_1="32" TOTAL_2="28" WEIGHT="5.824300409346264"/>
<CONT_DATA CI_END="-1.0850770628653548" CI_START="-4.314922937134644" EFFECT_SIZE="-2.6999999999999993" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="13.0" ORDER="2523" SD_1="6.4" SD_2="6.9" SE="0.8239554144223825" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" WEIGHT="7.150521517814631"/>
<CONT_DATA CI_END="3.1212531809402897" CI_START="-1.321253180940289" EFFECT_SIZE="0.9000000000000004" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="12.0" ORDER="2524" SD_1="7.1" SD_2="7.5" SE="1.1333132641524288" STUDY_ID="STD-HDTSG-2002" TOTAL_1="82" TOTAL_2="84" WEIGHT="6.5446282366059565"/>
<CONT_DATA CI_END="-2.8552302443876463" CI_START="-8.144769755612353" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="14.4" ORDER="2525" SD_1="4.3" SD_2="6.8" SE="1.349397119780751" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" WEIGHT="6.087601675263284"/>
<CONT_DATA CI_END="-3.9529302131607182" CI_START="-8.247069786839285" EFFECT_SIZE="-6.100000000000001" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="17.6" ORDER="2526" SD_1="7.7" SD_2="8.8" SE="1.0954638982017504" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" WEIGHT="6.622811625666288"/>
<CONT_DATA CI_END="-0.2816155486588978" CI_START="-4.918384451341105" EFFECT_SIZE="-2.6000000000000014" ESTIMABLE="YES" MEAN_1="10.7" MEAN_2="13.3" ORDER="2527" SD_1="5.0" SD_2="6.6" SE="1.1828709453991115" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" WEIGHT="6.441162826303342"/>
<CONT_DATA CI_END="-0.2926014620574182" CI_START="-3.1073985379425837" EFFECT_SIZE="-1.700000000000001" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="13.8" ORDER="2528" SD_1="6.7" SD_2="7.2" SE="0.7180736733143889" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" WEIGHT="7.333597026952528"/>
<CONT_DATA CI_END="1.5118220767993844" CI_START="-1.9118220767993865" EFFECT_SIZE="-0.20000000000000107" ESTIMABLE="YES" MEAN_1="10.6" MEAN_2="10.8" ORDER="2529" SD_1="6.1" SD_2="6.0" SE="0.8733946594437548" STUDY_ID="STD-Montgomery-2000" TOTAL_1="95" TOTAL_2="97" WEIGHT="7.059939127186632"/>
<CONT_DATA CI_END="-0.4140823462280827" CI_START="-4.985917653771919" EFFECT_SIZE="-2.700000000000001" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="11.9" ORDER="2530" SD_1="6.2" SD_2="6.7" SE="1.1663059483760645" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="46" WEIGHT="6.475870970875798"/>
<CONT_DATA CI_END="-4.998220608178304" CI_START="-8.281779391821694" EFFECT_SIZE="-6.639999999999999" ESTIMABLE="YES" MEAN_1="9.47" MEAN_2="16.11" ORDER="2531" SD_1="4.82" SD_2="5.7" SE="0.8376579390090028" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" WEIGHT="7.125715411239717"/>
<CONT_DATA CI_END="0.8897479980670155" CI_START="-3.1097479980670144" EFFECT_SIZE="-1.1099999999999994" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="16.11" ORDER="2532" SD_1="6.88" SD_2="6.2" SE="1.0202983390719278" STUDY_ID="STD-Shelton-2001" TOTAL_1="79" TOTAL_2="87" WEIGHT="6.775401258133607"/>
<CONT_DATA CI_END="-6.038061737609322" CI_START="-8.761938262390675" EFFECT_SIZE="-7.399999999999999" ESTIMABLE="YES" MEAN_1="11.8" MEAN_2="19.2" ORDER="2533" SD_1="4.4" SD_2="3.8" SE="0.6948792289723034" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" WEIGHT="7.371480104136558"/>
<CONT_DATA CI_END="-0.4730684371461349" CI_START="-4.1269315628538665" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="14.3" ORDER="2534" SD_1="5.1" SD_2="5.9" SE="0.9321250682484314" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" WEIGHT="6.948706539832401"/>
<CONT_DATA CI_END="1.1301631078187944" CI_START="-6.130163107818794" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="7.9" MEAN_2="10.4" ORDER="2535" SD_1="7.5" SD_2="8.1" SE="1.852158068440572" STUDY_ID="STD-Witte-1995" TOTAL_1="39" TOTAL_2="33" WEIGHT="5.033062072186201"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="71.42623940558401" CI_END="-1.3883260226075778" CI_START="-4.667336439005826" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.027831230806702" ESTIMABLE="YES" I2="87.39958861771407" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2008-07-14 16:07:40 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="7.991274308949414E-12" P_Q="1.0" P_Z="2.9499819245863175E-4" Q="0.0" RANDOM="YES" SCALE="40.89960824301906" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="5.976664032656803" TOTALS="YES" TOTAL_1="1573" TOTAL_2="1358" UNITS="" WEIGHT="99.99999999999997" Z="3.619653133133542">
<NAME>Difference HAMD (Hamilton Rating Scale for Depression) baseline - end of treatment</NAME>
<GROUP_LABEL_1>Hyericum</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.6442508772702644" CI_START="-3.0442508772702666" EFFECT_SIZE="-0.20000000000000107" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-9.7" ORDER="161" SD_1="8.1" SD_2="7.0" SE="1.4511750724530417" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" WEIGHT="8.657246367419281"/>
<CONT_DATA CI_END="-0.8366412204215385" CI_START="-3.923358779578463" EFFECT_SIZE="-2.380000000000001" ESTIMABLE="YES" MEAN_1="-8.65" MEAN_2="-6.27" MODIFIED="2008-07-02 16:30:04 +0100" MODIFIED_BY="[Empty name]" ORDER="2547" SD_1="5.27" SD_2="6.03" SE="0.7874424182037422" STUDY_ID="STD-Bracher-2001" TOTAL_1="104" TOTAL_2="103" WEIGHT="10.607199493247457"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="-9.4" MEAN_2="-7.3" ORDER="162" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0"/>
<CONT_DATA CI_END="-1.0093236019954968" CI_START="-4.190676398004502" EFFECT_SIZE="-2.5999999999999996" ESTIMABLE="YES" MEAN_1="-11.6" MEAN_2="-9.0" ORDER="163" SD_1="6.3" SD_2="6.8" SE="0.811584503874334" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" WEIGHT="10.545487645871793"/>
<CONT_DATA CI_END="2.39171408519963" CI_START="-1.3517140851996305" EFFECT_SIZE="0.5199999999999996" ESTIMABLE="YES" MEAN_1="-8.68" MEAN_2="-9.2" ORDER="164" SD_1="7.23" SD_2="7.22" SE="0.9549737137842694" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" WEIGHT="10.157714546221696"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="-12.1" MEAN_2="-6.0" ORDER="165" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="51" TOTAL_2="50" WEIGHT="0.0"/>
<CONT_DATA CI_END="-2.4370721631767847" CI_START="-7.762927836823216" EFFECT_SIZE="-5.1000000000000005" ESTIMABLE="YES" MEAN_1="-10.8" MEAN_2="-5.7" ORDER="166" SD_1="5.0" SD_2="6.4" SE="1.3586616171664636" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" WEIGHT="8.94492872061513"/>
<CONT_DATA CI_END="-3.23975373644788" CI_START="-7.160246263552119" EFFECT_SIZE="-5.199999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-6.0" ORDER="167" SD_1="6.8" SD_2="8.1" SE="1.0001440225505631" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" WEIGHT="10.029139633684887"/>
<CONT_DATA CI_END="-0.43595700171465634" CI_START="-4.364042998285345" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-7.9" ORDER="168" SD_1="4.6" SD_2="5.2" SE="1.0020811677038275" STUDY_ID="STD-Laakmann-1998" TOTAL_1="48" TOTAL_2="48" WEIGHT="10.023567370022711"/>
<CONT_DATA CI_END="-0.3930219636868726" CI_START="-3.206978036313129" EFFECT_SIZE="-1.8000000000000007" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-8.1" ORDER="169" SD_1="6.8" SD_2="7.1" SE="0.7178591277243823" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" WEIGHT="10.778339540645932"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="-9.2" MEAN_2="-9.3" ORDER="170" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Montgomery-2000" TOTAL_1="123" TOTAL_2="123" WEIGHT="0.0"/>
<CONT_DATA CI_END="-0.7666441136092415" CI_START="-5.433355886390758" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-10.3" ORDER="171" SD_1="7.8" SD_2="6.1" SE="1.1905095730309188" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="46" WEIGHT="9.463489823255893"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="-8.3" MEAN_2="-1.04" ORDER="172" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="-7.27" MEAN_2="-6.66" ORDER="173" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Shelton-2001" TOTAL_1="79" TOTAL_2="87" WEIGHT="0.0"/>
<CONT_DATA CI_END="-6.305018536826621" CI_START="-9.094981463173378" EFFECT_SIZE="-7.699999999999999" ESTIMABLE="YES" MEAN_1="-11.1" MEAN_2="-3.4" ORDER="174" SD_1="4.5" SD_2="3.9" SE="0.711738314671501" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" WEIGHT="10.792886859015203"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="-9.0" MEAN_2="-6.4" ORDER="175" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="-16.7" MEAN_2="-12.3" ORDER="176" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Witte-1995" TOTAL_1="39" TOTAL_2="33" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.27153796618569" CI_END="-0.4233522432788748" CI_START="-7.3045187884957965" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.8639355158873356" ESTIMABLE="YES" I2="80.52871919877938" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2008-07-14 16:07:40 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.005882555071870077" P_Q="1.0" P_Z="0.027726752285711965" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="7.326212874965642" TOTALS="YES" TOTAL_1="401" TOTAL_2="239" UNITS="" WEIGHT="100.0" Z="2.201130985556065">
<NAME>MADRS after treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.1028940486685324" CI_START="-5.102894048668536" EFFECT_SIZE="-1.5000000000000018" ESTIMABLE="YES" MEAN_1="15.6" MEAN_2="17.1" ORDER="177" SD_1="10.4" SD_2="8.7" SE="1.838245027504435" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" WEIGHT="28.785036456592138"/>
<CONT_DATA CI_END="-0.6299428060348216" CI_START="-4.470057193965176" EFFECT_SIZE="-2.549999999999999" ESTIMABLE="YES" MEAN_1="11.49" MEAN_2="14.04" MODIFIED="2008-07-02 16:28:42 +0100" MODIFIED_BY="[Empty name]" ORDER="2548" SD_1="6.32" SD_2="7.7" SE="0.9796390184260239" STUDY_ID="STD-Bracher-2001" TOTAL_1="104" TOTAL_2="103" WEIGHT="37.19015515011203"/>
<CONT_DATA CI_END="-4.721671304657309" CI_START="-9.878328695342692" EFFECT_SIZE="-7.300000000000001" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="21.5" ORDER="178" SD_1="9.8" SD_2="10.4" SE="1.3154979967388276" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" WEIGHT="34.02480839329584"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.714437671013708" CI_END="-1.1392120701331128" CI_START="-4.875284174805314" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.007248122469213" ESTIMABLE="YES" I2="61.111877133025196" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2008-07-14 16:07:40 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.052297288960375" P_Q="1.0" P_Z="0.0016036732355978083" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="2.1761760097342346" TOTALS="YES" TOTAL_1="587" TOTAL_2="428" UNITS="" WEIGHT="100.0" Z="3.1552378259747202">
<NAME>Difference MADRS baseline - end of treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.6015552986886115" CI_START="-4.80155529868861" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-8.3" ORDER="179" SD_1="9.1" SD_2="7.9" SE="1.6334765964793592" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" WEIGHT="18.751342888736865"/>
<CONT_DATA CI_END="-0.7020071337261782" CI_START="-4.737992866273823" EFFECT_SIZE="-2.7200000000000006" ESTIMABLE="YES" MEAN_1="-10.48" MEAN_2="-7.76" ORDER="2549" SD_1="7.12" SD_2="7.68" SE="1.0296071163508578" STUDY_ID="STD-Bracher-2001" TOTAL_1="104" TOTAL_2="103" WEIGHT="28.069198009421136"/>
<CONT_DATA CI_END="-3.4511163328376444" CI_START="-8.548883667162356" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-6.5" ORDER="180" SD_1="9.3" SD_2="10.4" SE="1.3004747471216944" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" WEIGHT="23.48843301333363"/>
<CONT_DATA CI_END="0.04206853926333909" CI_START="-3.642068539263337" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="-11.7" MEAN_2="-9.9" ORDER="181" SD_1="9.0" SD_2="9.2" SE="0.9398481573096953" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" WEIGHT="29.69102608850837"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="111.95210698416624" CI_END="-1.7805624530317348" CI_START="-4.292655986797184" CI_STUDY="95" CI_TOTAL="95" DF="16.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0366092199144594" ESTIMABLE="YES" I2="85.70817429790497" I2_Q="98.15251041018588" ID="CMP-002.08" MODIFIED="2008-07-14 16:07:40 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.1102230246251565E-16" P_Q="1.8762769116165146E-13" P_Z="2.1541845713942097E-6" Q="54.12750391197669" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="5.801480047601045" TOTALS="YES" TOTAL_1="1543" TOTAL_2="1328" UNITS="" WEIGHT="100.0" Z="4.738394192857555">
<NAME>Mean HAMD after treatment in studies from German-speaking countries and other studies</NAME>
<GROUP_LABEL_1>Hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="51.09688656582053" CI_END="-2.9700186830319057" CI_START="-5.608175084982458" DF="10.0" EFFECT_SIZE="-4.289096884007182" ESTIMABLE="YES" I2="80.42933596919161" ID="CMP-002.08.01" MODIFIED="2008-07-02 16:31:07 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.6759953003209205E-7" P_Z="1.8537501154984252E-10" STUDIES="11" TAU2="3.859149562514662" TOTAL_1="974" TOTAL_2="746" WEIGHT="65.01573787884763" Z="6.3729924523365025">
<NAME>Studies from German-speaking countries</NAME>
<CONT_DATA CI_END="-0.8652303446045599" CI_START="-3.97476965539544" EFFECT_SIZE="-2.42" ESTIMABLE="YES" MEAN_1="11.03" MEAN_2="13.45" ORDER="2550" SD_1="4.96" SD_2="6.36" SE="0.7932644006008603" STUDY_ID="STD-Bracher-2001" TOTAL_1="104" TOTAL_2="103" WEIGHT="6.386367640150341"/>
<CONT_DATA CI_END="-1.0850770628653548" CI_START="-4.314922937134644" EFFECT_SIZE="-2.6999999999999993" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="13.0" ORDER="182" SD_1="6.4" SD_2="6.9" SE="0.8239554144223825" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" WEIGHT="6.337453597379716"/>
<CONT_DATA CI_END="-3.658521244262742" CI_START="-7.341478755737258" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="14.4" ORDER="183" SD_1="4.3" SD_2="5.1" SE="0.9395472418180169" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="51" TOTAL_2="50" WEIGHT="6.14418258768581"/>
<CONT_DATA CI_END="-2.8552302443876463" CI_START="-8.144769755612353" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="14.4" ORDER="184" SD_1="4.3" SD_2="6.8" SE="1.349397119780751" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" WEIGHT="5.387985286997193"/>
<CONT_DATA CI_END="-3.9529302131607182" CI_START="-8.247069786839285" EFFECT_SIZE="-6.100000000000001" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="17.6" ORDER="185" SD_1="7.7" SD_2="8.8" SE="1.0954638982017504" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" WEIGHT="5.865742982774014"/>
<CONT_DATA CI_END="-0.2816155486588978" CI_START="-4.918384451341105" EFFECT_SIZE="-2.6000000000000014" ESTIMABLE="YES" MEAN_1="10.7" MEAN_2="13.3" ORDER="186" SD_1="5.0" SD_2="6.6" SE="1.1828709453991115" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" WEIGHT="5.703519208468602"/>
<CONT_DATA CI_END="-0.4140823462280827" CI_START="-4.985917653771919" EFFECT_SIZE="-2.700000000000001" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="11.9" ORDER="187" SD_1="6.2" SD_2="6.7" SE="1.1663059483760645" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="46" WEIGHT="5.734509870792015"/>
<CONT_DATA CI_END="-4.998220608178304" CI_START="-8.281779391821694" EFFECT_SIZE="-6.639999999999999" ESTIMABLE="YES" MEAN_1="9.47" MEAN_2="16.11" ORDER="188" SD_1="4.82" SD_2="5.7" SE="0.8376579390090028" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" WEIGHT="6.3152654252370795"/>
<CONT_DATA CI_END="-6.038061737609322" CI_START="-8.761938262390675" EFFECT_SIZE="-7.399999999999999" ESTIMABLE="YES" MEAN_1="11.8" MEAN_2="19.2" ORDER="189" SD_1="4.4" SD_2="3.8" SE="0.6948792289723034" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" WEIGHT="6.535155992139544"/>
<CONT_DATA CI_END="-0.4730684371461349" CI_START="-4.1269315628538665" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="14.3" ORDER="190" SD_1="5.1" SD_2="5.9" SE="0.9321250682484314" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" WEIGHT="6.156978676519825"/>
<CONT_DATA CI_END="1.1301631078187944" CI_START="-6.130163107818794" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="7.9" MEAN_2="10.4" ORDER="191" SD_1="7.5" SD_2="8.1" SE="1.852158068440572" STUDY_ID="STD-Witte-1995" TOTAL_1="39" TOTAL_2="33" WEIGHT="4.448576610703483"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.727716506369014" CI_END="0.19836764314673938" CI_START="-1.7381986862228722" DF="5.0" EFFECT_SIZE="-0.7699155215380664" ESTIMABLE="YES" I2="25.680578317077043" ID="CMP-002.08.02" NO="2" P_CHI2="0.24169085147126745" P_Z="0.11913008699915985" STUDIES="6" TAU2="0.372958929452887" TOTAL_1="569" TOTAL_2="582" WEIGHT="34.984262121152376" Z="1.5584353300660685">
<NAME>Studies from other countries</NAME>
<CONT_DATA CI_END="2.355667178982588" CI_START="-3.355667178982588" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="15.5" ORDER="192" SD_1="8.4" SD_2="6.7" SE="1.4569998232149806" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="55" WEIGHT="5.182662944711749"/>
<CONT_DATA CI_END="0.3162004723091001" CI_START="-5.116200472309101" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="10.2" MEAN_2="12.6" ORDER="193" SD_1="6.6" SD_2="6.4" SE="1.3858420326772038" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" WEIGHT="5.318430555713242"/>
<CONT_DATA CI_END="3.1212531809402897" CI_START="-1.321253180940289" EFFECT_SIZE="0.9000000000000004" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="12.0" ORDER="194" SD_1="7.1" SD_2="7.5" SE="1.1333132641524288" STUDY_ID="STD-HDTSG-2002" TOTAL_1="82" TOTAL_2="84" WEIGHT="5.795910970747504"/>
<CONT_DATA CI_END="-0.2926014620574182" CI_START="-3.1073985379425837" EFFECT_SIZE="-1.700000000000001" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="13.8" ORDER="195" SD_1="6.7" SD_2="7.2" SE="0.7180736733143889" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" WEIGHT="6.501252128842926"/>
<CONT_DATA CI_END="2.0961060020353752" CI_START="-1.496106002035374" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="12.4" MEAN_2="12.1" ORDER="196" SD_1="7.3" SD_2="7.1" SE="0.916397452301588" STUDY_ID="STD-Montgomery-2000" TOTAL_1="123" TOTAL_2="124" WEIGHT="6.183931515977961"/>
<CONT_DATA CI_END="0.8897479980670155" CI_START="-3.1097479980670144" EFFECT_SIZE="-1.1099999999999994" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="16.11" ORDER="197" SD_1="6.88" SD_2="6.2" SE="1.0202983390719278" STUDY_ID="STD-Shelton-2001" TOTAL_1="79" TOTAL_2="87" WEIGHT="6.002074005158991"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.5437059163705555" CI_END="-2.1232949598694786" CI_START="-5.318545103769211" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.720920031819345" ESTIMABLE="YES" I2="33.97460013441285" I2_Q="0.0" ID="CMP-002.09" MODIFIED="2008-07-14 16:07:40 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.2084248462194832" P_Q="1.0" P_Z="4.999255269699165E-6" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.8946336222426863" TOTALS="YES" TOTAL_1="209" TOTAL_2="202" UNITS="" WEIGHT="100.0" Z="4.564818980224667">
<NAME>Mean Depression Scale von Zerssen (D-S) after therapy/difference baseline - after therapy</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-3.482408318336443" CI_START="-7.117591681663555" EFFECT_SIZE="-5.299999999999999" ESTIMABLE="YES" MEAN_1="9.3" MEAN_2="14.6" ORDER="2540" SD_1="5.0" SD_2="4.3" SE="0.9273597351790579" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="51" TOTAL_2="50" WEIGHT="37.86762575869638"/>
<CONT_DATA CI_END="0.3615693347500182" CI_START="-5.361569334750018" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-6.4" ORDER="2541" SD_1="8.2" SD_2="6.1" SE="1.460011182512389" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" WEIGHT="21.95565584973059"/>
<CONT_DATA CI_END="-0.40444038110107305" CI_START="-4.795559618898926" EFFECT_SIZE="-2.5999999999999996" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="12.6" ORDER="2542" SD_1="6.0" SD_2="7.2" SE="1.1202040630425971" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" WEIGHT="30.911349762013447"/>
<CONT_DATA CI_END="1.01030638644374" CI_START="-8.810306386443742" EFFECT_SIZE="-3.9000000000000004" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="10.9" ORDER="2543" SD_1="10.7" SD_2="10.5" SE="2.5053043959866663" STUDY_ID="STD-Witte-1995" TOTAL_1="39" TOTAL_2="33" WEIGHT="9.265368629559593"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="46.708038360389516" CI_END="-0.2966330448515738" CI_START="-0.6410197555353061" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.46882640019343996" ESTIMABLE="YES" I2="74.30849074112149" I2_Q="66.00350286919661" ID="CMP-002.10" MODIFIED="2008-07-15 08:05:02 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="5.236742892322788E-6" P_Q="0.004426206711244274" P_Z="9.483975640621675E-8" Q="20.59035662723461" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.07115894791338984" TOTALS="YES" TOTAL_1="1271" TOTAL_2="1059" UNITS="" WEIGHT="100.0" Z="5.336343307535819">
<NAME>Various self-rating scales</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.512217750454347" CI_END="-0.14111525690188437" CI_START="-1.1065819881392707" DF="2.0" EFFECT_SIZE="-0.6238486225205775" ESTIMABLE="YES" I2="76.50436045420422" ID="CMP-002.10.01" MODIFIED="2008-07-15 08:01:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.014177388826669746" P_Z="0.011311954973684854" STUDIES="3" TAU2="0.13865010609038328" TOTAL_1="160" TOTAL_2="153" WEIGHT="20.302463345819447" Z="2.532911373089284">
<NAME>von Zerssen Depression Scale (D-S) after treatment</NAME>
<CONT_DATA CI_END="-0.7060272855881902" CI_START="-1.5481447019361596" EFFECT_SIZE="-1.1270859937621749" ESTIMABLE="YES" MEAN_1="9.3" MEAN_2="14.6" ORDER="198" SD_1="5.0" SD_2="4.3" SE="0.21482981906567775" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="51" TOTAL_2="50" WEIGHT="6.579586523340904"/>
<CONT_DATA CI_END="-0.05566320975583644" CI_START="-0.7247078184436819" EFFECT_SIZE="-0.39018551409975916" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="12.6" ORDER="199" SD_1="6.0" SD_2="7.2" SE="0.17067778131771397" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" WEIGHT="7.696257696352671"/>
<CONT_DATA CI_END="0.10393020876053871" CI_START="-0.8312466823879028" EFFECT_SIZE="-0.36365823681368203" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="10.9" ORDER="200" SD_1="10.7" SD_2="10.5" SE="0.23856991723444854" STUDY_ID="STD-Witte-1995" TOTAL_1="39" TOTAL_2="33" WEIGHT="6.026619126125872"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="11.4753969639367" CI_END="0.21681277785194064" CI_START="-2.016406385722587" DF="1.0" EFFECT_SIZE="-0.8997968039353232" ESTIMABLE="YES" I2="91.28570451076627" ID="CMP-002.10.02" MODIFIED="2008-07-15 08:01:20 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="7.052410358193706E-4" P_Z="0.11424512657728078" STUDIES="2" TAU2="0.592892336885495" TOTAL_1="86" TOTAL_2="84" WEIGHT="12.255627399520073" Z="1.5793965571159472">
<NAME>von Zerssen Depression Scale (D-S) difference baseline - after treatment</NAME>
<CONT_DATA CI_END="-0.9579427742635019" CI_START="-2.0079754468162374" EFFECT_SIZE="-1.4829591105398696" ESTIMABLE="YES" MEAN_1="-15.0" MEAN_2="-6.0" ORDER="201" SD_1="6.1" SD_2="5.9" SE="0.2678703998734821" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" WEIGHT="5.4008652632503935"/>
<CONT_DATA CI_END="0.05576831609008387" CI_START="-0.7422288956642509" EFFECT_SIZE="-0.34323028978708353" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-6.4" ORDER="202" SD_1="8.2" SD_2="6.1" SE="0.2035744580127071" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" WEIGHT="6.854762136269678"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.301950106936682" CI_END="-0.37341144659223363" CI_START="-0.8411275342799676" DF="1.0" EFFECT_SIZE="-0.6072694904361006" ESTIMABLE="YES" I2="23.192141183284736" ID="CMP-002.10.03" NO="3" P_CHI2="0.2538574432470946" P_Z="3.589617814582895E-7" STUDIES="2" TAU2="0.007025995164855591" TOTAL_1="201" TOTAL_2="200" WEIGHT="16.44989649330677" Z="5.089524869879572">
<NAME>von Zerssen Adjective Mood Scale</NAME>
<CONT_DATA CI_END="-0.2676931688969548" CI_START="-0.7610518936955488" EFFECT_SIZE="-0.5143725312962518" ESTIMABLE="YES" MEAN_1="21.1" MEAN_2="27.4" ORDER="203" SD_1="11.6" SD_2="12.8" SE="0.1258591302417148" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" WEIGHT="8.871968590555287"/>
<CONT_DATA CI_END="-0.41712546963272606" CI_START="-1.1039180716566501" EFFECT_SIZE="-0.7605217706446881" ESTIMABLE="YES" MEAN_1="20.7" MEAN_2="31.1" ORDER="204" SD_1="13.7" SD_2="13.5" SE="0.17520541383445215" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" WEIGHT="7.577927902751484"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0037645224820770373" CI_START="-0.5606123210771983" DF="0.0" EFFECT_SIZE="-0.2784238992975606" ESTIMABLE="YES" I2="0.0" ID="CMP-002.10.04" MODIFIED="2008-07-15 08:05:02 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.05313561102411682" STUDIES="1" TAU2="0.0" TOTAL_1="95" TOTAL_2="100" WEIGHT="8.399959162010111" Z="1.9338171694534163">
<NAME>Beck Depression Inventory</NAME>
<CONT_DATA CI_END="0.0037645224820770373" CI_START="-0.5606123210771983" EFFECT_SIZE="-0.2784238992975606" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="18.7" ORDER="205" SD_1="9.4" SD_2="9.9" SE="0.14397633018030123" STUDY_ID="STD-Shelton-2001" TOTAL_1="95" TOTAL_2="100" WEIGHT="8.399959162010111"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.828116911827175" CI_END="0.0907451789002478" CI_START="-0.7075863147142202" DF="1.0" EFFECT_SIZE="-0.3084205679069862" ESTIMABLE="YES" I2="79.28799119279083" ID="CMP-002.10.05" NO="5" P_CHI2="0.027999308226322017" P_Z="0.12992657944718725" STUDIES="2" TAU2="0.06577394994439364" TOTAL_1="356" TOTAL_2="197" WEIGHT="17.47474869977132" Z="1.5143914777863097">
<NAME>Beck Depression Inventory difference baseline - after treatment</NAME>
<CONT_DATA CI_END="0.15524417753199282" CI_START="-0.3632286890834534" EFFECT_SIZE="-0.1039922557757303" ESTIMABLE="YES" MEAN_1="-7.84" MEAN_2="-6.83" ORDER="206" SD_1="9.67" SD_2="9.69" SE="0.1322659167987509" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" WEIGHT="8.706469397027597"/>
<CONT_DATA CI_END="-0.25675058203655704" CI_START="-0.7658786509128308" EFFECT_SIZE="-0.5113146164746939" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-3.7" ORDER="207" SD_1="8.8" SD_2="7.9" SE="0.12988199601936845" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" WEIGHT="8.768279302743725"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="9.560070263058911E-32" CI_END="-0.022670311320767134" CI_START="-0.7264354964605375" DF="0.0" EFFECT_SIZE="-0.3745529038906523" ESTIMABLE="YES" I2="100.0" ID="CMP-002.10.06" NO="6" P_CHI2="0.0" P_Z="0.03695723285794461" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="46" WEIGHT="7.465352118083076" Z="2.086236197616891">
<NAME>Zung Self Rating Depression Scale (SDS) difference baseline - after treatment</NAME>
<CONT_DATA CI_END="-0.022670311320767078" CI_START="-0.7264354964605375" EFFECT_SIZE="-0.37455290389065227" ESTIMABLE="YES" MEAN_1="-14.1" MEAN_2="-10.2" ORDER="208" SD_1="11.3" SD_2="7.9" SE="0.17953523398669066" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="46" WEIGHT="7.465352118083076"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.039360674664769474" CI_START="-0.3661829504203564" DF="0.0" EFFECT_SIZE="-0.1634111378777935" ESTIMABLE="YES" I2="0.0" ID="CMP-002.10.07" NO="7" P_CHI2="1.0" P_Z="0.11421930627280746" STUDIES="1" TAU2="0.0" TOTAL_1="186" TOTAL_2="189" WEIGHT="9.428720483830816" Z="1.579509207405027">
<NAME>Symptom Checklist (SCL-58) depression score</NAME>
<CONT_DATA CI_END="0.039360674664769474" CI_START="-0.3661829504203564" EFFECT_SIZE="-0.1634111378777935" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-6.5" ORDER="209" SD_1="8.7" SD_2="8.4" SE="0.10345690744421894" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" WEIGHT="9.428720483830816"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.11058530747170503" CI_START="-0.48006299364386684" DF="0.0" EFFECT_SIZE="-0.1847388430860809" ESTIMABLE="YES" I2="0.0" ID="CMP-002.10.08" MODIFIED="2008-07-02 16:41:39 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.22018076951434717" STUDIES="1" TAU2="0.0" TOTAL_1="87" TOTAL_2="90" WEIGHT="8.223232297658388" Z="1.2260476439547623">
<NAME>von Zerssen Paranoid-Depressivitäts-Skala</NAME>
<CONT_DATA CI_END="0.11058530747170503" CI_START="-0.48006299364386684" EFFECT_SIZE="-0.1847388430860809" ESTIMABLE="YES" MEAN_1="-4.8" MEAN_2="-3.1" MODIFIED="2008-07-02 16:41:39 +0100" MODIFIED_BY="[Empty name]" ORDER="2587" SD_1="8.8" SD_2="9.5" SE="0.15067835576942493" STUDY_ID="STD-Bracher-2001" TOTAL_1="87" TOTAL_2="90" WEIGHT="8.223232297658388"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="46.70803836038951" CI_END="-0.2966330448515738" CI_START="-0.6410197555353061" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.46882640019343996" ESTIMABLE="YES" I2="74.30849074112149" I2_Q="93.64896436980654" ID="CMP-002.11" MODIFIED="2008-07-14 16:07:40 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="5.2367428918786985E-6" P_Q="7.24622343881709E-5" P_Z="9.483975640621675E-8" Q="15.745463546856811" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.07115894791338982" TOTALS="YES" TOTAL_1="1271" TOTAL_2="1059" UNITS="" WEIGHT="100.0" Z="5.336343307535819">
<NAME>Various self-rating scales in studies from German-speaking countries and other countries</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="30.145917815639507" CI_END="-0.37264091459343773" CI_START="-0.7730578665576742" DF="9.0" EFFECT_SIZE="-0.572849390575556" ESTIMABLE="YES" I2="70.14521151739204" ID="CMP-002.11.01" MODIFIED="2008-07-02 16:42:07 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="4.143307823325504E-4" P_Z="2.0470731545012506E-8" STUDIES="10" TAU2="0.07045384529413534" TOTAL_1="877" TOTAL_2="654" WEIGHT="73.46485095713147" Z="5.607975229750459">
<NAME>Studies from German-speaking countries</NAME>
<CONT_DATA CI_END="0.11058530747170503" CI_START="-0.48006299364386684" EFFECT_SIZE="-0.1847388430860809" ESTIMABLE="YES" MEAN_1="-4.8" MEAN_2="-3.1" ORDER="2588" SD_1="8.8" SD_2="9.5" SE="0.15067835576942493" STUDY_ID="STD-Bracher-2001" TOTAL_1="87" TOTAL_2="90" WEIGHT="8.223232297658388"/>
<CONT_DATA CI_END="-0.2676931688969548" CI_START="-0.7610518936955488" EFFECT_SIZE="-0.5143725312962518" ESTIMABLE="YES" MEAN_1="21.1" MEAN_2="27.4" ORDER="210" SD_1="11.6" SD_2="12.8" SE="0.1258591302417148" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" WEIGHT="8.871968590555287"/>
<CONT_DATA CI_END="-0.7060272855881902" CI_START="-1.5481447019361596" EFFECT_SIZE="-1.1270859937621749" ESTIMABLE="YES" MEAN_1="9.3" MEAN_2="14.6" ORDER="211" SD_1="5.0" SD_2="4.3" SE="0.21482981906567775" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="51" TOTAL_2="50" WEIGHT="6.579586523340905"/>
<CONT_DATA CI_END="-0.9579427742635019" CI_START="-2.0079754468162374" EFFECT_SIZE="-1.4829591105398696" ESTIMABLE="YES" MEAN_1="-15.0" MEAN_2="-6.0" ORDER="212" SD_1="6.1" SD_2="5.9" SE="0.2678703998734821" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" WEIGHT="5.4008652632503935"/>
<CONT_DATA CI_END="-0.25675058203655704" CI_START="-0.7658786509128308" EFFECT_SIZE="-0.5113146164746939" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-3.7" ORDER="213" SD_1="8.8" SD_2="7.9" SE="0.12988199601936845" STUDY_ID="STD-Kasper-2006" TOTAL_1="243" TOTAL_2="81" WEIGHT="8.768279302743725"/>
<CONT_DATA CI_END="0.05576831609008387" CI_START="-0.7422288956642509" EFFECT_SIZE="-0.34323028978708353" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-6.4" ORDER="214" SD_1="8.2" SD_2="6.1" SE="0.2035744580127071" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" WEIGHT="6.85476213626968"/>
<CONT_DATA CI_END="-0.022670311320767078" CI_START="-0.7264354964605375" EFFECT_SIZE="-0.37455290389065227" ESTIMABLE="YES" MEAN_1="-14.1" MEAN_2="-10.2" ORDER="215" SD_1="11.3" SD_2="7.9" SE="0.17953523398669066" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="46" WEIGHT="7.465352118083076"/>
<CONT_DATA CI_END="-0.41712546963272606" CI_START="-1.1039180716566501" EFFECT_SIZE="-0.7605217706446881" ESTIMABLE="YES" MEAN_1="20.7" MEAN_2="31.1" ORDER="216" SD_1="13.7" SD_2="13.5" SE="0.17520541383445215" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" WEIGHT="7.577927902751485"/>
<CONT_DATA CI_END="-0.05566320975583644" CI_START="-0.7247078184436819" EFFECT_SIZE="-0.39018551409975916" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="12.6" ORDER="217" SD_1="6.0" SD_2="7.2" SE="0.17067778131771397" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" WEIGHT="7.696257696352672"/>
<CONT_DATA CI_END="0.10393020876053871" CI_START="-0.8312466823879028" EFFECT_SIZE="-0.36365823681368203" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="10.9" ORDER="218" SD_1="10.7" SD_2="10.5" SE="0.23856991723444854" STUDY_ID="STD-Witte-1995" TOTAL_1="39" TOTAL_2="33" WEIGHT="6.026619126125872"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.8166569978931898" CI_END="-0.035236738847234994" CI_START="-0.31323072498282445" DF="2.0" EFFECT_SIZE="-0.17423373191502972" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.02" NO="2" P_CHI2="0.6647607328141545" P_Z="0.014016940052011151" STUDIES="3" TAU2="0.0" TOTAL_1="394" TOTAL_2="405" WEIGHT="26.535149042868525" Z="2.4568289709613014">
<NAME>Studies from other countries</NAME>
<CONT_DATA CI_END="0.15524417753199282" CI_START="-0.3632286890834534" EFFECT_SIZE="-0.1039922557757303" ESTIMABLE="YES" MEAN_1="-7.84" MEAN_2="-6.83" ORDER="219" SD_1="9.67" SD_2="9.69" SE="0.1322659167987509" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" WEIGHT="8.706469397027597"/>
<CONT_DATA CI_END="0.039360674664769474" CI_START="-0.3661829504203564" EFFECT_SIZE="-0.1634111378777935" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-6.5" ORDER="220" SD_1="8.7" SD_2="8.4" SE="0.10345690744421894" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" WEIGHT="9.428720483830817"/>
<CONT_DATA CI_END="0.0037645224820770373" CI_START="-0.5606123210771983" EFFECT_SIZE="-0.2784238992975606" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="18.7" ORDER="221" SD_1="9.4" SD_2="9.9" SE="0.14397633018030123" STUDY_ID="STD-Shelton-2001" TOTAL_1="95" TOTAL_2="100" WEIGHT="8.399959162010113"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2008-07-07 17:19:20 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Safety - Hypericum mono-preparations vs. placebo</NAME>
<DICH_OUTCOME CHI2="3.192727650571121" CI_END="1.8837973079502859" CI_START="0.4477410165354451" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9183971480837666" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.27503417193119556" LOG_CI_START="-0.34897311906513695" LOG_EFFECT_SIZE="-0.0369694735669707" METHOD="MH" MODIFIED="2008-07-07 17:18:10 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8666193705772958" P_Q="0.0" P_Z="0.8163538268131845" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1502" TOTAL_2="1282" WEIGHT="100.0" Z="0.2322371477518327">
<NAME>Number of patients discontinuing treatment/dropping out for adverse effects - primary analysis</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="11.81047265652078" CI_START="0.3647256883737524" EFFECT_SIZE="2.0754716981132075" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0722672784781422" LOG_CI_START="-0.43803364736327005" LOG_EFFECT_SIZE="0.317116815557436" ORDER="223" O_E="0.0" SE="0.8871582399494016" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="57" TOTAL_2="57" VAR="0.7870497427101201" WEIGHT="17.07074012313148"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-07-07 17:17:40 +0100" MODIFIED_BY="[Empty name]" ORDER="512" O_E="0.0" SE="0.0" STUDY_ID="STD-Bracher-2001" TOTAL_1="109" TOTAL_2="109" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="224" O_E="0.0" SE="0.0" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.3625727812299417" CI_START="0.17933630361718986" EFFECT_SIZE="0.6509186351706037" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3733851962287844" LOG_CI_START="-0.7463317859275904" LOG_EFFECT_SIZE="-0.18647329484940303" ORDER="225" O_E="0.0" SE="0.6577272980071075" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" VAR="0.43260519854373036" WEIGHT="31.057235712861665"/>
<DICH_DATA CI_END="4.139837319206579" CI_START="0.1112615577322527" EFFECT_SIZE="0.6786786786786787" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6169832752370706" LOG_CI_START="-0.9536548639549087" LOG_EFFECT_SIZE="-0.16833579435891893" ORDER="226" O_E="0.0" SE="0.9226006177455477" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" VAR="0.8511918998644663" WEIGHT="15.784362637756853"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="227" O_E="0.0" SE="0.0" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="53" TOTAL_2="55" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="228" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="78.71059173419626" CI_START="0.24445768653385452" EFFECT_SIZE="4.386503067484663" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="1.8960331773680248" LOG_CI_START="-0.6117963025737791" LOG_EFFECT_SIZE="0.6421184373971228" ORDER="229" O_E="0.0" SE="1.473111450473951" STUDY_ID="STD-Kasper-2006" TOTAL_1="250" TOTAL_2="82" VAR="2.1700573455174683" WEIGHT="6.191321003352629"/>
<DICH_DATA CI_END="8.215236866132303" CI_START="0.012984058995897458" EFFECT_SIZE="0.3265993265993266" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9146200897639226" LOG_CI_START="-1.8865895198658578" LOG_EFFECT_SIZE="-0.4859847150509675" ORDER="230" O_E="0.0" SE="1.645444390907732" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" VAR="2.7074872435697177" WEIGHT="4.962358235922005"/>
<DICH_DATA CI_END="7.291250354680501" CI_START="0.14165945169434083" EFFECT_SIZE="1.016304347826087" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8628020105641862" LOG_CI_START="-0.8487544435102612" LOG_EFFECT_SIZE="0.007023783526962488" ORDER="231" O_E="0.0" SE="1.0053767334644181" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" VAR="1.0107823761915835" WEIGHT="13.292200119677776"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="232" O_E="0.0" SE="0.0" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="47" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.100299859672138" CI_START="0.013043794476973417" EFFECT_SIZE="0.3250517598343685" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9085010960379737" LOG_CI_START="-1.8845960527225305" LOG_EFFECT_SIZE="-0.48804747834227846" ORDER="233" O_E="0.0" SE="1.6406790912357903" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" VAR="2.6918278804182982" WEIGHT="4.991226117954516"/>
<DICH_DATA CI_END="16.880966234138917" CI_START="0.06422468425612377" EFFECT_SIZE="1.041237113402062" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2273973011844892" LOG_CI_START="-1.1922980221516934" LOG_EFFECT_SIZE="0.017549639516397753" ORDER="234" O_E="0.0" SE="1.4213410106126978" STUDY_ID="STD-Shelton-2001" TOTAL_1="98" TOTAL_2="102" VAR="2.0202102684495253" WEIGHT="6.6505560493430576"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="235" O_E="0.0" SE="0.0" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="236" O_E="0.0" SE="0.0" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="237" O_E="0.0" SE="0.0" STUDY_ID="STD-Witte-1995" TOTAL_1="48" TOTAL_2="49" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.675218101300024" CI_END="1.1212721420352758" CI_START="0.6705244070460752" CI_STUDY="95" CI_TOTAL="95" DF="13.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8670872725253704" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="151" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.0497110322561988" LOG_CI_START="-0.1735854092329478" LOG_EFFECT_SIZE="-0.06193718848837447" METHOD="MH" MODIFIED="2008-07-07 17:18:41 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7970066583383684" P_Q="0.0" P_Z="0.27690605271556745" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1502" TOTAL_2="1282" WEIGHT="100.0" Z="1.0872959544837468">
<NAME>Number of patients dropping out</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.229554242357071" CI_START="0.6103968040193598" EFFECT_SIZE="1.95" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.7944569716975928" LOG_CI_START="-0.2143877489725567" LOG_EFFECT_SIZE="0.290034611362518" ORDER="238" O_E="0.0" SE="0.5926003827835531" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="57" TOTAL_2="57" VAR="0.3511752136752137" WEIGHT="4.899084754867696"/>
<DICH_DATA CI_END="7.290463332303396" CI_START="0.3958106004745252" EFFECT_SIZE="1.6987179487179487" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8627551300008751" LOG_CI_START="-0.40251257883618263" LOG_EFFECT_SIZE="0.23012127558234624" MODIFIED="2008-07-07 17:18:41 +0100" MODIFIED_BY="[Empty name]" ORDER="513" O_E="0.0" SE="0.7432245153470577" STUDY_ID="STD-Bracher-2001" TOTAL_1="109" TOTAL_2="109" VAR="0.5523826802128688" WEIGHT="3.1145747273260795"/>
<DICH_DATA CI_END="1.4807426358752838" CI_START="0.2734834993432702" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="22" LOG_CI_END="0.17047958145704256" LOG_CI_START="-0.563068871744979" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="239" O_E="0.0" SE="0.4308899925342728" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="43" VAR="0.18566618566618565" WEIGHT="9.266292240725333"/>
<DICH_DATA CI_END="2.1717207924800817" CI_START="0.2467278491118072" EFFECT_SIZE="0.732" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.3368039893884186" LOG_CI_START="-0.6077818272716349" LOG_EFFECT_SIZE="-0.13548891894160814" ORDER="240" O_E="0.0" SE="0.5548543844813179" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" VAR="0.30786338797814206" WEIGHT="5.588313527316195"/>
<DICH_DATA CI_END="1.772642790773644" CI_START="0.5555626868691129" EFFECT_SIZE="0.9923780487804879" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="32" LOG_CI_END="0.248621228761921" LOG_CI_START="-0.25526693037685755" LOG_EFFECT_SIZE="-0.003322850807468306" ORDER="241" O_E="0.0" SE="0.2959863989647336" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" VAR="0.08760794837211044" WEIGHT="19.637911486023768"/>
<DICH_DATA CI_END="2.8520611450996904" CI_START="0.08765590472334057" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4551588320826098" LOG_CI_START="-1.0572188234105722" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="242" O_E="0.0" SE="0.8883781212268287" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="53" TOTAL_2="55" VAR="0.7892156862745099" WEIGHT="2.1799327680940594"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="243" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.9749930665184436" CI_START="0.5762788297274831" EFFECT_SIZE="1.3093607305936072" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="8" LOG_CI_END="0.4734859579044712" LOG_CI_START="-0.2393673344380973" LOG_EFFECT_SIZE="0.11705931173318693" ORDER="244" O_E="0.0" SE="0.41873355260273165" STUDY_ID="STD-Kasper-2006" TOTAL_1="250" TOTAL_2="82" VAR="0.17533778807530465" WEIGHT="9.81212980093456"/>
<DICH_DATA CI_END="4.08703556969376" CI_START="0.10416672543136155" EFFECT_SIZE="0.6524822695035462" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6114084174166342" LOG_CI_START="-0.9822709880362834" LOG_EFFECT_SIZE="-0.1854312853098246" ORDER="245" O_E="0.0" SE="0.9361351716033304" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" VAR="0.8763490595127968" WEIGHT="1.9631870621965588"/>
<DICH_DATA CI_END="1.3368696437157173" CI_START="0.36952605333475286" EFFECT_SIZE="0.7028571428571428" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="25" LOG_CI_END="0.12608906188054567" LOG_CI_START="-0.43235493637433864" LOG_EFFECT_SIZE="-0.1531329372468965" ORDER="246" O_E="0.0" SE="0.32803276891729316" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" VAR="0.10760549748354627" WEIGHT="15.988375834298925"/>
<DICH_DATA CI_END="1.4957325346359926" CI_START="0.23288903507663483" EFFECT_SIZE="0.5902031063321386" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="9" LOG_CI_END="0.17485394037552643" LOG_CI_START="-0.6328509585147527" LOG_EFFECT_SIZE="-0.22899850906961308" ORDER="247" O_E="0.0" SE="0.4744498558118816" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="47" VAR="0.22510266567991524" WEIGHT="7.642899875961579"/>
<DICH_DATA CI_END="5.485451200246241" CI_START="0.04329671237864475" EFFECT_SIZE="0.4873417721518987" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7392123558337864" LOG_CI_START="-1.363545079397668" LOG_EFFECT_SIZE="-0.31216636178194074" ORDER="248" O_E="0.0" SE="1.235170126272132" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" VAR="1.5256452408351142" WEIGHT="1.1276783681781124"/>
<DICH_DATA CI_END="2.755353732659458" CI_START="0.555574469812082" EFFECT_SIZE="1.23725671918443" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.4401773615473342" LOG_CI_START="-0.2552577195119675" LOG_EFFECT_SIZE="0.09245982101768331" ORDER="249" O_E="0.0" SE="0.40850200907340434" STUDY_ID="STD-Shelton-2001" TOTAL_1="98" TOTAL_2="102" VAR="0.1668738914170077" WEIGHT="10.309804134095351"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="250" O_E="0.0" SE="0.0" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.195460551712757" CI_START="0.026046181879564496" EFFECT_SIZE="0.2391304347826087" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.34152563805740244" LOG_CI_START="-1.5842559311041005" LOG_EFFECT_SIZE="-0.6213651465233491" ORDER="251" O_E="0.0" SE="1.1312136264979766" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" VAR="1.2796442687747036" WEIGHT="1.3444651592516514"/>
<DICH_DATA CI_END="1.674169123358617" CI_START="0.24393536848197717" EFFECT_SIZE="0.6390532544378699" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" LOG_CI_END="0.22379932798901153" LOG_CI_START="-0.6127252262424591" LOG_EFFECT_SIZE="-0.1944629491267238" ORDER="252" O_E="0.0" SE="0.4913786640188923" STUDY_ID="STD-Witte-1995" TOTAL_1="48" TOTAL_2="49" VAR="0.24145299145299143" WEIGHT="7.125350260730141"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.978131008649337" CI_END="1.2255711572090262" CI_START="0.7778760390987058" CI_STUDY="95" CI_TOTAL="95" DF="13.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9763925631647214" ESTIMABLE="YES" EVENTS_1="418" EVENTS_2="353" I2="13.206794676231878" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.0883385316518128" LOG_CI_START="-0.1090896058698768" LOG_EFFECT_SIZE="-0.010375537109032017" METHOD="MH" MODIFIED="2008-07-07 17:19:20 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.30872019562056685" P_Q="0.0" P_Z="0.8367863148067756" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.024073228184324356" TOTALS="YES" TOTAL_1="1359" TOTAL_2="1137" WEIGHT="100.00000000000003" Z="0.20600588456371835">
<NAME>Number of patients reporting adverse effects</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.5539102495651824" CI_START="0.5370752211891481" EFFECT_SIZE="1.1711711711711712" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="18" LOG_CI_END="0.40720563106229346" LOG_CI_START="-0.26996488402193475" LOG_EFFECT_SIZE="0.06862037352017934" ORDER="253" O_E="0.0" SE="0.39777331260858645" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="57" TOTAL_2="57" VAR="0.15822360822360823" WEIGHT="7.377584104424312"/>
<DICH_DATA CI_END="2.0038541971664086" CI_START="0.6022491328817368" EFFECT_SIZE="1.0985533453887883" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="28" LOG_CI_END="0.30186611855763923" LOG_CI_START="-0.22022381662633628" LOG_EFFECT_SIZE="0.040821150965651504" MODIFIED="2008-07-07 17:19:20 +0100" MODIFIED_BY="[Empty name]" ORDER="514" O_E="0.0" SE="0.30667821231392683" STUDY_ID="STD-Bracher-2001" TOTAL_1="109" TOTAL_2="109" VAR="0.09405152590806598" WEIGHT="11.385507236849708"/>
<DICH_DATA CI_END="1.300928301244378" CI_START="0.460620334533893" EFFECT_SIZE="0.774102079395085" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="46" LOG_CI_END="0.11425336171763306" LOG_CI_START="-0.33665689359513007" LOG_EFFECT_SIZE="-0.1112017659387485" ORDER="254" O_E="0.0" SE="0.26486691601247875" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="130" VAR="0.07015448319796146" WEIGHT="14.272980027219857"/>
<DICH_DATA CI_END="1.287718199327501" CI_START="0.18951148987787178" EFFECT_SIZE="0.4940014114326041" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="109" LOG_CI_END="0.1098208336237734" LOG_CI_START="-0.7223644540901806" LOG_EFFECT_SIZE="-0.30627181023320355" ORDER="255" O_E="0.0" SE="0.48882975738678724" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="116" VAR="0.2389545317068253" WEIGHT="5.113187456436442"/>
<DICH_DATA CI_END="5.793000885581156" CI_START="0.044831313746749465" EFFECT_SIZE="0.5096153846153846" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7629035948900428" LOG_CI_START="-1.3484185342860255" LOG_EFFECT_SIZE="-0.2927574696979913" ORDER="256" O_E="0.0" SE="1.240201069891117" STUDY_ID="STD-H_x00e4_nsgen-1996" TOTAL_1="53" TOTAL_2="55" VAR="1.538098693759071" WEIGHT="0.8609233232773049"/>
<DICH_DATA CI_END="9.279448300932595" CI_START="0.22841804349430073" EFFECT_SIZE="1.4558823529411764" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9675221565008585" LOG_CI_START="-0.6412695927182313" LOG_EFFECT_SIZE="0.16312628189131356" ORDER="257" O_E="0.0" SE="0.945012237138888" STUDY_ID="STD-Kalb-2001" TOTAL_1="37" TOTAL_2="35" VAR="0.893048128342246" WEIGHT="1.4664474150548674"/>
<DICH_DATA CI_END="3.1002612860131213" CI_START="1.0312770108023868" EFFECT_SIZE="1.7880794701986755" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="22" LOG_CI_END="0.491398297154207" LOG_CI_START="0.0133753365774286" LOG_EFFECT_SIZE="0.2523868168658179" ORDER="258" O_E="0.0" SE="0.28079305329461696" STUDY_ID="STD-Kasper-2006" TOTAL_1="250" TOTAL_2="82" VAR="0.07884473877851361" WEIGHT="13.067788669549099"/>
<DICH_DATA CI_END="2.1595637453571332" CI_START="0.38065301207790947" EFFECT_SIZE="0.9066666666666666" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="15" LOG_CI_END="0.33436602794742476" LOG_CI_START="-0.41947072931835233" LOG_EFFECT_SIZE="-0.042552350685463744" ORDER="259" O_E="0.0" SE="0.44280744277004763" STUDY_ID="STD-Laakmann-1998" TOTAL_1="49" TOTAL_2="49" VAR="0.19607843137254902" WEIGHT="6.1090170534125"/>
<DICH_DATA CI_END="1.1539675429837244" CI_START="0.4889613590602317" EFFECT_SIZE="0.7511627906976744" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="70" LOG_CI_END="0.06219359382725199" LOG_CI_START="-0.31072546032421927" LOG_EFFECT_SIZE="-0.12426593324848362" ORDER="260" O_E="0.0" SE="0.21905449838766386" STUDY_ID="STD-Lecrubier-2002" TOTAL_1="186" TOTAL_2="189" VAR="0.047984873263871027" WEIGHT="18.664247538313187"/>
<DICH_DATA CI_END="2.7675374263777632" CI_START="0.4946387761310646" EFFECT_SIZE="1.1700133868808567" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="9" LOG_CI_END="0.44209350270683445" LOG_CI_START="-0.30571184106882604" LOG_EFFECT_SIZE="0.06819083081900422" ORDER="261" O_E="0.0" SE="0.4392645606299749" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="47" VAR="0.19295335422544488" WEIGHT="6.196983925363894"/>
<DICH_DATA CI_END="4.104571109859528" CI_START="0.3508283719439037" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.6132677840248906" LOG_CI_START="-0.4549052919296409" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="262" O_E="0.0" SE="0.6274501523576942" STUDY_ID="STD-Schrader-1998" TOTAL_1="80" TOTAL_2="79" VAR="0.39369369369369367" WEIGHT="3.219283701361826"/>
<DICH_DATA CI_END="5.971604455892589" CI_START="0.8477621110695781" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="7" LOG_CI_END="0.7760910334280217" LOG_CI_START="-0.07172599720529668" LOG_EFFECT_SIZE="0.3521825181113625" ORDER="263" O_E="0.0" SE="0.49801192055599736" STUDY_ID="STD-Uebelhack-2004" TOTAL_1="70" TOTAL_2="70" VAR="0.248015873015873" WEIGHT="4.942903764382853"/>
<DICH_DATA CI_END="1.2543598250222008" CI_START="0.24587678137502153" EFFECT_SIZE="0.5553539019963702" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="19" LOG_CI_END="0.0984221358612682" LOG_CI_START="-0.6092824806016784" LOG_EFFECT_SIZE="-0.25543017237020504" ORDER="264" O_E="0.0" SE="0.4157091949046851" STUDY_ID="STD-Volz-2000" TOTAL_1="70" TOTAL_2="70" VAR="0.17281413472830148" WEIGHT="6.830861171962789"/>
<DICH_DATA CI_END="8.386703410378948" CI_START="0.013248484615970299" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9235912847828851" LOG_CI_START="-1.8778337942222099" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="265" O_E="0.0" SE="1.6455709586853824" STUDY_ID="STD-Witte-1995" TOTAL_1="48" TOTAL_2="49" VAR="2.7079037800687282" WEIGHT="0.4922846123913751"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-08-11 14:04:28 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Hypericum mono-preparations vs. standard antidepressants. A. Dichotomous measures</NAME>
<DICH_OUTCOME CHI2="19.37040544429482" CI_END="1.0894463431354195" CI_START="0.9287430228907465" CI_STUDY="95" CI_TOTAL="95" DF="16.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0058904960286974" ESTIMABLE="YES" EVENTS_1="718" EVENTS_2="710" I2="17.399767155041708" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.0372058454551106" LOG_CI_START="-0.032104435822410196" LOG_EFFECT_SIZE="0.0025507048163501767" METHOD="MH" MODIFIED="2008-07-09 13:34:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.24992390294656697" P_Q="0.0" P_Z="0.8852965534668981" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.004666345955906349" TOTALS="YES" TOTAL_1="1413" TOTAL_2="1397" WEIGHT="100.00000000000001" Z="0.1442582394153598">
<NAME>Responder (intent to treat) - primary analysis</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours standard</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours hypericum</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.9700661971376534" CI_END="1.1469386855491743" CI_START="0.903891016921134" DF="4.0" EFFECT_SIZE="1.0181883788510022" ESTIMABLE="YES" EVENTS_1="247" EVENTS_2="248" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.05954020147632257" LOG_CI_START="-0.043883929704964644" LOG_EFFECT_SIZE="0.007828135885678973" NO="1" P_CHI2="0.4100722978766381" P_Z="0.7666971145308161" STUDIES="5" TAU2="0.0" TOTAL_1="508" TOTAL_2="508" WEIGHT="34.17792517115524" Z="0.29669796065528625">
<NAME>vs. older antidepressants</NAME>
<DICH_DATA CI_END="1.3806514055127095" CI_START="0.6734842227826571" EFFECT_SIZE="0.9642857142857143" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="28" LOG_CI_END="0.14008403935135297" LOG_CI_START="-0.1716725737178168" LOG_EFFECT_SIZE="-0.015794267183231903" ORDER="266" O_E="0.0" SE="0.18312737773695376" STUDY_ID="STD-Harrer-1993" TOTAL_1="51" TOTAL_2="51" VAR="0.033535636476812944" WEIGHT="4.338949805987302"/>
<DICH_DATA CI_END="1.3557794692526441" CI_START="0.9363014399129742" EFFECT_SIZE="1.1266846361185985" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="70" LOG_CI_END="0.13218905304458706" LOG_CI_START="-0.028584308724608345" LOG_EFFECT_SIZE="0.051802372159989354" ORDER="267" O_E="0.0" SE="0.09443906854420132" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="110" VAR="0.008918737667496356" WEIGHT="12.201359142113256"/>
<DICH_DATA CI_END="1.1951058136497088" CI_START="0.5862241656569622" EFFECT_SIZE="0.8370184636425804" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="41" LOG_CI_END="0.07740635904963093" LOG_CI_START="-0.23193628280111162" LOG_EFFECT_SIZE="-0.0772649618757403" ORDER="268" O_E="0.0" SE="0.18170939909389933" STUDY_ID="STD-Vorbach-1997" TOTAL_1="107" TOTAL_2="102" VAR="0.033018305719065985" WEIGHT="4.398514432199521"/>
<DICH_DATA CI_END="1.160395171888721" CI_START="0.6282987401203387" EFFECT_SIZE="0.8538587848932676" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="42" LOG_CI_END="0.06460591314471767" LOG_CI_START="-0.20183381114087015" LOG_EFFECT_SIZE="-0.06861394899807621" ORDER="269" O_E="0.0" SE="0.15650801294326042" STUDY_ID="STD-Wheatley-1997" TOTAL_1="87" TOTAL_2="78" VAR="0.02449475811544777" WEIGHT="5.684163530269265"/>
<DICH_DATA CI_END="1.3967678098831064" CI_START="0.8344064255567712" EFFECT_SIZE="1.0795703013594449" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="67" LOG_CI_END="0.14512421766216038" LOG_CI_START="-0.07862236017464146" LOG_EFFECT_SIZE="0.03325092874375945" ORDER="270" O_E="0.0" SE="0.13142984738476024" STUDY_ID="STD-Woelk-2000" TOTAL_1="157" TOTAL_2="167" VAR="0.01727380478358137" WEIGHT="7.554938260585895"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="15.429624688229687" CI_END="1.1198505871074935" CI_START="0.8991944357911367" DF="11.0" EFFECT_SIZE="1.0034756682872266" ESTIMABLE="YES" EVENTS_1="471" EVENTS_2="462" I2="28.708570543577615" ID="CMP-004.01.02" LOG_CI_END="0.0491600820243095" LOG_CI_START="-0.046146389177907976" LOG_EFFECT_SIZE="0.0015068464232008013" NO="2" P_CHI2="0.16366109844545595" P_Z="0.9505818142923985" STUDIES="12" TAU2="0.009815384539594858" TOTAL_1="905" TOTAL_2="889" WEIGHT="65.82207482884478" Z="0.06197616347456998">
<NAME>vs. SSRIs</NAME>
<DICH_DATA CI_END="1.1962390568577919" CI_START="0.4852699490835645" EFFECT_SIZE="0.7619047619047619" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.07781797789627831" LOG_CI_START="-0.31401660205226734" LOG_EFFECT_SIZE="-0.11809931207799451" ORDER="271" O_E="0.0" SE="0.23016557187422815" STUDY_ID="STD-Behnke-2002" TOTAL_1="35" TOTAL_2="35" VAR="0.05297619047619048" WEIGHT="2.8755931734551545"/>
<DICH_DATA CI_END="1.7665489068263274" CI_START="0.6849513168439878" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="20" LOG_CI_END="0.24712566536032649" LOG_CI_START="-0.16434029504387637" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="272" O_E="0.0" SE="0.24169714193078168" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" VAR="0.058417508417508424" WEIGHT="2.6275579688522"/>
<DICH_DATA CI_END="2.65606718850822" CI_START="0.5124535693223857" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.4242390568515887" LOG_CI_START="-0.2903454775903623" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="273" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Brenner-2000" TOTAL_1="15" TOTAL_2="15" VAR="0.17619047619047623" WEIGHT="0.9165066725026113"/>
<DICH_DATA CI_END="2.2590111182384263" CI_START="0.7120231126822512" EFFECT_SIZE="1.2682539682539682" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.3539183684049644" LOG_CI_START="-0.1475059086841451" LOG_EFFECT_SIZE="0.10320622986040966" ORDER="274" O_E="0.0" SE="0.2945391024523451" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="47" VAR="0.08675328287343304" WEIGHT="1.8131388891789213"/>
<DICH_DATA CI_END="1.1515977594272004" CI_START="0.7554123273373016" EFFECT_SIZE="0.9327009936766034" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="72" LOG_CI_END="0.061300811234396464" LOG_CI_START="-0.12181593233496482" LOG_EFFECT_SIZE="-0.030257560550284182" ORDER="275" O_E="0.0" SE="0.10756368161514239" STUDY_ID="STD-Gastpar-2005" TOTAL_1="123" TOTAL_2="118" VAR="0.01156994560260372" WEIGHT="10.209011316866768"/>
<DICH_DATA CI_END="1.2086821819035043" CI_START="0.7775936953332256" EFFECT_SIZE="0.9694656488549618" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="71" LOG_CI_END="0.08231211989241692" LOG_CI_START="-0.10924726929203182" LOG_EFFECT_SIZE="-0.013467574699807418" ORDER="276" O_E="0.0" SE="0.11252293344121458" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" VAR="0.012661410550216006" WEIGHT="9.565951841844702"/>
<DICH_DATA CI_END="1.1929661592665137" CI_START="0.767607651000268" EFFECT_SIZE="0.9569377990430622" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="57" LOG_CI_END="0.07662812426358034" LOG_CI_START="-0.11486070515772592" LOG_EFFECT_SIZE="-0.019116290447072807" ORDER="277" O_E="0.0" SE="0.11248148628706822" STUDY_ID="STD-Harrer-1999" TOTAL_1="77" TOTAL_2="84" VAR="0.012652084757347918" WEIGHT="9.571103006343394"/>
<DICH_DATA CI_END="1.0782044535573525" CI_START="0.6036500930678858" EFFECT_SIZE="0.8067578439259855" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="55" LOG_CI_END="0.03270112136331721" LOG_CI_START="-0.21921472807424894" LOG_EFFECT_SIZE="-0.09325680335546588" ORDER="278" O_E="0.0" SE="0.1479766169631925" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="109" VAR="0.02189707916787139" WEIGHT="6.240026784663547"/>
<DICH_DATA CI_END="0.9516083098450095" CI_START="0.13895570645049798" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.021541774175675356" LOG_CI_START="-0.8571236134848499" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="279" O_E="0.0" SE="0.49082490860702144" STUDY_ID="STD-Moreno-2005" TOTAL_1="20" TOTAL_2="20" VAR="0.24090909090909096" WEIGHT="0.6749717576839767"/>
<DICH_DATA CI_END="1.815988332412902" CI_START="0.9612675997993256" EFFECT_SIZE="1.3212307692307692" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="39" LOG_CI_END="0.2591130538849717" LOG_CI_START="-0.017155695642260674" LOG_EFFECT_SIZE="0.1209786791213555" ORDER="280" O_E="0.0" SE="0.16228163102466203" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="113" VAR="0.026335327768024552" WEIGHT="5.34669468948144"/>
<DICH_DATA CI_END="1.417839093166414" CI_START="0.9788682349642395" EFFECT_SIZE="1.178082191780822" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="73" LOG_CI_END="0.15162694670383217" LOG_CI_START="-0.009275764457608469" LOG_EFFECT_SIZE="0.07117559112311184" ORDER="281" O_E="0.0" SE="0.09451504901749597" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" VAR="0.008933094490779664" WEIGHT="12.188478262366312"/>
<DICH_DATA CI_END="1.600972495854868" CI_START="0.7379730027906314" EFFECT_SIZE="1.0869565217391304" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="23" LOG_CI_END="0.20438387095673613" LOG_CI_START="-0.13195952564784674" LOG_EFFECT_SIZE="0.03621217265444471" ORDER="282" O_E="0.0" SE="0.19756977609219678" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="45" TOTAL_2="45" VAR="0.03903381642512077" WEIGHT="3.793040465605743"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="27.834113233715378" CI_END="1.046980199910947" CI_START="0.8803085652628291" CI_STUDY="95" CI_TOTAL="95" DF="16.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9600341856633" ESTIMABLE="YES" EVENTS_1="697" EVENTS_2="696" I2="42.51658076672891" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.019938468545387143" LOG_CI_START="-0.05536507250668222" LOG_EFFECT_SIZE="-0.017713301980647557" METHOD="MH" MODIFIED="2008-07-07 17:10:39 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.03309248070526549" P_Q="0.0" P_Z="0.35649393272088503" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.012591167602288407" TOTALS="YES" TOTAL_1="1177" TOTAL_2="1129" WEIGHT="99.99999999999997" Z="0.9220664378942139">
<NAME>Responder (per protocol)</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours standard</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours hypericum</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.103372403690743" CI_END="1.108915439884469" CI_START="0.779213394872222" DF="4.0" EFFECT_SIZE="0.9295599843681959" ESTIMABLE="YES" EVENTS_1="247" EVENTS_2="248" I2="60.40925900604429" ID="CMP-004.02.01" LOG_CI_END="0.04489843037664536" LOG_CI_START="-0.10834359043502234" LOG_EFFECT_SIZE="-0.03172258002918846" NO="1" P_CHI2="0.03872202256968349" P_Z="0.41709984476750417" STUDIES="5" TAU2="0.02359096298110263" TOTAL_1="440" TOTAL_2="414" WEIGHT="33.92765000254284" Z="0.8114629919989284">
<NAME>vs. older antidepressants</NAME>
<DICH_DATA CI_END="1.2642109348893926" CI_START="0.6701702594607438" EFFECT_SIZE="0.9204545454545454" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="28" LOG_CI_END="0.10181954247140299" LOG_CI_START="-0.1738148490144408" LOG_EFFECT_SIZE="-0.035997653271518895" ORDER="283" O_E="0.0" SE="0.16190900597102748" STUDY_ID="STD-Harrer-1993" TOTAL_1="44" TOTAL_2="42" VAR="0.02621452621452621" WEIGHT="5.042089483525894"/>
<DICH_DATA CI_END="1.355086014214211" CI_START="0.9857544213147258" EFFECT_SIZE="1.1557603686635944" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="70" LOG_CI_END="0.13196686296909615" LOG_CI_START="-0.0062312663487975204" LOG_EFFECT_SIZE="0.0628677983101493" ORDER="284" O_E="0.0" SE="0.08117826525310377" STUDY_ID="STD-Philipp-1999" TOTAL_1="93" TOTAL_2="99" VAR="0.006589910749503275" WEIGHT="10.200770629582996"/>
<DICH_DATA CI_END="1.1109012025803822" CI_START="0.5595965703209949" EFFECT_SIZE="0.7884519661523146" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="41" LOG_CI_END="0.045675436904798" LOG_CI_START="-0.2521249558943469" LOG_EFFECT_SIZE="-0.10322475949477444" ORDER="285" O_E="0.0" SE="0.17492942486593666" STUDY_ID="STD-Vorbach-1997" TOTAL_1="98" TOTAL_2="88" VAR="0.03060030368392738" WEIGHT="4.530102237038883"/>
<DICH_DATA CI_END="0.9786852842980329" CI_START="0.6020274002397082" EFFECT_SIZE="0.767590618336887" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="42" LOG_CI_END="-0.009356941768209209" LOG_CI_START="-0.2203837421273828" LOG_EFFECT_SIZE="-0.11487034194779598" ORDER="286" O_E="0.0" SE="0.1239581871304874" STUDY_ID="STD-Wheatley-1997" TOTAL_1="67" TOTAL_2="54" VAR="0.015365632156676932" WEIGHT="6.998718822669998"/>
<DICH_DATA CI_END="1.2223875306807608" CI_START="0.7593530250836673" EFFECT_SIZE="0.963443651308674" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="67" LOG_CI_END="0.08720891110713905" LOG_CI_START="-0.11955627258726377" LOG_EFFECT_SIZE="-0.016173680740062354" ORDER="287" O_E="0.0" SE="0.12145489240625833" STUDY_ID="STD-Woelk-2000" TOTAL_1="138" TOTAL_2="131" VAR="0.014751290889415788" WEIGHT="7.155968829725071"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="18.16753868687248" CI_END="1.079468821855536" CI_START="0.8733725956175185" DF="11.0" EFFECT_SIZE="0.9709678093696794" ESTIMABLE="YES" EVENTS_1="450" EVENTS_2="448" I2="39.452447634261034" ID="CMP-004.02.02" LOG_CI_END="0.03321010318563732" LOG_CI_START="-0.058800439342559914" LOG_EFFECT_SIZE="-0.012795168078461283" NO="2" P_CHI2="0.07777371737816074" P_Z="0.585675846854163" STUDIES="12" TAU2="0.012219782665541535" TOTAL_1="737" TOTAL_2="715" WEIGHT="66.07234999745714" Z="0.5451129386012558">
<NAME>vs. SSRIs</NAME>
<DICH_DATA CI_END="1.2705280781564934" CI_START="0.5563153835445632" EFFECT_SIZE="0.8407224958949097" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.10398426722478467" LOG_CI_START="-0.2546789305388739" LOG_EFFECT_SIZE="-0.07534733165704462" ORDER="288" O_E="0.0" SE="0.21068053777783546" STUDY_ID="STD-Behnke-2002" TOTAL_1="29" TOTAL_2="32" VAR="0.04438628899835796" WEIGHT="3.4340209684345084"/>
<DICH_DATA CI_END="1.733026358607571" CI_START="0.6982005749596303" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="20" LOG_CI_END="0.23880516820195116" LOG_CI_START="-0.15601979788550094" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="289" O_E="0.0" SE="0.23192213949487187" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="48" TOTAL_2="48" VAR="0.0537878787878788" WEIGHT="2.9476437420419224"/>
<DICH_DATA CI_END="3.2644430339455264" CI_START="0.9381385945946648" EFFECT_SIZE="1.75" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.5138090943652102" LOG_CI_START="-0.027732996992621377" LOG_EFFECT_SIZE="0.24303804868629442" ORDER="290" O_E="0.0" SE="0.3181045051401759" STUDY_ID="STD-Brenner-2000" TOTAL_1="8" TOTAL_2="12" VAR="0.1011904761904762" WEIGHT="1.7196251888490377"/>
<DICH_DATA CI_END="1.4352758776544534" CI_START="0.621466104551031" EFFECT_SIZE="0.9444444444444444" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.15693538582791278" LOG_CI_START="-0.20658255327797706" LOG_EFFECT_SIZE="-0.024823583725032152" ORDER="291" O_E="0.0" SE="0.2135322368736193" STUDY_ID="STD-Fava-2005" TOTAL_1="27" TOTAL_2="21" VAR="0.045596016184251464" WEIGHT="3.362626749774891"/>
<DICH_DATA CI_END="1.1151001804895222" CI_START="0.7824723661548839" EFFECT_SIZE="0.9340958605664488" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="72" LOG_CI_END="0.0473138861100679" LOG_CI_START="-0.10653099108293658" LOG_EFFECT_SIZE="-0.029608552486434344" ORDER="292" O_E="0.0" SE="0.09036924240759496" STUDY_ID="STD-Gastpar-2005" TOTAL_1="102" TOTAL_2="98" VAR="0.00816659997332266" WEIGHT="9.425954885658117"/>
<DICH_DATA CI_END="1.214085599148602" CI_START="0.8397362888037043" EFFECT_SIZE="1.0097087378640777" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="71" LOG_CI_END="0.08424930776670327" LOG_CI_START="-0.07585707857948694" LOG_EFFECT_SIZE="0.004196114593608148" ORDER="293" O_E="0.0" SE="0.09404728387914645" STUDY_ID="STD-Gastpar-2006" TOTAL_1="103" TOTAL_2="104" VAR="0.008844891605044758" WEIGHT="9.12769361206802"/>
<DICH_DATA CI_END="1.0339846718026238" CI_START="0.7227628814203494" EFFECT_SIZE="0.8644800406814137" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="57" LOG_CI_END="0.014514100652623489" LOG_CI_START="-0.14100415938760666" LOG_EFFECT_SIZE="-0.06324502936749157" ORDER="294" O_E="0.0" SE="0.09135219577543402" STUDY_ID="STD-Harrer-1999" TOTAL_1="69" TOTAL_2="68" VAR="0.008345223672993226" WEIGHT="9.345535155606935"/>
<DICH_DATA CI_END="1.0962920131564704" CI_START="0.6695683267127361" EFFECT_SIZE="0.8567627494456763" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="55" LOG_CI_END="0.03992625014367141" LOG_CI_START="-0.17420509841268092" LOG_EFFECT_SIZE="-0.06713942413450477" ORDER="295" O_E="0.0" SE="0.12578181410927167" STUDY_ID="STD-HDTSG-2002" TOTAL_1="82" TOTAL_2="84" VAR="0.015821064760619372" WEIGHT="6.886533173300513"/>
<DICH_DATA CI_END="0.8153509978075194" CI_START="0.12814007104070482" EFFECT_SIZE="0.32323232323232326" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.0886553929835468" LOG_CI_START="-0.892315039571741" LOG_EFFECT_SIZE="-0.49048521627764385" ORDER="296" O_E="0.0" SE="0.4720736545853151" STUDY_ID="STD-Moreno-2005" TOTAL_1="18" TOTAL_2="16" VAR="0.22285353535353536" WEIGHT="0.8310307186286481"/>
<DICH_DATA CI_END="1.815988332412902" CI_START="0.9612675997993256" EFFECT_SIZE="1.3212307692307692" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="39" LOG_CI_END="0.2591130538849717" LOG_CI_START="-0.017155695642260674" LOG_EFFECT_SIZE="0.1209786791213555" ORDER="297" O_E="0.0" SE="0.16228163102466203" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="113" VAR="0.026335327768024552" WEIGHT="5.026442242830497"/>
<DICH_DATA CI_END="1.3269405231387301" CI_START="0.9027789793756225" EFFECT_SIZE="1.0945017182130585" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="60" LOG_CI_END="0.12285145711346666" LOG_CI_START="-0.04441856174254272" LOG_EFFECT_SIZE="0.03921644768546199" ORDER="298" O_E="0.0" SE="0.0982552370759671" STUDY_ID="STD-Szegedi-2005" TOTAL_1="97" TOTAL_2="91" VAR="0.009654091612854502" WEIGHT="8.79566197913733"/>
<DICH_DATA CI_END="1.1985205330660802" CI_START="0.6428197592289224" EFFECT_SIZE="0.877742946708464" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="22" LOG_CI_END="0.0786454787709311" LOG_CI_START="-0.1919107822008549" LOG_EFFECT_SIZE="-0.056632651714961894" ORDER="299" O_E="0.0" SE="0.15892608696991847" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="29" TOTAL_2="28" VAR="0.02525750111957009" WEIGHT="5.169581581126724"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.53728685578224" CI_END="1.0906036944696476" CI_START="0.9351066259136119" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.00986669464065" ESTIMABLE="YES" EVENTS_1="688" EVENTS_2="665" I2="24.33251053565938" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.03766696454561621" LOG_CI_START="-0.029138865698905406" LOG_EFFECT_SIZE="0.004264049423355417" METHOD="MH" MODIFIED="2008-07-07 17:10:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.20467494271942166" P_Q="0.0" P_Z="0.8024332889236685" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.004345176222348785" TOTALS="YES" TOTAL_1="1131" TOTAL_2="1103" WEIGHT="100.0" Z="0.25019921966348874">
<NAME>Responders according to CGI (Clinical Global Impression Index at least "much improved")</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours standard</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours hypericum</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3402865258752277" CI_END="1.0850600446040395" CI_START="0.8683973933468344" DF="3.0" EFFECT_SIZE="0.9707024849864905" ESTIMABLE="YES" EVENTS_1="214" EVENTS_2="215" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="0.03545377165797584" LOG_CI_START="-0.06128148882976068" LOG_EFFECT_SIZE="-0.012913858585892415" NO="1" P_CHI2="0.7195897457691698" P_Z="0.6007666996525451" STUDIES="4" TAU2="0.0" TOTAL_1="351" TOTAL_2="341" WEIGHT="33.60750235846735" Z="0.5232982803204679">
<NAME>vs. older antidepressants</NAME>
<DICH_DATA CI_END="1.7508658171696594" CI_START="0.6910866544621967" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="20" LOG_CI_END="0.24325286390425702" LOG_CI_START="-0.1604674935878069" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="300" O_E="0.0" SE="0.23714733643883848" STUDY_ID="STD-Harrer-1993" TOTAL_1="51" TOTAL_2="51" VAR="0.056238859180035655" WEIGHT="2.54182553190451"/>
<DICH_DATA CI_END="1.2109415462717774" CI_START="0.8666479320475754" EFFECT_SIZE="1.0244315432994677" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="78" LOG_CI_END="0.08312317968779648" LOG_CI_START="-0.062157294936884024" LOG_EFFECT_SIZE="0.010482942375456227" ORDER="301" O_E="0.0" SE="0.08533846994448503" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="110" VAR="0.007282654452465776" WEIGHT="13.243575032884918"/>
<DICH_DATA CI_END="1.1188400622417984" CI_START="0.7138506054787062" EFFECT_SIZE="0.8936915887850467" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="64" LOG_CI_END="0.04876800873545934" LOG_CI_START="-0.14639266778253057" LOG_EFFECT_SIZE="-0.04881232952353562" ORDER="302" O_E="0.0" SE="0.11463834744759646" STUDY_ID="STD-Vorbach-1997" TOTAL_1="107" TOTAL_2="102" VAR="0.013141950705515847" WEIGHT="8.806137717580567"/>
<DICH_DATA CI_END="1.160699281064419" CI_START="0.7457695113304017" EFFECT_SIZE="0.9303838646714379" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="53" LOG_CI_END="0.06471971543956995" LOG_CI_START="-0.12739537550893662" LOG_EFFECT_SIZE="-0.03133783003468333" ORDER="303" O_E="0.0" SE="0.11284935540819023" STUDY_ID="STD-Wheatley-1997" TOTAL_1="87" TOTAL_2="78" VAR="0.012734977016044032" WEIGHT="9.015964076097353"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.282141040670309" CI_END="1.1453440857643287" CI_START="0.9181084478088982" DF="7.0" EFFECT_SIZE="1.025451159630818" ESTIMABLE="YES" EVENTS_1="474" EVENTS_2="450" I2="43.0066795616445" ID="CMP-004.03.02" LOG_CI_END="0.05893597759279781" LOG_CI_START="-0.03710601650766472" LOG_EFFECT_SIZE="0.010914980542566548" NO="2" P_CHI2="0.09165407209080767" P_Z="0.6559642601943214" STUDIES="8" TAU2="0.010429160085286196" TOTAL_1="780" TOTAL_2="762" WEIGHT="66.39249764153264" Z="0.44549197370909027">
<NAME>vs. newer antidepressants</NAME>
<DICH_DATA CI_END="1.2434121837141243" CI_START="0.6157451326502577" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="24" LOG_CI_END="0.09461511853631055" LOG_CI_START="-0.21059901249168406" LOG_EFFECT_SIZE="-0.057991946977686754" ORDER="304" O_E="0.0" SE="0.17928429140015903" STUDY_ID="STD-Behnke-2002" TOTAL_1="35" TOTAL_2="35" VAR="0.03214285714285714" WEIGHT="4.220398684419982"/>
<DICH_DATA CI_END="1.7491036061834202" CI_START="0.7382766289455424" EFFECT_SIZE="1.1363636363636365" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="22" LOG_CI_END="0.24281553518541893" LOG_CI_START="-0.1317808794857561" LOG_EFFECT_SIZE="0.05551732784983142" ORDER="305" O_E="0.0" SE="0.2200397882600063" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" VAR="0.048417508417508415" WEIGHT="2.9186166144256354"/>
<DICH_DATA CI_END="1.3636827032713426" CI_START="0.8603064139255453" EFFECT_SIZE="1.0831366378179912" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="62" LOG_CI_END="0.1347133320150603" LOG_CI_START="-0.06534683924959943" LOG_EFFECT_SIZE="0.03468324638273045" ORDER="306" O_E="0.0" SE="0.11751633491468047" STUDY_ID="STD-Gastpar-2005" TOTAL_1="123" TOTAL_2="118" VAR="0.013810088971779348" WEIGHT="8.482059962494683"/>
<DICH_DATA CI_END="1.1403483345962875" CI_START="0.805134185487375" EFFECT_SIZE="0.9581927924729274" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="86" LOG_CI_END="0.05703753263950438" LOG_CI_START="-0.09413173309766915" LOG_EFFECT_SIZE="-0.018547100229082365" ORDER="307" O_E="0.0" SE="0.08879757499394952" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" VAR="0.00788500932480609" WEIGHT="12.591309217496816"/>
<DICH_DATA CI_END="1.248624600684897" CI_START="0.784783520735972" EFFECT_SIZE="0.98989898989899" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="54" LOG_CI_END="0.09643188724788336" LOG_CI_START="-0.10525012505799346" LOG_EFFECT_SIZE="-0.004409118905055039" ORDER="308" O_E="0.0" SE="0.11846901237053402" STUDY_ID="STD-Harrer-1999" TOTAL_1="77" TOTAL_2="84" VAR="0.014034906892049743" WEIGHT="8.378310753717548"/>
<DICH_DATA CI_END="0.9781930314927999" CI_START="0.5646867405021024" EFFECT_SIZE="0.7432177571449297" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="61" LOG_CI_END="-0.009575435355468266" LOG_CI_START="-0.24819240988022306" LOG_EFFECT_SIZE="-0.12888392261784565" ORDER="309" O_E="0.0" SE="0.14016479200891455" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="109" VAR="0.019646168918902272" WEIGHT="6.418733385099277"/>
<DICH_DATA CI_END="1.4241842317196696" CI_START="1.0057955218792778" EFFECT_SIZE="1.1968450704225353" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="71" LOG_CI_END="0.15356617303956102" LOG_CI_START="0.002509697672412345" LOG_EFFECT_SIZE="0.0780379353559867" ORDER="310" O_E="0.0" SE="0.0887313213722756" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="113" VAR="0.007873247392470053" WEIGHT="12.603430104094553"/>
<DICH_DATA CI_END="1.441605546602487" CI_START="0.9752448377160768" EFFECT_SIZE="1.1857142857142857" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="70" LOG_CI_END="0.158846444593797" LOG_CI_START="-0.01088633987016284" LOG_EFFECT_SIZE="0.07398005236181707" ORDER="311" O_E="0.0" SE="0.09970187778496352" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" VAR="0.009940464433847803" WEIGHT="10.779638919784148"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="19.532266670201235" CI_END="1.0863680548909325" CI_START="0.9279741886385326" CI_STUDY="95" CI_TOTAL="95" DF="16.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0040525455872487" ESTIMABLE="YES" EVENTS_1="718" EVENTS_2="710" I2="18.084264001935434" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.03597698651248581" LOG_CI_START="-0.03246410340156049" LOG_EFFECT_SIZE="0.0017564415554626822" METHOD="MH" MODIFIED="2008-07-07 17:10:55 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.2420296030697916" P_Q="0.0" P_Z="0.9198685681596961" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.004695018061315556" TOTALS="YES" TOTAL_1="1392" TOTAL_2="1377" WEIGHT="100.00000000000001" Z="0.10059928016867523">
<NAME>Responder among studies from German-speaking studies and other studies</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours standard</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours hypericum</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="8.671511256072852" CI_END="1.1265245659330119" CI_START="0.9597002810293433" DF="8.0" EFFECT_SIZE="1.0397720627677831" ESTIMABLE="YES" EVENTS_1="541" EVENTS_2="518" I2="7.743878042049224" ID="CMP-004.04.01" LOG_CI_END="0.051740666750326424" LOG_CI_START="-0.017864378021618443" LOG_EFFECT_SIZE="0.01693814436435403" NO="1" P_CHI2="0.37076010919695845" P_Z="0.3401338852090342" STUDIES="9" TAU2="0.0011762270452904766" TOTAL_1="978" TOTAL_2="974" WEIGHT="76.00651220824366" Z="0.9539007704928538">
<NAME>Studies from German-speaking countries</NAME>
<DICH_DATA CI_END="1.1151001804895222" CI_START="0.7824723661548839" EFFECT_SIZE="0.9340958605664488" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="72" LOG_CI_END="0.0473138861100679" LOG_CI_START="-0.10653099108293658" LOG_EFFECT_SIZE="-0.029608552486434344" ORDER="312" O_E="0.0" SE="0.09036924240759496" STUDY_ID="STD-Gastpar-2005" TOTAL_1="102" TOTAL_2="98" VAR="0.00816659997332266" WEIGHT="12.566473805564573"/>
<DICH_DATA CI_END="1.2086821819035043" CI_START="0.7775936953332256" EFFECT_SIZE="0.9694656488549618" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="71" LOG_CI_END="0.08231211989241692" LOG_CI_START="-0.10924726929203182" LOG_EFFECT_SIZE="-0.013467574699807418" ORDER="313" O_E="0.0" SE="0.11252293344121458" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" VAR="0.012661410550216006" WEIGHT="9.312122311964268"/>
<DICH_DATA CI_END="1.3806514055127095" CI_START="0.6734842227826571" EFFECT_SIZE="0.9642857142857143" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="28" LOG_CI_END="0.14008403935135297" LOG_CI_START="-0.1716725737178168" LOG_EFFECT_SIZE="-0.015794267183231903" ORDER="314" O_E="0.0" SE="0.18312737773695376" STUDY_ID="STD-Harrer-1993" TOTAL_1="51" TOTAL_2="51" VAR="0.033535636476812944" WEIGHT="4.227633245678928"/>
<DICH_DATA CI_END="1.1929661592665137" CI_START="0.767607651000268" EFFECT_SIZE="0.9569377990430622" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="57" LOG_CI_END="0.07662812426358034" LOG_CI_START="-0.11486070515772592" LOG_EFFECT_SIZE="-0.019116290447072807" ORDER="315" O_E="0.0" SE="0.11248148628706822" STUDY_ID="STD-Harrer-1999" TOTAL_1="77" TOTAL_2="84" VAR="0.012652084757347918" WEIGHT="9.317128503761912"/>
<DICH_DATA CI_END="1.3557794692526441" CI_START="0.9363014399129742" EFFECT_SIZE="1.1266846361185985" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="70" LOG_CI_END="0.13218905304458706" LOG_CI_START="-0.028584308724608345" LOG_EFFECT_SIZE="0.051802372159989354" ORDER="316" O_E="0.0" SE="0.09443906854420132" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="110" VAR="0.008918737667496356" WEIGHT="11.87219672139389"/>
<DICH_DATA CI_END="1.815988332412902" CI_START="0.9612675997993256" EFFECT_SIZE="1.3212307692307692" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="39" LOG_CI_END="0.2591130538849717" LOG_CI_START="-0.017155695642260674" LOG_EFFECT_SIZE="0.1209786791213555" ORDER="317" O_E="0.0" SE="0.16228163102466203" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="113" VAR="0.026335327768024552" WEIGHT="5.208616978307624"/>
<DICH_DATA CI_END="1.417839093166414" CI_START="0.9788682349642395" EFFECT_SIZE="1.178082191780822" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="73" LOG_CI_END="0.15162694670383217" LOG_CI_START="-0.009275764457608469" LOG_EFFECT_SIZE="0.07117559112311184" ORDER="318" O_E="0.0" SE="0.09451504901749597" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" VAR="0.008933094490779664" WEIGHT="11.859689704764683"/>
<DICH_DATA CI_END="1.1951058136497088" CI_START="0.5862241656569622" EFFECT_SIZE="0.8370184636425804" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="41" LOG_CI_END="0.07740635904963093" LOG_CI_START="-0.23193628280111162" LOG_EFFECT_SIZE="-0.0772649618757403" ORDER="319" O_E="0.0" SE="0.18170939909389933" STUDY_ID="STD-Vorbach-1997" TOTAL_1="107" TOTAL_2="102" VAR="0.033018305719065985" WEIGHT="4.285625607296258"/>
<DICH_DATA CI_END="1.3967678098831064" CI_START="0.8344064255567712" EFFECT_SIZE="1.0795703013594449" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="67" LOG_CI_END="0.14512421766216038" LOG_CI_START="-0.07862236017464146" LOG_EFFECT_SIZE="0.03325092874375945" ORDER="320" O_E="0.0" SE="0.13142984738476024" STUDY_ID="STD-Woelk-2000" TOTAL_1="157" TOTAL_2="167" VAR="0.01727380478358137" WEIGHT="7.357025329511522"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.93495625413616" CI_END="1.0640353607177586" CI_START="0.7649114652966039" DF="7.0" EFFECT_SIZE="0.9021601004777485" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="192" I2="11.782752471367518" ID="CMP-004.04.02" LOG_CI_END="0.026956060956604137" LOG_CI_START="-0.11638882936698632" LOG_EFFECT_SIZE="-0.04471638420519106" NO="2" P_CHI2="0.3383644617262107" P_Z="0.22139769594960546" STUDIES="8" TAU2="0.00674878608031721" TOTAL_1="414" TOTAL_2="403" WEIGHT="23.993487791756355" Z="1.2228200442050479">
<NAME>Studies from other countries</NAME>
<DICH_DATA CI_END="1.1962390568577919" CI_START="0.4852699490835645" EFFECT_SIZE="0.7619047619047619" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.07781797789627831" LOG_CI_START="-0.31401660205226734" LOG_EFFECT_SIZE="-0.11809931207799451" ORDER="321" O_E="0.0" SE="0.23016557187422815" STUDY_ID="STD-Behnke-2002" TOTAL_1="35" TOTAL_2="35" VAR="0.05297619047619048" WEIGHT="2.8025281631534793"/>
<DICH_DATA CI_END="1.7665489068263274" CI_START="0.6849513168439878" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="20" LOG_CI_END="0.24712566536032649" LOG_CI_START="-0.16434029504387637" LOG_EFFECT_SIZE="0.04139268515822507" ORDER="322" O_E="0.0" SE="0.24169714193078168" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" VAR="0.058417508417508424" WEIGHT="2.5609050238812388"/>
<DICH_DATA CI_END="2.65606718850822" CI_START="0.5124535693223857" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.4242390568515887" LOG_CI_START="-0.2903454775903623" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="323" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Brenner-2000" TOTAL_1="15" TOTAL_2="15" VAR="0.17619047619047623" WEIGHT="0.8935220969376159"/>
<DICH_DATA CI_END="2.2590111182384263" CI_START="0.7120231126822512" EFFECT_SIZE="1.2682539682539682" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.3539183684049644" LOG_CI_START="-0.1475059086841451" LOG_EFFECT_SIZE="0.10320622986040966" ORDER="324" O_E="0.0" SE="0.2945391024523451" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="47" VAR="0.08675328287343304" WEIGHT="1.7673940847165988"/>
<DICH_DATA CI_END="1.0782044535573525" CI_START="0.6036500930678858" EFFECT_SIZE="0.8067578439259855" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="55" LOG_CI_END="0.03270112136331721" LOG_CI_START="-0.21921472807424894" LOG_EFFECT_SIZE="-0.09325680335546588" ORDER="325" O_E="0.0" SE="0.1479766169631925" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="109" VAR="0.02189707916787139" WEIGHT="6.077940552656431"/>
<DICH_DATA CI_END="0.9516083098450095" CI_START="0.13895570645049798" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="-0.021541774175675356" LOG_CI_START="-0.8571236134848499" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="326" O_E="0.0" SE="0.49082490860702144" STUDY_ID="STD-Moreno-2005" TOTAL_1="20" TOTAL_2="20" VAR="0.24090909090909096" WEIGHT="0.6580719956478118"/>
<DICH_DATA CI_END="1.600972495854868" CI_START="0.7379730027906314" EFFECT_SIZE="1.0869565217391304" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="23" LOG_CI_END="0.20438387095673613" LOG_CI_START="-0.13195952564784674" LOG_EFFECT_SIZE="0.03621217265444471" ORDER="327" O_E="0.0" SE="0.19756977609219678" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="45" TOTAL_2="45" VAR="0.03903381642512077" WEIGHT="3.6960780690276676"/>
<DICH_DATA CI_END="1.160395171888721" CI_START="0.6282987401203387" EFFECT_SIZE="0.8538587848932676" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="42" LOG_CI_END="0.06460591314471767" LOG_CI_START="-0.20183381114087015" LOG_EFFECT_SIZE="-0.06861394899807621" ORDER="328" O_E="0.0" SE="0.15650801294326042" STUDY_ID="STD-Wheatley-1997" TOTAL_1="87" TOTAL_2="78" VAR="0.02449475811544777" WEIGHT="5.537047805735511"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.1939108814601824" CI_END="1.5008734542341644" CI_START="1.0217653943124116" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2383620459213864" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="116" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="0.17634407635743704" LOG_CI_START="0.009351189681471462" LOG_EFFECT_SIZE="0.09284763301945421" METHOD="MH" MODIFIED="2008-08-11 14:04:28 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5331488152317243" P_Q="0.0" P_Z="0.029296750136705015" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="344" TOTAL_2="341" WEIGHT="100.0" Z="2.179470280324382">
<NAME>Remission (HAMD score &lt; 8)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>vs. older antidepressants</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.1939108814601824" CI_END="1.5008734542341644" CI_START="1.0217653943124116" DF="3.0" EFFECT_SIZE="1.2383620459213864" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="116" I2="0.0" ID="CMP-004.05.02" LOG_CI_END="0.17634407635743704" LOG_CI_START="0.009351189681471462" LOG_EFFECT_SIZE="0.09284763301945421" NO="2" P_CHI2="0.5331488152317243" P_Z="0.029296750136705015" STUDIES="4" TAU2="0.0" TOTAL_1="344" TOTAL_2="341" WEIGHT="100.0" Z="2.179470280324382">
<NAME>vs. SSRIs</NAME>
<DICH_DATA CI_END="1.643254417700671" CI_START="0.45708753496741283" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.21570480850478338" LOG_CI_START="-0.34000062200247233" LOG_EFFECT_SIZE="-0.062147906748844454" ORDER="329" O_E="0.0" SE="0.32642412066620713" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" VAR="0.10655270655270654" WEIGHT="9.030393236601377"/>
<DICH_DATA CI_END="2.2590111182384263" CI_START="0.7120231126822512" EFFECT_SIZE="1.2682539682539682" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.3539183684049644" LOG_CI_START="-0.1475059086841451" LOG_EFFECT_SIZE="0.10320622986040966" ORDER="330" O_E="0.0" SE="0.2945391024523451" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="47" VAR="0.08675328287343304" WEIGHT="11.091370939805625"/>
<DICH_DATA CI_END="1.5752932174506455" CI_START="0.8476933473289872" EFFECT_SIZE="1.155580192165558" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="44" LOG_CI_END="0.1973614031215552" LOG_CI_START="-0.07176122515889714" LOG_EFFECT_SIZE="0.06280008898132905" ORDER="331" O_E="0.0" SE="0.1580839640304328" STUDY_ID="STD-Gastpar-2005" TOTAL_1="123" TOTAL_2="118" VAR="0.024990539683575168" WEIGHT="38.50308367800232"/>
<DICH_DATA CI_END="1.9127948677034348" CI_START="1.0520935570665266" EFFECT_SIZE="1.4186046511627908" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="43" LOG_CI_END="0.2816683978363528" LOG_CI_START="0.02205436102600816" LOG_EFFECT_SIZE="0.15186137943118053" ORDER="332" O_E="0.0" SE="0.15249857033260467" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" VAR="0.023255813953488372" WEIGHT="41.37515214559069"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2008-08-13 22:15:43 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Hypericum mono-preparations vs. standard antidepressants. B. Continuous measures</NAME>
<CONT_OUTCOME CHI2="21.131496208152665" CI_END="0.44910835997394977" CI_START="-1.2305894530030523" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3907405465145513" ESTIMABLE="YES" I2="47.94500166175583" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2008-07-08 14:13:49 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.032034072227597576" P_Q="0.6974863099197772" P_Z="0.3618344228517446" Q="0.15110022958020153" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.9366683619623787" TOTALS="YES" TOTAL_1="959" TOTAL_2="930" UNITS="" WEIGHT="100.0" Z="0.911875210590042">
<NAME>Mean HAMD (Hamilton Rating Scale for Depression) after therapy</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.023106982308281" CI_END="1.705044665237623" CI_START="-1.8180043347184192" DF="2.0" EFFECT_SIZE="-0.05647983474039817" ESTIMABLE="YES" I2="50.28717832274775" ID="CMP-005.01.01" MODIFIED="2008-07-08 14:13:32 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1337809071542767" P_Z="0.9498919956059321" STUDIES="3" TAU2="1.1891810055036038" TOTAL_1="242" TOTAL_2="235" WEIGHT="25.76184507601784" Z="0.06284240834875461">
<NAME>vs. older antidepressants</NAME>
<CONT_DATA CI_END="4.40157540024091" CI_START="-3.0015754002409114" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="10.5" ORDER="333" SD_1="9.9" SD_2="7.5" SE="1.8885935810241743" STUDY_ID="STD-Harrer-1993" TOTAL_1="44" TOTAL_2="42" WEIGHT="4.077184849363356"/>
<CONT_DATA CI_END="0.2846354519849732" CI_START="-3.084635451984974" EFFECT_SIZE="-1.4000000000000004" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="10.6" ORDER="334" SD_1="6.2" SD_2="6.1" SE="0.8595236776150802" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="105" WEIGHT="10.959098895020212"/>
<CONT_DATA CI_END="2.725728042396401" CI_START="-0.7257280423964012" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="14.4" MEAN_2="13.4" ORDER="335" SD_1="6.1" SD_2="5.9" SE="0.8804896702228835" STUDY_ID="STD-Vorbach-1997" TOTAL_1="98" TOTAL_2="88" WEIGHT="10.725561331634271"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="16.957288996264182" CI_END="0.5120729279411866" CI_START="-1.5505732912353756" DF="8.0" EFFECT_SIZE="-0.5192501816470945" ESTIMABLE="YES" I2="52.822647524834544" ID="CMP-005.01.02" MODIFIED="2008-07-08 14:13:49 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.030556938668573785" P_Z="0.32373975182102865" STUDIES="9" TAU2="1.1597506024302755" TOTAL_1="717" TOTAL_2="695" WEIGHT="74.23815492398217" Z="0.9868019493914677">
<NAME>vs. SSRIs</NAME>
<CONT_DATA CI_END="3.268440055413281" CI_START="-3.068440055413282" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="14.9" ORDER="339" SD_1="8.4" SD_2="8.4" SE="1.6165807537309522" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" WEIGHT="5.17222703127551"/>
<CONT_DATA CI_END="4.814765726717558" CI_START="-4.414765726717559" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="12.7" MEAN_2="12.5" ORDER="340" SD_1="6.7" SD_2="5.6" SE="2.354515574325978" STUDY_ID="STD-Brenner-2000" TOTAL_1="13" TOTAL_2="15" WEIGHT="2.8333715304393152"/>
<CONT_DATA CI_END="-0.2585052215835657" CI_START="-5.941494778416438" EFFECT_SIZE="-3.1000000000000014" ESTIMABLE="YES" MEAN_1="10.2" MEAN_2="13.3" ORDER="341" SD_1="6.6" SD_2="7.3" SE="1.4497688737292032" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="47" WEIGHT="6.042924440924322"/>
<CONT_DATA CI_END="1.7467629457626512" CI_START="-1.346762945762649" EFFECT_SIZE="0.20000000000000107" ESTIMABLE="YES" MEAN_1="8.3" MEAN_2="8.1" ORDER="342" SD_1="5.5" SD_2="5.6" SE="0.7891792696005226" STUDY_ID="STD-Gastpar-2005" TOTAL_1="101" TOTAL_2="97" WEIGHT="11.774120609231193"/>
<CONT_DATA CI_END="1.5620697048961782" CI_START="-1.5620697048961782" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="10.3" ORDER="343" SD_1="6.4" SD_2="6.4" SE="0.7969889840923531" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" WEIGHT="11.681331056133684"/>
<CONT_DATA CI_END="4.224400887906943" CI_START="0.17559911209305934" EFFECT_SIZE="2.200000000000001" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="10.7" ORDER="345" SD_1="7.1" SD_2="5.9" SE="1.0328765752203395" STUDY_ID="STD-HDTSG-2002" TOTAL_1="82" TOTAL_2="77" WEIGHT="9.16465829943622"/>
<CONT_DATA CI_END="0.5060225891951522" CI_START="-1.6060225891951536" EFFECT_SIZE="-0.5500000000000007" ESTIMABLE="YES" MEAN_1="10.92" MEAN_2="11.47" ORDER="346" SD_1="4.27" SD_2="4.04" SE="0.5387969358237826" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="113" WEIGHT="14.964837972266466"/>
<CONT_DATA CI_END="-0.7539832751316" CI_START="-5.2460167248684" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.2" ORDER="347" SD_1="9.0" SD_2="8.9" SE="1.1459479575056957" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" WEIGHT="8.161118133698958"/>
<CONT_DATA CI_END="1.3736058788528922" CI_START="-5.633605878852894" EFFECT_SIZE="-2.130000000000001" ESTIMABLE="YES" MEAN_1="9.43" MEAN_2="11.56" ORDER="348" SD_1="8.26" SD_2="8.41" SE="1.7875868671510746" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="44" TOTAL_2="43" WEIGHT="4.443565850576499"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="17.442377554928925" CI_END="0.7809762789756537" CI_START="-1.0204401041520625" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.11973191258820441" ESTIMABLE="YES" I2="54.13469307835655" I2_Q="0.0" ID="CMP-005.02" NO="2" P_CHI2="0.025818533248112674" P_Q="0.8921217016971664" P_Z="0.7944475012105693" Q="0.01839278388208143" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.9914340346770377" TOTALS="YES" TOTAL_1="782" TOTAL_2="747" UNITS="" WEIGHT="100.0" Z="0.2605396938441644">
<NAME>Mean HAMD (Hamilton Rating Scale for Depression) scores after 2 or 3 weeks of treatment</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.435959536647983" CI_END="1.1962869289297398" CI_START="-1.305622907235653" DF="2.0" EFFECT_SIZE="-0.05466798915295676" ESTIMABLE="YES" I2="17.896829979692015" ID="CMP-005.02.01" NO="1" P_CHI2="0.29582727524103203" P_Z="0.9317427430510096" STUDIES="3" TAU2="0.23046017894443743" TOTAL_1="242" TOTAL_2="235" WEIGHT="30.58417967879353" Z="0.08565239905786792">
<NAME>vs. older antidepressants</NAME>
<CONT_DATA CI_END="5.310952161091389" CI_START="-0.91095216109139" EFFECT_SIZE="2.1999999999999993" ESTIMABLE="YES" MEAN_1="15.1" MEAN_2="12.9" ORDER="349" SD_1="7.9" SD_2="6.8" SE="1.5872496564376606" STUDY_ID="STD-Harrer-1993" TOTAL_1="44" TOTAL_2="42" WEIGHT="6.015427669105878"/>
<CONT_DATA CI_END="1.2018120394249963" CI_START="-2.001812039424993" EFFECT_SIZE="-0.3999999999999986" ESTIMABLE="YES" MEAN_1="16.5" MEAN_2="16.9" ORDER="350" SD_1="5.8" SD_2="5.9" SE="0.8172660579785567" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="105" WEIGHT="12.72717425262499"/>
<CONT_DATA CI_END="1.2442823481648082" CI_START="-2.244282348164808" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="20.1" ORDER="351" SD_1="5.9" SD_2="6.2" SE="0.8899563267098195" STUDY_ID="STD-Vorbach-1997" TOTAL_1="98" TOTAL_2="88" WEIGHT="11.841577757062662"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.988025234398862" CI_END="0.9952382531666808" CI_START="-1.4998521208186657" DF="5.0" EFFECT_SIZE="-0.2523069338259924" ESTIMABLE="YES" I2="66.64003481576377" ID="CMP-005.02.02" NO="2" P_CHI2="0.010413641819626118" P_Z="0.6918184860741976" STUDIES="6" TAU2="1.5822086763115815" TOTAL_1="540" TOTAL_2="512" WEIGHT="69.41582032120647" Z="0.396388450297937">
<NAME>vs. SSRIs</NAME>
<CONT_DATA CI_END="-0.16894968438660518" CI_START="-4.6310503156133915" EFFECT_SIZE="-2.3999999999999986" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="14.7" ORDER="352" SD_1="5.9" SD_2="4.1" SE="1.1383118941019497" STUDY_ID="STD-Fava-2005" TOTAL_1="42" TOTAL_2="36" WEIGHT="9.233581324989746"/>
<CONT_DATA CI_END="1.9607935905137879" CI_START="-1.1607935905137872" EFFECT_SIZE="0.40000000000000036" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="15.6" ORDER="353" SD_1="5.3" SD_2="5.8" SE="0.7963378933618822" STUDY_ID="STD-Gastpar-2005" TOTAL_1="99" TOTAL_2="96" WEIGHT="12.991567023860581"/>
<CONT_DATA CI_END="1.2036642431983566" CI_START="-1.6036642431983552" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="13.5" MEAN_2="13.7" ORDER="354" SD_1="5.7" SD_2="5.8" SE="0.7161683858837613" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" WEIGHT="14.038754596261633"/>
<CONT_DATA CI_END="3.710147152516741" CI_START="0.48985284748326174" EFFECT_SIZE="2.1000000000000014" ESTIMABLE="YES" MEAN_1="18.6" MEAN_2="16.5" ORDER="355" SD_1="5.7" SD_2="5.6" SE="0.8215187448429537" STUDY_ID="STD-HDTSG-2002" TOTAL_1="102" TOTAL_2="88" WEIGHT="12.67394417850372"/>
<CONT_DATA CI_END="1.5939432663430544" CI_START="-1.7939432663430572" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="20.4" MEAN_2="20.5" ORDER="356" SD_1="6.8" SD_2="6.7" SE="0.8642726497551302" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" WEIGHT="12.148482093780544"/>
<CONT_DATA CI_END="0.05541385421159495" CI_START="-4.815413854211593" EFFECT_SIZE="-2.379999999999999" ESTIMABLE="YES" MEAN_1="14.36" MEAN_2="16.74" ORDER="357" SD_1="5.85" SD_2="5.74" SE="1.2425809215994925" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="44" TOTAL_2="43" WEIGHT="8.329491103810241"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="18.83217630490903" CI_END="0.8015357733580448" CI_START="-1.4784269513215371" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3384455889817462" ESTIMABLE="YES" I2="57.51951409930981" I2_Q="0.0" ID="CMP-005.03" NO="3" P_CHI2="0.015783420027699724" P_Q="0.6802401819597288" P_Z="0.5606423099091031" Q="0.16985589316398375" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="1.6453153560777447" TOTALS="YES" TOTAL_1="694" TOTAL_2="673" UNITS="" WEIGHT="100.00000000000001" Z="0.581887728207392">
<NAME>Mean HAMD (Hamilton Rating Scale for Depression) scores after 4 weeks of treatment</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.655390159362782" CI_END="1.1503737699777254" CI_START="-1.106445731701218" DF="2.0" EFFECT_SIZE="0.02196401913825384" ESTIMABLE="YES" I2="0.0" ID="CMP-005.03.01" NO="1" P_CHI2="0.4370557435927903" P_Z="0.969568188890161" STUDIES="3" TAU2="0.0" TOTAL_1="242" TOTAL_2="235" WEIGHT="34.86159353612443" Z="0.03814987103284092">
<NAME>vs. older antidepressants</NAME>
<CONT_DATA CI_END="4.40157540024091" CI_START="-3.0015754002409114" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="10.5" ORDER="358" SD_1="9.9" SD_2="7.5" SE="1.8885935810241743" STUDY_ID="STD-Harrer-1993" TOTAL_1="44" TOTAL_2="42" WEIGHT="6.490624598823713"/>
<CONT_DATA CI_END="0.8762384072841287" CI_START="-2.2762384072841275" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="13.0" ORDER="359" SD_1="5.9" SD_2="5.6" SE="0.8042180467178455" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="105" WEIGHT="14.759415711637827"/>
<CONT_DATA CI_END="2.5963986552184175" CI_START="-0.9963986552184161" EFFECT_SIZE="0.8000000000000007" ESTIMABLE="YES" MEAN_1="17.1" MEAN_2="16.3" ORDER="360" SD_1="6.6" SD_2="5.9" SE="0.9165467678937879" STUDY_ID="STD-Vorbach-1997" TOTAL_1="98" TOTAL_2="88" WEIGHT="13.611553225662888"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="17.006930252382265" CI_END="1.0559754707665592" CI_START="-2.4421441222713587" DF="5.0" EFFECT_SIZE="-0.6930843257523996" ESTIMABLE="YES" I2="70.60022046424504" ID="CMP-005.03.02" NO="2" P_CHI2="0.004486687674833734" P_Z="0.43736090528684524" STUDIES="6" TAU2="3.251509089209362" TOTAL_1="452" TOTAL_2="438" WEIGHT="65.13840646387558" Z="0.7766574472911142">
<NAME>vs. SSRIs</NAME>
<CONT_DATA CI_END="3.268440055413281" CI_START="-3.068440055413282" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="14.9" ORDER="361" SD_1="8.4" SD_2="8.4" SE="1.6165807537309522" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" WEIGHT="7.943785431978129"/>
<CONT_DATA CI_END="-0.034138316636822985" CI_START="-5.565861683363178" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="14.3" ORDER="362" SD_1="6.9" SD_2="4.7" SE="1.4111798508441693" STUDY_ID="STD-Fava-2005" TOTAL_1="35" TOTAL_2="35" WEIGHT="9.302219813439894"/>
<CONT_DATA CI_END="1.7351715591974899" CI_START="-1.5351715591974906" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="12.0" ORDER="363" SD_1="5.7" SD_2="6.0" SE="0.8342865338830279" STUDY_ID="STD-Gastpar-2005" TOTAL_1="100" TOTAL_2="97" WEIGHT="14.448843797328145"/>
<CONT_DATA CI_END="4.307712467798565" CI_START="0.49228753220143284" EFFECT_SIZE="2.3999999999999986" ESTIMABLE="YES" MEAN_1="16.9" MEAN_2="14.5" ORDER="364" SD_1="7.1" SD_2="6.1" SE="0.9733405730137688" STUDY_ID="STD-HDTSG-2002" TOTAL_1="97" TOTAL_2="87" WEIGHT="13.048056897658515"/>
<CONT_DATA CI_END="0.8954506392475374" CI_START="-3.2954506392475396" EFFECT_SIZE="-1.200000000000001" ESTIMABLE="YES" MEAN_1="15.1" MEAN_2="16.3" ORDER="365" SD_1="8.3" SD_2="8.4" SE="1.0691271144654624" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" WEIGHT="12.132556511723038"/>
<CONT_DATA CI_END="-0.7928963235110875" CI_START="-6.927103676488912" EFFECT_SIZE="-3.8599999999999994" ESTIMABLE="YES" MEAN_1="10.93" MEAN_2="14.79" ORDER="366" SD_1="7.03" SD_2="7.55" SE="1.564877569527723" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="44" TOTAL_2="43" WEIGHT="8.262944011747862"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="19.211915845928704" CI_END="0.5665210176563849" CI_START="-1.238665479332336" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3360722308379756" ESTIMABLE="YES" I2="53.154073377292896" I2_Q="0.0" ID="CMP-005.04" MODIFIED="2008-07-08 14:14:17 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.023450132533189616" P_Q="0.9263538542348114" P_Z="0.4655280855081524" Q="0.008543898497116231" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="1.0186339175673347" TOTALS="YES" TOTAL_1="847" TOTAL_2="812" UNITS="" WEIGHT="100.00000000000001" Z="0.7297744246871344">
<NAME>Mean HAMD (Hamilton Rating Scale for Depression) scores after 6 to 8 weeks of treatment</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.8043833334310255" CI_END="2.1443093776897584" CI_START="-2.559509838934863" DF="1.0" EFFECT_SIZE="-0.2076002306225522" ESTIMABLE="YES" I2="73.71453104600427" ID="CMP-005.04.01" MODIFIED="2008-07-08 14:14:09 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.05111863970536379" P_Z="0.8626485491502275" STUDIES="2" TAU2="2.1229784941249243" TOTAL_1="198" TOTAL_2="193" WEIGHT="23.889392965714197" Z="0.17300366211539397">
<NAME>vs. older antidepressants</NAME>
<CONT_DATA CI_END="0.2846354519849732" CI_START="-3.084635451984974" EFFECT_SIZE="-1.4000000000000004" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="10.6" ORDER="367" SD_1="6.2" SD_2="6.1" SE="0.8595236776150802" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="105" WEIGHT="12.067399273212812"/>
<CONT_DATA CI_END="2.725728042396401" CI_START="-0.7257280423964012" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="14.4" MEAN_2="13.4" ORDER="368" SD_1="6.1" SD_2="5.9" SE="0.8804896702228835" STUDY_ID="STD-Vorbach-1997" TOTAL_1="98" TOTAL_2="88" WEIGHT="11.821993692501385"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="15.398988614000562" CI_END="0.688096528256585" CI_START="-1.4577755411714" DF="7.0" EFFECT_SIZE="-0.38483950645740744" ESTIMABLE="YES" I2="54.54246914868363" ID="CMP-005.04.02" MODIFIED="2008-07-08 14:14:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.031211840572204275" P_Z="0.48205718326818503" STUDIES="8" TAU2="1.1619293114817768" TOTAL_1="649" TOTAL_2="619" WEIGHT="76.11060703428582" Z="0.7029977073011169">
<NAME>vs. SSRIs</NAME>
<CONT_DATA CI_END="4.814765726717558" CI_START="-4.414765726717559" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="12.7" MEAN_2="12.5" ORDER="370" SD_1="6.7" SD_2="5.6" SE="2.354515574325978" STUDY_ID="STD-Brenner-2000" TOTAL_1="13" TOTAL_2="15" WEIGHT="3.23166823315496"/>
<CONT_DATA CI_END="2.065472189472457" CI_START="-3.865472189472454" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="11.2" ORDER="371" SD_1="5.9" SD_2="5.8" SE="1.5130238172046637" STUDY_ID="STD-Fava-2005" TOTAL_1="32" TOTAL_2="28" WEIGHT="6.4111935895088905"/>
<CONT_DATA CI_END="2.06885188155813" CI_START="-1.06885188155813" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="9.8" MEAN_2="9.3" ORDER="372" SD_1="5.2" SD_2="5.9" SE="0.8004493418925213" STUDY_ID="STD-Gastpar-2005" TOTAL_1="100" TOTAL_2="94" WEIGHT="12.78053920678523"/>
<CONT_DATA CI_END="1.5620697048961782" CI_START="-1.5620697048961782" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="10.3" ORDER="373" SD_1="6.4" SD_2="6.4" SE="0.7969889840923531" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" WEIGHT="12.823256589642497"/>
<CONT_DATA CI_END="4.224400887906943" CI_START="0.17559911209305934" EFFECT_SIZE="2.200000000000001" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="10.7" ORDER="375" SD_1="7.1" SD_2="5.9" SE="1.0328765752203395" STUDY_ID="STD-HDTSG-2002" TOTAL_1="82" TOTAL_2="77" WEIGHT="10.16914551693256"/>
<CONT_DATA CI_END="0.5060225891951522" CI_START="-1.6060225891951536" EFFECT_SIZE="-0.5500000000000007" ESTIMABLE="YES" MEAN_1="10.92" MEAN_2="11.47" ORDER="376" SD_1="4.27" SD_2="4.04" SE="0.5387969358237826" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="113" WEIGHT="16.202034341773164"/>
<CONT_DATA CI_END="-0.7539832751316" CI_START="-5.2460167248684" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.2" ORDER="377" SD_1="9.0" SD_2="8.9" SE="1.1459479575056957" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" WEIGHT="9.094754383424814"/>
<CONT_DATA CI_END="0.3835121010817444" CI_START="-6.3035121010817425" EFFECT_SIZE="-2.959999999999999" ESTIMABLE="YES" MEAN_1="10.23" MEAN_2="13.19" ORDER="378" SD_1="8.16" SD_2="7.75" SE="1.7059048673623292" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="44" TOTAL_2="43" WEIGHT="5.398015173063704"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="15.457199648436731" CI_END="0.5239746619468296" CI_START="-1.228004920037915" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3520151290455428" ESTIMABLE="YES" I2="41.77470560839772" I2_Q="0.0" ID="CMP-005.05" MODIFIED="2008-07-14 15:55:03 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.07911908159760317" P_Q="0.41820028128227416" P_Z="0.4309257684206913" Q="0.6553679890942625" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.7642897094202374" TOTALS="YES" TOTAL_1="830" TOTAL_2="822" UNITS="" WEIGHT="99.99999999999997" Z="0.7876084653462485">
<NAME>Difference HAMD (Hamilton Rating Scale for Depression) baseline - end of treatment</NAME>
<GROUP_LABEL_1>Hyericum</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.8931778039906542" CI_START="-3.2931778039906563" DF="0.0" EFFECT_SIZE="-1.200000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-005.05.01" MODIFIED="2008-07-08 14:14:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.26117016258524184" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="110" WEIGHT="10.486786714719214" Z="1.1236297160059925">
<NAME>vs. older antidepressants</NAME>
<CONT_DATA CI_END="0.8931778039906542" CI_START="-3.2931778039906563" EFFECT_SIZE="-1.200000000000001" ESTIMABLE="YES" MEAN_1="-15.4" MEAN_2="-14.2" ORDER="384" SD_1="8.1" SD_2="7.3" SE="1.0679674833320278" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="110" WEIGHT="10.486786714719214"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.801831659342469" CI_END="0.7141848070035965" CI_START="-1.2140765879282276" DF="8.0" EFFECT_SIZE="-0.2499458904623155" ESTIMABLE="YES" I2="45.952634889273035" ID="CMP-005.05.02" MODIFIED="2008-07-08 14:14:57 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.06311529085741274" P_Z="0.611375844798771" STUDIES="9" TAU2="0.9057448661374181" TOTAL_1="730" TOTAL_2="712" WEIGHT="89.51321328528076" Z="0.5081105131052549">
<NAME>vs. SSRIs</NAME>
<CONT_DATA CI_END="5.215133144052149" CI_START="-1.2151331440521487" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-12.0" ORDER="388" SD_1="5.8" SD_2="6.8" SE="1.640404195899878" STUDY_ID="STD-Behnke-2002" TOTAL_1="27" TOTAL_2="32" WEIGHT="5.781316575811575"/>
<CONT_DATA CI_END="2.036480289896345" CI_START="-4.036480289896345" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-8.9" ORDER="389" SD_1="8.1" SD_2="8.0" SE="1.5492531055915895" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" WEIGHT="6.312483458055956"/>
<CONT_DATA CI_END="5.1056339991758115" CI_START="-3.705633999175813" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-9.1" ORDER="390" SD_1="6.5" SD_2="5.2" SE="2.2478137526642787" STUDY_ID="STD-Brenner-2000" TOTAL_1="13" TOTAL_2="15" WEIGHT="3.4340459398576133"/>
<CONT_DATA CI_END="1.81890069482994" CI_START="-1.2189006948299386" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="-13.7" MEAN_2="-14.0" ORDER="392" SD_1="5.4" SD_2="5.5" SE="0.7749635742344421" STUDY_ID="STD-Gastpar-2005" TOTAL_1="101" TOTAL_2="97" WEIGHT="14.635728958496925"/>
<CONT_DATA CI_END="1.3626386919645979" CI_START="-1.7626386919645964" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="-11.6" MEAN_2="-11.4" ORDER="393" SD_1="6.3" SD_2="6.5" SE="0.7972792889514765" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" WEIGHT="14.268924897326032"/>
<CONT_DATA CI_END="3.7916537750663117" CI_START="-0.09165377506631267" EFFECT_SIZE="1.8499999999999996" ESTIMABLE="YES" MEAN_1="-8.68" MEAN_2="-10.53" ORDER="395" SD_1="7.23" SD_2="7.52" SE="0.9906578847273876" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="109" WEIGHT="11.4428471905731"/>
<CONT_DATA CI_END="0.3469361138401381" CI_START="-2.066936113840137" EFFECT_SIZE="-0.8599999999999994" ESTIMABLE="YES" MEAN_1="-8.11" MEAN_2="-7.25" ORDER="396" SD_1="5.0" SD_2="4.5" SE="0.6157950469295842" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="113" WEIGHT="17.46901036700464"/>
<CONT_DATA CI_END="-0.8166110237187132" CI_START="-5.183388976281287" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-14.4" MEAN_2="-11.4" ORDER="397" SD_1="8.8" SD_2="8.6" SE="1.1139944373996564" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" WEIGHT="9.961582426927924"/>
<CONT_DATA CI_END="1.7702204613254087" CI_START="-4.37022046132541" EFFECT_SIZE="-1.3000000000000007" ESTIMABLE="YES" MEAN_1="-9.5" MEAN_2="-8.2" ORDER="398" SD_1="7.1" SD_2="7.5" SE="1.5664677950936428" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="44" TOTAL_2="43" WEIGHT="6.2072734712269995"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.9296928729543774" CI_START="-4.729692872954378" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.9000000000000004" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.06" MODIFIED="2008-07-14 15:55:06 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.6450835428222557" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="54" TOTAL_2="54" UNITS="" WEIGHT="100.0" Z="0.4606028850363801">
<NAME>MADRS after treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.06.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>vs. older antidepressants</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.9296928729543774" CI_START="-4.729692872954378" DF="0.0" EFFECT_SIZE="-0.9000000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-005.06.02" NO="2" P_CHI2="1.0" P_Z="0.6450835428222557" STUDIES="1" TAU2="0.0" TOTAL_1="54" TOTAL_2="54" WEIGHT="100.0" Z="0.4606028850363801">
<NAME>vs. SSRIs</NAME>
<CONT_DATA CI_END="2.9296928729543774" CI_START="-4.729692872954378" EFFECT_SIZE="-0.9000000000000004" ESTIMABLE="YES" MEAN_1="15.6" MEAN_2="16.5" ORDER="399" SD_1="10.4" SD_2="9.9" SE="1.9539608396697625" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.0885229229824511" CI_END="-0.6971214097850882" CI_START="-5.0989412601549855" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.898031334970037" ESTIMABLE="YES" I2="8.132389416284095" I2_Q="0.0" ID="CMP-005.07" MODIFIED="2008-07-14 15:55:08 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.2967991740268565" P_Q="1.0" P_Z="0.009858091822880043" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.21510170006071408" TOTALS="YES" TOTAL_1="176" TOTAL_2="176" UNITS="" WEIGHT="100.0" Z="2.5807676078031667">
<NAME>Difference MADRS baseline - end of treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.07.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>vs. older antidepressants</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.0885229229824511" CI_END="-0.6971214097850882" CI_START="-5.0989412601549855" DF="1.0" EFFECT_SIZE="-2.898031334970037" ESTIMABLE="YES" I2="8.132389416284095" ID="CMP-005.07.02" NO="2" P_CHI2="0.2967991740268565" P_Z="0.009858091822880043" STUDIES="2" TAU2="0.21510170006071408" TOTAL_1="176" TOTAL_2="176" WEIGHT="100.0" Z="2.5807676078031667">
<NAME>vs. SSRIs</NAME>
<CONT_DATA CI_END="1.8949667486749497" CI_START="-4.89496674867495" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-8.4" ORDER="400" SD_1="9.1" SD_2="8.9" SE="1.7321577209856989" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" WEIGHT="39.216028914346175"/>
<CONT_DATA CI_END="-1.1273778249115929" CI_START="-6.472622175088405" EFFECT_SIZE="-3.799999999999999" ESTIMABLE="YES" MEAN_1="-16.4" MEAN_2="-12.6" ORDER="401" SD_1="10.7" SD_2="10.6" SE="1.3636077990053432" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" WEIGHT="60.783971085653825"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="21.13149620815266" CI_END="0.44910835997394966" CI_START="-1.2305894530030521" CI_STUDY="95" CI_TOTAL="95" DF="11.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3907405465145512" ESTIMABLE="YES" I2="47.94500166175582" I2_Q="0.0" ID="CMP-005.08" MODIFIED="2008-07-14 15:55:12 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.03203407222759724" P_Q="0.5731236640254287" P_Z="0.3618344228517446" Q="0.3174841065998386" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.9366683619623786" TOTALS="YES" TOTAL_1="1215" TOTAL_2="1208" UNITS="" WEIGHT="99.99999999999999" Z="0.911875210590042">
<NAME>Mean HAMD after treatment in studies from German-speaking countries and other studies</NAME>
<GROUP_LABEL_1>Hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="10.274193604559564" CI_END="0.41476116417826464" CI_START="-1.2807816082370094" DF="6.0" EFFECT_SIZE="-0.4330102220293724" ESTIMABLE="YES" I2="41.60125620625572" ID="CMP-005.08.01" NO="1" P_CHI2="0.11357009575571952" P_Z="0.316789594676813" STUDIES="9" TAU2="0.5171020322519932" TOTAL_1="948" TOTAL_2="940" WEIGHT="72.34325284734813" Z="1.0010770048653208">
<NAME>Studies from German-speaking countries</NAME>
<CONT_DATA CI_END="1.7467629457626512" CI_START="-1.346762945762649" EFFECT_SIZE="0.20000000000000107" ESTIMABLE="YES" MEAN_1="8.3" MEAN_2="8.1" ORDER="402" SD_1="5.5" SD_2="5.6" SE="0.7891792696005226" STUDY_ID="STD-Gastpar-2005" TOTAL_1="101" TOTAL_2="97" WEIGHT="11.774120609231188"/>
<CONT_DATA CI_END="1.5620697048961782" CI_START="-1.5620697048961782" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="10.3" MEAN_2="10.3" ORDER="403" SD_1="6.4" SD_2="6.4" SE="0.7969889840923531" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" WEIGHT="11.681331056133683"/>
<CONT_DATA CI_END="4.40157540024091" CI_START="-3.0015754002409114" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="10.5" ORDER="404" SD_1="9.9" SD_2="7.5" SE="1.8885935810241743" STUDY_ID="STD-Harrer-1993" TOTAL_1="44" TOTAL_2="42" WEIGHT="4.077184849363354"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="7.91" MEAN_2="8.11" ORDER="405" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Harrer-1999" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.2846354519849732" CI_START="-3.084635451984974" EFFECT_SIZE="-1.4000000000000004" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="10.6" ORDER="406" SD_1="6.2" SD_2="6.1" SE="0.8595236776150802" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="105" WEIGHT="10.959098895020208"/>
<CONT_DATA CI_END="0.5060225891951522" CI_START="-1.6060225891951536" EFFECT_SIZE="-0.5500000000000007" ESTIMABLE="YES" MEAN_1="10.92" MEAN_2="11.47" ORDER="407" SD_1="4.27" SD_2="4.04" SE="0.5387969358237826" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="113" WEIGHT="14.964837972266464"/>
<CONT_DATA CI_END="-0.7539832751316" CI_START="-5.2460167248684" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.2" ORDER="408" SD_1="9.0" SD_2="8.9" SE="1.1459479575056957" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" WEIGHT="8.161118133698956"/>
<CONT_DATA CI_END="2.725728042396401" CI_START="-0.7257280423964012" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="14.4" MEAN_2="13.4" ORDER="409" SD_1="6.1" SD_2="5.9" SE="0.8804896702228835" STUDY_ID="STD-Vorbach-1997" TOTAL_1="98" TOTAL_2="88" WEIGHT="10.72556133163427"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="10.4" MEAN_2="9.35" ORDER="410" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Woelk-2000" TOTAL_1="157" TOTAL_2="167" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="10.53981849699326" CI_END="1.7940743371410972" CI_START="-2.670927246595553" DF="4.0" EFFECT_SIZE="-0.4384264547272279" ESTIMABLE="YES" I2="62.04868232654009" ID="CMP-005.08.02" NO="2" P_CHI2="0.03225294321336569" P_Z="0.7003080199467469" STUDIES="6" TAU2="3.88020974263368" TOTAL_1="267" TOTAL_2="268" WEIGHT="27.65674715265186" Z="0.3849047060878398">
<NAME>Studies from other countries</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="10.0" MEAN_2="8.7" ORDER="411" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Behnke-2002" TOTAL_1="29" TOTAL_2="32" WEIGHT="0.0"/>
<CONT_DATA CI_END="3.268440055413281" CI_START="-3.068440055413282" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="14.9" ORDER="412" SD_1="8.4" SD_2="8.4" SE="1.6165807537309522" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="54" TOTAL_2="54" WEIGHT="5.172227031275509"/>
<CONT_DATA CI_END="4.814765726717558" CI_START="-4.414765726717559" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="12.7" MEAN_2="12.5" ORDER="413" SD_1="6.7" SD_2="5.6" SE="2.354515574325978" STUDY_ID="STD-Brenner-2000" TOTAL_1="13" TOTAL_2="15" WEIGHT="2.8333715304393143"/>
<CONT_DATA CI_END="-0.2585052215835657" CI_START="-5.941494778416438" EFFECT_SIZE="-3.1000000000000014" ESTIMABLE="YES" MEAN_1="10.2" MEAN_2="13.3" ORDER="414" SD_1="6.6" SD_2="7.3" SE="1.4497688737292032" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="47" WEIGHT="6.0429244409243195"/>
<CONT_DATA CI_END="4.224400887906943" CI_START="0.17559911209305934" EFFECT_SIZE="2.200000000000001" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="10.7" ORDER="415" SD_1="7.1" SD_2="5.9" SE="1.0328765752203395" STUDY_ID="STD-HDTSG-2002" TOTAL_1="82" TOTAL_2="77" WEIGHT="9.164658299436217"/>
<CONT_DATA CI_END="1.3736058788528922" CI_START="-5.633605878852894" EFFECT_SIZE="-2.130000000000001" ESTIMABLE="YES" MEAN_1="9.43" MEAN_2="11.56" ORDER="416" SD_1="8.26" SD_2="8.41" SE="1.7875868671510746" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="44" TOTAL_2="43" WEIGHT="4.443565850576498"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.1705168891898216" CI_END="4.496052158262527" CI_START="0.8265228459679743" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.661287502115251" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.09" MODIFIED="2008-07-14 15:55:12 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.9822023793119858" P_Q="0.7443974780696232" P_Z="0.004470698929443568" Q="0.10629919190759873" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="183" TOTAL_2="177" UNITS="" WEIGHT="100.00000000000001" Z="2.8428864918323153">
<NAME>Mean D-S (Depression Scale von Zerssen) scores after therapy</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.05006302660386111" CI_END="4.854346676594231" CI_START="0.7675069689972247" DF="1.0" EFFECT_SIZE="2.810926822795728" ESTIMABLE="YES" I2="0.0" ID="CMP-005.09.01" NO="1" P_CHI2="0.8229536402366573" P_Z="0.007015133791714194" STUDIES="2" TAU2="0.0" TOTAL_1="142" TOTAL_2="130" WEIGHT="80.62050491843073" Z="2.6961249914529266">
<NAME>vs. older antidepressants</NAME>
<CONT_DATA CI_END="7.92839763560271" CI_START="-3.5283976356027082" EFFECT_SIZE="2.200000000000001" ESTIMABLE="YES" MEAN_1="16.1" MEAN_2="13.9" ORDER="379" SD_1="15.0" SD_2="12.0" SE="2.9227055602998724" STUDY_ID="STD-Harrer-1993" TOTAL_1="44" TOTAL_2="42" WEIGHT="10.258749315567577"/>
<CONT_DATA CI_END="5.087318529480779" CI_START="0.7126814705192213" EFFECT_SIZE="2.9000000000000004" ESTIMABLE="YES" MEAN_1="16.5" MEAN_2="13.6" ORDER="380" SD_1="8.4" SD_2="6.8" SE="1.1159993483217387" STUDY_ID="STD-Vorbach-1997" TOTAL_1="98" TOTAL_2="88" WEIGHT="70.36175560286314"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.014154670678361757" CI_END="6.206595737809461" CI_START="-2.1290477622123705" DF="1.0" EFFECT_SIZE="2.038773987798545" ESTIMABLE="YES" I2="0.0" ID="CMP-005.09.02" NO="2" P_CHI2="0.9052964297841093" P_Z="0.33768175482995133" STUDIES="2" TAU2="0.0" TOTAL_1="41" TOTAL_2="47" WEIGHT="19.37949508156929" Z="0.9587558749823663">
<NAME>vs. SSRIs</NAME>
<CONT_DATA CI_END="6.653657258116325" CI_START="-2.853657258116324" EFFECT_SIZE="1.9000000000000004" ESTIMABLE="YES" MEAN_1="14.3" MEAN_2="12.4" ORDER="381" SD_1="10.4" SD_2="8.3" SE="2.4253799026985017" STUDY_ID="STD-Behnke-2002" TOTAL_1="29" TOTAL_2="32" WEIGHT="14.897212058249854"/>
<CONT_DATA CI_END="11.166240312860822" CI_START="-6.166240312860825" EFFECT_SIZE="2.4999999999999982" ESTIMABLE="YES" MEAN_1="18.4" MEAN_2="15.9" ORDER="382" SD_1="12.1" SD_2="10.5" SE="4.421632428564515" STUDY_ID="STD-Brenner-2000" TOTAL_1="12" TOTAL_2="15" WEIGHT="4.482283023319435"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="15.908049128113907" CI_END="0.15009828703314065" CI_START="-0.12594551515377383" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.012076385939683406" ESTIMABLE="YES" I2="43.424866697862285" I2_Q="59.25614864306385" ID="CMP-005.10" MODIFIED="2008-08-13 22:15:43 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.06882681822190317" P_Q="0.04361796484699487" P_Z="0.8638390301382267" Q="9.817432242617507" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02025691859795531" TOTALS="YES" TOTAL_1="789" TOTAL_2="781" UNITS="" WEIGHT="99.99999999999997" Z="0.1714893166785064">
<NAME>Various self-rating scales</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.8486158497386267" CI_END="0.4899811440657501" CI_START="0.07380757654790207" DF="3.0" EFFECT_SIZE="0.2818943603068261" ESTIMABLE="YES" I2="0.0" ID="CMP-005.10.01" MODIFIED="2008-07-15 08:02:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.837806925907157" P_Z="0.007927182854660401" STUDIES="4" TAU2="0.0" TOTAL_1="183" TOTAL_2="177" WEIGHT="27.794022100359022" Z="2.6551556214470153">
<NAME>von Zerssen Depression Scale (D-S) after treatment</NAME>
<CONT_DATA CI_END="0.7043430717371018" CI_START="-0.303352958569413" EFFECT_SIZE="0.2004950565838444" ESTIMABLE="YES" MEAN_1="14.3" MEAN_2="12.4" ORDER="417" SD_1="10.4" SD_2="8.3" SE="0.25707003757596886" STUDY_ID="STD-Behnke-2002" TOTAL_1="29" TOTAL_2="32" WEIGHT="5.743519659070814"/>
<CONT_DATA CI_END="0.9774735586339544" CI_START="-0.5458108673095269" EFFECT_SIZE="0.21583134566221376" ESTIMABLE="YES" MEAN_1="18.4" MEAN_2="15.9" ORDER="418" SD_1="12.1" SD_2="10.5" SE="0.38860010642005527" STUDY_ID="STD-Brenner-2000" TOTAL_1="12" TOTAL_2="15" WEIGHT="2.8955177771396317"/>
<CONT_DATA CI_END="0.5836178883892725" CI_START="-0.2634219582332946" EFFECT_SIZE="0.16009796507798896" ESTIMABLE="YES" MEAN_1="16.1" MEAN_2="13.9" ORDER="419" SD_1="15.0" SD_2="12.0" SE="0.2160855641491143" STUDY_ID="STD-Harrer-1993" TOTAL_1="44" TOTAL_2="42" WEIGHT="7.4071299270507005"/>
<CONT_DATA CI_END="0.6662291544585566" CI_START="0.08539688437005355" EFFECT_SIZE="0.37581301941430506" ESTIMABLE="YES" MEAN_1="16.5" MEAN_2="13.6" ORDER="420" SD_1="8.4" SD_2="6.8" SE="0.1481742202076247" STUDY_ID="STD-Vorbach-1997" TOTAL_1="98" TOTAL_2="88" WEIGHT="11.747854737097878"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4198237488073764" CI_START="-0.4412813984401991" DF="0.0" EFFECT_SIZE="-0.010728824816411348" ESTIMABLE="YES" I2="0.0" ID="CMP-005.10.02" MODIFIED="2008-08-13 22:15:43 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9610469481757666" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="43" WEIGHT="7.238089089062302" Z="0.04883982009356177">
<NAME>Beck Depression Inventory</NAME>
<CONT_DATA CI_END="0.4198237488073764" CI_START="-0.4412813984401991" EFFECT_SIZE="-0.010728824816411348" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="12.1" ORDER="421" SD_1="8.2" SD_2="10.1" SE="0.2196737169763993" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="40" TOTAL_2="43" WEIGHT="7.238089089062302"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.034179927747051" CI_END="0.2913625646606306" CI_START="-0.5272793505366232" DF="1.0" EFFECT_SIZE="-0.1179583929379963" ESTIMABLE="YES" I2="80.13579144264853" ID="CMP-005.10.03" MODIFIED="2008-08-13 22:15:43 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.024851880159412643" P_Z="0.5721936478090264" STUDIES="2" TAU2="0.0699064875908043" TOTAL_1="235" TOTAL_2="231" WEIGHT="26.39775798775719" Z="0.5648237588152075">
<NAME>Beck Depression Inventory difference baseline - after treatment</NAME>
<CONT_DATA CI_END="0.35587594938864253" CI_START="-0.1706731301892929" EFFECT_SIZE="0.0926014095996748" ESTIMABLE="YES" MEAN_1="-7.84" MEAN_2="-8.75" ORDER="422" SD_1="9.67" SD_2="9.92" SE="0.13432621306597656" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="109" WEIGHT="12.947799036802492"/>
<CONT_DATA CI_END="-0.0724678678905693" CI_START="-0.5777216152154114" EFFECT_SIZE="-0.3250947415529904" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-7.0" ORDER="423" SD_1="10.3" SD_2="9.3" SE="0.12889363052337166" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" WEIGHT="13.449958950954699"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.16595389094715043" CI_START="-0.38217589607157776" DF="0.0" EFFECT_SIZE="-0.10811100256221365" ESTIMABLE="YES" I2="0.0" ID="CMP-005.10.04" MODIFIED="2008-08-13 22:15:43 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.4394327582431701" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="105" WEIGHT="12.456897680702392" Z="0.7731514556322276">
<NAME>Zung Self Rating Depression Scale (SDS) difference baseline - after treatment</NAME>
<CONT_DATA CI_END="0.16595389094715043" CI_START="-0.38217589607157776" EFFECT_SIZE="-0.10811100256221365" ESTIMABLE="YES" MEAN_1="-17.4" MEAN_2="-16.0" ORDER="424" SD_1="13.6" SD_2="12.2" SE="0.13983159673909978" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="105" WEIGHT="12.456897680702392"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2078211080107228" CI_END="0.1264781224626134" CI_START="-0.24080904766966657" DF="1.0" EFFECT_SIZE="-0.0571654626035266" ESTIMABLE="YES" I2="0.0" ID="CMP-005.10.05" MODIFIED="2008-08-13 22:15:43 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.6484805961729637" P_Z="0.5417908931907126" STUDIES="2" TAU2="0.0" TOTAL_1="231" TOTAL_2="225" WEIGHT="26.11323314211908" Z="0.6101070604896489">
<NAME>von Zerssen Adjective Mood Scale</NAME>
<CONT_DATA CI_END="0.17283651016255416" CI_START="-0.38474491357666185" EFFECT_SIZE="-0.10595420170705386" ESTIMABLE="YES" MEAN_1="19.8" MEAN_2="21.4" ORDER="425" SD_1="13.7" SD_2="16.3" SE="0.14224277286147785" STUDY_ID="STD-Gastpar-2005" TOTAL_1="100" TOTAL_2="98" WEIGHT="12.247652489955476"/>
<CONT_DATA CI_END="0.2243100034881249" CI_START="-0.2638488850737245" EFFECT_SIZE="-0.01976944079279981" ESTIMABLE="YES" MEAN_1="21.1" MEAN_2="21.33" ORDER="426" SD_1="11.6" SD_2="11.6" SE="0.12453261703081904" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" WEIGHT="13.865580652163601"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="15.908049128113905" CI_END="0.15009828703314065" CI_START="-0.12594551515377383" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.012076385939683406" ESTIMABLE="YES" I2="43.42486669786228" I2_Q="23.600314224550733" ID="CMP-005.11" NO="11" P_CHI2="0.06882681822190317" P_Q="0.25259296974750456" P_Z="0.8638390301382267" Q="1.308905906942023" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.020256918597955306" TOTALS="YES" TOTAL_1="789" TOTAL_2="781" UNITS="" WEIGHT="99.99999999999999" Z="0.1714893166785064">
<NAME>Various self-rating scales in studies from German-speaking countries and other countries</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="14.10213793270295" CI_END="0.1773353776900877" CI_START="-0.21455800870104583" DF="5.0" EFFECT_SIZE="-0.018611315505479065" ESTIMABLE="YES" I2="64.5443831009129" ID="CMP-005.11.01" NO="1" P_CHI2="0.014973491860906907" P_Z="0.8523190041531092" STUDIES="6" TAU2="0.037989686625605056" TOTAL_1="595" TOTAL_2="582" WEIGHT="71.17507443792475" Z="0.18616036586666998">
<NAME>Studies from German-speaking countries</NAME>
<CONT_DATA CI_END="0.17283651016255416" CI_START="-0.38474491357666185" EFFECT_SIZE="-0.10595420170705386" ESTIMABLE="YES" MEAN_1="19.8" MEAN_2="21.4" ORDER="427" SD_1="13.7" SD_2="16.3" SE="0.14224277286147785" STUDY_ID="STD-Gastpar-2005" TOTAL_1="100" TOTAL_2="98" WEIGHT="12.247652489955476"/>
<CONT_DATA CI_END="0.2243100034881249" CI_START="-0.2638488850737245" EFFECT_SIZE="-0.01976944079279981" ESTIMABLE="YES" MEAN_1="21.1" MEAN_2="21.33" ORDER="428" SD_1="11.6" SD_2="11.6" SE="0.12453261703081904" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" WEIGHT="13.865580652163601"/>
<CONT_DATA CI_END="0.5836178883892725" CI_START="-0.2634219582332946" EFFECT_SIZE="0.16009796507798896" ESTIMABLE="YES" MEAN_1="16.1" MEAN_2="13.9" ORDER="429" SD_1="15.0" SD_2="12.0" SE="0.2160855641491143" STUDY_ID="STD-Harrer-1993" TOTAL_1="44" TOTAL_2="42" WEIGHT="7.407129927050701"/>
<CONT_DATA CI_END="0.16595389094715043" CI_START="-0.38217589607157776" EFFECT_SIZE="-0.10811100256221365" ESTIMABLE="YES" MEAN_1="-17.4" MEAN_2="-16.0" ORDER="430" SD_1="13.6" SD_2="12.2" SE="0.13983159673909978" STUDY_ID="STD-Philipp-1999" TOTAL_1="100" TOTAL_2="105" WEIGHT="12.456897680702394"/>
<CONT_DATA CI_END="-0.0724678678905693" CI_START="-0.5777216152154114" EFFECT_SIZE="-0.3250947415529904" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-7.0" ORDER="431" SD_1="10.3" SD_2="9.3" SE="0.12889363052337166" STUDY_ID="STD-Szegedi-2005" TOTAL_1="122" TOTAL_2="122" WEIGHT="13.4499589509547"/>
<CONT_DATA CI_END="0.6662291544585566" CI_START="0.08539688437005355" EFFECT_SIZE="0.37581301941430506" ESTIMABLE="YES" MEAN_1="16.5" MEAN_2="13.6" ORDER="432" SD_1="8.4" SD_2="6.8" SE="0.1481742202076247" STUDY_ID="STD-Vorbach-1997" TOTAL_1="98" TOTAL_2="88" WEIGHT="11.74785473709788"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4970052884689318" CI_END="0.29383076352507137" CI_START="-0.102347572819053" DF="3.0" EFFECT_SIZE="0.09574159535300918" ESTIMABLE="YES" I2="0.0" ID="CMP-005.11.02" NO="2" P_CHI2="0.9195488930388329" P_Z="0.34348540310441467" STUDIES="4" TAU2="0.0" TOTAL_1="194" TOTAL_2="199" WEIGHT="28.82492556207524" Z="0.9473010586389596">
<NAME>Studies from other countries</NAME>
<CONT_DATA CI_END="0.7043430717371018" CI_START="-0.303352958569413" EFFECT_SIZE="0.2004950565838444" ESTIMABLE="YES" MEAN_1="14.3" MEAN_2="12.4" ORDER="433" SD_1="10.4" SD_2="8.3" SE="0.25707003757596886" STUDY_ID="STD-Behnke-2002" TOTAL_1="29" TOTAL_2="32" WEIGHT="5.743519659070814"/>
<CONT_DATA CI_END="0.9774735586339544" CI_START="-0.5458108673095269" EFFECT_SIZE="0.21583134566221376" ESTIMABLE="YES" MEAN_1="18.4" MEAN_2="15.9" ORDER="434" SD_1="12.1" SD_2="10.5" SE="0.38860010642005527" STUDY_ID="STD-Brenner-2000" TOTAL_1="12" TOTAL_2="15" WEIGHT="2.8955177771396317"/>
<CONT_DATA CI_END="0.35587594938864253" CI_START="-0.1706731301892929" EFFECT_SIZE="0.0926014095996748" ESTIMABLE="YES" MEAN_1="-7.84" MEAN_2="-8.75" ORDER="435" SD_1="9.67" SD_2="9.92" SE="0.13432621306597656" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="109" WEIGHT="12.947799036802492"/>
<CONT_DATA CI_END="0.4198237488073764" CI_START="-0.4412813984401991" EFFECT_SIZE="-0.010728824816411348" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="12.1" ORDER="436" SD_1="8.2" SD_2="10.1" SE="0.2196737169763993" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="40" TOTAL_2="43" WEIGHT="7.238089089062302"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2008-07-07 17:12:09 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Safety - Hypericum mono-preparations vs. standard antidepressants</NAME>
<DICH_OUTCOME CHI2="10.420547083121132" CI_END="0.5955971688349121" CI_START="0.28535382728930236" CI_STUDY="95" CI_TOTAL="95" DF="15.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.4122571183736128" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="110" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-0.2250473753293601" LOG_CI_START="-0.5446162981299951" LOG_EFFECT_SIZE="-0.3848318367296776" METHOD="MH" MODIFIED="2008-07-07 17:11:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7924861822668552" P_Q="0.0" P_Z="2.3530911934457906E-6" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1399" TOTAL_2="1386" WEIGHT="100.00000000000001" Z="4.7204623871709455">
<NAME>Number of patients discontinuing treatment/dropping out due to adverse/side effects</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.03116171918823" CI_END="0.4637207525535157" CI_START="0.12557484048233736" DF="4.0" EFFECT_SIZE="0.2413123692027766" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="50" I2="0.0" ID="CMP-006.01.01" LOG_CI_END="-0.3337434680080031" LOG_CI_START="-0.9010973648521451" LOG_EFFECT_SIZE="-0.6174204164300742" NO="1" P_CHI2="0.5526242484459143" P_Z="1.9914736396684157E-5" STUDIES="5" TAU2="0.0" TOTAL_1="508" TOTAL_2="508" WEIGHT="31.72641444929827" Z="4.265844603355569">
<NAME>vs. older antidepressants</NAME>
<DICH_DATA CI_END="4.105287753098059" CI_START="0.009001446973794397" EFFECT_SIZE="0.19223300970873786" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6133436036485829" LOG_CI_START="-2.045687672535865" LOG_EFFECT_SIZE="-0.7161720344436411" ORDER="437" O_E="0.0" SE="1.5619281340478426" STUDY_ID="STD-Harrer-1993" TOTAL_1="51" TOTAL_2="51" VAR="2.4396194959301756" WEIGHT="1.4443823945830538"/>
<DICH_DATA CI_END="8.506845487327817" CI_START="0.013807592734819116" EFFECT_SIZE="0.3427230046948357" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9297685446409987" LOG_CI_START="-1.8598820312775624" LOG_EFFECT_SIZE="-0.46505674331828184" ORDER="438" O_E="0.0" SE="1.638654557287622" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="110" VAR="2.685188758119493" WEIGHT="1.3122889177708676"/>
<DICH_DATA CI_END="0.9027888108634802" CI_START="0.013610617679448302" EFFECT_SIZE="0.11084905660377359" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.04441383219325786" LOG_CI_START="-1.8661221651207727" LOG_EFFECT_SIZE="-0.9552679986570152" ORDER="439" O_E="0.0" SE="1.0700804923633043" STUDY_ID="STD-Vorbach-1997" TOTAL_1="107" TOTAL_2="102" VAR="1.1450722601364915" WEIGHT="3.077310989075137"/>
<DICH_DATA CI_END="1.1603432218147745" CI_START="0.16495658043371084" EFFECT_SIZE="0.4375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.06458646965163418" LOG_CI_START="-0.78263035493497" LOG_EFFECT_SIZE="-0.359021942641668" ORDER="440" O_E="0.0" SE="0.4976593565530896" STUDY_ID="STD-Wheatley-1997" TOTAL_1="87" TOTAL_2="78" VAR="0.24766483516483517" WEIGHT="14.227871498421955"/>
<DICH_DATA CI_END="0.4163490291012935" CI_START="0.048280426080280395" EFFECT_SIZE="0.14177978883861236" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="26" LOG_CI_END="-0.38054244375083135" LOG_CI_START="-1.3162289058593175" LOG_EFFECT_SIZE="-0.8483856748050745" ORDER="441" O_E="0.0" SE="0.5496268595652117" STUDY_ID="STD-Woelk-2000" TOTAL_1="157" TOTAL_2="167" VAR="0.302089684755517" WEIGHT="11.664560649447255"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.5211165864643026" CI_END="0.8253335195470185" CI_START="0.3387446801001016" DF="10.0" EFFECT_SIZE="0.5287507343303135" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="60" I2="0.0" ID="CMP-006.01.02" LOG_CI_END="-0.08337051638503103" LOG_CI_START="-0.47012751654945584" LOG_EFFECT_SIZE="-0.27674901646724337" NO="2" P_CHI2="0.9663765149300976" P_Z="0.005032351267493838" STUDIES="11" TAU2="0.0" TOTAL_1="891" TOTAL_2="878" WEIGHT="68.27358555070174" Z="2.8049555912476176">
<NAME>vs. SSRIs</NAME>
<DICH_DATA CI_END="7.526899615309096" CI_START="0.13285682699501958" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8766161239779365" LOG_CI_START="-0.8766161239779365" LOG_EFFECT_SIZE="0.0" ORDER="442" O_E="0.0" SE="1.0298573010888745" STUDY_ID="STD-Behnke-2002" TOTAL_1="35" TOTAL_2="35" VAR="1.0606060606060606" WEIGHT="3.3223866808658085"/>
<DICH_DATA CI_END="4.131694096123556" CI_START="0.23298437084743345" EFFECT_SIZE="0.9811320754716981" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6161281595843939" LOG_CI_START="-0.6326732115163737" LOG_EFFECT_SIZE="-0.008272525965989883" ORDER="443" O_E="0.0" SE="0.7335521070510745" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="57" TOTAL_2="56" VAR="0.5380986937590712" WEIGHT="6.548507718513166"/>
<DICH_DATA CI_END="8.209886041079294" CI_START="0.12180437036474837" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.9143371288522161" LOG_CI_START="-0.9143371288522161" LOG_EFFECT_SIZE="0.0" ORDER="444" O_E="0.0" SE="1.0741723110591492" STUDY_ID="STD-Brenner-2000" TOTAL_1="15" TOTAL_2="15" VAR="1.1538461538461537" WEIGHT="3.053910989482713"/>
<DICH_DATA CI_END="4.282789704841814" CI_START="0.009339706769813813" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6317267500283706" LOG_CI_START="-2.0296667587004085" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="445" O_E="0.0" SE="1.5633157211376223" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="47" VAR="2.4439560439560437" WEIGHT="1.441819486941029"/>
<DICH_DATA CI_END="1.3813891853103692" CI_START="0.15160288059691074" EFFECT_SIZE="0.4576271186440678" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.1403160516567973" LOG_CI_START="-0.8192925466231111" LOG_EFFECT_SIZE="-0.33948824748315687" ORDER="446" O_E="0.0" SE="0.5636788407687889" STUDY_ID="STD-Gastpar-2005" TOTAL_1="123" TOTAL_2="118" VAR="0.3177338355304457" WEIGHT="11.090236718164943"/>
<DICH_DATA CI_END="1.0720069253267335" CI_START="0.10290715172238402" EFFECT_SIZE="0.33214030064423766" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.030197590973794895" LOG_CI_START="-0.9875544420923971" LOG_EFFECT_SIZE="-0.478678425559301" ORDER="447" O_E="0.0" SE="0.5978325821768958" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" VAR="0.35740379631229485" WEIGHT="9.85927817712414"/>
<DICH_DATA CI_END="2.4283279376457636" CI_START="0.2654151307965086" EFFECT_SIZE="0.8028169014084507" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.38530733639529324" LOG_CI_START="-0.5760743224884608" LOG_EFFECT_SIZE="-0.09538349304658386" ORDER="448" O_E="0.0" SE="0.5647203453442795" STUDY_ID="STD-Harrer-1999" TOTAL_1="77" TOTAL_2="84" VAR="0.3189090684457623" WEIGHT="11.049367352820894"/>
<DICH_DATA CI_END="2.0115459051710753" CI_START="0.07253636826472226" EFFECT_SIZE="0.38198198198198197" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.30352994798607946" LOG_CI_START="-1.1394441923739291" LOG_EFFECT_SIZE="-0.41795712219392483" ORDER="449" O_E="0.0" SE="0.847610152884662" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="111" VAR="0.71844297127316" WEIGHT="4.904694722197183"/>
<DICH_DATA CI_END="7.474863939032613" CI_START="0.012157897290180436" EFFECT_SIZE="0.301460823373174" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8736032918372523" LOG_CI_START="-1.9151415298524077" LOG_EFFECT_SIZE="-0.5207691190075778" ORDER="450" O_E="0.0" SE="1.6381225127700099" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="114" VAR="2.683445366843931" WEIGHT="1.3131414907647234"/>
<DICH_DATA CI_END="1.6627451248061385" CI_START="0.14299063654767985" EFFECT_SIZE="0.48760330578512395" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.2208256831500636" LOG_CI_START="-0.8446924004986753" LOG_EFFECT_SIZE="-0.3119333586743059" ORDER="451" O_E="0.0" SE="0.6258905967348477" STUDY_ID="STD-Szegedi-2005" TOTAL_1="125" TOTAL_2="126" VAR="0.39173903908110375" WEIGHT="8.995129659961185"/>
<DICH_DATA CI_END="1.6072521840468184" CI_START="0.09354724831053901" EFFECT_SIZE="0.3877551020408163" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.20608402458368394" LOG_CI_START="-1.0289689827350534" LOG_EFFECT_SIZE="-0.4114424790756847" ORDER="452" O_E="0.0" SE="0.7254762501100116" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="45" TOTAL_2="45" VAR="0.5263157894736842" WEIGHT="6.695112553865947"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.250745341988644" CI_END="0.9473904315069516" CI_START="0.6177326627841832" CI_STUDY="95" CI_TOTAL="95" DF="15.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.7650058914485859" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="247" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="-0.023471005891275307" LOG_CI_START="-0.20919943461519142" LOG_EFFECT_SIZE="-0.11633522025323334" METHOD="MH" MODIFIED="2008-07-07 17:11:50 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5829373885904516" P_Q="0.0" P_Z="0.014075298903531075" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1399" TOTAL_2="1386" WEIGHT="100.0" Z="2.455335926723543">
<NAME>Number of patients dropping out</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.7632237340713752" CI_END="0.9507739955783235" CI_START="0.4678647726132287" DF="4.0" EFFECT_SIZE="0.6669585138881002" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="90" I2="0.0" ID="CMP-006.02.01" LOG_CI_END="-0.02192270507940835" LOG_CI_START="-0.32987965332381786" LOG_EFFECT_SIZE="-0.17590117920161313" NO="1" P_CHI2="0.43899738828182233" P_Z="0.025154998141506485" STUDIES="5" TAU2="0.0" TOTAL_1="508" TOTAL_2="508" WEIGHT="36.37280168028455" Z="2.2390141092037945">
<NAME>vs. older antidperessants</NAME>
<DICH_DATA CI_END="2.1740358865665854" CI_START="0.25353480094098185" EFFECT_SIZE="0.7424242424242424" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.33726670865975555" LOG_CI_START="-0.5959624196864656" LOG_EFFECT_SIZE="-0.129347855513355" ORDER="453" O_E="0.0" SE="0.5481834095492589" STUDY_ID="STD-Harrer-1993" TOTAL_1="51" TOTAL_2="51" VAR="0.3005050505050505" WEIGHT="3.960775233685057"/>
<DICH_DATA CI_END="2.9474586673231564" CI_START="0.5369799903522948" EFFECT_SIZE="1.2580645161290323" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" LOG_CI_END="0.46944772362994724" LOG_CI_START="-0.2700418972454941" LOG_EFFECT_SIZE="0.09970291319222652" ORDER="454" O_E="0.0" SE="0.4343798638348939" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="110" VAR="0.18868586610522098" WEIGHT="6.308013346235196"/>
<DICH_DATA CI_END="1.3993585517513267" CI_START="0.23812946389806888" EFFECT_SIZE="0.577259475218659" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="14" LOG_CI_END="0.14592900619734023" LOG_CI_START="-0.623186865759819" LOG_EFFECT_SIZE="-0.23862892978123934" ORDER="455" O_E="0.0" SE="0.451782470372603" STUDY_ID="STD-Vorbach-1997" TOTAL_1="107" TOTAL_2="102" VAR="0.20410740053597193" WEIGHT="5.83140522348632"/>
<DICH_DATA CI_END="1.4234168201023354" CI_START="0.3600672826174932" EFFECT_SIZE="0.7159090909090909" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="24" LOG_CI_END="0.15333209345273696" LOG_CI_START="-0.44361633884591073" LOG_EFFECT_SIZE="-0.14514212269658688" ORDER="456" O_E="0.0" SE="0.35065046407462225" STUDY_ID="STD-Wheatley-1997" TOTAL_1="87" TOTAL_2="78" VAR="0.12295574795574796" WEIGHT="9.680173407314383"/>
<DICH_DATA CI_END="0.8596441557339365" CI_START="0.23102272100777452" EFFECT_SIZE="0.4456426056338028" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="32" LOG_CI_END="-0.06568128501507485" LOG_CI_START="-0.6363453052894754" LOG_EFFECT_SIZE="-0.3510132951522751" ORDER="457" O_E="0.0" SE="0.33521087034164154" STUDY_ID="STD-Woelk-2000" TOTAL_1="157" TOTAL_2="167" VAR="0.11236632759520084" WEIGHT="10.592434469563603"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.585158773011283" CI_END="1.081772137458425" CI_START="0.6328431978632143" DF="10.0" EFFECT_SIZE="0.8274008332292846" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="157" I2="0.0" ID="CMP-006.02.02" LOG_CI_END="0.03413579139344653" LOG_CI_START="-0.19870388356646307" LOG_EFFECT_SIZE="-0.08228404608650824" NO="2" P_CHI2="0.5718729129665141" P_Z="0.16596766923917275" STUDIES="11" TAU2="0.0" TOTAL_1="891" TOTAL_2="878" WEIGHT="63.627198319715454" Z="1.3852773747391494">
<NAME>vs. SSRIs</NAME>
<DICH_DATA CI_END="9.638622945244158" CI_START="0.5052996073899763" EFFECT_SIZE="2.206896551724138" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.9840149913716337" LOG_CI_START="-0.2964510392017717" LOG_EFFECT_SIZE="0.3437819760849311" ORDER="458" O_E="0.0" SE="0.7521520847678943" STUDY_ID="STD-Behnke-2002" TOTAL_1="35" TOTAL_2="35" VAR="0.5657327586206896" WEIGHT="2.1038784540947963"/>
<DICH_DATA CI_END="3.160640687206527" CI_START="0.4004330530588084" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4997751265155793" LOG_CI_START="-0.39747008162081676" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="459" O_E="0.0" SE="0.5270462766947298" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="57" TOTAL_2="56" VAR="0.27777777777777773" WEIGHT="4.284838661895653"/>
<DICH_DATA CI_END="17.71404575656742" CI_START="0.6915416256875345" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="1.2483177621549824" LOG_CI_START="-0.16018167345443102" LOG_EFFECT_SIZE="0.5440680443502757" ORDER="460" O_E="0.0" SE="0.8273595406616217" STUDY_ID="STD-Brenner-2000" TOTAL_1="15" TOTAL_2="15" VAR="0.6845238095238095" WEIGHT="1.7387751091750474"/>
<DICH_DATA CI_END="1.5894599577562565" CI_START="0.3044631257984507" EFFECT_SIZE="0.6956521739130435" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="23" LOG_CI_END="0.20124959148668467" LOG_CI_START="-0.5164652982100209" LOG_EFFECT_SIZE="-0.1576078533616681" ORDER="461" O_E="0.0" SE="0.4215892789538468" STUDY_ID="STD-Fava-2005" TOTAL_1="45" TOTAL_2="47" VAR="0.17773752012882446" WEIGHT="6.696576844185731"/>
<DICH_DATA CI_END="1.6986199065304999" CI_START="0.4111053135975137" EFFECT_SIZE="0.8356504468718967" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="19" LOG_CI_END="0.2300962093788488" LOG_CI_START="-0.38604690986239965" LOG_EFFECT_SIZE="-0.07797535024177536" ORDER="462" O_E="0.0" SE="0.3619255181999387" STUDY_ID="STD-Gastpar-2005" TOTAL_1="123" TOTAL_2="118" VAR="0.13099008072429416" WEIGHT="9.086435820608926"/>
<DICH_DATA CI_END="3.084349289401247" CI_START="0.3037995739392735" EFFECT_SIZE="0.968" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.48916355416162016" LOG_CI_START="-0.517412839544833" LOG_EFFECT_SIZE="-0.014124642691606343" ORDER="463" O_E="0.0" SE="0.5912679562966783" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" VAR="0.3495977961432507" WEIGHT="3.4045779886723686"/>
<DICH_DATA CI_END="1.2270769884257986" CI_START="0.19787359347093153" EFFECT_SIZE="0.4927536231884058" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="16" LOG_CI_END="0.08887181178941214" LOG_CI_START="-0.7036121591794126" LOG_EFFECT_SIZE="-0.3073701736950002" ORDER="464" O_E="0.0" SE="0.465509007406011" STUDY_ID="STD-Harrer-1999" TOTAL_1="77" TOTAL_2="84" VAR="0.2166986359761296" WEIGHT="5.492572467178756"/>
<DICH_DATA CI_END="1.6712835097200989" CI_START="0.5211944479893957" EFFECT_SIZE="0.9333079268292683" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="32" LOG_CI_END="0.22305012808792035" LOG_CI_START="-0.2830002192457375" LOG_EFFECT_SIZE="-0.02997504557890854" ORDER="465" O_E="0.0" SE="0.2972564790134099" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="111" VAR="0.0883614143154498" WEIGHT="13.470053312960289"/>
<DICH_DATA CI_END="14.740662997829746" CI_START="0.05633736095529779" EFFECT_SIZE="0.9112903225806451" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1685170174323645" LOG_CI_START="-1.249203500789995" LOG_EFFECT_SIZE="-0.04034324167881536" ORDER="466" O_E="0.0" SE="1.4201810003133952" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="114" VAR="2.0169140736511557" WEIGHT="0.590125765488383"/>
<DICH_DATA CI_END="1.0171284418703563" CI_START="0.27253482549801045" EFFECT_SIZE="0.526500638569604" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="29" LOG_CI_END="0.007375798619276852" LOG_CI_START="-0.564577994102051" LOG_EFFECT_SIZE="-0.278601097741387" ORDER="467" O_E="0.0" SE="0.3359684890614432" STUDY_ID="STD-Szegedi-2005" TOTAL_1="125" TOTAL_2="126" VAR="0.11287482564222909" WEIGHT="10.54471583779251"/>
<DICH_DATA CI_END="2.1426092111055994" CI_START="0.38540666588885425" EFFECT_SIZE="0.9087221095334685" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="17" LOG_CI_END="0.33094296761821373" LOG_CI_START="-0.4140807781763857" LOG_EFFECT_SIZE="-0.041568905279086014" ORDER="468" O_E="0.0" SE="0.4376306362067675" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="45" TOTAL_2="45" VAR="0.19152057374674009" WEIGHT="6.214648057662998"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="31.436425921149972" CI_END="0.7378867780126885" CI_START="0.42687862236072877" CI_STUDY="95" CI_TOTAL="95" DF="13.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.5612379987636738" ESTIMABLE="YES" EVENTS_1="543" EVENTS_2="706" I2="58.64669847454322" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="-0.13201027158698486" LOG_CI_START="-0.3696955936693235" LOG_EFFECT_SIZE="-0.25085293262815406" METHOD="MH" MODIFIED="2008-07-07 17:12:09 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0029096343145192938" P_Q="0.0" P_Z="3.517390917875384E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.15254083095169343" TOTALS="YES" TOTAL_1="1339" TOTAL_2="1324" WEIGHT="99.99999999999999" Z="4.137089400893789">
<NAME>Number of patients reporting adverse effects</NAME>
<GROUP_LABEL_1>hypericum</GROUP_LABEL_1>
<GROUP_LABEL_2>standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours hypericum</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours standard</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.0504647732940118" CI_END="0.5039814162387077" CI_START="0.29787661903206814" DF="4.0" EFFECT_SIZE="0.38745874660946766" ESTIMABLE="YES" EVENTS_1="155" EVENTS_2="266" I2="0.0" ID="CMP-006.03.01" LOG_CI_END="-0.2975854773913434" LOG_CI_START="-0.5259635841426512" LOG_EFFECT_SIZE="-0.4117745307669973" NO="1" P_CHI2="0.726477518436808" P_Z="1.574304544564807E-12" STUDIES="5" TAU2="0.0" TOTAL_1="508" TOTAL_2="508" WEIGHT="38.70423756688718" Z="7.06778124693928">
<NAME>vs. older antidepressants</NAME>
<DICH_DATA CI_END="1.4707845155520176" CI_START="0.2674566077373935" EFFECT_SIZE="0.6271929824561403" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="18" LOG_CI_END="0.16754904896014175" LOG_CI_START="-0.5727466680309258" LOG_EFFECT_SIZE="-0.202598809535392" ORDER="469" O_E="0.0" SE="0.43485336868345287" STUDY_ID="STD-Harrer-1993" TOTAL_1="51" TOTAL_2="51" VAR="0.189097452255347" WEIGHT="5.705758683533784"/>
<DICH_DATA CI_END="0.5810732152247837" CI_START="0.17686109169905723" EFFECT_SIZE="0.3205764233404205" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="51" LOG_CI_END="-0.23576914305748034" LOG_CI_START="-0.7523676985710661" LOG_EFFECT_SIZE="-0.49406842081427316" ORDER="470" O_E="0.0" SE="0.3034525487127721" STUDY_ID="STD-Philipp-1999" TOTAL_1="106" TOTAL_2="110" VAR="0.09208344932027733" WEIGHT="7.968569591166204"/>
<DICH_DATA CI_END="0.7909528166143253" CI_START="0.2398311862829369" EFFECT_SIZE="0.4355400696864111" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="42" LOG_CI_END="-0.1018494230702399" LOG_CI_START="-0.6200943443816319" LOG_EFFECT_SIZE="-0.3609718837259359" ORDER="471" O_E="0.0" SE="0.30441963213204565" STUDY_ID="STD-Vorbach-1997" TOTAL_1="107" TOTAL_2="102" VAR="0.09267131242740999" WEIGHT="7.949466018175435"/>
<DICH_DATA CI_END="0.6151598337768899" CI_START="0.1725689516357593" EFFECT_SIZE="0.32581818181818184" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="50" LOG_CI_END="-0.2110120290885112" LOG_CI_START="-0.7630373392477634" LOG_EFFECT_SIZE="-0.4870246841681374" ORDER="472" O_E="0.0" SE="0.3242623997569004" STUDY_ID="STD-Wheatley-1997" TOTAL_1="87" TOTAL_2="78" VAR="0.10514610389610389" WEIGHT="7.564627217858373"/>
<DICH_DATA CI_END="0.6033212766758731" CI_START="0.2461457309203091" EFFECT_SIZE="0.38536340852130324" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="105" LOG_CI_END="-0.21945135862195392" LOG_CI_START="-0.6088076921026024" LOG_EFFECT_SIZE="-0.4141295253622781" ORDER="473" O_E="0.0" SE="0.22870983763146752" STUDY_ID="STD-Woelk-2000" TOTAL_1="157" TOTAL_2="167" VAR="0.05230818982941224" WEIGHT="9.515816056153389"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="18.482145531615007" CI_END="0.9967045372963834" CI_START="0.491875535507417" DF="8.0" EFFECT_SIZE="0.7001818178340045" ESTIMABLE="YES" EVENTS_1="388" EVENTS_2="440" I2="56.714982109001156" ID="CMP-006.03.02" LOG_CI_END="-0.001433564696521112" LOG_CI_START="-0.30814477747797403" LOG_EFFECT_SIZE="-0.15478917108724752" NO="2" P_CHI2="0.017888434487919658" P_Z="0.04789648732206108" STUDIES="9" TAU2="0.15817932396331041" TOTAL_1="831" TOTAL_2="816" WEIGHT="61.295762433112806" Z="1.9782856829821096">
<NAME>vs. SSRIs</NAME>
<DICH_DATA CI_END="3.3091113092906554" CI_START="0.48682156476249033" EFFECT_SIZE="1.2692307692307692" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="20" LOG_CI_END="0.5197113758626872" LOG_CI_START="-0.3126301920485483" LOG_EFFECT_SIZE="0.10354059190706949" ORDER="474" O_E="0.0" SE="0.48892155714827" STUDY_ID="STD-Behnke-2002" TOTAL_1="35" TOTAL_2="35" VAR="0.23904428904428904" WEIGHT="4.977986908838988"/>
<DICH_DATA CI_END="0.9295847231156625" CI_START="0.20442038175716776" EFFECT_SIZE="0.43591979075850046" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="31" LOG_CI_END="-0.03171102213219275" LOG_CI_START="-0.689475804998305" LOG_EFFECT_SIZE="-0.3605934135652489" ORDER="475" O_E="0.0" SE="0.3863742894437414" STUDY_ID="STD-Bjerkenstedt-2005" TOTAL_1="57" TOTAL_2="56" VAR="0.14928509154315606" WEIGHT="6.458377017200729"/>
<DICH_DATA CI_END="2.432206833621623" CI_START="0.8762423944125762" EFFECT_SIZE="1.4598639455782314" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="60" LOG_CI_END="0.3860005043511194" LOG_CI_START="-0.057375738587606945" LOG_EFFECT_SIZE="0.1643123828817562" ORDER="476" O_E="0.0" SE="0.2604413998500068" STUDY_ID="STD-Gastpar-2005" TOTAL_1="123" TOTAL_2="118" VAR="0.06782972275583113" WEIGHT="8.845581082594455"/>
<DICH_DATA CI_END="0.9900336968650166" CI_START="0.35384680868406254" EFFECT_SIZE="0.5918785890073831" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="53" LOG_CI_END="-0.004350023469638794" LOG_CI_START="-0.451184716908099" LOG_EFFECT_SIZE="-0.22776737018886892" ORDER="477" O_E="0.0" SE="0.2624729107931566" STUDY_ID="STD-Gastpar-2006" TOTAL_1="131" TOTAL_2="127" VAR="0.06889202890023234" WEIGHT="8.80314512642642"/>
<DICH_DATA CI_END="1.6420650336446216" CI_START="0.3224015998162983" EFFECT_SIZE="0.7276018099547511" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="17" LOG_CI_END="0.2153903532667934" LOG_CI_START="-0.49160281181214993" LOG_EFFECT_SIZE="-0.13810622927267827" ORDER="478" O_E="0.0" SE="0.41529128483998046" STUDY_ID="STD-Harrer-1999" TOTAL_1="77" TOTAL_2="84" VAR="0.17246685126404177" WEIGHT="5.9977216161377545"/>
<DICH_DATA CI_END="1.5032675065610188" CI_START="0.237455673048094" EFFECT_SIZE="0.5974607916355489" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="103" LOG_CI_END="0.17703627019827936" LOG_CI_START="-0.6244174502384101" LOG_EFFECT_SIZE="-0.22369059002006542" ORDER="479" O_E="0.0" SE="0.4707778826444108" STUDY_ID="STD-HDTSG-2002" TOTAL_1="113" TOTAL_2="111" VAR="0.2216318147871546" WEIGHT="5.2096421885330795"/>
<DICH_DATA CI_END="0.9963346192028614" CI_START="0.26794957579041917" EFFECT_SIZE="0.5166889185580774" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="28" LOG_CI_END="-0.00159477917953185" LOG_CI_START="-0.5719469261815784" LOG_EFFECT_SIZE="-0.2867708526805551" ORDER="480" O_E="0.0" SE="0.3350276744376632" STUDY_ID="STD-Schrader-2000" TOTAL_1="125" TOTAL_2="114" VAR="0.11224354263910882" WEIGHT="7.3618604247718995"/>
<DICH_DATA CI_END="0.661188555800815" CI_START="0.22423161395075364" EFFECT_SIZE="0.38504464285714285" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="96" LOG_CI_END="-0.179674672032787" LOG_CI_START="-0.6493031571449152" LOG_EFFECT_SIZE="-0.41448891458885107" ORDER="481" O_E="0.0" SE="0.2758620968533576" STUDY_ID="STD-Szegedi-2005" TOTAL_1="125" TOTAL_2="126" VAR="0.07609989648033126" WEIGHT="8.525627183440784"/>
<DICH_DATA CI_END="3.2045185294757434" CI_START="0.49203548489711796" EFFECT_SIZE="1.2556818181818181" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="32" LOG_CI_END="0.5057627871467363" LOG_CI_START="-0.3080035754048145" LOG_EFFECT_SIZE="0.09887960587096085" ORDER="482" O_E="0.0" SE="0.47801038957124165" STUDY_ID="STD-van-Gurp-2002" TOTAL_1="45" TOTAL_2="45" VAR="0.2284939325380502" WEIGHT="5.115820885168695"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-07-15 08:10:28 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-07-15 08:10:28 +0100" MODIFIED_BY="[Empty name]" NO="1" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Hypericum mono-preparations vs. placebo A. Dichotomous measures, outcome: 1.1 Responder - grouped by precision - primary analysis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAAJQCAMAAAC3lyKeAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2008-07-15 08:09:17 +0100" MODIFIED_BY="[Empty name]" NO="2" REF_ID="CMP-001.05" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Hypericum mono-preparations vs. placebo A. Dichotomous measures, outcome: 1.5 Responder among studies from German-speaking countries and other studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsEAAAJQCAMAAABYVUmgAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2008-07-15 08:10:28 +0100" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.01" SETTINGS="DISTINGUISH_SUBGROUPS:YES;SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;SHOW_STUDY_NAMES:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Hypericum mono-preparations vs. placebo A. Dichotomous measures, outcome: 1.1 Responder - grouped by precision - primary analysis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2008-07-09 13:34:23 +0100" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-004.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Hypericum mono-preparations vs. standard antidepressants. A. Dichotomous measures, outcome: 4.1 Responder (intent to treat) - primary analysis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAJACAMAAABSaOtBAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2008-07-09 13:42:59 +0100" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-004.04" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Hypericum mono-preparations vs. standard antidepressants. A. Dichotomous measures, outcome: 4.4 Responder among studies from German-speaking studies and other studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAJACAMAAABSaOtBAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2008-07-09 13:43:21 +0100" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-004.01" SETTINGS="DISTINGUISH_SUBGROUPS:YES;SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;SHOW_STUDY_NAMES:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 4 Hypericum mono-preparations vs. standard antidepressants. A. Dichotomous measures, outcome: 4.1 Responder (intent to treat) - primary analysis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2008-07-09 13:49:31 +0100" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-006.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Safety - Hypericum mono-preparations vs. standard antidepressants, outcome: 6.1 Number of patients discontinuing treatment/dropping out due to adverse/side effects.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsUAAAIwCAMAAABZSuaAAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAA1aElEQVR42u19TcwdyXVdkXzUJZ2RPPJHUpyRrJEVSEAAAQZiBEiy
yia7MiIgAQxk5U02WWmXhbcOkFWQVbKMEwTeEZlF77LLxotAQgQIgSFHimYkZ0bkUMORJhSvyRHz
vdc/9V9d1V3V3e/1OTP83nvd1berq0/dvlV9+vYNEgBw5riJJgDAYgAAiwFgNg4bqosUzaz1Sfto
0gyX2FfiQYt+V90+jV3L099Gr/9iVTufKh/OqMc1ZU7ApnA8v1I28aNWBWSZZri0Kh82d1JP/fZ0
6Oqb+t3/bLqi3bdEByI7zyCG7TV3IgzzC15+GqnclVEbf/1VM6x3xdxYlbcVF3cU035cH3/XAH2L
6UVOZYyNIm3fnMKJ49/ORr+D9rvaT7do+e6rf1gH1davEcLbDOt5nG1UeVssbjpX2Pb3UKHG3iC1
0ZtuG2mGbo2+sFjwMjVgaszaXtfr2BpW/bYV461e5e3PUZRpikYz5A0YVh8zhWrbNNur39aqvH0W
N03TFDHTj+22T2K9tvrVaePnab0q39xir26PXwa8cfsz00PLSJvK9eYyTqGiNjzqPuSGSbvFKm/Y
FzdDcNXoTdgtbbLbvtvQitc6U/rCfOuzONENAvpqNNpSvUJSzaLY6xen8daqfGODaiB9AgwAxnHY
IIfBX+D8fTEAXNocBQCAxQBYDABgMQDUhz5H0c3rWbOlsSmvfovxkmOwRanGuiZhC+mvRq7dRKtN
P5ciLaWt9s0w35fWZGDapqE6jrV9f7uskcYs92xl3nnV1mCx7HShMuNgDSXpPOTcWhPOgctCdlOt
ju9G5h17bjMqlW/TM8NdVQfbq+3BcxYHQWijdUN1V9iSinbr+vWNGJS/IqAHHusWatvOjoypUx3h
cBG7I1b7vu6TPIt+V9apGfcPUeGzX0ot3etGVBCYzrtzqq0RF3d3DI0YQVq10NW+rsRBU+z2Ul1H
D5zUc5UCuOmaJbClTzg8326K1W6pMjEcuNR0tVnE8Qmf9Tr7mk+uJNncUm1vmtdEdx9NRKDkbNGM
XcUjJ/b6+KS9p8bi1diVztdEc+1myWSb8FGaUmjzbFqCXG8zhqTUTSfPKcuQ86rtwY0mso41d4vE
wNI+wCZJ6Od9SGO23dFHP+S0o5U+t55sq5H60Po0JpfVHlHZem0PvotkLo+rNJu7HzlOtwp2fVab
1ht1Kq3UXiy18b/HYpM3TG8q60fPqbY3rajY8TCxeRBtC2l4JRlplNFO0XhqM1fVV8uu3RAJZ0oX
/cspTr7TV0sz2pGNeYEsxJnzqO1NMwDUNLiadtSMERvfFk1/gTbFv7YeONKDpQqUzN0MmuAmGLb6
hMOz7I5a9bWJ2VrOVaoR8affZVj4HKhhY62W3rM0td+fUW3TNG1Zu5FBdfCFa4Zlvix60phCNise
4CZre0jicF4ItIXUH2sg/8BB4jKAvhgAAMDAP11jpwf4YqAo1iAUlJnA+QMsBi6MxdqtbRnKaeIZ
hcrEculFYzYAIMZiqcRbsjxvdCkcSAwUHd1ZNAuR2FToOlt4kgALU2xqyJaFI0TVtvN9pEmNAfhi
PaLwihiFlYXWUdbayYYbW87rKSr1tMFaxuL+o0mXGgNgcU8lP4kHhW5IjxsSI3jWNSPbdbs4ffhs
SNHAFwPT5yiakaGZtB8NSS2qFnW76PckPX1AwhUDgbg4kcZRPW7y09Mi9OzIsIv2Q06TGgM798WB
OTZDx+jzo2EXGy3q5CZWu2hCPhwUBkIsThF6GmUcZa0v2bDRDTxFlbdVml77w9+VAKDDypo28PHS
sEqshzvQwP5Gd4UBTwzAFwMAWAyAxQAAFgMAWAzk4C2wGDh3vP18Hyxm7W8MXTlm96MeRnfAfU2K
2k2yytbX0ybT68HmguOnWtt/Y38NWH2YB/bW/7tghzVhvrhrRTr9Mz8qknh8BySmkHjMboJVh8TH
9shsDa0ebC/Qm7f/Nk5iQXqZt57feL03FvPp7B1Pxel0qJ+nduTQuV4TPQUoj8Y032ruLkcPhCcX
6hZ71j6/+Tr8aMG74tvl6j9bNdsUYvHQ4U1H257SrSawaLsaLW+VfOSafmGi/ELDbilo4pOHL143
RZkTIvEat2MPvgsTaZ8Ubl82w+mV6T05phkLKLKtXnPq+v/5DVLUxX/4kEuGlRuOKGgYGIw3Z3uq
+o8+eFuVxKtbZc0X8swGGRp2ZjfUaLyzuNgePlDkBJ99hqySnY/VIIwX7ECcdBQfXi6LbyZezVjE
wgnB65OxCokzh4pExXo1r7PbC/LF1tWM2OMZuoXmR8WAYWwHE2vAIrpdhlU2RnmnNsw/PmXE2LNa
a1bI6IK8XyYjf/E5hzwjF5I1zi2e9QBKBku8nxY6gCRbB00cAe7oKgtfDIDFAAAWA4vhAVgMnDvu
/nQfo7vuTrIScoVvo3J/s5qcj3oD9ZB1X2UyDFN0uWF8zMRQh3z5hdrD8G1QapJnrTE9ra/t739b
Qo67z64+3cccBRmtQ+GR7vIS44h1X2Wy2BNbzmN7102oOszQFw/fWJ2IuL5Yr50mUTZugt99Jp7S
PlisnRe92Zi63yymiXirwq0MzdraWJ5ypKpMEZrQjGqH5dDPxKQJ5Fvis8wtHtU/45TGYjuQMB3u
xmYiydcDZ3MmQ+tEOXHK/P4VrVdQDk0Pnk/xxa+yz/U29MXkaaPwKd2aJmi+InJu9E7z9cW5W2ra
inDk8/j+lLj4TG6KHaZeioUtMc4QxC57uVl270yz9cWUuXHaczhPHuxkdDeRMZeiNK4arE+ZlCl7
UXl8uc19M7FBfQHD9sKJtblb0Mgk0fBez0GSL+4mJ2zJ7JIS41R9cZ1apFjVxb9z9MW+fcX1xfFt
94AUfbEx/w+sMF6dsEpAXwxcQKACfXFkEAcsPu8xZRX0xQAAFgMAWAzUAPTFwNljJ/pidnSr3rka
K++CsJS9XGtgEVFGarXI3n1whjVdtayt7Deaoy+2ZzYz9cVDdfeqL84m1tDaSvVmKGNLkjitFrm7
DyqH01XLvtTD8/MXa0eRri82qrtPfTFpLTSkK2bzaQ7lakRMm1vDE3PqmiK7N60mzmgV0V0nKZuz
9/RMiFuvssXCmaANsNju2vqTC+63cKWr3DKi5DVMq50QKlGLpNn5bOv04Pmzy51CPsRbyn5qiUSC
zPickKw8iNHS1ZcUyV9cNPJ6fF9cblx802z90KNtsVe4EDOpjzPDdfhYIEmrZYLcuHSpPhk+B09+
axdzFCNDj9Rr4MpcrrT77MHaOtelWC33oi92B9acEDPsQV8cjye2U02xTxzioSJpD5KFJLNLpTAu
FOBmbdZLd2MTxk7q4SL5iwNrk/TFu5MZI3/xOV8HoC/2RBTANmmM8KLE6A5YE9AXwxcDYDEAgMUA
ABYDQN7ojkn98YsVKSI4riwyHreYveekzMSduUAptu5XFslfbAuMTX2xt9pMnoPi/YzvDvZpyZ5k
XEZkPGoxe88pmYl7c4FSbH+WyF/s3gwlr4RZp673oMreBH/lYctWWaw5ZSdNPBsdnZTfjni6ou6Y
SpZjSnTbsWdM2OV8ZWj7JHeZb+14T07CrcTyj5ZrCy+LybqHaqeJJyvXebS2WydxcivzuLLZ15Fn
HH9UJq/5X3IPxbe2RCP0vjih/Pr5i9tb8a4C3pfV2b1mrqsKmqwdSDnh6caZltEXx3PDrpvEeRsR
xQgzOXCe101iPPm1IiknfPS5O080PZVIaVnxCj8KMpsom2axalEeaaLaIuPCAUXJ3bJnsmJGX+ah
wZHfMRHmsx4kXJExexwwO8XOVWRcoMJapuEStOvMTcpfvFccUuLBPk7oWO5zx6srW+voizNKMSkZ
cj19caS4s3Y/mK4vxuVuwYh/0jmAvhgkPvuoB/rilKE9sFCsNPEkQF8MAGAxAIDFQHkgfzFw9thT
/mL1RxhrDBkghT7qDtXjt4Dbl1in64vHap6SFdnJNCy64iXyF/v1xaragjzb9oLEXecvHtfFmkLi
lPy+pUg8tmJQMXFqn4jVPCUrsisE7m8cF8hf7NcXD9/Iu61gtSCSv/iVuKyn30P6Yp+nYhIbnL8Z
hIyjPtsAeb/aVtVqn0jeI6Gc35eTJBicO8f2zOiHt0T+dDKdB4t19+HzVOve5wieXLIuq7nVDKTt
slb7rHoyDRdoLEpiM492Psvqg+eWL76k6eSbdheP5GwXm6Bz8OxnP6LTjQFGkrbnq9Pa/KvMax6t
c44e373axeguHoyufD9ztOdM7VlUwewsffHUmGFsoycPPk0965fGYv1hGF41QXGq3Da9djnHwZRX
rED+4kn6Yg7MMp288eX64lR9ccnxy8Qr6OiD/IW9++oBUvzlZLGN9ibVOoRCO1cuTN1U5GmZWWAD
gtbcKpjHUcDqovmLjeLOtix2JjBG/uLNA/rizDkKYJM0XnSzc4+LgY1GyNNmUCjXFX/14f3PfeHq
7U/Or4luIQ03IMSLP3v5hds//eSXf/P8V8/+A33+8//9P/5moqVv/hAsBtZgMNG/+esXnz7vfv/6
+a9++e8//y9//OaTPz0XFuujO3n806hfjR2uS99K2W7UbiyP34di7arrsjVD/q7WWjWaxawOy2X/
4WmFxL01IYuNsXvp1MdZO2w0XoPb9//Bf/vN09Da3//o9ufeO7PR3XULNE13IqzT6XxVS45bdef8
+ovRcGqVZ9OCaKt9+qPtcgGrw3KptmlEfj9S9h2LnRsYdi+thhXu2msiNYObibjgT966+vyn/+fP
n1yTuL85bX1+/8VPfvj5q4fffbH1y4kdUDRtf+779NGt9P5W6q5XFTeds9YbT4uawTtVc8XNalYb
T/f2XMJyuk7KJWKkVMLl6PZ/+eM7N66O9G3/PQ1/fiSuvnX15p1bP7pzLnMUUtoXB9koZ9B+bQw3
YGwsR5u/Do+lXM2qbElbvCMF+0Bj7DewVbTu77x99zuffvvZh+IYSKT9e/rz935844v3tjt7cdNs
IOPwG28rhlqoZbesRqvIpV/1kSZwfmtZbez4cwhMJ7dCtP6Np3bxurt4/cZ/mlKvz8TrH52DL26a
BKdpN3JH66bpA8Nrh9Asy2F/KL6i1Tmt0I7eJm2bttV7Hzz5+PV333l4r4t/U/49/N2vv/HLjz74
u2cRUVgnL81TNE0jgFJRej81IacEYclb3fmHH3784gdfe/v4/elVFzj4P+/dfvNvv/748V+/3HKz
3/RGxRkTC1KacYZyCG2EUTu4qLMDKfNL6b8mOVMpexI70z2m/e6bsXsp/VsF8fIPPnj60Td/7+37
/USb+ym//M4bv/r41z+7s3Xn4ZsvPk1NdP/3UxZC/9qtaU9WFxf2I2OpRYrDfHHNWURzSrfkfPG4
VWN2V83tmK2QvDfZz+U0mlNWu5dqub4gtDb5uvDie9/mz5w547du3T68Xy2sqcjiehdQKRB1VGjh
OGNyGv3F3fuvXn50mni7DiIOdPjfU/3vGWramuIFAZ+fnkbiDNx5/fgXv/rBO/T797/8tW8++fjD
7QcRBX0xAJy/LwaAjc1RAABYDABgMQCAxQBYDABnCz1/cfvh5stLSQZbEXoi4ZJmRZ+aGJONF8Ri
2mZOGSORcElQJbvAJiIKPqZ7POWXYT3xY7dYqBUs/CXLe2Kx2nulgfPyxfr5PSY89aQv1hMODimO
qWoy+WpkQyixk9GdL/M062ylRfhWx3sSEeP8X6wvdmJSzw92yX1mng1+eC8sZtL5SjEO0EJTFQCQ
GVE4Tpe19MYsIr55+yRGNHHZvriPDk6vtNBeNaQFDVYA0b78oqqvLJ6SdzuZl4HCLCbrL/X/a1EE
+YrUZALVCWMJ8fFuIgoAAIsBACwGALAYAIsBACwGgCWgz7Sx9d7u7BsN9ltjLcWyWmgZVnO2/VS1
OR0t9FcRtq/1zLPQ34Ykt8JCM+pOuxl2Ozmy9dr3cG1YQPa5PItng9zf7L1X7XKJdbWvqZCz9HKU
byHUKVlf5Xtnp25G+zBezxqszel/kHi9iMJWGOsSYuZWZKwpjPViqrxtT2mTU9/mqchH/a79Fije
n7x1yr7MWD1BdQEwdZO+2FUYq6/H/4WlMFY+i/rXeFPIpfUv3GY//UJU1F9zn25BBTrqBcBqo+GV
4yYN/XaNSOVoK+l4QPDlWcxpsYKuy3XPErmXUZ8MecLppYgFdmNT8lU5/oLwyM1uGuIO6+go3BAn
NTbucS/M4v4xTY3OHL/cj/M/ZXWRkNwhV+ZDr5TSgyi31zHBH681uqPxc5tDAXZHQOnxQPDSzPm8
siIK/xV/kl3/VozHSdado4hMuLF3BSvZZpAaAc193KOFnumjCMeZAhcDGplBCdXMHd2lbAWsyGJD
YTxcTAdB7umbMSGr/fKdbrWN1zd1Wx9HTIbot3/8eVwCHLcQ2q/ZUXLtRgjNKk0AIS5eAJPyFzPN
WV1qNwUt5O4JWSyCWCV/cfZdD06Kgs8MmTcnQOBziYunx3/FTjEtZ4HyzYLJ2wHUQABYDABgMQCA
xQAQy19sjsfzpj2d+67sTJzq6iDfWIkNvbCu/k3SApPzgemxXbA4dpJnnv2YmoBETPrbUU/J0RK0
wI4IT90Ch953NxEFa5rhTkxsSY1FIJuxm8e4N2IplFspckIfoYSOxIkdCdiBL7acmhIZty6MyePv
DC/oecbCUCrremRdoesJLVwZDZOfjakZqob76GDzLljs9YT+ZaaWmJJvBZCPoBnRDGt0xzkEDsEr
dEYePg5f3RMya/pYSqm9ANkCAT+LaXy0FwteOeh1KaEvONJf+8lsd9/wxxjdhRiVNGbyZDNmMe6O
2ed36YT+q6DkURlIDF/sYaaR2ZfJd+0OZDO2pbzGRppCuR3AkZrzCEnTnbzF2Vpgs97w25eIG2d3
VufxECyujFX0xed3B5oYJAbOncWzwmCQGCwGALAYAMBiAACLAbAYAMBiAACLAQAsBsBiAACLAQAs
BgCwGACLAQAsBgCwGADAYgAsBgCwGACqwngGWgrRDF+bfpEIPg94XHlc232ePk6fDRoWWMkXy6Zn
Yv9xJOSwzEPi5rS2/xTDJwCs5Is1tzswsRG6b77+4/jmxi4pxn04ANSLi6WUfk4a7lfztn15KePl
AGAxFjcqtjUI2UW7vT/W3a+U6rPtBo3GYwDYxByFOVRrDL974qlUnwbBJVwxsBEW2/MNTSP0SKGn
rUZf6SsHAIuyWPlQKTUStxNoXcTQxw+BqFgIidk2YJU5ikZKz7DOnGwwypx+XP/qP/WFXlsAUAU3
kLkMKAnkzAQAsBgAiwEALAYAsBgAwGIALAYAsBgAVoP+rIf14jnzfUTO24n61+H5PiqAE15d2tUg
qwojdlOsKhND6QlvRB3K2015tKbVsnsXq1Yf7bx19Tyt5f28i8d4YolEeuNze6K8HzVIPGZ5KEAl
7aZYVSZUKzBlk9jfsO1p0X6wW23SNtfqMeuValPx6l3vS5mXZLHtXDqfwtrbbAcf4D1J9To/JRbI
JQ/Nt0olDp8TOdeVI78jZ0qqR0V636pqnTJY3Hd008dWdraLRR7LWC3cm0bK2dFIoZ1N8cWrvFPw
YPdRcg6WgpExFTh95YjRXjLyu1m8eIpVFYFy/6Jrrh2W+s339VwtJj6sogbyxsUcvgyx2CxOVwpa
wyqpV76fvpHQrmA1jzboZGlf7wo+JF9x1AnapivelF1edGi1+7db38wfAPBG44lp14qxeGLcKi8x
ako7Pbx0Pbboi7u4mAJjBGpnb/oZn9PXbkH3wdUmjEctmxUpZTfFan/spIq132lSX/XtUu0itCC8
7R6AZz02j5Hp7I0FGnjWA8iN7ipsdjGjO2BLoEmrdhVTwBcDYDEAgMUAABYDgF9fPCIsDq1S91xD
0uN5Aw4e1Re3Qtyiwh1dsBspQ1bpCWoOV6Ts1Rf7hdzsUR/vXF889+ADmuOZZkcnjmg4hJJ2deFw
9HCN0tn6Yp9I2acv9gu52fyynr74lXj3sDaL9RbtvLLSZApdbNx1diU45u7WXZCutafglf2Se+JE
8TAtcozC0Rk61Z1wLcrxFGMoIS+mMiwWhsRYGJ2/f5Sh7ey6w+XTLeqUS+ZEPnHaJTnbCXKS1ejT
HtblXix832w4BlqeQLYvXiWMiemLhYcXYd9ksMGvGqwsVaxh33xgINjl1UMWnYRilr6YRUwLwePd
arWY+CC2oy82ry0eYTGZA5oFuvkoQamKXUoPJ6zSk/XFbR8YfaqG7BFdaO3uRnd+UjjCYsPxLRUE
c6LVCU9t1qjtjKEVZR8g711ifDMj1A8JaR1n7WvSmUE/0cjcCVexW3S6o4iRYSotcgzQF5MdMghL
WKyvHpZ3l8H+oS+P9Li25rWO/cX0xY6RgL7YbFv2zhlDX7z4+BqYESNBXxyMKEDirdF40c0uZHQH
Em8L0BfPGd0BAFgMAGAxAIDFwC5Hd7l6qEUzGHPiTa3C+YtTrHqSCy+av9hVH3eyROQvTmv2xTIY
j9vlSUPzMbsJVn3JhRfNX+yojzt/tJ+pNr++2NYTG7Li/hQt2tNpnI4sRPGMqylWyS49rZfOyl9s
ViVmrDK1b7372QpMOAS8izeHsak63hbyMvjWsTqWinFOL80pRwV2NBGvVgljjNEdX8Pyst5nC6o8
VpEeOMbPYPaTOil241bZNEGn38xLNQcx8zqnxOMVv72puJhXuBwtEXnUsGqreZfIX5w1ZthjXBw+
cTTFOy7qijdit37+YqZFW2nbuJkybA4s3CKJuYpdLrpLkLiqL9ZmRb0SVbJmKReUEadmRi6cvzjF
qkfrWz1/cVftdoGjPt4dkL9484C+eFZEAWyExotudlGjO2ArgL4YvhgAiwEALAa2gwdgMXDuuPvT
fYzu4vriOkmJc0bco6+an1KjUbtK6RjfsVGH6vmLA0mm9W3NCeu7z64+3cccBY2dzOJJidNPMiWl
4Ral9cWKwElix17HWTt/sTc7k7WtcRP87jPxlPbBYt0t9A0yZAsacUIbQS1FZDRlZtGZWUqrDedt
+yzaD28JUUoW/GipJhhhse6eEh6FoM3wlyvUqKdLpBHIR67K/Zty+xE9eB7xxQXTDq+f+bW7g98e
9umiOPaGj+1pAidEpKUPYH7+YprT7fyyj8f3I3Hxud/78sXF7I/5Srj+6qEEVbGaWXoFffF4sP/k
wU5Gd9ag3PN9w5iaxHf0mdQMETqrQRgv1XXMQ49s+1jsicWiT8lPzvh3w6O7qY8EMiVYrRbNFCEx
JZH4knEIhXX291WSEhuVStpTHX1xLvnm5C82G9pea0m8rfzFvm33AOiLNw/oi0eBO9BnQONFN7uc
uBjYEKAvhi8GwGIAAIsBACwGgOzRnXeeMThhs6jiOGLXyOibPlXqSQTsOexoKaOMXnqOvlgJpeP5
i33zxmF98X5YnHfza2HFcUy+L0R+/mSOHzInlDLKGKVn6IuVSDmSv9hsDn/u4+JJtl5tdkrrYHsW
6qQTWpc+npLU/MXLZ1MzM/pm9EFOWB0t5ZQpnZ2NIvv0Hkqedim3OrdStnmU6nzqRRTdbq0unZW/
ePE3IlAxhnhWU1YZKtKbB0mzb+++hMp1WsDri8e3WV9f3LdOKH8x2ce/oOI4wa4WlJbeeVbfnK0v
VnFJdnPwsvKWTY7u2giiv3C4jcHlO3hxx1FD18vZ2rbp+mLOuAwEjr5SQuPD2bBYnTThf+s7LxAE
lw6d16jL9AiZ8SruXNy0rpv6UJh9o+AR2tSSoHAiic9fAkNECe/iKTRgu8SIog8hOlVx/3NQy+rK
44UVx6N2J0pr08pTajYM9X2yvti3y9Ba+0q5uOx7I7iR+OA4rlpbjJSgL3YjCmCjNF50s0uYo1h2
5gGY1/jQF8MXA2AxAIDFAAAWA4B/dFdGX7y0rM2UACfPLzni4LDVpMzOehvUy1/sFTxb+uK2utAX
p7LA0RfXeycxx1f4E/uO2+MUq9H8xb7Uw9XyF3sFz7a+uOtJs6faXokzeUi+tL446rQquWjdUyYL
GEYExKZVseAthLgYyFdf/7JUJxDBrQnbPRIrzPEV1xfXelAmSE+a1oNGlGOUGs7khj9lOD62zN39
lPq8mrDdZeiLF8x4ulT3yYl2WMzXF3dbMm42TWXxXH3x4kM7o+qrnHalkeq/zcxfTP0DjGvLVw7n
ymI1SBDb0hevpbrl8YkPzyNLTKuqGPam3iqtL67m8MZUt7waH7hsHbjq8ewgotiwvjjlul5hxynp
jT3Jhefoi30Nmakv3h2gL948oC/OiiiAjdJ40c0uYY5i0YkHYGbjQ18MXwyAxQAAFgMAWAwAvtEd
J+pzffmCq09UjuejEP3988wX3glKWc0p+YsX0Bf7BM/+3Md71Rcnt7cQi8mKtZMzehtYSwReyO6w
msMt4UsfXE1f7BM8B3IfL3cTfHUd8iHiGE66YmIyZcXrSQQSs/MsNtmfkuO4XhtwOPPrzAaYkth4
2OhRsdM5l8W6jtiRFa91mRq9QNYksZepMYly9a7ElFzP0t7C64v7jdbXF9spya0nOih6QeXqZ60G
M0aUB5OECfP0xeMZ6RJU8bzj/MVD1kkev8QoxZD2sWI4USfe1q5GmXWdlb94an9l5X+WFFEcNsVi
oyHHGETjl9VlI46aUXGuurlirOybSdInSfao3LqZGOGzWDOcWBtJOYUX7awBF9zWc3fa5EM4sItH
agvLilfKi0xZr89bQF/M7uRwvyyQ+3gPuAG52tYBffHkiALYEI0X3exiIgpgU0H5pFXQFwMAWAwA
YDFQAw/AYuDccfen+xjdDXeFevUq98OEPm2TkUd34ezFYcvGXTue8GZ6GrWaOKe1ur5YT+JsTljf
fXb16c7mKPpcKr24tv+j59FdOHtx2LJx+zC/BiTGrY7MWrFZyfX0xUYSZ+Mm+N1n4unUE/Nq81NZ
4ep5zoNKcBzXVlRAbOZfV/nShN4xbnVJCTFl15wCldfxTEyfQL6Vs+mjUsdXhsXBvW9sHnKmHImj
OYGTjCdlwa5xccogCj14PscXp2+6HX2x65aFE3mJ+KNoC5834yByA4qSVS6WvzhPCzF+CI/vT46L
t39nzK8vDsTJaqi3YeRJa6lk7yqZv7j4EOPJg8sd3d1MdTCJ/X91V7wCmIfZHFonoEja3WOxQxZ7
WkZPcLzZeCI/Apjr/Afxccn8xZfRwVedo7AmUYfLJOkzk57sxVxtwjjVcq60tpwUdxl9sVlfW1+M
/MXAVgMW6IuLxMXAujRedLPLiSiADQH6YvhiACwGALAY2A6gLwbOHnvRF5vTxJyYRW8hnfGovlhL
+5onMKbo8uhNHtvEYvpiw7wh5tOFmbvUFzOJaS+fX0BnPKovHgpQdu+ILeeRYsa65fTFTgIythnN
5fTFZ+aL1WlRL4XXEhir5Vo649WbxhQW53dCji1PERarMkXagqZU2zlse0G2vviW+GxS9R/VPNeU
yuKIa+2eZbIe+lgblBx55LSLJSyOsXmN/MUUCmmI/bvP1he/mtgnV9cXazJiMk4kmUXsluQtJeJb
t3tpr8ueqS8ujVx98VndDnP0xX6pWlIouUHPXLJ/pO2eqYy+uHg9L1lffEhpA2s4QYtePMtTbdoM
yVbyF0ePnCPB3v70xZw+ZN8WieuQJzF/8Vr64tx6XrQv7uNiRxrrvP1Al7j6dMblda7jb7sw6rFO
L1pJX7wxd7ICoC/ePKAvnhpRAFui8fKhyRlHFMAmAX0xfDEAFgMAWAwAYDEA5I7ukrS56tZqSFm8
9G3gWfri4PyybZUSTBTRF/cSWb++2Ct4Zl9S6R29C3qSvjiSwbje0JjjKybuP3i/lj3HOGaiiL64
23VAX+wVPHsEztf/atwE32gq40Pg/Oma4k5GoRTGkQzGy8+0z9MXp1kVYisTV/4ss56XdtNEnxDH
eCrjR1HPtxSLSUQ0xTyeMbNaiquQa6Eq+3dU5xN8fOkj1eulFyK3nqPVnVi98VTGW9IXC3ux/5cv
I+F6N/Sn6IvHdRecoLNk2+YsffEMf2lGeItcujcXUeiv75ioKaaaDK2w/8SHVijeESzvOUtf3AfD
jtWU5qC6Z+FsRneBsHf1IHhc4VvvtTj5FJ+jL+6OlGY2x55wc/ySxt5fgRNcS4Iyrpytoy9OoApX
OVKe2Ry79cVdXNwqdZXMVdMUG5e5hZTFyR5skr54pHyKVY/4d46+2FcxZ62vjwW0yXtAir4Yl65V
AX3x7EFnvVtxQOmR7ULB3dbnKBaccwDSg42JZwf6YgAAiwEALAbKA/mLgbPHbvIXhwe7o+La2umL
U0zyBH0xj46Dxq1qSmDRvfavev5iszlsfXGXzWmX+Ysjp3FMXFs7fXGKSZ4yNHcVI9lWVdU6Ywvk
Lzabw9YXD2m4dRJPz1/8avOPyh9cQvbZiTUx/EljPDTg6T8tuaaXGoVBGWyY0EHmFimYP3TKAVj6
Yo+KIzt/sYZbOZs+KnVUs3yxlp2Y/RrxqtK/Od6aEyOPHIYmWWXncaJFW8fRF3v2nZ2/2PTF6Zuu
fe/u5GOH+lIwKLUfC1roteaJuoQ6+uaoVbtLl8pfzCkBVLwqCrn5izPHTlubo2B224c24HdHniNj
qnHlSrJKvuaa8dxbq8TiWGcMrY3lL/6tHc1RMGUGUAu54pRB/pS9ckkdL6e8QaFIfDzhSHeSv5jY
dyUjFs4DuFqRxeKJUQeWIMud4BZrWE05Up7XHPuC+/So+/xNFxXra9QMhk9kzGL5/MWZ5Qru3SP+
rZ6/2Cc4ZtqfsLjDjTnPhgHLTL5Mnl9ZobbIXwyUDB92FHVMYzFc8YKITBDRxO1m4LsPf/u3796+
CBYD+8RXH37xW+999vjZp7/z1guwGDhDvHP3O3/13odCPL3+/sFPbnzx4XaIrI/u5PFPo341drgu
fStlu1G7sTx+H4q1q67L1gz5tf03etVKWD0dlGiUcU8xfd9qsyZrmGMa0Hcozd37jtJZq1WiHIX5
xc+dhf/8L358Z2uju+uGafoTZ1Hb+aqWHLfq2v76i9FwapVn03IkPu1k2JcsabU5HZN+IPYpM/Y9
fGsm7a1F0+25X9B47JtnxVrb171cG99++IUfvnck8VW3oPv881/+4b0vb8Ej2/PFTdvN20aQJ+fa
+1upu15V3HTOWm88LWq/N3Kp45EVekmCC7WbY6pP6vYW2jbJZmFn+NU//ndPPj3S9uqpeHr9z/j8
i6fi3oMnv76zJRZbZ0w28vr/jtP91yPNFU+di2vw9Cx1oVmuw3gPevZ1vDMg4yFM/CjLBRNf/Ztf
/9WfiDYWDvx7+lT84YMnr7cyujs1nhzp1I1ZRF/TtAHG0ciCTDpVqCntiAar3QVFBlxy03fxfvXs
VujCg0AIE1xuVDpWKA//9TdvJZT66bocNucouhgw7wrb0bpp+qDu2usuGeBLjUnFrXp/jRSe1QpN
0kaBC5ssSN8Of/D4L7/xuw9OcXDo37237/zPlV2xFRc32SRW8xMro041pGjEBiEXjNHeF+IbL77y
/VMsfAoi9M+/88ndn/9KrB0WG3MU0hojJbFCSjPOUI3bXlsXYriU5cc1+VXwtMIkA95WU6u72SCj
lPpRvsnff/yX3/zP9592v4bPq3/19f/19GcvN9CrffPFp6mJ7v9+ykLoX7s17clSw5H2U5tqGuaL
azoONUnaFHSf2hH7JiOcfffH6WmF5L0ZLa3PC7v2tYmk4MalryPvPL/6vvbzS3fovTWH8SEW17vg
bvTCfAaQ0yd+KjT67Tdfnu59XB3u3n5/5cmo0OhuUjBauCDg89PTSFweL588+8ZXvnT/zd959sH7
W2qjG5CnAUU7HfTFAAAWA2AxAIDFAAAWAwBYDOwVes7M9sPNlzf2RHjdJ8ZrpUSul2oZWJHFtMk8
E7VSItdLtQxsIqI45Rs85fcxMg92i4VacV3GW7Ikar6fG+y9PF9seimyHZX+w0hyTGfq0hgs3sXo
zpfNmXW20hKerU9yWvwdC4ScfZfri4Uz4HN/sEvuaiyulLYejngnLDZzGVOMAvUjCozBgEkRheN0
WSU5Dvvp0tErSAzk++I+OjgFjip21IMGsl+3Vi+iqJUS2ZcmGLgIFpP1l4T2yh79wy5SkQlV3tch
6k7hAduKKAAALAYAsBgAwGIALAYAsBgAloA+09beWODp75e330JsKZbVQsuwmrP1in6H+etuJ2MW
uvcsklU1V/7THbCuqWa3wp4KtqW0Y41VigXUnwuyeDbI/c3ee9UumVQPchRyll6Ooha6Svg0dk5V
2N6Wyegv4Qp25NTLBSt1+h8kXiGisBXGuoSYuRUZawpjvZgqb9tT2uTEU6pY1t1C5JAFsqlquX9f
nWa6R+dGPIOp2/LFrsJYfT3+LyyFsXJW1L/Gm0Kusn8/OHu9d9C1kxawRC147ii3VaZ+W2HcfwzS
Ol7B/mhF0mGB4AuymNNiBV2X654ecq+fPhnyhPNKEQusLbXje73Ko7vlIMnjjUTh9jiJsnGreykW
94Md7UyxSDqZnBIb1EQ/rqT5hqJrnXe9p1lkgj9efHRH4yeVMs49u0OflIhi5JqccMkXmRuNl6SR
EMG7FeOpkpXmKCITbn7JLyvZJgW9MSfy3oxQ/KyhWGWZ/BeDdIdIGX1D5B8WUJvFhsJ4iPgGQe7p
mzGK0n75HpJT23idUi8hJkv02883jEuAHQudHLmLMqJhgDIfnA9zzPtGrWHD7Xbgdz1Myl/MNGd1
qd2Ut5C7QySzcLFK/uLsux6cFAWfJzJvToDAm4+Lpwd+xc4tLW6B8kuDyRsA1EAAWAwAYDEAgMUA
EMtfbA7E8+Y7nRuu7MyY6uogkaU4ThUBax8C0si9sDg2+TmTBDEZQZKgd4oIWAntQOMdRhSsaYY7
MbElNRaBbMZuHuPeiKVQbqXIwT5SOt02sBtfbDk1JTJuPZmmKBaRbMYmbQylsq5H1qW5sdBihJQp
2/R3tcHmPbF4xCeaAgkysxknMoV8xPQv9IooRkXA1s7A4P2xmCP8CXk7z1f3N+df8jn07F4yQOB9
sphyfZil8gpyiBL6AiVQOzcKAfYZUaQ+m0CunpejvtZ9mojJw3GeFJpgdAcWK2YamX3Z1BcL95cp
QjakvMZGmkL5ZLd7nNMz+6vkwU6a4XQRsFesDFwibpzdyZ1IR7B4GayiLz6/O9DTnmEDiS8ZZ6ij
oMU2AsBiAACLAQAsBsBiAACLAQAsBgCwGACLAQAsBgCwGADAYgAsBgCwGADAYgAAiwGwGABMvHj7
O19868WGK3gD8nEgjh/8vdtPjp//+s/eTyiNJ5aA7eGT+3//2YnE4k9+8Z0vb9Qha75Ynv42bqeS
3cLrJbItcSrayOP3oVi76rrscr1R9nVxPgpbFdKxKr077RtBb5ikXSr7XWsPH6Jx7JtHqf2Q2lo5
uyGO9Hjz5VP99/2X/+Nb2/bFTdP+0zltNbU8FmgpfCptntVulWfTWiRW+zU/Clu9PjW2VV8p1QhN
dr8Z7Eu7+RvXvnGUesPra+ez6cVbb7748ETiq27J1ZNn37j68vZ88SHgGKTueof2tJyz1vVOi9rv
jVyQxKJZwKr0LqnpkwL2m2SPPh/vPL73VFxdk/j631Pt8/9efeFvffRy63MUbVdu2oui0ef1QlLm
n4PS6DuQLEplr1XneGtdN3vyT7MfPy05+O7VD59dM/foiZ1/T35y5947G2excapCrdJdaIs23ES6
zY8hwlabnsz2PppxVzqrYZp41B7crFhT/JN/FFv7+sb758Nip8k6WnfR87WnvnYdzSaOo6+ZKNqp
JobZ0xtmNA7pIrfqruNnj974yr1TPOz+e/DOR09ebz0ujvX7ZrmxW773kpuuYHpALEc98RJH+fLJ
7a99egwgjvGw9vm5d//okzsba7W8+WLb36n2biOMFQjU7VOvWVPM6uRtJo3tjtGLPfVjru6n3zyX
nQpt//KDJ19/2MbCoouJ5ZsvfvFH2+v7xr072c+Ntp29GeaFm/7MSKEX6aYxzKnSZrkpQ2vO1j+x
O9dqYBbaLSW1mV2ZN+GmDLjzxbp9qTxGo08pm3vXTuB8fO8f8zBj/M++96NRL7zKfHHGHejUVpEb
CZUvAtHGjDOm1Hm4fbj9m2si3/u3f/peich+5YiiKV4QSPTT00hcKrD49eM3Hn7p9178i/c220ZQ
AwFlOx3UQAAAFgNgMQCAxQAAFgMAWAyAxYJbDD+F+80PrlxHLrwbw552xMC5QlMDbfXVhnVJjBc6
XmhEcXJPp9d/Go6qWyzUiusy3pKbRsdZUPcyfbF+mpmoexX0cLb1H/33UxmnZGnWsfYxH2R8ABc/
uvOc6WsuaWylkdIAsJIvDo3bODKgM191jgAA2A6LT3GC19eSx23XiiiGeoDJwISIwnG6R487xMYi
4pvLgYiOXaT7AIA0X9xHB8dxm1BjKj1osAKIU8nzJNnZVhwIspisv9T/bw/u7SJVmVB6VoHcgwUu
OqIAALAYAMBiAACLgT0AT4/uAyNz7elT8WMl566fZAm+GDh/HBxyK4pn3yvrZEHqd/thmmFniVBz
tv1UtTkd3c9fdzvxWOjrrq1g11B/F5AC2w61aGfJncMfrPWrTwu0Q/bWbTgmiECXYPFskPubvfeq
XRapHuQo5Cy9HHkseMTC7NnU3zfZrj2T0W089ew6iFL/jR/d6X+QeEkWtz7m1PIdF4evR5/CvRs6
OR/l846/eCjvuKP+fKbeadCuDcS6O/N4U07oVu3mNjkH5eesQFMJWDd6H4Vnrc4oWe7JIJ7HYldh
rL62dLZWDF6Kej6R34kJXd0jRu6c2fKjPmBxLZDnENgX76j+4GyrwgVym5JiJD6aTDq6NV3xBY7u
AizmtDbQCeLuidwLp0+GTNNPRJYFoy7E4XNqBh8c7iBRf0HhZhH9lQqoGlEMo5yEJ0e5zvVqmYml
cV+VtL2hlkrZgT38BWrGxTR+NinzeuUfj825vEQt9HLkAGnS9x6NDShrq2IPXQGpcxSRCTf2rmDS
wsSQN+Y8ZzeYY8qL9MhPYg5vG/KRNMnjb87h0qzVGSXnrp9k6RC4UiqF8RDqtV+7q6ipy9V++Z4w
Utt4vRENUxhqH1qYmi4BNrcT3ePZ/VU8fv1XewnOhznmyZh7GTPcHt9q/NZakcm3eKyZjZLBomM3
CZN5zBFnY1uZdAe62O1MsYidXENTJt02H+5qldS7kjNXn2SAItyjQk3lLcbDRL6xOvsO9DF90DIk
Xu/qy+t0tnVHvlTigLlY5OInMWXGxdPrUfqZjOUNUX7pM2Ly/KqGw4KCzcD+Z5TLsBi4XKReVWZF
UDV2Ak0bsNo1sthOwGJg0QC/yk7AYiCXX7y5ndwgezu/kDFvotO508rOVKmuDhJhuY2h5O3XjKh/
LZWypVnea65X9t8LGhbz2HVcmxyP3bWkUW5SRn395uPzxRycZs6ecTXl8hSX+bKHkmRvrSYrOa7+
dUR4ugUWJKBWvzAE8xfraYz1FMWs52C3sxm7eYx7I/rK3i4n9l8av6m0rdgPWBjB/MXGgwyW1FhE
shlb1ytdqazrkXVNrie00IQzITl69MIzNvTFUxeXzuKR6Q5TIEFmNmPK4pJJzAx5NQu/pB0Aiy2n
mCfcCFzdEzJrcrrAzO0FyBYI+ONiOqZZPX0kRpzdBif6EQVW2T984fgQVfMQNTPFiZ1ey71DyuSS
M9bm7y1mVqYVO6RNMgT565KMo47VnfJgcsMMGg2Hx+IewDn9TSFDzaJ7m+qLqVWtdR/qQXdDzKb/
0r6TJXgzNlKGSU12sDDeshcIR3iY/Ah63s462wdgHc5epyrk0YvJo4eUrUc7fR9+qCWDJ5XdVu3S
vrhsl5vbStv3Zu2tK6eV6ncpzD0HHXw4f7EvmbHwP8JJxldP0mMzyTHpQ0GKOFh3rzHna9fU/7FX
z91ce8ejg+ydpP69/akt6X5p3/uV7WJ9fftLGEuy9tZ+a8yddP9rm6olaXHxtlEiDN7pzEbTMcxz
vW/cj65c4w8nGnNZM2NvqqxvJ423SM5M2zZpvAkTZxpWRL11LOaV1fam7VdO3DP0xTsb4Mmoqw4P
ypp6ezNji0wzZxpRAHO9cWNyVYZ8XltO+p2iTPGTSXuTYccrnYUSvnjvuL52N9K8omuLAhHFsYS9
cljWyPl7678dR3i6we6XuY1/h8jCDcRjguYMKoqIAoiR+DwAXwycP+CLAbAYAMBiAACLAQAsBsBi
AACLAQAsBoAj/j+QOfr6SQZ4WAAAAABJRU5ErkJggg==
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-07-15 08:17:26 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-07-15 08:17:26 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-07-09 13:18:19 +0100" MODIFIED_BY="[Empty name]">Summary of meta-regression analyses</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-15 08:17:26 +0100" MODIFIED_BY="[Empty name]">
<P>Table 1: Univariable meta-regression analysis of response rate ratio (relative risk of response) in comparison to placebo</P>
<TABLE COLS="6" ROWS="4">
<TR>
<TD VALIGN="TOP">
<P>Explanatory variable</P>
</TD>
<TD VALIGN="TOP">
<P>Coefficient (B)</P>
</TD>
<TD VALIGN="TOP">
<P>95% confidence interval</P>
</TD>
<TD VALIGN="TOP">
<P>Statistical significance (p)</P>
</TD>
<TD VALIGN="TOP">
<P>Proportion of heterogeneity explained (R<SUP>2</SUP>)</P>
</TD>
<TD VALIGN="TOP">
<P>Interpretation</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Country</P>
</TD>
<TD VALIGN="TOP">
<P>0.53</P>
</TD>
<TD VALIGN="TOP">
<P>0.20 to 0.86</P>
</TD>
<TD VALIGN="TOP">
<P>.002</P>
</TD>
<TD VALIGN="TOP">
<P>0.29</P>
</TD>
<TD VALIGN="TOP">
<P>Studies form German-speaking countries result statistically significant in 0.53 higher effect size estimates on average than studies form non-German-speaking countries.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Precision</P>
</TD>
<TD VALIGN="TOP">
<P>-0.11</P>
</TD>
<TD VALIGN="TOP">
<P>-0.21 to -0.01</P>
</TD>
<TD VALIGN="TOP">
<P>.032</P>
</TD>
<TD VALIGN="TOP">
<P>0.16</P>
</TD>
<TD VALIGN="TOP">
<P>Studies with one unit increase in precision (1/SE) result statistically significant in 0.11 lower effect size estimates on average.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Baseline HAMD</P>
</TD>
<TD VALIGN="TOP">
<P>-0.12</P>
</TD>
<TD VALIGN="TOP">
<P>-0.23 to 0</P>
</TD>
<TD VALIGN="TOP">
<P>.048</P>
</TD>
<TD VALIGN="TOP">
<P>0.16</P>
</TD>
<TD VALIGN="TOP">
<P>Studies with one point increase in mean baseline HAMD severity result statistically significant in 0.12 lower effect size estimates on average.</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>Table 2: Multiple meta-regression analysis of response rate ratio (relative risk of response) in comparison to placebo</P>
<TABLE COLS="6" ROWS="4">
<TR>
<TD VALIGN="TOP">
<P>Explanatory variable</P>
</TD>
<TD VALIGN="TOP">
<P>Coefficient (B)</P>
</TD>
<TD VALIGN="TOP">
<P>95% confidence interval</P>
</TD>
<TD VALIGN="TOP">
<P>Statistical significance (p)</P>
</TD>
<TD VALIGN="TOP">
<P>Proportion of heterogeneity explained (Beta<SUP>2</SUP>)</P>
</TD>
<TD VALIGN="TOP">
<P>Interpretation</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Country</P>
</TD>
<TD VALIGN="TOP">
<P>0.32</P>
</TD>
<TD VALIGN="TOP">
<P>0.02 to 0.61</P>
</TD>
<TD VALIGN="TOP">
<P>.035</P>
</TD>
<TD VALIGN="TOP">
<P>0.13</P>
</TD>
<TD VALIGN="TOP">
<P>Studies form German-speaking countries result statistically significant in 0.32 higher effect size estimates on average than studies form non-German-speaking countries.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Precision</P>
</TD>
<TD VALIGN="TOP">
<P>-0.09</P>
</TD>
<TD VALIGN="TOP">
<P>-0.18 to -0.02</P>
</TD>
<TD VALIGN="TOP">
<P>.017</P>
</TD>
<TD VALIGN="TOP">
<P>0.17</P>
</TD>
<TD VALIGN="TOP">
<P>Studies with one unit increase in precision (1/SE) result statistically significant in 0.09 lower effect size estimates on average.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Baseline HAMD</P>
</TD>
<TD VALIGN="TOP">
<P>-0.07</P>
</TD>
<TD VALIGN="TOP">
<P>-0.16 to 0.03</P>
</TD>
<TD VALIGN="TOP">
<P>.161</P>
</TD>
<TD VALIGN="TOP">
<P>0.06</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>Table 3: Univariable meta-regression analysis of response rate ratio (relative risk of response) in comparison to standard antidepressants</P>
<TABLE COLS="6" ROWS="4">
<TR>
<TD VALIGN="TOP">
<P>Explanatory variable</P>
</TD>
<TD VALIGN="TOP">
<P>Coefficient (B)</P>
</TD>
<TD VALIGN="TOP">
<P>95% confidence interval</P>
</TD>
<TD VALIGN="TOP">
<P>Statistical significance (p)</P>
</TD>
<TD VALIGN="TOP">
<P>Proportion of heterogeneity explained (R<SUP>2</SUP>)</P>
</TD>
<TD VALIGN="TOP">
<P>Interpretation</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Country</P>
</TD>
<TD VALIGN="TOP">
<P>0.18</P>
</TD>
<TD VALIGN="TOP">
<P>0.01 to 0.36</P>
</TD>
<TD VALIGN="TOP">
<P>.037</P>
</TD>
<TD VALIGN="TOP">
<P>0.23</P>
</TD>
<TD VALIGN="TOP">
<P>Studies form German-speaking countries result statistically significant in 0.18 higher effect size estimates on average than studies form non-German-speaking countries.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Precision</P>
</TD>
<TD VALIGN="TOP">
<P>0.03</P>
</TD>
<TD VALIGN="TOP">
<P>0 to 0.06</P>
</TD>
<TD VALIGN="TOP">
<P>.065</P>
</TD>
<TD VALIGN="TOP">
<P>0.18</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Baseline HAMD</P>
</TD>
<TD VALIGN="TOP">
<P>0.01</P>
</TD>
<TD VALIGN="TOP">
<P>-0.02 to 0.04</P>
</TD>
<TD VALIGN="TOP">
<P>.546</P>
</TD>
<TD VALIGN="TOP">
<P>0.02</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>Table 4: Multiple meta-regression analysis of response rate ratio (relative risk of response) in comparison to standard antidepressants</P>
<TABLE COLS="6" ROWS="4">
<TR>
<TD VALIGN="TOP">
<P>Explanatory variable</P>
</TD>
<TD VALIGN="TOP">
<P>Coefficient (B)</P>
</TD>
<TD VALIGN="TOP">
<P>95% confidence interval</P>
</TD>
<TD VALIGN="TOP">
<P>Statistical significance (p)</P>
</TD>
<TD VALIGN="TOP">
<P>Proportion of heterogeneity explained (Beta<SUP>2</SUP>)</P>
</TD>
<TD VALIGN="TOP">
<P>Interpretation</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Country</P>
</TD>
<TD VALIGN="TOP">
<P>0.14</P>
</TD>
<TD VALIGN="TOP">
<P>-0.10 to 0.38</P>
</TD>
<TD VALIGN="TOP">
<P>.244</P>
</TD>
<TD VALIGN="TOP">
<P>0.17</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Precision</P>
</TD>
<TD VALIGN="TOP">
<P>0.01</P>
</TD>
<TD VALIGN="TOP">
<P>-0.04 to 0.05</P>
</TD>
<TD VALIGN="TOP">
<P>.832</P>
</TD>
<TD VALIGN="TOP">
<P>0.01</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Baseline HAMD</P>
</TD>
<TD VALIGN="TOP">
<P>0.01</P>
</TD>
<TD VALIGN="TOP">
<P>-0.02 to 0.04</P>
</TD>
<TD VALIGN="TOP">
<P>.704</P>
</TD>
<TD VALIGN="TOP">
<P>0.01</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>Table 5: Univariable meta-regression analysis of mean difference in post-treatment HAMD scores in placebo comparisons</P>
<TABLE COLS="6" ROWS="4">
<TR>
<TD VALIGN="TOP">
<P>Explanatory variable</P>
</TD>
<TD VALIGN="TOP">
<P>Coefficient (B)</P>
</TD>
<TD VALIGN="TOP">
<P>95% confidence interval</P>
</TD>
<TD VALIGN="TOP">
<P>Statistical significance (p)</P>
</TD>
<TD VALIGN="TOP">
<P>Proportion of heterogeneity explained (R<SUP>2</SUP>)</P>
</TD>
<TD VALIGN="TOP">
<P>Interpretation</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Country</P>
</TD>
<TD VALIGN="TOP">
<P>3.80</P>
</TD>
<TD VALIGN="TOP">
<P>1.95 to 5.66</P>
</TD>
<TD VALIGN="TOP">
<P>&lt;.001</P>
</TD>
<TD VALIGN="TOP">
<P>0.54</P>
</TD>
<TD VALIGN="TOP">
<P>Studies form German-speaking countries result statistically significant in 3.80 HAMD points higher effect size estimates on average than studies form non-German-speaking countries.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Precision</P>
</TD>
<TD VALIGN="TOP">
<P>3.02</P>
</TD>
<TD VALIGN="TOP">
<P>-2.10 to 8.15</P>
</TD>
<TD VALIGN="TOP">
<P>.247</P>
</TD>
<TD VALIGN="TOP">
<P>0.09</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Baseline HAMD</P>
</TD>
<TD VALIGN="TOP">
<P>-0.57</P>
</TD>
<TD VALIGN="TOP">
<P>-1.27 to 0.14</P>
</TD>
<TD VALIGN="TOP">
<P>.117</P>
</TD>
<TD VALIGN="TOP">
<P>0.15</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>Table 6: Multiple meta-regression analysis of mean difference in post-treatment HAMD scores in placebo comparisons</P>
<TABLE COLS="6" ROWS="4">
<TR>
<TD VALIGN="TOP">
<P>Explanatory variable</P>
</TD>
<TD VALIGN="TOP">
<P>Coefficient (B)</P>
</TD>
<TD VALIGN="TOP">
<P>95% confidence interval</P>
</TD>
<TD VALIGN="TOP">
<P>Statistical significance (p)</P>
</TD>
<TD VALIGN="TOP">
<P>Proportion of heterogeneity explained (Beta<SUP>2</SUP>)</P>
</TD>
<TD VALIGN="TOP">
<P>Interpretation</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Country</P>
</TD>
<TD VALIGN="TOP">
<P>3.52</P>
</TD>
<TD VALIGN="TOP">
<P>1.70 to 5.33</P>
</TD>
<TD VALIGN="TOP">
<P>&lt;.001</P>
</TD>
<TD VALIGN="TOP">
<P>0.46</P>
</TD>
<TD VALIGN="TOP">
<P>Studies form German-speaking countries result statistically significant in 3.52 HAMD points higher effect size estimates on average than studies form non-German-speaking countries.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Precision</P>
</TD>
<TD VALIGN="TOP">
<P>2.43</P>
</TD>
<TD VALIGN="TOP">
<P>-1.14 to 5.99</P>
</TD>
<TD VALIGN="TOP">
<P>.183</P>
</TD>
<TD VALIGN="TOP">
<P>0.05</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Baseline HAMD</P>
</TD>
<TD VALIGN="TOP">
<P>-0.24</P>
</TD>
<TD VALIGN="TOP">
<P>-0.76 to 0.29</P>
</TD>
<TD VALIGN="TOP">
<P>.378</P>
</TD>
<TD VALIGN="TOP">
<P>0.03</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>Table 7: Univariable meta-regression analysis of mean difference in post-treatment HAMD scores in standard antidepressant comparisons</P>
<TABLE COLS="6" ROWS="4">
<TR>
<TD VALIGN="TOP">
<P>Explanatory variable</P>
</TD>
<TD VALIGN="TOP">
<P>Coefficient (B)</P>
</TD>
<TD VALIGN="TOP">
<P>95% confidence interval</P>
</TD>
<TD VALIGN="TOP">
<P>Statistical significance (p)</P>
</TD>
<TD VALIGN="TOP">
<P>Proportion of heterogeneity explained (R<SUP>2</SUP>)</P>
</TD>
<TD VALIGN="TOP">
<P>Interpretation</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Country</P>
</TD>
<TD VALIGN="TOP">
<P>0.02</P>
</TD>
<TD VALIGN="TOP">
<P>-1.64 to 1.68</P>
</TD>
<TD VALIGN="TOP">
<P>.982</P>
</TD>
<TD VALIGN="TOP">
<P>0</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Precision</P>
</TD>
<TD VALIGN="TOP">
<P>0.04</P>
</TD>
<TD VALIGN="TOP">
<P>-1.71 to 1.79</P>
</TD>
<TD VALIGN="TOP">
<P>.966</P>
</TD>
<TD VALIGN="TOP">
<P>0</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Baseline HAMD</P>
</TD>
<TD VALIGN="TOP">
<P>-0.24</P>
</TD>
<TD VALIGN="TOP">
<P>-0.48 to 0</P>
</TD>
<TD VALIGN="TOP">
<P>.045</P>
</TD>
<TD VALIGN="TOP">
<P>0.26</P>
</TD>
<TD VALIGN="TOP">
<P>Studies with one point increase in mean baseline HAMD severity result statistically significant in 0.24 lower effect size estimates on average.</P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>Table 8: Multiple meta-regression analysis of mean difference in post-treatment HAMD scores in standard antidepressant comparisons</P>
<TABLE COLS="6" ROWS="4">
<TR>
<TD VALIGN="TOP">
<P>Explanatory variable</P>
</TD>
<TD VALIGN="TOP">
<P>Coefficient (B)</P>
</TD>
<TD VALIGN="TOP">
<P>95% confidence interval</P>
</TD>
<TD VALIGN="TOP">
<P>Statistical significance (p)</P>
</TD>
<TD VALIGN="TOP">
<P>Proportion of heterogeneity explained (Beta<SUP>2</SUP>)</P>
</TD>
<TD VALIGN="TOP">
<P>Interpretation</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Country</P>
</TD>
<TD VALIGN="TOP">
<P>1.34</P>
</TD>
<TD VALIGN="TOP">
<P>-0.76 to 3.45</P>
</TD>
<TD VALIGN="TOP">
<P>.211</P>
</TD>
<TD VALIGN="TOP">
<P>0.22</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Precision</P>
</TD>
<TD VALIGN="TOP">
<P>-2.11</P>
</TD>
<TD VALIGN="TOP">
<P>-4.62 to 0.40</P>
</TD>
<TD VALIGN="TOP">
<P>.099</P>
</TD>
<TD VALIGN="TOP">
<P>0.60</P>
</TD>
<TD VALIGN="TOP">
<P>No statistically significant association was found.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Baseline HAMD</P>
</TD>
<TD VALIGN="TOP">
<P>-0.45</P>
</TD>
<TD VALIGN="TOP">
<P>-0.79 to 0.11</P>
</TD>
<TD VALIGN="TOP">
<P>.010</P>
</TD>
<TD VALIGN="TOP">
<P>0.88</P>
</TD>
<TD VALIGN="TOP">
<P>Studies with one point increase in mean baseline HAMD severity result statistically significant in 0.45 lower effect size estimates on average.</P>
</TD>
</TR>
</TABLE>
<P> </P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>